{
    "10/13/2023": {
        "artical1": {
            "title": "Phase 3 CheckMate -67T Trial of Subcutaneous Nivolumab ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi5wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9QaGFzZS0zLUNoZWNrTWF0ZS0tNjdULVRyaWFsLW9mLVN1YmN1dGFuZW91cy1OaXZvbHVtYWItbml2b2x1bWFiLWFuZC1oeWFsdXJvbmlkYXNlLU1lZXRzLUNvLVByaW1hcnktRW5kcG9pbnRzLWluLUFkdmFuY2VkLW9yLU1ldGFzdGF0aWMtQ2xlYXItQ2VsbC1SZW5hbC1DZWxsLUNhcmNpbm9tYS9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers' injectable form of Opdivo meets main goal in kidney ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzcy1pbmplY3RhYmxlLWtpbmRleS1jYW5jZXItZHJ1Zy1mb3VuZC1ub24taW5mZXJpb3ItaXYtZm9ybS0yMDIzLTEwLTE5L9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Positive Topline Results Reported from Bristol Myers Squibb's ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilQJodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3Bvc2l0aXZlLXRvcGxpbmUtcmVzdWx0cy1yZXBvcnRlZC1mcm9tLWJyaXN0b2wtbXllcnMtc3F1aWJicy1waGFzZS0zLWNoZWNrbWF0ZS02N3QtdHJpYWwtb2Ytc3ViY3V0YW5lb3VzLW5pdm9sdW1hYi13aXRoLWhhbG96eW1lcy1lbmhhbnplLWRydWctZGVsaXZlcnktdGVjaG5vbG9neS1mb3ItYWR2YW5jZWQtb3ItbWV0YXN0YXRpYy1jbGVhci1jZWxsLXJlbmFsLWNlbGwtY2FyY2lub21hLTMwMTk2MTYxOC5odG1s0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "U.S. Food and Drug Administration Approves Opdivo\u00ae(nivolumab ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQXBwcm92ZXMtT3BkaXZvbml2b2x1bWFiLWFzLUFkanV2YW50LVRyZWF0bWVudC1mb3ItRWxpZ2libGUtUGF0aWVudHMtd2l0aC1Db21wbGV0ZWx5LVJlc2VjdGVkLVN0YWdlLUlJQi1vci1TdGFnZS1JSUMtTWVsYW5vbWExL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Is Bristol Myers Squibb Stock a Buy Now? - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzEwLzEzL2lzLWJyaXN0b2wtbXllcnMtc3F1aWJiLXN0b2NrLWEtYnV5LW5vdy_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Could Bristol Myers Squibb Stock Help You Become a Millionaire? - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzEwLzE5L2NvdWxkLWJyaXN0b2wtbXllcnMtc3F1aWJiLXN0b2NrLWhlbHAteW91LWJlY29tZS1hL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Cellares Expands Agreement with Bristol Myers Squibb for Second ... - BioPharm International",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJpb3BoYXJtaW50ZXJuYXRpb25hbC5jb20vdmlldy9jZWxsYXJlcy1leHBhbmRzLWFncmVlbWVudC13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLWZvci1zZWNvbmQtY2FyLXQtcHJvZ3JhbdIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/06/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Strengthens and ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1TdHJlbmd0aGVucy1hbmQtRGl2ZXJzaWZpZXMtT25jb2xvZ3ktUG9ydGZvbGlvLVdpdGgtQWNxdWlzaXRpb24tb2YtTWlyYXRpLVRoZXJhcGV1dGljcy9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL21hcmtldHMvZGVhbHMvYnJpc3RvbC1teWVycy1zcXVpYmItYWNxdWlyZS1taXJhdGktNDgtYmlsbGlvbi1kZWFsLTIwMjMtMTAtMDgv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Acquires Mirati Therapeutics for up to $5.8 Billion - BioPharm International",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtaW50ZXJuYXRpb25hbC5jb20vdmlldy9icmlzdG9sLW15ZXJzLXNxdWliYi1hY3F1aXJlcy1taXJhdGktdGhlcmFwZXV0aWNzLWZvci11cC10by01LTgtYmlsbGlvbtIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Presents New Zeposia ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi3QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1QcmVzZW50cy1OZXctWmVwb3NpYS1vemFuaW1vZC1EYXRhLW9uLUxvbmctVGVybS1EaXNlYXNlLVByb2dyZXNzaW9uLWFuZC1Db2duaXRpb24taW4tUGF0aWVudHMtd2l0aC1SZWxhcHNpbmctRm9ybXMtb2YtTXVsdGlwbGUtU2NsZXJvc2lzL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Sotyktu (deucravacitinib) Long-Term Data Demonstrate Durable ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi1gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9Tb3R5a3R1LWRldWNyYXZhY2l0aW5pYi1Mb25nLVRlcm0tRGF0YS1EZW1vbnN0cmF0ZS1EdXJhYmxlLUVmZmljYWN5LWFuZC1Db25zaXN0ZW50LVNhZmV0eS1mb3ItdXAtdG8tVGhyZWUtWWVhcnMtaW4tTW9kZXJhdGUtdG8tU2V2ZXJlLVBsYXF1ZS1Qc29yaWFzaXMvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb to Showcase Data ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinAJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1TaG93Y2FzZS1EYXRhLURlbW9uc3RyYXRpbmctSW1wcm92ZWQtT3V0Y29tZXMtaW4tRWFybGllci1TdGFnZXMtb2YtQ2FuY2VyLUR1cmFibGUtTG9uZy1UZXJtLUJlbmVmaXRzLXdpdGgtT3BkaXZvLUJhc2VkLVJlZ2ltZW5zLWFuZC1BZGRyZXNzaW5nLUhpZ2gtVW5tZXQtTmVlZHMtaW4tTXVsdGlwbGUtVHVtb3ItVHlwZXMtYXQtRVNNTy0yMDIzL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Paradigm and Bristol Myers Squibb collaborate to build a new ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3BhcmFkaWdtLWFuZC1icmlzdG9sLW15ZXJzLXNxdWliYi1jb2xsYWJvcmF0ZS10by1idWlsZC1hLW5ldy1tb2RlbC1mb3ItY2xpbmljYWwtdHJpYWxzLTMwMTk0OTAzOC5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/29/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb Co. stock rises Thursday, outperforms market - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stcmlzZXMtdGh1cnNkYXktb3V0cGVyZm9ybXMtbWFya2V0LTJkNTdlMzNlLTc3ZjNhNmQ2ZWUyNtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Sponsors and Partners with New Jersey Pride ... - InsiderNJ",
            "link": "https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5pbnNpZGVybmouY29tL3ByZXNzLXJlbGVhc2UvYnJpc3RvbC1teWVycy1zcXVpYmItc3BvbnNvcnMtYW5kLXBhcnRuZXJzLXdpdGgtbmV3LWplcnNleS1wcmlkZS1jaGFtYmVyLW9mLWNvbW1lcmNlLW5qcGNjL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers notches diversity gains after revamping its clinical trial ... - Endpoints News",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vZW5kcHRzLmNvbS9icmlzdG9sLW15ZXJzLW5vdGNoZXMtZGl2ZXJzaXR5LWdhaW5zLWFmdGVyLXJldmFtcGluZy1pdHMtY2xpbmljYWwtdHJpYWwtbG9jYXRpb24tc3RyYXRlZ3kv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Why You Might Be Interested In Bristol-Myers Squibb Company (NYSE:BMY) For Its Upcoming Dividend - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktbWlnaHQtaW50ZXJlc3RlZC1icmlzdG9sLW15ZXJzLTEyMDQzMzI2OC5odG1s0gFYaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3Mvd2h5LW1pZ2h0LWludGVyZXN0ZWQtYnJpc3RvbC1teWVycy0xMjA0MzMyNjguaHRtbA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "ICER weighs in on Medicare price negotiations with new appraisals ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Nvc3Qtd2F0Y2hkb2ctaWNlci1jaGlwcy1tZWRpY2FyZXMtbG9vbWluZy1wcmljZS1uZWdvdGlhdGlvbnMtYXBwcmFpc2FsLWVsaXF1aXMtYW5kLXhhcmVsdG_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Inflation Reduction Act forces Big Pharma to embrace Medicare ... - MM+M Online",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9pbmZsYXRpb24tcmVkdWN0aW9uLWFjdC1tZWRpY2FyZS1iaWctcGhhcm1hL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Transcenta to Start US Pivotal Stomach Cancer Trial of CLDN18.2 ... - precisionmedicineonline.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5wcmVjaXNpb25tZWRpY2luZW9ubGluZS5jb20vcHJlY2lzaW9uLW9uY29sb2d5L3RyYW5zY2VudGEtc3RhcnQtdXMtcGl2b3RhbC1zdG9tYWNoLWNhbmNlci10cmlhbC1jbGRuMTgyLWFudGlib2R5LXBsdXMtb3BkaXZv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/22/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb to Report Results for ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1SZXBvcnQtUmVzdWx0cy1mb3ItVGhpcmQtUXVhcnRlci0yMDIzLW9uLU9jdG9iZXItMjYtMjAyMy9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Will Bristol Myers Squibb Stock Rebound To Its Pre-Inflation Shock Level Of $80? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjMvMDkvMjcvd2lsbC1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay1yZWJvdW5kLXRvLWl0cy1wcmUtaW5mbGF0aW9uLXNob2NrLWxldmVsLW9mLTgwL9IBjQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjMvMDkvMjcvd2lsbC1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay1yZWJvdW5kLXRvLWl0cy1wcmUtaW5mbGF0aW9uLXNob2NrLWxldmVsLW9mLTgwL2FtcC8?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb: Undervalued Already, But Could Go Lower ... - Seeking Alpha",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ2MzczNjMtYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2stdW5kZXJ2YWx1ZWQtYWxyZWFkeS1idXQtY291bGQtZ28tbG93ZXItbWFpbnRhaW4tYnV50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiowJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtUGVyaW9wZXJhdGl2ZS1SZWdpbWVuLW9mLU5lb2FkanV2YW50LU9wZGl2by1uaXZvbHVtYWItYW5kLUNoZW1vdGhlcmFweS1Gb2xsb3dlZC1ieS1BZGp1dmFudC1PcGRpdm8tU2lnbmlmaWNhbnRseS1JbXByb3Zlcy1FdmVudC1GcmVlLVN1cnZpdmFsLWluLVBhdGllbnRzLXdpdGgtUmVzZWN0YWJsZS1Ob24tU21hbGwtQ2VsbC1MdW5nLUNhbmNlci9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "In Brief This Week: Bristol Myers Squibb, Kinnate Biopharma ... - precisionmedicineonline.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5wcmVjaXNpb25tZWRpY2luZW9ubGluZS5jb20vcHJlY2lzaW9uLW9uY29sb2d5L2JyaWVmLXdlZWstYnJpc3RvbC1teWVycy1zcXVpYmIta2lubmF0ZS1iaW9waGFybWEtYmlvY2VwdC1uZXhjZWxsYS1kZXJtdGVjaNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Amphista Therapeutics Achieves First Milestone in Second ... - GlobeNewswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMirgFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8wOS8yNi8yNzQ5NjU4LzAvZW4vQW1waGlzdGEtVGhlcmFwZXV0aWNzLUFjaGlldmVzLUZpcnN0LU1pbGVzdG9uZS1pbi1TZWNvbmQtRGlzY292ZXJ5LVByb2dyYW1tZS13aXRoLUJyaXN0b2wtTXllcnMtU3F1aWJiLmh0bWzSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Merck, AstraZeneca, Bristol Myers Squibb to participate in Medicare drug price negotiations - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMDkvMjcvZGlhYmV0ZXMtbWVkaWNhcmUtZHJ1Zy1wcmljZS1uZWdvdGlhdGlvbnMuaHRtbNIBUmh0dHBzOi8vd3d3LmNuYmMuY29tL2FtcC8yMDIzLzA5LzI3L2RpYWJldGVzLW1lZGljYXJlLWRydWctcHJpY2UtbmVnb3RpYXRpb25zLmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/15/2023": {
        "artical1": {
            "title": "Samsung Biologics announces expanded strategic agreement with ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiuwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3NhbXN1bmctYmlvbG9naWNzLWFubm91bmNlcy1leHBhbmRlZC1zdHJhdGVnaWMtYWdyZWVtZW50LXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tbWFudWZhY3R1cmUtYW4tYW50aWJvZHktY2FuY2VyLWRydWctc3Vic3RhbmNlLTMwMTkyOTg4MC5odG1s0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Samsung Biologics adds to BMS manufacturing partnership with ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FmdGVyLXBmaXplci1wYWN0LXNhbXN1bmctZXhwYW5kcy1hbnRpYm9keS1wcm9kdWN0aW9uLWRlYWwtYnJpc3RvbC1teWVycy1zcXVpYmLSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Samsung Biologics Expands Strategic Manufacturing Agreement ... - Pharmaceutical Technology Magazine",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LnBoYXJtdGVjaC5jb20vdmlldy9zYW1zdW5nLWJpb2xvZ2ljcy1leHBhbmRzLXN0cmF0ZWdpYy1tYW51ZmFjdHVyaW5nLWFncmVlbWVudC13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJi0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb Announces Dividend - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvY29ycG9yYXRlLWZpbmFuY2lhbC8yMDIzL0JyaXN0b2wtTXllcnMtU3F1aWJiLUFubm91bmNlcy1EaXZpZGVuZC1lZTI1N2NlYTIvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "BMS aims for staggering 25 label expansions in the coming years - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JkLWRheS1icmlzdG9sLW15ZXJzLWJhbmtzLWRvemVucy1sYWJlbC1leHBhbnNpb25zLWhlbHAtd2VhdGhlci1pcmEtcmV2bGltaWQtZ2VuZXJpY3MtYW5k0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb Co. stock outperforms competitors despite losses on the day - MarketWatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLW91dHBlcmZvcm1zLWNvbXBldGl0b3JzLWRlc3BpdGUtbG9zc2VzLW9uLXRoZS1kYXktODMyMThlOTUtOGE5YTRjNmI2ZmJh0gGPAWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLW91dHBlcmZvcm1zLWNvbXBldGl0b3JzLWRlc3BpdGUtbG9zc2VzLW9uLXRoZS1kYXktODMyMThlOTUtOGE5YTRjNmI2ZmJh?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLW91dHBlcmZvcm1zLWNvbXBldGl0b3JzLW9uLXN0cm9uZy10cmFkaW5nLWRheS1hZjYxMTk0Zi00ZGRmYzcyYzliMTjSAYsBaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stb3V0cGVyZm9ybXMtY29tcGV0aXRvcnMtb24tc3Ryb25nLXRyYWRpbmctZGF5LWFmNjExOTRmLTRkZGZjNzJjOWIxOA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/08/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Highlights Advancing ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMiygFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2NvcnBvcmF0ZS1maW5hbmNpYWwvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1IaWdobGlnaHRzLUFkdmFuY2luZy1QaXBlbGluZS1hbmQtRGlmZmVyZW50aWF0ZWQtUmVzZWFyY2gtUGxhdGZvcm1zLXRvLVN1cHBvcnQtTG9uZy1UZXJtLVN1c3RhaW5hYmxlLUdyb3d0aC1hdC1SRC1EYXkvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb's Investigational LPA1 Antagonist Reduces ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiyQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYnMtSW52ZXN0aWdhdGlvbmFsLUxQQTEtQW50YWdvbmlzdC1SZWR1Y2VzLVJhdGUtb2YtTHVuZy1GdW5jdGlvbi1EZWNsaW5lLWluLVByb2dyZXNzaXZlLVB1bG1vbmFyeS1GaWJyb3Npcy1Db2hvcnQtb2YtUGhhc2UtMi1TdHVkeS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Co. stock underperforms Thursday when compared to competitors - MarketWatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLXVuZGVycGVyZm9ybXMtdGh1cnNkYXktd2hlbi1jb21wYXJlZC10by1jb21wZXRpdG9ycy1mNDI2YmUwMy0yOTA3ZmIxYmYxNGPSAZEBaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stdW5kZXJwZXJmb3Jtcy10aHVyc2RheS13aGVuLWNvbXBhcmVkLXRvLWNvbXBldGl0b3JzLWY0MjZiZTAzLTI5MDdmYjFiZjE0Yw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Here's Why We Think Bristol-Myers Squibb (NYSE:BMY) Might Deserve Your Attention Today - Simply Wall St",
            "link": "https://news.google.com/rss/articles/CBMimQFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL255c2UtYm15L2JyaXN0b2wtbXllcnMtc3F1aWJiL25ld3MvaGVyZXMtd2h5LXdlLXRoaW5rLWJyaXN0b2wtbXllcnMtc3F1aWJiLW55c2VibXktbWlnaHQtZGVzZXJ2LTHSAZ0BaHR0cHM6Ly9zaW1wbHl3YWxsLnN0L3N0b2Nrcy91cy9waGFybWFjZXV0aWNhbHMtYmlvdGVjaC9ueXNlLWJteS9icmlzdG9sLW15ZXJzLXNxdWliYi9uZXdzL2hlcmVzLXdoeS13ZS10aGluay1icmlzdG9sLW15ZXJzLXNxdWliYi1ueXNlYm15LW1pZ2h0LWRlc2Vydi0xL2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb\u2019s Reblozyl reinforces market share in first-line ... - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5waGFybWFjZXV0aWNhbC10ZWNobm9sb2d5LmNvbS9jb21tZW50L2JyaXN0b2wtbXllcnMtc3F1aWJiLXJlYmxvenlsLXJlaW5mb3JjZXMtbWFya2V0LXNoYXJlLWluLWZpcnN0LWxpbmUtbWRzLXNwYWNlL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Six-Year Outcomes from Phase 3 CheckMate -227 Trial Show ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9TaXgtWWVhci1PdXRjb21lcy1mcm9tLVBoYXNlLTMtQ2hlY2tNYXRlLS0yMjctVHJpYWwtU2hvdy1EdXJhYmxlLUxvbmctVGVybS1TdXJ2aXZhbC13aXRoLU9wZGl2by1uaXZvbHVtYWItUGx1cy1ZZXJ2b3ktaXBpbGltdW1hYi1pbi10aGUtRmlyc3QtTGluZS1UcmVhdG1lbnQtb2YtUGF0aWVudHMtd2l0aC1NZXRhc3RhdGljLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb\u2019s Camzyos recommended by NICE for ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYnJpc3RvbF9teWVyc19zcXVpYmJzX2NhbXp5b3NfcmVjb21tZW5kZWRfYnlfbmljZV9mb3JfaW5oZXJpdGVkX2hlYXJ0X2NvbmRpdGlvbl8xNDk4NDcx0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/01/2023": {
        "artical1": {
            "title": "Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL2JyaXN0b2wtbXllcnMtYWNjdXNlZC1pbGxlZ2FsLXRhY3RpY3Mta2VlcC1wb21hbHlzdC1tb25vcG9seS1sYXdzdWl0LTIwMjMtMDktMDYv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb and Celgene named in class action suit over ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vZW5kcHRzLmNvbS9icmlzdG9sLW15ZXJzLXNxdWliYi1hbmQtY2VsZ2VuZS1uYW1lZC1pbi1jbGFzcy1hY3Rpb24tc3VpdC1vdmVyLWNhbmNlci1ibG9ja2J1c3Rlci1wb21hbHlzdC_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS accused of anticompetitive tactics to keep Pomalyst chugging - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLWFjY3VzZWQtZnJhdWR1bGVudC1wYXRlbnRzLXJldmVyc2UtcGF5bWVudHMtYW5kLXNoYW0tbGF3c3VpdHMtZXh0ZW5k0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "We Think Bristol-Myers Squibb (NYSE:BMY) Can Stay On Top Of Its Debt - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy90aGluay1icmlzdG9sLW15ZXJzLXNxdWliYi1ueXNlLTEzMDAxMzg4OS5odG1s0gFVaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvdGhpbmstYnJpc3RvbC1teWVycy1zcXVpYmItbnlzZS0xMzAwMTM4ODkuaHRtbA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Zenas BioPharma Announces Strategic License and Collaboration ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijwJodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy96ZW5hcy1iaW9waGFybWEtYW5ub3VuY2VzLXN0cmF0ZWdpYy1saWNlbnNlLWFuZC1jb2xsYWJvcmF0aW9uLWFncmVlbWVudC13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLXRvLWRldmVsb3AtYW5kLWNvbW1lcmNpYWxpemUtbm92ZWwtYmktZnVuY3Rpb25hbC1hbnRpYm9keS1vYmV4ZWxpbWFiLWluLWphcGFuLXNvdXRoLWtvcmVhLXRhaXdhbi1zaW5nYXBvcmUtaG9uZy1rb25nLWFuZC1hdXN0cmFsaWEv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb's Camzyos gets NICE recommendation - PharmaTimes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2JyaXN0b2xfbXllcnNfc3F1aWJic19jYW16eW9zX2dldHNfbmljZV9yZWNvbW1lbmRhdGlvbl8xNDk4Mjk50gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Pipeline Moves: Advancement prospects plunge for Bristol-Myers ... - Clinical Trials Arena",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmNsaW5pY2FsdHJpYWxzYXJlbmEuY29tL2ZlYXR1cmVzL3BpcGVsaW5lLW1vdmVzLW1ldGFzdGF0aWMtaGVwYXRvY2VsbHVsYXItY2FyY2lub21hL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/25/2023": {
        "artical1": {
            "title": "U.S. FDA Approves Bristol Myers Squibb's Reblozyl\u00ae (luspatercept ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi7QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9VLlMuLUZEQS1BcHByb3Zlcy1CcmlzdG9sLU15ZXJzLVNxdWliYnMtUmVibG96eWwtbHVzcGF0ZXJjZXB0LWFhbXQtYXMtRmlyc3QtTGluZS1UcmVhdG1lbnQtb2YtQW5lbWlhLWluLUFkdWx0cy13aXRoLUxvd2VyLVJpc2stTXllbG9keXNwbGFzdGljLVN5bmRyb21lcy1NRFMtV2hvLU1heS1SZXF1aXJlLVRyYW5zZnVzaW9ucy9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "FDA Approves Bristol Myers Squibb Anemia Treatment - BioPharm International",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtaW50ZXJuYXRpb25hbC5jb20vdmlldy9mZGEtYXBwcm92ZXMtYnJpc3RvbC1teWVycy1zcXVpYmItYW5lbWlhLXRyZWF0bWVudNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb has FDA approval for Reblozyl for anaemia - Pharmaceutical Technology",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItZmRhLXJlYmxvenlsL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Retrospective Observational Study Assessing Real-World Clinical ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi7gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9SZXRyb3NwZWN0aXZlLU9ic2VydmF0aW9uYWwtU3R1ZHktQXNzZXNzaW5nLVJlYWwtV29ybGQtQ2xpbmljYWwtSW1wYWN0LW9mLVN3aXRjaGluZy1vci1Db250aW51aW5nLUVsaXF1aXMtb3ItUml2YXJveGFiYW4tUHJlc2VudGVkLWF0LXRoZS1FdXJvcGVhbi1Tb2NpZXR5LW9mLUNhcmRpb2xvZ3ktRVNDLUNvbmdyZXNzLTIwMjMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Cellares Announces Bristol Myers Squibb has Joined Technology ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi6QFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2NlbGxhcmVzLWFubm91bmNlcy1icmlzdG9sLW15ZXJzLXNxdWliYi1oYXMtam9pbmVkLXRlY2hub2xvZ3ktYWRvcHRpb24tcGFydG5lcnNoaXAtcHJvZ3JhbS10by1ldmFsdWF0ZS1hdXRvbWF0ZWQtbWFudWZhY3R1cmluZy1vZi1jYXItdC1jZWxsLXRoZXJhcHktb24tdGhlLWNlbGwtc2h1dHRsZS1wbGF0Zm9ybS0zMDE5MTA2MTYuaHRtbNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Drexel Develops New Innovative Model For Cell And Gene Therapy ... - Drexel University",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vZHJleGVsLmVkdS9uZXdzL2FyY2hpdmUvMjAyMy9BdWd1c3QvRHJleGVsLURldmVsb3BzLU5ldy1Jbm5vdmF0aXZlLU1vZGVsLUZvci1DZWxsLUFuZC1HZW5lLVRoZXJhcHktRWR1Y2F0aW9u0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb Co. stock rises Friday, outperforms market - MarketWatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stcmlzZXMtZnJpZGF5LW91dHBlcmZvcm1zLW1hcmtldC1hOWNlYjc2MS00NDYzOWE3YjZjNjTSAX1odHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL2RhdGEtbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jby1zdG9jay1yaXNlcy1mcmlkYXktb3V0cGVyZm9ybXMtbWFya2V0LWE5Y2ViNzYxLTQ0NjM5YTdiNmM2NA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/18/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Shares Progress ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMitQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1TaGFyZXMtUHJvZ3Jlc3MtVG93YXJkLUl0cy1FbnZpcm9ubWVudGFsLVNvY2lhbC1hbmQtR292ZXJuYW5jZS1Jbml0aWF0aXZlcy1hbmQtSXRzLUhlYWx0aC1FcXVpdHktQ29tbWl0bWVudHMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi3AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLWZvci1PcGRpdm8tbml2b2x1bWFiLWFzLWFuLUFkanV2YW50LVRyZWF0bWVudC1mb3ItUGF0aWVudHMtd2l0aC1Db21wbGV0ZWx5LVJlc2VjdGVkLVN0YWdlLUlJQi1vci1JSUMtTWVsYW5vbWEvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb to Showcase Data ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMivAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1TaG93Y2FzZS1EYXRhLUFjcm9zcy1pdHMtSW5ub3ZhdGl2ZS1DYXJkaW92YXNjdWxhci1Qb3J0Zm9saW8tYXQtdGhlLUV1cm9wZWFuLVNvY2lldHktb2YtQ2FyZGlvbG9neS1Db25ncmVzcy0yMDIzL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb To Cut 108 Jobs In NJ, Including Lawrenceville - Patch",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vcGF0Y2guY29tL25ldy1qZXJzZXkvbGF3cmVuY2V2aWxsZS9icmlzdG9sLW15ZXJzLXNxdWliYi1jdXQtMTA4LWpvYnMtbmotaW5jbHVkaW5nLWxhd3JlbmNldmlsbGXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Startup Cellares adds $255M as investors pour cash into cell ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsbGFyZXMtY2VsbC10aGVyYXB5LW1hbnVmYWN0dXJpbmctc3RhcnR1cC1mdW5kaW5nLzY5MTcyOC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "maintenance probs as CAR-T rivalry heats - BioProcess Insider - BioProcess Insider",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL2Jpb3Byb2Nlc3NpbnRsLmNvbS9iaW9wcm9jZXNzLWluc2lkZXIvdGhlcmFwZXV0aWMtY2xhc3MvcGxhbnQtbWFpbnRlbmFuY2UtcG9zZXMtc3VwcGx5LWJsaXBzLWFzLWJjbWEtY2FyLXQtcml2YWxyeS1oZWF0cy11cC_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol-Myers, J&J on Deck to Negotiate Prices With Medicare - Bloomberg Law",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcuY29tL3BoYXJtYS1hbmQtbGlmZS1zY2llbmNlcy9icmlzdG9sLW15ZXJzLWotai1saWtlbHktZmlyc3QtZm9yLW1lZGljYXJlLXByaWNlLW5lZ290aWF0aW9u0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/11/2023": {
        "artical1": {
            "title": "Updated Data from TRIDENT-1 Trial Show Durable Efficacy Benefits ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9VcGRhdGVkLURhdGEtZnJvbS1UUklERU5ULTEtVHJpYWwtU2hvdy1EdXJhYmxlLUVmZmljYWN5LUJlbmVmaXRzLXdpdGgtUmVwb3RyZWN0aW5pYi1mb3ItUGF0aWVudHMtd2l0aC1Mb2NhbGx5LUFkdmFuY2VkLW9yLU1ldGFzdGF0aWMtUk9TMS1Qb3NpdGl2ZS1Ob24tU21hbGwtQ2VsbC1MdW5nLUNhbmNlci9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS, looking to build a market for a heart drug, turns to a Viz.ai ... - STAT",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiO2h0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDIzLzA4LzE1L2Jtcy1jYW16eW9zLWhjbS12aXotYWkv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Viz.ai Receives First De Novo Approval by the FDA for Hypertrophic ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDgxNTk1MTIwMi9lbi9WaXouYWktUmVjZWl2ZXMtRmlyc3QtRGUtTm92by1BcHByb3ZhbC1ieS10aGUtRkRBLWZvci1IeXBlcnRyb3BoaWMtQ2FyZGlvbXlvcGF0aHktQUktQWxnb3JpdGht0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "AI model for HCM, the first of its kind, gains FDA approval - Cardiovascular Business",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vY2FyZGlvdmFzY3VsYXJidXNpbmVzcy5jb20vdG9waWNzL2NsaW5pY2FsL2hlYXJ0LXJoeXRobS9haS1tb2RlbC1oY20tZmlyc3QtaXRzLWtpbmQtZ2FpbnMtZmRhLWFwcHJvdmFs0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb Co. stock outperforms competitors on strong trading day - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLW91dHBlcmZvcm1zLWNvbXBldGl0b3JzLW9uLXN0cm9uZy10cmFkaW5nLWRheS1mNWU0ZDQzNC1iMDIwOTVmZmQ5OTfSAYsBaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stb3V0cGVyZm9ybXMtY29tcGV0aXRvcnMtb24tc3Ryb25nLXRyYWRpbmctZGF5LWY1ZTRkNDM0LWIwMjA5NWZmZDk5Nw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "BMS again cuts staff after disappointing 2Q earnings - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jtcy1hZ2Fpbi1sYXlzLXN0YWZmLWFmdGVyLWRpc2FwcG9pbnRpbmctc2Vjb25kLXF1YXJ0ZXItZWFybmluZ3PSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "A Fierce Focus On Unmet Need - Pharmaceutical Executive",
            "link": "https://news.google.com/rss/articles/CBMiNmh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy9maWVyY2UtZm9jdXMtdW5tZXQtbmVlZNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/04/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Enters Into $4 Billion ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1FbnRlcnMtSW50by00LUJpbGxpb24tQWdncmVnYXRlLUFjY2VsZXJhdGVkLVNoYXJlLVJlcHVyY2hhc2UtQWdyZWVtZW50cy9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Launches Clear ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMivgFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1MYXVuY2hlcy1DbGVhci1VbmRlcnN0YW5kaW5nLUNhbXBhaWduLXRvLVJldmVhbC10aGUtUGxhaW4tVHJ1dGgtQWJvdXQtTGl2aW5nLXdpdGgtTW9kZXJhdGUtdG8tU2V2ZXJlLVBsYXF1ZS1Qc29yaWFzaXMvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Inducted into the Billion ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMilwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1JbmR1Y3RlZC1pbnRvLXRoZS1CaWxsaW9uLURvbGxhci1Sb3VuZHRhYmxlLUV4cGFuZHMtU3VwcGxpZXItRGl2ZXJzaXR5LUVmZm9ydHMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "BMS-BeiGene, Sumitomo-Otuska, AstraZeneca\u2014Fierce Pharma Asia - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2ZpZXJjZS1waGFybWEtYXNpYS1ibXMtYmVpZ2VuZS1kZWFsLWVuZC1zdW1pdG9tby1vdHN1a2Etc2NoaXpvcGhyZW5pYS1mbG9wcy1hc3RyYXplbmVjYS1jZW_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Viz.ai collects de novo clearance for BMS-backed software to spot ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvdml6YWktY29sbGVjdHMtZGUtbm92by1jbGVhcmFuY2UtYm1zLWJhY2tlZC1zb2Z0d2FyZS1zcG90LWh5cGVydHJvcGhpYy1jYXJkaW9teW9wYXRoedIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Should Dividend Investors Buy Bristol Myers Stock? - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA4LzA2L3Nob3VsZC1kaXZpZGVuZC1pbnZlc3RvcnMtYnV5LWJyaXN0b2wtbXllcnMtc3RvY2sv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bristol-Myers Squibb Company (NYSE:BMY) is favoured by institutional owners who hold 78% of the company - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55LW55c2UtMTIwMDQ1OTI0Lmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55LW55c2UtMTIwMDQ1OTI0Lmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/28/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb reports 6% drop in Q2 2023 revenues - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItcTItMjAyMy_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy80LW1lYXN1cmVzLWluZGljYXRlLWJyaXN0b2wtbXllcnMtMTEwMDI0NTc4Lmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy80LW1lYXN1cmVzLWluZGljYXRlLWJyaXN0b2wtbXllcnMtMTEwMDI0NTc4Lmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Co. stock underperforms Tuesday when compared to competitors - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLXVuZGVycGVyZm9ybXMtdHVlc2RheS13aGVuLWNvbXBhcmVkLXRvLWNvbXBldGl0b3JzLTljOTUxMWZhLTEyMmQ1NmUwMDc5YdIBkAFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL2RhdGEtbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jby1zdG9jay11bmRlcnBlcmZvcm1zLXR1ZXNkYXktd2hlbi1jb21wYXJlZC10by1jb21wZXRpdG9ycy05Yzk1MTFmYS0xMjJkNTZlMDA3OWE?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers, AstraZeneca settle PD-1, CTLA-4 cancer ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtYXN0cmF6ZW5lY2Etc2V0dGxlLXBkLTEtY3RsYS00LWNhbmNlci1pbW11bm90aGVyYXB5LXBhdGVudC1zdWl0cy01MTBt0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb runs inspirational video taking a journey into ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy9icmlzdG9sLW15ZXJzLXNxdWliYi1ydW5zLWluc3BpcmF0aW9uYWwtdmlkZW8tbG9va2luZy1vdXItaW5uZXItc3BhY2UtYmlvbG9neS13b3JsZHMtbW9zdNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol-Myers Gets to Shift Racial Bias Lawsuit to Arbitration - Bloomberg Law",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcuY29tL2xpdGlnYXRpb24vYnJpc3RvbC1teWVycy1nZXRzLXRvLXNoaWZ0LXJhY2lhbC1iaWFzLWxhd3N1aXQtdG8tYXJiaXRyYXRpb27SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjIuMDIzMjLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/21/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Reports Second Quarter ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIzL0JyaXN0b2wtTXllcnMtU3F1aWJiLVJlcG9ydHMtU2Vjb25kLVF1YXJ0ZXItRmluYW5jaWFsLVJlc3VsdHMtZm9yLTIwMjMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers sales fall, cuts 2023 forecast as drugs face competition - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLXNhbGVzLWZhbGwtY3V0cy0yMDIzLWZvcmVjYXN0LWRydWdzLWZhY2UtY29tcGV0aXRpb24tMjAyMy0wNy0yNy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMy8wNy8yNy9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktcTItMjAyMy1lYXJuaW5ncy1jYWxsLXRyYS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "The 33% return delivered to Bristol-Myers Squibb's (NYSE:BMY) shareholders actually lagged YoY earnings growth - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy8zMy1yZXR1cm4tZGVsaXZlcmVkLWJyaXN0b2wtbXllcnMtMTMwMDM3NDI5Lmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy8zMy1yZXR1cm4tZGVsaXZlcmVkLWJyaXN0b2wtbXllcnMtMTMwMDM3NDI5Lmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "The Bristol-Myers Squibb Phenomenon: A Game Changer In The ... - Seeking Alpha",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ2MTg3NjEtdGhlLWJyaXN0b2wtbXllcnMtc3F1aWJiLXBoZW5vbWVub24tYS1nYW1lLWNoYW5nZXItaW4tcGhhcm1hY2V1dGljYWwtaW5kdXN0cnnSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Immatics Announces $35 Million Equity Investment from Bristol ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3JlbGVhc2VzL2ltbWF0aWNzLWFubm91bmNlcy0zNS1taWxsaW9uLWVxdWl0eS1pbnZlc3RtZW50LWZyb20tYnJpc3RvbC1teWVycy1zcXVpYmIv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Our research in Neuroscience \u2013 Bristol Myers Squibb - Bristol Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmJtcy5jb20vcmVzZWFyY2hlcnMtYW5kLXBhcnRuZXJzL2FyZWFzLW9mLWZvY3VzL291ci1yZXNlYXJjaC1pbi1uZXVyb3NjaWVuY2UuaHRtbNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/14/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktZ2FpbnMtMjE1MDIyMDk1Lmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktZ2FpbnMtMjE1MDIyMDk1Lmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS teams with ex-soccer player for Women's World Cup ulcerative ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Jtcy10ZWFtcy1leC1zb2NjZXItcGxheWVyLXdvbWVucy13b3JsZC1jdXAtdWxjZXJhdGl2ZS1jb2xpdGlzLW1hcmtldGluZy1wdXNo0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Chutes & Ladders\u2014Flagship plucks former BMS R&D exec Rupert ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvY2h1dGVzLWxhZGRlcnMtZmxhZ3NoaXAtcGx1Y2tzLWZvcm1lci10b3AtYm1zLWV4ZWMtdmVzc2V5LWJlLWNoaWVmLXNjaWVudGlzdHPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Former World Cup star Rosie White signs onto BMS marketing push - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9mb3JtZXItd29ybGQtY3VwLXN0YXItcm9zaWUtd2hpdGUtc2lnbnMtb250by1ibXMtbWFya2V0aW5nLXB1c2gv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Antengene doses first US patient in ATG-017 with nivolumab ... - Clinical Trials Arena",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmNsaW5pY2FsdHJpYWxzYXJlbmEuY29tL25ld3MvYW50ZW5nZW5lLWZpcnN0LXVzLXBhdGllbnQtYXRnLTAxNy1uaXZvbHVtYWItY29tYmluYXRpb24tdHJpYWwv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb patents new RXFP1 inhibitors - BioWorld Online",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmJpb3dvcmxkLmNvbS9hcnRpY2xlcy82OTkwOTYtYnJpc3RvbC1teWVycy1zcXVpYmItcGF0ZW50cy1uZXctcnhmcDEtaW5oaWJpdG9yc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "With 77% ownership of the shares, Bristol-Myers Squibb Company (NYSE:BMY) is heavily dominated by institutional owners - Simply Wall St",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL255c2UtYm15L2JyaXN0b2wtbXllcnMtc3F1aWJiL25ld3Mvd2l0aC03Ny1vd25lcnNoaXAtb2YtdGhlLXNoYXJlcy1icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW550gGbAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnlzZS1ibXkvYnJpc3RvbC1teWVycy1zcXVpYmIvbmV3cy93aXRoLTc3LW93bmVyc2hpcC1vZi10aGUtc2hhcmVzLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBhbnkvYW1w?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/07/2023": {
        "artical1": {
            "title": "Opdivo (nivolumab) in Combination with Cisplatin-Based ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMiqwJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9PcGRpdm8tbml2b2x1bWFiLWluLUNvbWJpbmF0aW9uLXdpdGgtQ2lzcGxhdGluLUJhc2VkLUNoZW1vdGhlcmFweS1TaG93cy1PdmVyYWxsLVN1cnZpdmFsLWFuZC1Qcm9ncmVzc2lvbi1GcmVlLVN1cnZpdmFsLUJlbmVmaXQtZm9yLUNpc3BsYXRpbi1FbGlnaWJsZS1QYXRpZW50cy13aXRoLVVucmVzZWN0YWJsZS1vci1NZXRhc3RhdGljLVVyb3RoZWxpYWwtQ2FyY2lub21hLWluLXRoZS1QaGFzZS0zLUNoZWNrTWF0ZS0tOTAxLVRyaWFsL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers' Opdivo extends survival in bladder cancer study - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLWJsYWRkZXItY2FuY2VyLWRydWctbWVldHMtZ29hbC1sYXRlLXN0YWdlLXN1Yi1zdHVkeS0yMDIzLTA3LTExL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers' Opdivo stages comeback in bladder cancer, teeing up ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtb3BkaXZvLW1ha2VzLWNvbWViYWNrLWJsYWRkZXItY2FuY2VyLXRlZWluZy0yLW1lcmNrLXNob3dkb3duc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Evotec and Bristol Myers Squibb enter licence agreement within ... - Evotec",
            "link": "https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5ldm90ZWMuY29tL2VuL2ludmVzdG9yLXJlbGF0aW9ucy9uZXdzL3AvZXZvdGVjLWFuZC1icmlzdG9sLW15ZXJzLXNxdWliYi1lbnRlci1saWNlbmNlLWFncmVlbWVudC13aXRoaW4tbmV1cm9zY2llbmNlLXBhcnRuZXJzaGlwLTYzMTLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Prothena Announces Bristol Myers Squibb Opt-in for Worldwide ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMipQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDcxMDU5OTI5Ny9lbi9Qcm90aGVuYS1Bbm5vdW5jZXMtQnJpc3RvbC1NeWVycy1TcXVpYmItT3B0LWluLWZvci1Xb3JsZHdpZGUtUmlnaHRzLW9mLVBSWDAwNS1hLU5vdmVsLUFudGktTVRCUi1UYXUtQW50aWJvZHnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb Scoops Up Global Rights to Prothena's Anti ... - precisionmedicineonline.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnByZWNpc2lvbm1lZGljaW5lb25saW5lLmNvbS9idXNpbmVzcy1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLXNjb29wcy1nbG9iYWwtcmlnaHRzLXByb3RoZW5hcy1hbnRpLXRhdS1kcnVnLTU1bdIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Launches Supporting ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi1wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1MYXVuY2hlcy1TdXBwb3J0aW5nLVlvdS13aXRoLVVDLXdpdGgtV29tZW5zLVdvcmxkLUN1cC1Db21tZW50YXRvci1Gb3JtZXItUHJvZmVzc2lvbmFsLVNvY2Nlci1QbGF5ZXItYW5kLVVsY2VyYXRpdmUtQ29saXRpcy1QYXRpZW50LVJvc2llLVdoaXRlL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/30/2023": {
        "artical1": {
            "title": "Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLWJteS1vcGRpdm8tY2hlbW8tMTMzNDAwODAzLmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9icmlzdG9sLW15ZXJzLWJteS1vcGRpdm8tY2hlbW8tMTMzNDAwODAzLmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Co. stock rises Wednesday, outperforms market - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stcmlzZXMtd2VkbmVzZGF5LW91dHBlcmZvcm1zLW1hcmtldC05MGE0OTJkZS0wMDdmMzQ1ZTgwMTXSAYABaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stcmlzZXMtd2VkbmVzZGF5LW91dHBlcmZvcm1zLW1hcmtldC05MGE0OTJkZS0wMDdmMzQ1ZTgwMTU?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Squibb Company (NYSE:BMY) Looks Like A Good Stock, And It's Going Ex-Dividend Soon - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55LW55c2UtMTIxNTM0NTQzLmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55LW55c2UtMTIxNTM0NTQzLmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "BMS' Sotyktu gets NICE green light for NHS use - PharmaTimes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2Jtc19zb3R5a3R1X2dldHNfbmljZV9ncmVlbl9saWdodF9mb3JfbmhzX3VzZV8xNDk0MTIz0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Preparing the NHS oncology workforce for the innovations of tomorrow - Health Service Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5oc2ouY28udWsvdGVjaG5vbG9neS1hbmQtaW5ub3ZhdGlvbi9wcmVwYXJpbmctdGhlLW5ocy1vbmNvbG9neS13b3JrZm9yY2UtZm9yLXRoZS1pbm5vdmF0aW9ucy1vZi10b21vcnJvdy83MDM1MDI3LmFydGljbGXSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Collaboration is crucial to innovative cancer treatment - The New Statesman",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3Lm5ld3N0YXRlc21hbi5jb20vc3BvdGxpZ2h0L2hlYWx0aGNhcmUvMjAyMy8wNi9jb2xsYWJvcmF0aW9uLWlzLWNydWNpYWwtdG8taW5ub3ZhdGl2ZS1jYW5jZXItdHJlYXRtZW500gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "SpaceX's Dragon Spacecraft Returns to Earth - ISS National Lab",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiO2h0dHBzOi8vd3d3Lmlzc25hdGlvbmFsbGFiLm9yZy9zcGFjeC1jcnMyOC1yZXR1cm5zLXNjaWVuY2Uv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/23/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi0QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLW9mLUNBTVpZT1MtbWF2YWNhbXRlbi1mb3ItdGhlLVRyZWF0bWVudC1vZi1TeW1wdG9tYXRpYy1PYnN0cnVjdGl2ZS1IeXBlcnRyb3BoaWMtQ2FyZGlvbXlvcGF0aHktSENNL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Co. stock falls Monday, still outperforms market - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stZmFsbHMtbW9uZGF5LXN0aWxsLW91dHBlcmZvcm1zLW1hcmtldC0zYTU5Y2JkMS1hYjRiNjA4OWUzNDPSAYMBaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stZmFsbHMtbW9uZGF5LXN0aWxsLW91dHBlcmZvcm1zLW1hcmtldC0zYTU5Y2JkMS1hYjRiNjA4OWUzNDM?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Co. stock underperforms Friday when compared to competitors - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLXVuZGVycGVyZm9ybXMtZnJpZGF5LXdoZW4tY29tcGFyZWQtdG8tY29tcGV0aXRvcnMtNGEzMzNmNWUtMzUyZjM5MTUyMzBi0gGPAWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLXVuZGVycGVyZm9ybXMtZnJpZGF5LXdoZW4tY29tcGFyZWQtdG8tY29tcGV0aXRvcnMtNGEzMzNmNWUtMzUyZjM5MTUyMzBi?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Big Pharma Vs. Washington\u2014An Opportunity To Buy Bristol Myers - Forbes",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvam9obmJ1Y2tpbmdoYW0vMjAyMy8wNi8yMy9iaWctcGhhcm1hLXZzLXdhc2hpbmd0b24tYW4tb3Bwb3J0dW5pdHktdG8tYnV5LWJyaXN0b2wtbXllcnMv0gF4aHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9qb2huYnVja2luZ2hhbS8yMDIzLzA2LzIzL2JpZy1waGFybWEtdnMtd2FzaGluZ3Rvbi1hbi1vcHBvcnR1bml0eS10by1idXktYnJpc3RvbC1teWVycy9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "NICE recommends Bristol Myers Squibb's psoriasis treatment - Pf Media",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vcGYtbWVkaWEuY28udWsvbmV3cy9uaWNlLXJlY29tbWVuZHMtYnJpc3RvbC1teWVycy1zcXVpYmJzLXBzb3JpYXNpcy10cmVhdG1lbnQv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Botswana-Baylor pediatric HIV/AIDS program: The impact 20 years ... - Baylor College of Medicine News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmJjbS5lZHUvbmV3cy9ib3Rzd2FuYS1iYXlsb3ItcGVkaWF0cmljLWhpdi1haWRzLXByb2dyYW0tdGhlLWltcGFjdC0yMC15ZWFycy1sYXRlctIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "K36 Therapeutics raises $70M in Series B to fund multiple myeloma ... - Endpoints News",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZW5kcHRzLmNvbS9rMzYtdGhlcmFwZXV0aWNzLXJhaXNlcy03MG0taW4tc2VyaWVzLWItdG8tZnVuZC1tdWx0aXBsZS1teWVsb21hLXJlc2VhcmNoL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/16/2023": {
        "artical1": {
            "title": "BMS files new IRA suit alleging constitutional violations - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLWZvbGxvd3MtbWVyY2tzLWxlYWQtaXRzLW93bi1sYXdzdWl0LWJsYXN0aW5nLWlyYS1wcmljZS1zZXR0aW5n0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS Follows Merck\u2019s Lead, Sues Government Over Drug Pricing ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jtcy1mb2xsb3dzLW1lcmNrLXMtbGVhZC1zdWVzLWdvdmVybm1lbnQtb3Zlci1kcnVnLXByaWNpbmctbmVnb3RpYXRpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb follows Merck in suing US over Medicare price negotiation program - BenefitsPro",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmJlbmVmaXRzcHJvLmNvbS8yMDIzLzA2LzIxL2JyaXN0b2wtbXllcnMtc3F1aWJiLWZvbGxvd3MtbWVyY2staW4tc3VpbmctdXMtb3Zlci1tZWRpY2FyZS1wcmljZS1uZWdvdGlhdGlvbi1wcm9ncmFtL9IBhAFodHRwczovL3d3dy5iZW5lZml0c3Byby5jb20vMjAyMy8wNi8yMS9icmlzdG9sLW15ZXJzLXNxdWliYi1mb2xsb3dzLW1lcmNrLWluLXN1aW5nLXVzLW92ZXItbWVkaWNhcmUtcHJpY2UtbmVnb3RpYXRpb24tcHJvZ3JhbS8_YW1wPTE?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb sues Biden administration over Medicare drug negotiations in third such lawsuit - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMDYvMTYvYnJpc3RvbC1teWVycy1zcXVpYmItc3Vlcy1iaWRlbi1hZG1pbmlzdHJhdGlvbi1vdmVyLW1lZGljYXJlLWRydWctbmVnb3RpYXRpb25zLmh0bWzSAXdodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMy8wNi8xNi9icmlzdG9sLW15ZXJzLXNxdWliYi1zdWVzLWJpZGVuLWFkbWluaXN0cmF0aW9uLW92ZXItbWVkaWNhcmUtZHJ1Zy1uZWdvdGlhdGlvbnMuaHRtbA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers sues US government over Medicare drug price ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMikgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLXN1ZXMtdXMtZ292ZXJubWVudC1vdmVyLW1lZGljYXJlLWRydWctcHJpY2UtbmVnb3RpYXRpb24tcGxhbi0yMDIzLTA2LTE2L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb joins in on challenging Medicare drug price negotiation program - The Hill",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vdGhlaGlsbC5jb20vaG9tZW5ld3MvNDA1NDQ0My1icmlzdG9sLW15ZXJzLXNxdWliYi1qb2lucy1pbi1vbi1jaGFsbGVuZ2luZy1tZWRpY2FyZS1kcnVnLXByaWNlLW5lZ290aWF0aW9uLXByb2dyYW0v0gF-aHR0cHM6Ly90aGVoaWxsLmNvbS9ob21lbmV3cy80MDU0NDQzLWJyaXN0b2wtbXllcnMtc3F1aWJiLWpvaW5zLWluLW9uLWNoYWxsZW5naW5nLW1lZGljYXJlLWRydWctcHJpY2UtbmVnb3RpYXRpb24tcHJvZ3JhbS9hbXAv?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers reports primary analysis from lymphoma therapy trials - Clinical Trials Arena",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmNsaW5pY2FsdHJpYWxzYXJlbmEuY29tL25ld3MvYnJpc3RvbC1teWVycy1wcmltYXJ5LWFuYWx5c2lzLWx5bXBob21hL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/09/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb Announces Dividend - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIzL0JyaXN0b2wtTXllcnMtU3F1aWJiLUFubm91bmNlcy1EaXZpZGVuZC02N2JiNjIxNWUvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb gets FDA approval to begin production - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItZmRhLWFwcHJvdmFsL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Drugmakers want to stop Medicare from negotiating prices. Here\u2019s what you should know - CNN",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmNubi5jb20vMjAyMy8wNi8xNS9wb2xpdGljcy9tZWRpY2FyZS1kcnVnLXByaWNlLW5lZ290aWF0aW9ucy1sYXdzdWl0cy9pbmRleC5odG1s0gFgaHR0cHM6Ly9hbXAuY25uLmNvbS9jbm4vMjAyMy8wNi8xNS9wb2xpdGljcy9tZWRpY2FyZS1kcnVnLXByaWNlLW5lZ290aWF0aW9ucy1sYXdzdWl0cy9pbmRleC5odG1s?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb Co. stock remains steady Tuesday, underperforms market - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLXJlbWFpbnMtc3RlYWR5LXR1ZXNkYXktdW5kZXJwZXJmb3Jtcy1tYXJrZXQtNjExZTZjOWQtNTc4MjUyZDQ1ZDg40gGJAWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvZGF0YS1uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvLXN0b2NrLXJlbWFpbnMtc3RlYWR5LXR1ZXNkYXktdW5kZXJwZXJmb3Jtcy1tYXJrZXQtNjExZTZjOWQtNTc4MjUyZDQ1ZDg4?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Insiders At Bristol-Myers Squibb Sold US$33m In Stock, Alluding To Potential Weakness \\ - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnNpZGVycy1icmlzdG9sLW15ZXJzLXNxdWliYi1zb2xkLTExMDAzMzI0My5odG1s0gFYaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvaW5zaWRlcnMtYnJpc3RvbC1teWVycy1zcXVpYmItc29sZC0xMTAwMzMyNDMuaHRtbA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "This Drug Candidate Could Be a Winner for Bristol Myers - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA2LzEyL3RoaXMtZHJ1Zy1jYW5kaWRhdGUtY291bGQtYmUtYS13aW5uZXItZm9yLWJyaXN0b2wv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers offers a $100000 vote of support for Kristen Hege's ... - Endpoints News",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vZW5kcHRzLmNvbS9icmlzdG9sLW15ZXJzLW9mZmVycy1hLTEwMDAwMC12b3RlLW9mLXN1cHBvcnQtZm9yLWtyaXN0ZW4taGVnZXMtYWR2ZW50dXJvdXMtZnVuZHJhaXNpbmctY2FtcGFpZ24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/02/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives U.S. FDA ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMitwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1VLlMuLUZEQS1BcHByb3ZhbC1vZi1OZXctU3RhdGUtb2YtdGhlLUFydC1DZWxsLVRoZXJhcHktTWFudWZhY3R1cmluZy1GYWNpbGl0eS1pbi1EZXZlbnMtTWFzc2FjaHVzZXR0cy9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb, Medic Life Sciences Collaborate on Tumor ... - GenomeWeb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3Lmdlbm9tZXdlYi5jb20vY2FuY2VyL2JyaXN0b2wtbXllcnMtc3F1aWJiLW1lZGljLWxpZmUtc2NpZW5jZXMtY29sbGFib3JhdGUtdHVtb3ItdGFyZ2V0LWRpc2NvdmVyedIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb to Report Results for Second Quarter 2023 on ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDYwNzAwNTg2Mi9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1SZXBvcnQtUmVzdWx0cy1mb3ItU2Vjb25kLVF1YXJ0ZXItMjAyMy1vbi1KdWx5LTI3LTIwMjPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Here's Why Bristol-Myers Squibb (NYSE:BMY) Has Caught The Eye Of Investors - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktYnJpc3RvbC1teWVycy1zcXVpYmItMTEwMDM1MzcyLmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9oZXJlcy13aHktYnJpc3RvbC1teWVycy1zcXVpYmItMTEwMDM1MzcyLmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "The Zacks Analyst Blog Highlights NVIDIA, Bristol-Myers Squibb, ICICI Bank, Palo Alto and Walgreens Boots Alliance - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1udmlkaWEtMDg1OTAwMjcyLmh0bWzSAVpodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy96YWNrcy1hbmFseXN0LWJsb2ctaGlnaGxpZ2h0cy1udmlkaWEtMDg1OTAwMjcyLmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Four-Year Outcomes from Phase 3 CheckMate -9LA Trial Show ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMijQJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9Gb3VyLVllYXItT3V0Y29tZXMtZnJvbS1QaGFzZS0zLUNoZWNrTWF0ZS0tOUxBLVRyaWFsLVNob3ctRHVyYWJsZS1Mb25nLVRlcm0tU3Vydml2YWwtd2l0aC1PcGRpdm8tbml2b2x1bWFiLVBsdXMtWWVydm95LWlwaWxpbXVtYWItd2l0aC1Ud28tQ3ljbGVzLW9mLUNoZW1vdGhlcmFweS1mb3ItUGF0aWVudHMtd2l0aC1NZXRhc3RhdGljLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "ASCO: Seagen's top-selling drug under threat as Bristol Myers ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NlYWdlbnMtdG9wLXNlbGxpbmctZHJ1Zy11bmRlci10aHJlYXQtYnJpc3RvbC1teWVycy1vcGRpdm8tYmVhdHMtYWRjZXRyaXMtbHltcGhvbWHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/26/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives Positive ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiqQJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tUmVjb21tZW5kaW5nLUFwcHJvdmFsLWZvci1PcGRpdm8tbml2b2x1bWFiLXdpdGgtQ2hlbW90aGVyYXB5LWFzLU5lb2FkanV2YW50LVRyZWF0bWVudC1vZi1SZXNlY3RhYmxlLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyLWF0LUhpZ2gtUmlzay1vZi1SZWN1cnJlbmNlLWluLVBhdGllbnRzLXdpdGgtVHVtb3ItQ2VsbC1QRC1MMS1FeHByZS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "FDA accepts Bristol Myers Squibb's repotrectinib NDA for review - Pharmaceutical Technology",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvZmRhLWJyaXN0b2wtcmVwb3RyZWN0aW5pYi1uZGEtcmV2aWV3L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA Gives Priority Review to Repotrectinib in Advanced ROS1+ ... - Cancer Network",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZmRhLWdpdmVzLXByaW9yaXR5LXJldmlldy10by1yZXBvdHJlY3RpbmliLWluLWFkdmFuY2VkLXJvczEtbnNjbGPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Is Bristol Myers Squibb a Top Dividend Stock? - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA1LzMxL2lzLWJyaXN0b2wtbXllcnMtc3F1aWJiLWEtdG9wLWRpdmlkZW5kLXN0b2NrL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb to Hold R&D Day on September 14 - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjMwNTMxMDA1MjQxL2VuL0JyaXN0b2wtTXllcnMtU3F1aWJiLXRvLUhvbGQtUkQtRGF5LW9uLVNlcHRlbWJlci0xNNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "U.S. Food and Drug Administration Accepts for Priority Review ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQWNjZXB0cy1mb3ItUHJpb3JpdHktUmV2aWV3LUJyaXN0b2wtTXllcnMtU3F1aWJicy1BcHBsaWNhdGlvbi1mb3ItUmVwb3RyZWN0aW5pYi1mb3ItdGhlLVRyZWF0bWVudC1vZi1QYXRpZW50cy13aXRoLUxvY2FsbHktQWR2YW5jZWQtb3ItTWV0YXN0YXRpYy1ST1MxLVBvc2l0aXZlLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "IPF lung function decline may slow with LPA1 antagonist BMS ... - Pulmonary Fibrosis News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vcHVsbW9uYXJ5Zmlicm9zaXNuZXdzLmNvbS9uZXdzL2lwZi1sdW5nLWZ1bmN0aW9uLWRlY2xpbmUtbWF5LXNsb3ctd2l0aC1scGExLWFudGFnb25pc3QtYm1zLTk4NjI3OC_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/19/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb's Investigational LPA1 Antagonist Reduces the ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiwgFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYnMtSW52ZXN0aWdhdGlvbmFsLUxQQTEtQW50YWdvbmlzdC1SZWR1Y2VzLXRoZS1SYXRlLW9mLUx1bmctRnVuY3Rpb24tRGVjbGluZS1pbi1QYXRpZW50cy13aXRoLUlkaW9wYXRoaWMtUHVsbW9uYXJ5LUZpYnJvc2lzL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb eyes phase 3 after pulmonary fibrosis drug ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYm1zLWV5ZXMtcGhhc2UtMy1hZnRlci1wdWxtb25hcnktZmlicm9zaXMtZHJ1Zy1yZWR1Y2VzLWx1bmctZnVuY3Rpb24tZGVjbGluZdIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "ASCO: BMS pitches Breyanzi as the first CAR-T for CLL. But will a ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jtcy1waXRjaGVzLWJyZXlhbnppLWZpcnN0LWNhci10LWNsbC1jYW4tc2luZ2xlLWFybS10cmlhbC1wZXJzdWFkZS1mZGHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb Co. Shares Near 52-Week Low - Market Mover - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYnJpc3RvbC1teWVycy1zcXVpYmItY28uLXNoYXJlcy1uZWFyLTUyLXdlZWstbG93LW1hcmtldC1tb3ZlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Milvexian Granted U.S. FDA Fast Track Designation for All Three ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi7AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9NaWx2ZXhpYW4tR3JhbnRlZC1VLlMuLUZEQS1GYXN0LVRyYWNrLURlc2lnbmF0aW9uLWZvci1BbGwtVGhyZWUtSW5kaWNhdGlvbnMtVW5kZXItRXZhbHVhdGlvbi1pbi1QaGFzZS0zLUxpYnJleGlhLVByb2dyYW0tSXNjaGVtaWMtU3Ryb2tlLUFjdXRlLUNvcm9uYXJ5LVN5bmRyb21lLWFuZC1BdHJpYWwtRmlicmlsbGF0aW9uL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Mirati's Sitravatinib Flunks Phase 3 Combo Therapy Study In Type Of Lung Cancer Setting - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9taXJhdGlzLXNpdHJhdmF0aW5pYi1mbHVua3MtcGhhc2UtMy0xNDE1NDA2NjcuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL21pcmF0aXMtc2l0cmF2YXRpbmliLWZsdW5rcy1waGFzZS0zLTE0MTU0MDY2Ny5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Pharma world braces for major changes in new era of AI - Clinical Trials Arena",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmNsaW5pY2FsdHJpYWxzYXJlbmEuY29tL25ld3MvcGhhcm1hLXdvcmxkLWJyYWNlcy1mb3ItbWFqb3ItY2hhbmdlcy1pbi1uZXctZXJhLW9mLWFpL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/12/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb awards $430 million US media business to ... - Ad Age",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vYWRhZ2UuY29tL2FydGljbGUvYWdlbmN5LW5ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItYXdhcmRzLTQzMC1taWxsaW9uLXVzLW1lZGlhLWJ1c2luZXNzLWlwZ3MtbWVkaWFicmFuZHMvMjQ5NDg0NtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb\u2019s Sotyktu approved by MHRA for plaque ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYnJpc3RvbF9teWVyc19zcXVpYmJzX3NvdHlrdHVfYXBwcm92ZWRfYnlfbWhyYV9mb3JfcGxhcXVlX3Bzb3JpYXNpc18xNDkxNTY10gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Which Pharmaceuticals Stock Is A Better Pick: Johnson & Johnson Or Eliquis\u2019 Maker? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjMvMDUvMTcvd2hpY2gtcGhhcm1hY2V1dGljYWxzLXN0b2NrLWlzLWEtYmV0dGVyLXBpY2stam9obnNvbi0tam9obnNvbi1vci1lbGlxdWlzLW1ha2VyL9IBjQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjMvMDUvMTcvd2hpY2gtcGhhcm1hY2V1dGljYWxzLXN0b2NrLWlzLWEtYmV0dGVyLXBpY2stam9obnNvbi0tam9obnNvbi1vci1lbGlxdWlzLW1ha2VyL2FtcC8?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "EHA 2023 \u2013 earlier leak limits the surprise factor - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy1zbmlwcGV0cy9laGEtMjAyMy1lYXJsaWVyLWxlYWstbGltaXRzLXN1cnByaXNlLWZhY3RvctIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE4ODM1L2FtcA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "BMS' Sotyktu gains another approval, now in the UK - The Pharma Letter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9ibXMtc290eWt0dS1nYWlucy1hbm90aGVyLWFwcHJvdmFsLW5vdy1pbi10aGUtdWvSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Milestone for Amphista Therapeutics in collaboration with Bristol Myers Squibb - Cambridge Independent",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmNhbWJyaWRnZWluZGVwZW5kZW50LmNvLnVrL2J1c2luZXNzL21pbGVzdG9uZS1mb3ItYW1waGlzdGEtdGhlcmFwZXV0aWNzLWluLWNvbGxhYm9yYXRpb24td2l0aC1ici05MzEyMzUwL9IBeWh0dHBzOi8vd3d3LmNhbWJyaWRnZWluZGVwZW5kZW50LmNvLnVrL2J1c2luZXNzL2FtcC9taWxlc3RvbmUtZm9yLWFtcGhpc3RhLXRoZXJhcGV1dGljcy1pbi1jb2xsYWJvcmF0aW9uLXdpdGgtYnItOTMxMjM1MC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Wyden blasts Big Pharma for tax ploys and lack of cooperation in ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3Nlbi13eWRlbi1waW5ncy1iaWctcGhhcm1hLWFnYWluLW9mZnNob3JpbmctcHJvZml0c9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/05/2023": {
        "artical1": {
            "title": "Is Bristol-Myers Squibb Stock a Buy Now? - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA1LzExL2lzLWJyaXN0b2wtbXllcnMtc3F1aWJiLXN0b2NrLWEtYnV5LW5vdy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Here's Why We Think Bristol-Myers Squibb (NYSE:BMY) Is Well Worth Watching - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9oZXJlcy13aHktdGhpbmstYnJpc3RvbC1teWVycy0xMTAwMjc4ODguaHRtbNIBU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2hlcmVzLXdoeS10aGluay1icmlzdG9sLW15ZXJzLTExMDAyNzg4OC5odG1s?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Squibb: Attractive Entry As New Products Sales ... - Seeking Alpha",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ2MDAzODMtYm15LWF0dHJhY3RpdmUtZW50cnktYXMtbmV3LXByb2R1Y3RzLXNhbGVzLWFjY2VsZXJhdGXSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Which Is the Better Passive Income Stock, Eli Lilly or Bristol Myers ... - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzA1LzA1L3doaWNoLWlzLXRoZS1iZXR0ZXItcGFzc2l2ZS1pbmNvbWUtc3RvY2stZWxpLWxpbGx5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb Will Lay Off 48 Employees At Princeton Location - Patch",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vcGF0Y2guY29tL25ldy1qZXJzZXkvcHJpbmNldG9uL2JyaXN0b2wtbXllcnMtc3F1aWJiLXdpbGwtbGF5b2ZmLTQ4LWVtcGxveWVlcy1wcmluY2V0b24tbG9jYXRpb27SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Court of Appeal confirms invalidity of Bristol-Myers Squibb apixaban ... - JUVE Patent",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3Lmp1dmUtcGF0ZW50LmNvbS9jYXNlcy9jb3VydC1vZi1hcHBlYWwtY29uZmlybXMtaW52YWxpZGl0eS1vZi1icmlzdG9sLW15ZXJzLXNxdWliYi1hcGl4YWJhbi1wYXRlbnQv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "$2.9 billion in sales forecast for BMS' Sotyktu by 2029 - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS8yLTktYmlsbGlvbi1pbi1zYWxlcy1mb3JlY2FzdC1mb3ItYm1zLXNvdHlrdHUtYnktMjAyOdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/28/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb's TRANSCEND FL and TRANSCEND NHL 001 ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYnMtVFJBTlNDRU5ELUZMLWFuZC1UUkFOU0NFTkQtTkhMLTAwMS1TdHVkaWVzLW9mLUJyZXlhbnppLWxpc29jYWJ0YWdlbmUtbWFyYWxldWNlbGluLVJlbGFwc2VkLW9yLVJlZnJhY3RvcnktRm9sbGljdWxhci1MeW1waG9tYS1hbmQtTWFudGxlLUNlbGwtTHltcGhvbWEtTWVldC1QcmltYXJ5LUVuZHBvaW50LW9mLU92ZXJhbGwtUmVzcG9uc2UtUmF0ZS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS boosts its CAR T therapy manufacturing capabilities - European Pharmaceutical Review",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmV1cm9wZWFucGhhcm1hY2V1dGljYWxyZXZpZXcuY29tL25ld3MvMTgyMTAyL2JyaXN0b2wtbXllcnMtc3F1aWJiLWJvb3N0cy1jYXItdC10aGVyYXB5LW1hbnVmYWN0dXJpbmctY2FwYWJpbGl0aWVzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Immatics Announces First Bristol Myers Squibb Opt-in of TCR-T ... - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMiwQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8wNS8wMS8yNjU4MTY2LzAvZW4vSW1tYXRpY3MtQW5ub3VuY2VzLUZpcnN0LUJyaXN0b2wtTXllcnMtU3F1aWJiLU9wdC1pbi1vZi1UQ1ItVC1DYW5kaWRhdGUtZnJvbS1PbmdvaW5nLU11bHRpLXRhcmdldC1TdHJhdGVnaWMtQ29sbGFib3JhdGlvbi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "U.S. FDA Accepts for Priority Review Supplemental Biologics ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimgJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9VLlMuLUZEQS1BY2NlcHRzLWZvci1Qcmlvcml0eS1SZXZpZXctU3VwcGxlbWVudGFsLUJpb2xvZ2ljcy1MaWNlbnNlLUFwcGxpY2F0aW9uLWFuZC1FTUEtVmFsaWRhdGVzLUFwcGxpY2F0aW9uLWZvci1SZWJsb3p5bC1sdXNwYXRlcmNlcHQtYWFtdC1hcy1GaXJzdC1MaW5lLVRyZWF0bWVudC1vZi1BbmVtaWEtaW4tQWR1bHRzLXdpdGgtTG93ZXItUmlzay1NeWVsb2R5c3BsYXN0aWMtU3luZHJvbWVzLU1EUy9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi8AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLWZvci1DQVItVC1DZWxsLVRoZXJhcHktQnJleWFuemktbGlzb2NhYnRhZ2VuZS1tYXJhbGV1Y2VsLWZvci1SZWxhcHNlZC1vci1SZWZyYWN0b3J5LUxhcmdlLUItY2VsbC1MeW1waG9tYS1BZnRlci1PbmUtUHJpb3ItVGhlcmFweS9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "BMS CEO set to leave after 8-year run\u2014Chutes & Ladders - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvY2h1dGVzLWxhZGRlcnMtYm1zLWNlby1zZXQtbGVhdmUtYWZ0ZXItOC15ZWFyLXJ1btIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb to Participate in Bank of America Securities ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1QYXJ0aWNpcGF0ZS1pbi1CYW5rLW9mLUFtZXJpY2EtU2VjdXJpdGllcy0yMDIzLUhlYWx0aGNhcmUtQ29uZmVyZW5jZS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/21/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIzL0JyaXN0b2wtTXllcnMtU3F1aWJiLVJlcG9ydHMtRmlyc3QtUXVhcnRlci1GaW5hbmNpYWwtUmVzdWx0cy1mb3ItMjAyMy9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces Leadership ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIzL0JyaXN0b2wtTXllcnMtU3F1aWJiLUFubm91bmNlcy1MZWFkZXJzaGlwLVRyYW5zaXRpb24tUGxhbi9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers looks to new CEO as competition from generic drugs ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2JyaXN0b2wtbXllcnMtcG9zdHMtbG93ZXItcTEtc2FsZXMtcmV2bGltaWQtZmFsbHMtMjAyMy0wNC0yNy_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers' Caforio stepping down as CEO in November - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1teWVycy1jYWZvcmlvLXJldGlyZS1jZW8tYm9lcm5lci1zdWNjZWVkLzY0ODc1Ny_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Strengthens Cell ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1TdHJlbmd0aGVucy1DZWxsLVRoZXJhcHktQ2FwYWJpbGl0aWVzLWJ5LUFkZGluZy1OZXctVS5TLi1NYW51ZmFjdHVyaW5nLUZhY2lsaXR5LWZvci1WaXJhbC1WZWN0b3ItUHJvZHVjdGlvbi9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb and Tubulis partner in deal worth over $1bn - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYnJpc3RvbF9teWVyc19zcXVpYmJfYW5kX3R1YnVsaXNfcGFydG5lcl9pbl9kZWFsX3dvcnRoX292ZXJfMWJuXzE0OTEwMDPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb's Sotyktu scores European approval for plaque ... - Clinical Trials Arena",
            "link": "https://news.google.com/rss/articles/CBMiQWh0dHBzOi8vd3d3LmNsaW5pY2FsdHJpYWxzYXJlbmEuY29tL2NvbW1lbnQvYm1zLXNvdHlrdHUtYXBwcm92YWwv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/14/2023": {
        "artical1": {
            "title": "Regulatory Applications Accepted Across Three Regions Globally ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi3AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9SZWd1bGF0b3J5LUFwcGxpY2F0aW9ucy1BY2NlcHRlZC1BY3Jvc3MtVGhyZWUtUmVnaW9ucy1HbG9iYWxseS1mb3ItQWJlY21hLWZvci1FYXJsaWVyLVVzZS1pbi1BZHVsdHMtd2l0aC1UcmlwbGUtQ2xhc3MtRXhwb3NlZC1SZWxhcHNlZC1hbmRvci1SZWZyYWN0b3J5LU11bHRpcGxlLU15ZWxvbWEvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Three regulators accept Bristol Myers' applications for myeloma - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvcmVndWxhdG9ycy1icmlzdG9sLW15ZXJzLW15ZWxvbWEv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA Accepts sBLA for Ide-cel in Triple-class Exposed Relapsed ... - OncLive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvZmRhLWFjY2VwdHMtc2JsYS1mb3ItaWRlLWNlbC1pbi10cmlwbGUtY2xhc3MtZXhwb3NlZC1yZWxhcHNlZC1yZWZyYWN0b3J5LW15ZWxvbWHSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Tubulis, Bristol Myers agree to develop ADCs for cancer treatment - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvdHVidWxpcy1icmlzdG9sLW15ZXJzLXNxdWliYi_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol-Myers Squibb (NYSE:BMY) shareholders have earned a 9.7% CAGR over the last five years - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1ueXNlLWJteS0xMzAwMjYzOTkuaHRtbNIBU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLW55c2UtYm15LTEzMDAyNjM5OS5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "How a Korean company that does just about everything is saving a historic pharmaceutical campus in East Syracuse - WSYR",
            "link": "https://news.google.com/rss/articles/CBMijwFodHRwczovL3d3dy5sb2NhbHN5ci5jb20vbmV3cy9ob3ctYS1rb3JlYW4tY29tcGFueS10aGF0LWRvZXMtanVzdC1hYm91dC1ldmVyeXRoaW5nLWlzLXNhdmluZy1hLWhpc3RvcmljLXBoYXJtYWNldXRpY2FsLWNhbXB1cy1pbi1lYXN0LXN5cmFjdXNlL9IBkwFodHRwczovL3d3dy5sb2NhbHN5ci5jb20vbmV3cy9ob3ctYS1rb3JlYW4tY29tcGFueS10aGF0LWRvZXMtanVzdC1hYm91dC1ldmVyeXRoaW5nLWlzLXNhdmluZy1hLWhpc3RvcmljLXBoYXJtYWNldXRpY2FsLWNhbXB1cy1pbi1lYXN0LXN5cmFjdXNlL2FtcC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Big Pharma Companies Ranked by Revenue 2022 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RvcC0yMC1waGFybWEtY29tcGFuaWVzLTIwMjItcmV2ZW51ZdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/07/2023": {
        "artical1": {
            "title": "Foundation Medicine and Bristol Myers Squibb Expand Partnership ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDQxMTAwNTQxOS9lbi9Gb3VuZGF0aW9uLU1lZGljaW5lLWFuZC1CcmlzdG9sLU15ZXJzLVNxdWliYi1FeHBhbmQtUGFydG5lcnNoaXAtdG8tRm9jdXMtb24tQ29tcGFuaW9uLURpYWdub3N0aWMtRGV2ZWxvcG1lbnTSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers, Pfizer Sue to Block Copies of Blockbuster Eliquis - Bloomberg Law",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcuY29tL2lwLWxhdy9icmlzdG9sLW15ZXJzLXBmaXplci1zdWUtdG8tYmxvY2stY29waWVzLW9mLWJsb2NrYnVzdGVyLWVsaXF1aXPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Abortion-pill ruling threatens FDA's authority, say drug firms - Nature.com",
            "link": "https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvZDQxNTg2LTAyMy0wMTA0NC030gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "BMS' DTC Search campaign educates cancer patients on treatment ... - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9jYW1wYWlnbnMvYm1zLWR0Yy1zZWFyY2gtY2FtcGFpZ24tZWR1Y2F0ZXMtY2FuY2VyLXBhdGllbnRzLW9uLXRyZWF0bWVudC1wb3NzaWJpbGl0aWVzL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Addition of Ipilimumab to Nivolumab in Recurrent or Metastatic Head ... - The ASCO Post",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vYXNjb3Bvc3QuY29tL25ld3MvYXByaWwtMjAyMy9hZGRpdGlvbi1vZi1pcGlsaW11bWFiLXRvLW5pdm9sdW1hYi1pbi1yZWN1cnJlbnQtb3ItbWV0YXN0YXRpYy1oZWFkLWFuZC1uZWNrLWNhbmNlci_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Accelerating the Evolution of Immune-Related Enterocolitis ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDI5MTTSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Evotec shuts down network after cyberattack - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYmlnLXBoYXJtYS1wYXJ0bmVyZWQtZXZvdGVjLWNsb3Nlcy1kb3duLWhhdGNoZXRzLWFmdGVyLWN5YmVyLWF0dGFja9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/31/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives Positive ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi6QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tZm9yLUNBUi1ULUNlbGwtVGhlcmFweS1CcmV5YW56aS1saXNvY2FidGFnZW5lLW1hcmFsZXVjZWwtZm9yLVJlbGFwc2VkLW9yLVJlZnJhY3RvcnktTGFyZ2UtQi1jZWxsLUx5bXBob21hLUFmdGVyLU9uZS1Qcmlvci1UaGVyYXB5L2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Evotec and BMS sign eight-year neuro discovery deal - OutSourcing-Pharma.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3Lm91dHNvdXJjaW5nLXBoYXJtYS5jb20vQXJ0aWNsZS8yMDIzLzA0LzAzL0V2b3RlYy1hbmQtQk1TLXNpZ24tZWlnaHQteWVhci1uZXVyby1kaXNjb3ZlcnktZGVhbNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Pharmaceutical Giant Boosts San Diego Presence With Signing at ... - CoStar Group",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmNvc3Rhci5jb20vYXJ0aWNsZS8xNDEzMTU4Mjc4L3BoYXJtYWNldXRpY2FsLWdpYW50LWJvb3N0cy1zYW4tZGllZ28tcHJlc2VuY2Utd2l0aC1zaWduaW5nLWF0LWFsZXhhbmRyaWEtY2FtcHVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "CHMP recommends Bristol Myers Squibb's Breyanzi approval - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvY2htcC1icmlzdG9sLW15ZXJzLXNxdWliYi1icmV5YW56aS_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Molecular Templates halves head count, parting company with 100 ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvbW9sZWN1bGFyLXRlbXBsYXRlcy1oYWx2ZXMtaGVhZGNvdW50LXBhcnRpbmctY29tcGFueS0xMDAtcGx1cy1zdGFmZmVycy1jYXNoLWNydW5jaC1sb29tc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "MRK vs. BMY: Which Pharmaceutical Stock is Better? - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvbXJrLXZzLi1ibXk6LXdoaWNoLXBoYXJtYWNldXRpY2FsLXN0b2NrLWlzLWJldHRlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "$2.5 Million Grant From BMS Foundation to Support Geriatric ... - University of Pennsylvania",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vYWxtYW5hYy51cGVubi5lZHUvYXJ0aWNsZXMvZ3JhbnQtZnJvbS1ibXMtZm91bmRhdGlvbi10by1zdXBwb3J0LWdlcmlhdHJpYy1vbmNvbG9neS1hdC1wZW5uLW1lZGljaW5lLXByaW5jZXRvbi1oZWFsdGjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/24/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi2QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLW9mLVNvdHlrdHUtZGV1Y3JhdmFjaXRpbmliLWEtT25jZS1EYWlseS1PcmFsLVRyZWF0bWVudC1mb3ItQWR1bHRzLVdpdGgtTW9kZXJhdGUtdG8tU2V2ZXJlLVBsYXF1ZS1Qc29yaWFzaXMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Evotec and Bristol Myers Squibb extend and expand strategic ... - Evotec",
            "link": "https://news.google.com/rss/articles/CBMikgFodHRwczovL3d3dy5ldm90ZWMuY29tL2VuL2ludmVzdG9yLXJlbGF0aW9ucy9uZXdzL3AvZXZvdGVjLWFuZC1icmlzdG9sLW15ZXJzLXNxdWliYi1leHRlbmQtYW5kLWV4cGFuZC1zdHJhdGVnaWMtbmV1cm9kZWdlbmVyYXRpb24tcGFydG5lcnNoaXAtNjI2OdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Early Innovation at BMS - Bristol Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMiPmh0dHBzOi8vd3d3LmJtcy5jb20vYnVzaW5lc3MtZGV2ZWxvcG1lbnQvZWFybHktaW5ub3ZhdGlvbi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Is Eli Lilly or Bristol Myers Squibb the Better Value Stock to Buy ... - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzAzLzI4L2lzLWVsaS1saWxseS1vci1icmlzdG9sLW15ZXJzLXNxdWliYi10aGUtYmV0dGVyLXZhL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Neoadjuvant Opdivo (nivolumab) with Chemotherapy Demonstrates ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi9gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9OZW9hZGp1dmFudC1PcGRpdm8tbml2b2x1bWFiLXdpdGgtQ2hlbW90aGVyYXB5LURlbW9uc3RyYXRlcy1Mb25nLVRlcm0tRHVyYWJsZS1DbGluaWNhbC1CZW5lZml0cy1mb3ItUGF0aWVudHMtd2l0aC1SZXNlY3RhYmxlLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyLWF0LVRocmVlLVllYXJzLWluLXRoZS1DaGVja01hdGUtLTgxNi1UcmlhbC9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "The Bristol-Myers Squibb Children's Hospital at RWJUH Pediatric ... - RWJBarnabas Health",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LnJ3amJoLm9yZy9ibG9nLzIwMjMvbWFyY2gvdGhlLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNoaWxkcmVuLXMtaG9zcGl0YWwtYm1zL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers creates dark and stark film about the experience of ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtY3JlYXRlcy1kYXJrLWFuZC1zdGFyay1maWxtLWFib3V0LWV4cGVyaWVuY2UtbGl2aW5nLXNlcmlvdXMtZGlzZWFzZXPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/17/2023": {
        "artical1": {
            "title": "CHARM Therapeutics Announces Collaboration with Bristol Myers ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMivQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDMyMDAwNTEwMS9lbi9DSEFSTS1UaGVyYXBldXRpY3MtQW5ub3VuY2VzLUNvbGxhYm9yYXRpb24td2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYi10by1FbmFibGUtYW5kLUFjY2VsZXJhdGUtU21hbGwtTW9sZWN1bGUtRHJ1Zy1EaXNjb3ZlcnktUHJvZ3JhbXPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "$2.5 Million Grant Supports Specialized Geriatric Cancer Care at ... - Penn Medicine",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnBlbm5tZWRpY2luZS5vcmcvbmV3cy9uZXdzLXJlbGVhc2VzLzIwMjMvbWFyY2gvZ3JhbnQtc3VwcG9ydHMtc3BlY2lhbGl6ZWQtZ2VyaWF0cmljLWNhbmNlci1jYXJl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "BMS grants $10m in funding to address health disparity - OutSourcing-Pharma.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3Lm91dHNvdXJjaW5nLXBoYXJtYS5jb20vQXJ0aWNsZS8yMDIzLzAzLzIwL2Jtcy1ncmFudHMtMTBtLWluLWZ1bmRpbmctdG8tYWRkcmVzcy1oZWFsdGgtZGlzcGFyaXR50gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers plots interstellar manufacturing move aboard ISS - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9icmlzdG9sLW15ZXJzLXNob290cy1zdGFycy1uZXh0LWxlZy1pbnRlcm5hdGlvbmFsLXNwYWNlLXN0YXRpb24tYmlvbWFudWZhY3R1cmluZ9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Takeda, chasing Bristol Myers, unveils awaited TYK2 drug data - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGFrZWRhLXR5azItcHNvcmlhc2lzLXN0dWR5LXJlc3VsdHMtYWFkLW5pbWJ1cy82NDUyOTEv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Initial Evidence for the Efficacy of Naporafenib in Combination With ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjIuMDIwMTjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Definition and Clinical Significance of the Monoclonal Gammopathy ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDE5MTbSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/10/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces Progress ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtUHJvZ3Jlc3MtVG93YXJkLUxvbmctVGVybS1JbmNsdXNpb24tLURpdmVyc2l0eS1Hb2Fscy1hbmQtSGVhbHRoLUVxdWl0eS1Db21taXRtZW50cy9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Evotec announces progress in strategic protein degradation ... - Evotec",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5ldm90ZWMuY29tL2VuL2ludmVzdG9yLXJlbGF0aW9ucy9uZXdzL3AvZXZvdGVjLWFubm91bmNlcy1wcm9ncmVzcy1pbi1zdHJhdGVnaWMtcHJvdGVpbi1kZWdyYWRhdGlvbi1wYXJ0bmVyc2hpcC13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLTYyNTnSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLXBmaXplci1hYmJ2aWUtZHJ1Z3MtbGlrZWx5LWZhY2UtdXMtcHJpY2UtbmVnb3RpYXRpb24tMjAyMy0wMy0xMy_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Should Investors Buy Bristol Myers or CVS Stock Near 52-week Lows? - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9pbnZlc3RvcnMtYnV5LWJyaXN0b2wtbXllcnMtY3ZzLTAxNDAwMTIwOC5odG1s0gFVaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvaW52ZXN0b3JzLWJ1eS1icmlzdG9sLW15ZXJzLWN2cy0wMTQwMDEyMDguaHRtbA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "BMS declines option on two Exscientia oncology candidates - The Pharma Letter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9ibXMtZGVjbGluZXMtb3B0aW9uLW9uLXR3by1leHNjaWVudGlhLW9uY29sb2d5LWNhbmRpZGF0ZXPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Tearing Down Silos to Usher Innovative Medicines to Patients Faster - Pharmaceutical Executive",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy90ZWFyaW5nLWRvd24tc2lsb3MtdG8tdXNoZXItaW5ub3ZhdGl2ZS1tZWRpY2luZXMtdG8tcGF0aWVudHMtZmFzdGVy0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "BMS will not launch cancer drug Opdualag in Germany due to ... - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYm1zX3dpbGxfbm90X2xhdW5jaF9jYW5jZXJfZHJ1Z19vcGR1YWxhZ19pbl9nZXJtYW55X2R1ZV90b19wcmljaW5nX3ByZXNzdXJlc18xNDg5MDk10gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/03/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi1AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLW9mLVJlYmxvenlsLWx1c3BhdGVyY2VwdC1mb3ItQW5lbWlhLWluLUFkdWx0LVBhdGllbnRzLXdpdGgtTm9uLVRyYW5zZnVzaW9uLURlcGVuZGVudC1CZXRhLVRoYWxhc3NlbWlhL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "U.S. Supreme Court Declines to Consider Whether Bristol-Myers ... - Jackson Lewis",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmphY2tzb25sZXdpcy5jb20vaW5zaWdodHMvdXMtc3VwcmVtZS1jb3VydC1kZWNsaW5lcy1jb25zaWRlci13aGV0aGVyLWJyaXN0b2wtbXllcnMtYXBwbGllcy1jb2xsZWN0aXZlLWFjdGlvbnPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Announces Dividend - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIzL0JyaXN0b2wtTXllcnMtU3F1aWJiLUFubm91bmNlcy1EaXZpZGVuZC9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb Sending Science to Space - ISS National Lab",
            "link": "https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vd3d3Lmlzc25hdGlvbmFsbGFiLm9yZy9zcHgyNy1icmlzdG9sLW15ZXJzLXNxdWliYi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Viz.ai Announces Agreement with Bristol Myers Squibb to Enable ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMixQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDMwMzAwNTA4Ni9lbi9WaXouYWktQW5ub3VuY2VzLUFncmVlbWVudC13aXRoLUJyaXN0b2wtTXllcnMtU3F1aWJiLXRvLUVuYWJsZS1FYXJsaWVyLURldGVjdGlvbi1hbmQtTWFuYWdlbWVudC1vZi1TdXNwZWN0ZWQtSHlwZXJ0cm9waGljLUNhcmRpb215b3BhdGh5LUhDTdIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol-Myers Squibb (NYSE:BMY) Is Increasing Its Dividend To $0.57 - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1ueXNlLWJteS0xMDMzMDkzMTguaHRtbNIBU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLW55c2UtYm15LTEwMzMwOTMxOC5odG1s?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers axes German launch of new cancer drug, citing pricing ... - Endpoints News",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vZW5kcHRzLmNvbS9icmlzdG9sLW15ZXJzLWF4ZXMtZ2VybWFuLWxhdW5jaC1vZi1uZXctY2FuY2VyLWRydWctY2l0aW5nLXByaWNpbmctaHVyZGxlcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/24/2023": {
        "artical1": {
            "title": "U.S. Food and Drug Administration Accepts Bristol Myers Squibb's ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi6AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQWNjZXB0cy1CcmlzdG9sLU15ZXJzLVNxdWliYnMtU3VwcGxlbWVudGFsLUJpb2xvZ2ljcy1MaWNlbnNlLUFwcGxpY2F0aW9uLWFuZC1FdXJvcGVhbi1NZWRpY2luZXMtQWdlbmN5LVZhbGlkYXRlcy1BcHBsaWNhdGlvbi1mb3ItT3BkaXZvLW5pdm9sdW1hYi0vZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "FDA Accepts Bristol Myers Squibb's sBLA for Nivolumab for ... - Dermatology Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmRlcm1hdG9sb2d5dGltZXMuY29tL3ZpZXcvZmRhLWFjY2VwdHMtYnJpc3RvbC1teWVycy1zcXVpYmItcy1zYmxhLWZvci1uaXZvbHVtYWItZm9yLXJlc2VjdGVkLXN0YWdlLWlpYi1jLW1lbGFub21h0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA Accepts Supplemental BLA for Nivolumab in Stage IIB/C ... - Cancer Network",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvZmRhLWFjY2VwdHMtc3VwcGxlbWVudGFsLWJsYS1mb3Itbml2b2x1bWFiLWluLXN0YWdlLWlpYi1jLW1lbGFub21h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb - The Bristol Myers Squibb-Janssen ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi3QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9UaGUtQnJpc3RvbC1NeWVycy1TcXVpYmItSmFuc3Nlbi1Db2xsYWJvcmF0aW9uLUxhdW5jaGVzLVBpdm90YWwtUGhhc2UtMy1MaWJyZXhpYS1DbGluaWNhbC1UcmlhbC1Qcm9ncmFtLUV2YWx1YXRpbmctTWlsdmV4aWFuLWFuLUludmVzdGlnYXRpb25hbC1PcmFsLUZhY3Rvci1YSWEtSW5oaWJpdG9yL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers wins dismissal of a $6.4 billion lawsuit over cancer ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL2JyaXN0b2wtbXllcnMtd2lucy1kaXNtaXNzYWwtbGF3c3VpdC1vdmVyLWNlbGdlbmUtZHJ1Z3MtMjAyMy0wMy0wMS_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb to Participate in Cowen's 43rd Annual Health ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMihAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1QYXJ0aWNpcGF0ZS1pbi1Db3dlbnMtNDNyZC1Bbm51YWwtSGVhbHRoLUNhcmUtQ29uZmVyZW5jZS9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb to Present Data ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi6wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1QcmVzZW50LURhdGEtU3VwcG9ydGluZy1pdHMtQ2FyZGlvdmFzY3VsYXItUG9ydGZvbGlvLWF0LXRoZS1BbWVyaWNhbi1Db2xsZWdlLW9mLUNhcmRpb2xvZ3ktQW5udWFsLVNjaWVudGlmaWMtU2Vzc2lvbi1Ub2dldGhlci1XaXRoLVdvcmxkLUNvbmdyZXNzLW9mLUNhcmRpb2xvZ3kvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/17/2023": {
        "artical1": {
            "title": "Adjuvant Opdivo (nivolumab) Continues to Provide Significant ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMihgJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9BZGp1dmFudC1PcGRpdm8tbml2b2x1bWFiLUNvbnRpbnVlcy10by1Qcm92aWRlLVNpZ25pZmljYW50LUR1cmFibGUtQ2xpbmljYWwtQmVuZWZpdHMtZm9yLVBhdGllbnRzLXdpdGgtUmFkaWNhbGx5LVJlc2VjdGVkLUhpZ2gtUmlzay1NdXNjbGUtSW52YXNpdmUtVXJvdGhlbGlhbC1DYXJjaW5vbWEtQWZ0ZXItVGhyZWUtWWVhcnMtaW4tQ2hlY2tNYXRlLS0yNzQtVHJpYWwvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "What To Expect From Bristol-Myers Squibb In 2023 (NYSE:BMY) - Seeking Alpha",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1Nzk5NTEtYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2std2hhdC10by1leHBlY3QtaW4tMjAyM9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMY Stock: Can Bristol Myers' New Products Fill The Looming ... - Investor's Business Daily",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2JteS1zdG9jay1jYW4taXRzLW5ldy1wcm9kdWN0cy1maWxsLXRoZS1sb29taW5nLXBhdGVudC1jbGlmZi1nYXAv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait Campaign to Raise Awareness of Atrial Fibrillation (AFib) and its Symptoms - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iYXNrZXRiYWxsLWxlZ2VuZC1rYXJlZW0tYWJkdWwtamFiYmFyLTE2NTAwMDQ0My5odG1s0gFbaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvYmFza2V0YmFsbC1sZWdlbmQta2FyZWVtLWFiZHVsLWphYmJhci0xNjUwMDA0NDMuaHRtbA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Kareem Abdul-Jabbar Has Atrial Fibrillation, Partners With Bristol ... - Black Enterprise",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5ibGFja2VudGVycHJpc2UuY29tL2thcmVlbS1hYmR1bC1qYWJiYXItcGFydG5lcnMtd2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi1hbmQtcGl6ZXItdG8tcmFpc2UtYXdhcmVuZXNzLWFib3V0LWF0cmlhbC1maWJyaWxsYXRpb24v0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "With FDA approval for Filspari, Travere turns Bristol Myers castoff ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3RyYXZlcmUtZmRhLWFwcHJvdmFsLWJyaXN0b2wtbXllcnMtY2FzdG9mZi11bmlxdWUtZHJ1Zy1yYXJlLWtpZG5leS1kaXNlYXNl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "'An opportunity for cure' pushes cancer researcher to persevere - Healio",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjMwMjE3L2FuLW9wcG9ydHVuaXR5LWZvci1jdXJlLXB1c2hlcy1jYW5jZXItcmVzZWFyY2hlci10by1wZXJzZXZlcmXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/10/2023": {
        "artical1": {
            "title": "Abecma (idecabtagene vicleucel) Reduced the Risk of Disease ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMilwJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9BYmVjbWEtaWRlY2FidGFnZW5lLXZpY2xldWNlbC1SZWR1Y2VkLXRoZS1SaXNrLW9mLURpc2Vhc2UtUHJvZ3Jlc3Npb24tb3ItRGVhdGgtYnktNTEtVmVyc3VzLVN0YW5kYXJkLVJlZ2ltZW5zLWluLUVhcmxpZXItTGluZXMtb2YtVGhlcmFweS1mb3ItUmVsYXBzZWQtYW5kLVJlZnJhY3RvcnktTXVsdGlwbGUtTXllbG9tYS1CYXNlZC1vbi1SZXN1bHRzLWZyb20tUGhhc2UtMy1LYXJNTWEtMy1TdHVkeS9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "CAR-T cancer therapy reduces risk of multiple myeloma relapse - STAT",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDIzLzAyLzEwL2Nhci10LW15ZWxvbWEv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Ide-cel CAR-T significantly extends PFS in advanced multiple ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjMwMjEwL2lkZWNlbC1jYXJ0LXNpZ25pZmljYW50bHktZXh0ZW5kcy1wZnMtaW4tYWR2YW5jZWQtbXVsdGlwbGUtbXllbG9tYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Basketball Legend Kareem Abdul-Jabbar Joins No Time to Wait ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMiuAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CYXNrZXRiYWxsLUxlZ2VuZC1LYXJlZW0tQWJkdWwtSmFiYmFyLUpvaW5zLU5vLVRpbWUtdG8tV2FpdC1DYW1wYWlnbi10by1SYWlzZS1Bd2FyZW5lc3Mtb2YtQXRyaWFsLUZpYnJpbGxhdGlvbi1BRmliLWFuZC1pdHMtU3ltcHRvbXMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Kareem Abdul-Jabbar Speaks About His Atrial Fibrillation Diagnosis ... - PEOPLE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vcGVvcGxlLmNvbS9oZWFsdGgva2FyZWVtLWFiZHVsLWphYmJhci1hdHJpYWwtZmlicmlsbGF0aW9uLWdldC1oZWFydC1jaGVja2VkL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Kareem Abdul-Jabbar reveals atrial fibrillation diagnosis: what does it mean for the NBA legend? - Marca",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3Lm1hcmNhLmNvbS9lbi9iYXNrZXRiYWxsL25iYS8yMDIzLzAyLzE3LzYzZWVlYzU3Y2E0NzQxYjgxNzhiNDVhNy5odG1s0gFQaHR0cHM6Ly9hbXAubWFyY2EuY29tL2VuL2Jhc2tldGJhbGwvbmJhLzIwMjMvMDIvMTcvNjNlZWVjNTdjYTQ3NDFiODE3OGI0NWE3Lmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Opdivo\u00ae (nivolumab) in Combination with CABOMETYX ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi8QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9PcGRpdm8tbml2b2x1bWFiLWluLUNvbWJpbmF0aW9uLXdpdGgtQ0FCT01FVFlYLWNhYm96YW50aW5pYi1TaG93cy1EdXJhYmxlLVN1cnZpdmFsLXdpdGgtT3Zlci1UaHJlZS1ZZWFycy1vZi1Gb2xsb3ctVXAtaW4tdGhlLUNoZWNrTWF0ZS0tOUVSLVRyaWFsLWluLUZpcnN0LUxpbmUtQWR2YW5jZWQtUmVuYWwtQ2VsbC1DYXJjaW5vbWEvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/03/2023": {
        "artical1": {
            "title": "BMS Collaboration Paying Off for Exscientia - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL2Jtcy1jb2xsYWJvcmF0aW9uLXBheWluZy1vZmYtZm9yLWV4c2NpZW50aWEv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Dragonfly asset flies home as BMS deal crumbles - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYm1zLXJldHVybnMtNDc1bS1vbmNvbG9neS1hc3NldC1iYWNrLWRyYWdvbmZseXMtcG9uZNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb to Participate in the Guggenheim Healthcare ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1QYXJ0aWNpcGF0ZS1pbi10aGUtR3VnZ2VuaGVpbS1IZWFsdGhjYXJlLVRhbGtzLTIwMjMtT25jb2xvZ3ktQ29uZmVyZW5jZS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb Children's Hospital Earns First Accreditation in ... - RWJBarnabas Health",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LnJ3amJoLm9yZy9ibG9nLzIwMjMvZmVicnVhcnkvdGhlLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNoaWxkcmVuLXMtaG9zcGl0YWwtYXQtL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Could This Indication Provide a Lift for Bristol Myers Squibb's Stock? - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzAyLzA2L2NvdWxkLXRoaXMtaW5kaWNhdGlvbi1saWZ0LWJyaXN0b2wtbXllcnMtc3RvY2sv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Meet Pam Fisher: The Chief Diversity Officer Advocating For ... - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2tlbm5ldGhqd2lsbGlhbXNqci8yMDIzLzAyLzA3L21lZXQtcGFtLWZpc2hlci10aGUtY2hpZWYtZGl2ZXJzaXR5LW9mZmljZXItYWR2b2NhdGluZy1mb3ItdW5kZXJyZXByZXNlbnRlZC1jb21tdW5pdGllcy_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Updated: R&D turbulence at Bristol Myers now includes the end of a ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vZW5kcHRzLmNvbS9yZC10dXJidWxlbmNlLWJyaXN0b2wtbXllcnMtZW5kLTY1MG0tYWxsaWFuY2UtZHJhZ29uZmx5LXJ1cGVydC12ZXNzZXktZGVwYXJ0dXJlL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/27/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Reports Fourth Quarter ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMiiAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZXBvcnRzLUZvdXJ0aC1RdWFydGVyLWFuZC1GdWxsLVllYXItRmluYW5jaWFsLVJlc3VsdHMtZm9yLTIwMjIvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives Positive ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi2gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tZm9yLVJlYmxvenlsLWx1c3BhdGVyY2VwdC1mb3ItQWR1bHQtUGF0aWVudHMtd2l0aC1BbmVtaWEtQXNzb2NpYXRlZC1Ob24tVHJhbnNmdXNpb24tRGVwZW5kZW50LU5URC1CZXRhLVRoYWxhc3NlbWlhL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb reports data from trial of Breyanzi for CLL - Clinical Trials Arena",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vd3d3LmNsaW5pY2FsdHJpYWxzYXJlbmEuY29tL25ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItdHJpYWwtYnJleWFuemkv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Exscientia Announces First-in-Human Study for Bristol Myers Squibb ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiowFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDIwMTAwNjAyNC9lbi9FeHNjaWVudGlhLUFubm91bmNlcy1GaXJzdC1pbi1IdW1hbi1TdHVkeS1mb3ItQnJpc3RvbC1NeWVycy1TcXVpYmItSW4tTGljZW5zZWQtUEtDLVRoZXRhLUluaGliaXRvci1FWFM0MzE40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb to settle lawsuit with two employees fired for ... - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5tbW0tb25saW5lLmNvbS9ob21lL2NoYW5uZWwvYnJpc3RvbC1teWVycy1zcXVpYmItdG8tc2V0dGxlLWxhd3N1aXQtd2l0aC10d28tZW1wbG95ZWVzLWZpcmVkLWZvci1yZWZ1c2luZy1jb3ZpZC0xOS12YWNjaW5lL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Prothena Reports Topline Phase 1 Single Ascending Dose Study ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMi4QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIzMDEzMTAwNTk4MS9lbi9Qcm90aGVuYS1SZXBvcnRzLVRvcGxpbmUtUGhhc2UtMS1TaW5nbGUtQXNjZW5kaW5nLURvc2UtU3R1ZHktUmVzdWx0cy1vZi1QUlgwMDUtYS1Ob3ZlbC1BbnRpLU1UQlItVGF1LUFudGlib2R5LWZvci10aGUtUG90ZW50aWFsLVRyZWF0bWVudC1vZi1BbHpoZWltZXIlRTIlODAlOTlzLURpc2Vhc2XSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb One Young World Scholarship 2023 (Fully Funded to attend the 2023 One Young World Summit in Belfast, Northern Ireland') - Opportunities For Africans",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3Lm9wcG9ydHVuaXRpZXNmb3JhZnJpY2Fucy5jb20vYnJpc3RvbC1teWVycy1zcXVpYmItc2Nob2xhcnNoaXAtMjAyMy_SAVNodHRwczovL3d3dy5vcHBvcnR1bml0aWVzZm9yYWZyaWNhbnMuY29tL2JyaXN0b2wtbXllcnMtc3F1aWJiLXNjaG9sYXJzaGlwLTIwMjMvP2FtcA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/20/2023": {
        "artical1": {
            "title": "BMS claims AstraZeneca's Imjudo violates two Yervoy patents - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtZG91Ymxlcy1kb3duLWltbXVuby1vbmNvbG9neS1wYXRlbnQtZmlnaHQtYXotdGltZS10YXJnZXRpbmctaW1qdWRv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers sues AstraZeneca for patent infringement over cancer ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL2xpdGlnYXRpb24vYnJpc3RvbC1teWVycy1zdWVzLWFzdHJhemVuZWNhLXBhdGVudC1pbmZyaW5nZW1lbnQtb3Zlci1jYW5jZXItZHJ1Zy0yMDIzLTAxLTI0L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Says AstraZeneca's Imjudo Infringes Yervoy Patent - IPWatchdog.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vaXB3YXRjaGRvZy5jb20vMjAyMy8wMS8yNi9icmlzdG9sLW15ZXJzLXNheXMtYXN0cmF6ZW5lY2EtaW1qdWRvLWluZnJpbmdlcy15ZXJ2b3ktcGF0ZW50L2lkPTE1NTc4My_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Liso-cel Meets CR End Point in Relapsed/Refractory CLL/SLL - OncLive",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvbGlzby1jZWwtbWVldHMtY3ItZW5kLXBvaW50LWluLXJlbGFwc2VkLXJlZnJhY3RvcnktY2xsLXNsbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "iVexSol\u00ae Closes $23.8M Series A-3 Financing; Funds to - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMirQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8wMS8yNi8yNTk2MDAzLzAvZW4vaVZleFNvbC1DbG9zZXMtMjMtOE0tU2VyaWVzLUEtMy1GaW5hbmNpbmctRnVuZHMtdG8tUmV2b2x1dGlvbml6ZS10aGUtUHJvZHVjdGlvbi1vZi1MZW50aXZpcmFsLVZlY3RvcnMuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Mavacamten improves functional status beyond peak O2 in patients ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvY2FyZGlvbG9neS8yMDIzMDEyMC9tYXZhY2FtdGVuLWltcHJvdmVzLWZ1bmN0aW9uYWwtc3RhdHVzLWJleW9uZC1wZWFrLW8yLWluLXBhdGllbnRzLXdpdGgtb2JzdHJ1Y3RpdmUtaGNt0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Another Year of Blockbuster Drug and Treatment Approvals ... - Global X",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3Lmdsb2JhbHhldGZzLmNvbS9hbm90aGVyLXllYXItb2YtYmxvY2tidXN0ZXItZHJ1Zy1hbmQtdHJlYXRtZW50LWFwcHJvdmFscy1wb3NzaWJsZS1pbi0yMDIzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/13/2023": {
        "artical1": {
            "title": "Bristol Myers Squibb - The Robert A. Winn Diversity in Clinical Trials ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi1wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL3BoaWxhbnRocm9weS8yMDIzL1RoZS1Sb2JlcnQtQS4tV2lubi1EaXZlcnNpdHktaW4tQ2xpbmljYWwtVHJpYWxzLUF3YXJkLVByb2dyYW0tRXN0YWJsaXNoZWQtYnktdGhlLUJyaXN0b2wtTXllcnMtU3F1aWJiLUZvdW5kYXRpb24tdG8tRXhwYW5kLXdpdGgtQW1nZW5zLUNvbW1pdG1lbnQtb2YtOC1NaWxsaW9uL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Stock: The Better U.S. Large Cap Pharma Buy - Seeking Alpha",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vc2Vla2luZ2FscGhhLmNvbS9hcnRpY2xlLzQ1NzA0OTktd2h5LWJyaXN0b2wtbXllcnMtc3F1aWJiLWlzLXRoZS1iZXR0ZXItYnV5LWZyb20tdXMtbGFyZ2UtY2FwLXBoYXJtYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Wins Another Approval for Its Multimillion ... - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIzLzAxLzE3L2JyaXN0b2wtbXllcnMtc3F1aWJiLXdpbnMtYW5vdGhlci1hcHByb3ZhbC1mb3ItaXRzL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "How BMS Uses AI To Improve Study Design And Reduce Costs - Clinical Leader",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmNsaW5pY2FsbGVhZGVyLmNvbS9kb2MvaG93LWJtcy11c2VzLWFpLXRvLWltcHJvdmUtc3R1ZHktZGVzaWduLWFuZC1yZWR1Y2UtY29zdHMtMDAwMdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy80LW1lYXN1cmVzLWluZGljYXRlLWJyaXN0b2wtbXllcnMtMTMwMDE5MDAxLmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy80LW1lYXN1cmVzLWluZGljYXRlLWJyaXN0b2wtbXllcnMtMTMwMDE5MDAxLmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "REPORT: These Pharma Companies Are Hiking Prices on Life ... - Accountable.US",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMioQFodHRwczovL2FjY291bnRhYmxlLnVzL3JlcG9ydC10aGVzZS1waGFybWEtY29tcGFuaWVzLWFyZS1oaWtpbmctcHJpY2VzLW9uLWxpZmUtc2F2aW5nLW1lZGljaW5lLWFmdGVyLXJlcG9ydGluZy1iaWxsaW9ucy1pbi1oaWdoZXItcHJvZml0cy1hbmQtaW52ZXN0b3ItZ2l2ZWF3YXlzL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Asco-GI 2023 \u2013 zolbetuximab opens up a stomach cancer niche - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy10cmlhbC1yZXN1bHRzL2FzY28tZ2ktMjAyMy16b2xiZXR1eGltYWItb3BlbnMtc3RvbWFjaC1jYW5jZXLSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODU0MC9hbXA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/06/2023": {
        "artical1": {
            "title": "U.S. Supreme Court again rebuffs Bristol Myers' appeal in Gilead ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL2xpdGlnYXRpb24vdXMtc3VwcmVtZS1jb3VydC1hZ2Fpbi1yZWJ1ZmZzLWJyaXN0b2wtbXllcnMtYXBwZWFsLWdpbGVhZC1wYXRlbnQtZmlnaHQtMjAyMy0wMS0wOS_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Dragonfly Therapeutics Announces Sixth Dragonfly TriNKET Opt-in ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMijwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2RyYWdvbmZseS10aGVyYXBldXRpY3MtYW5ub3VuY2VzLXNpeHRoLWRyYWdvbmZseS10cmlua2V0LW9wdC1pbi1ieS1icmlzdG9sLW15ZXJzLXNxdWliYi0zMDE3MTUxNTAuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "JPM23: Schr\u00f6dinger expands neuroscience work with BMS, Otsuka ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvanBtMjMtc2Nocm9kaW5nZXItZXhwYW5kcy1uZXVyb3NjaWVuY2Utd29yay1ibXMtb3RzdWthLXBhcnRuZXJzaGlwc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers, Bayer forecast blockbuster future for rival blood thinners - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1teWVycy1iYXllci1mYWN0b3IteGlhLWluaGliaXRvcnMtc2FsZXMtZm9yZWNhc3QvNjQwMTU1L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "With 75% ownership, Bristol-Myers Squibb Company (NYSE:BMY) boasts of strong institutional backing - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy83NS1vd25lcnNoaXAtYnJpc3RvbC1teWVycy1zcXVpYmItMTEwMDUxMzY4Lmh0bWzSAVdodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy83NS1vd25lcnNoaXAtYnJpc3RvbC1teWVycy1zcXVpYmItMTEwMDUxMzY4Lmh0bWw?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bluebird has pawned off the second of two PRVs for $95M - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JsdWViaXJkLXNjb3Jlcy1hbm90aGVyLW5lc3QtZWdnLWFmdGVyLXNlbGxpbmctc2Vjb25kLWZkYS1yZXZpZXctdm91Y2hlci1ibXMtOTVt0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Biden administration will select first 10 drugs for Medicare price negotiations by September - CNBC",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjMvMDEvMTEvYmlkZW4tYWRtaW5pc3RyYXRpb24td2lsbC1zZWxlY3QtZHJ1Z3MtZm9yLW1lZGljYXJlLXByaWNlLW5lZ290aWF0aW9ucy1ieS1zZXB0ZW1iZXIuaHRtbNIBfGh0dHBzOi8vd3d3LmNuYmMuY29tL2FtcC8yMDIzLzAxLzExL2JpZGVuLWFkbWluaXN0cmF0aW9uLXdpbGwtc2VsZWN0LWRydWdzLWZvci1tZWRpY2FyZS1wcmljZS1uZWdvdGlhdGlvbnMtYnktc2VwdGVtYmVyLmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/30/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb Completes Sale of Manufacturing Facility in ... - Contract Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5jb250cmFjdHBoYXJtYS5jb20vY29udGVudHMvdmlld19icmVha2luZy1uZXdzLzIwMjMtMDEtMDMvYnJpc3RvbC1teWVycy1zcXVpYmItY29tcGxldGVzLXNhbGUtb2YtbWFudWZhY3R1cmluZy1mYWNpbGl0eS1pbi1zeXJhY3VzZS1ueS_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Lotte completes purchase of Bristol Myers Squibb\u2019s pharmaceutical plant in East Syracuse - syracuse.com",
            "link": "https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5zeXJhY3VzZS5jb20vYnVzaW5lc3MvMjAyMy8wMS9sb3R0ZS1jb21wbGV0ZXMtcHVyY2hhc2Utb2YtYnJpc3RvbC1teWVycy1zcXVpYmJzLXBoYXJtYWNldXRpY2FsLXBsYW50LWluLWVhc3Qtc3lyYWN1c2UuaHRtbNIBlQFodHRwczovL3d3dy5zeXJhY3VzZS5jb20vYnVzaW5lc3MvMjAyMy8wMS9sb3R0ZS1jb21wbGV0ZXMtcHVyY2hhc2Utb2YtYnJpc3RvbC1teWVycy1zcXVpYmJzLXBoYXJtYWNldXRpY2FsLXBsYW50LWluLWVhc3Qtc3lyYWN1c2UuaHRtbD9vdXRwdXRUeXBlPWFtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Lotte Biologics completes acqusition of BMS drug plant - The Korea Herald",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiNmh0dHBzOi8vd3d3LmtvcmVhaGVyYWxkLmNvbS92aWV3LnBocD91ZD0yMDIzMDEwMzAwMDY5N9IBOGh0dHBzOi8vbS5rb3JlYWhlcmFsZC5jb20vYW1wL3ZpZXcucGhwP3VkPTIwMjMwMTAzMDAwNjk3?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb to Present at J.P. Morgan's 41st Annual ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMy9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1QcmVzZW50LWF0LUouUC4tTW9yZ2Fucy00MXN0LUFubnVhbC1IZWFsdGhjYXJlLUNvbmZlcmVuY2UvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "After 33 years Geron could have an approved drug - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9hZnRlci0zMy15ZWFycy1nZXJvbi1jb3VsZC1oYXZlLWFwcHJvdmVkLWRydWfSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODQ5OC9hbXA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "2022 drug approvals: Biopharma delivered 34 new drugs - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzLzIwMjItZHJ1Zy1hcHByb3ZhbHMtYWZ0ZXItYWR1aGVsbS1maWFzY28tZmRhLWVuZG9yc2VtZW50cy13ZXJlLWhhcmRlci1jb21l0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Reply to Y. Yu et al | Journal of Clinical Oncology - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDI1ODjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/23/2022": {
        "artical1": {
            "title": "What\u2019s Driving Growth For Bristol Myers Squibb Stock? - Forbes",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8xMi8yNy93aGF0cy1kcml2aW5nLWdyb3d0aC1mb3ItYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2sv0gFyaHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9ncmVhdHNwZWN1bGF0aW9ucy8yMDIyLzEyLzI3L3doYXRzLWRyaXZpbmctZ3Jvd3RoLWZvci1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Is There An Opportunity With Bristol-Myers Squibb Company's (NYSE:BMY) 38% Undervaluation? - Simply Wall St",
            "link": "https://news.google.com/rss/articles/CBMilwFodHRwczovL3NpbXBseXdhbGwuc3Qvc3RvY2tzL3VzL3BoYXJtYWNldXRpY2Fscy1iaW90ZWNoL255c2UtYm15L2JyaXN0b2wtbXllcnMtc3F1aWJiL25ld3MvaXMtdGhlcmUtYW4tb3Bwb3J0dW5pdHktd2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55cy1u0gGbAWh0dHBzOi8vc2ltcGx5d2FsbC5zdC9zdG9ja3MvdXMvcGhhcm1hY2V1dGljYWxzLWJpb3RlY2gvbnlzZS1ibXkvYnJpc3RvbC1teWVycy1zcXVpYmIvbmV3cy9pcy10aGVyZS1hbi1vcHBvcnR1bml0eS13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBhbnlzLW4vYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA signs off on Roche's Lunsumio to treat follicular lymphoma - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JvY2hlLWdldHMtbHVuc3VtaW8tYWNyb3NzLWZkYS1maW5pc2gtbGluZS1vZmZlcmluZy1jb252ZW5pZW50LW9wdGlvbi1mb2xsaWN1bGFyLWx5bXBob21h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Melanoma/skin cancer 2022: 'Transformative' advances and new ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMTIxNi9tZWxhbm9tYXNraW4tY2FuY2VyLTIwMjItdHJhbnNmb3JtYXRpdmUtYWR2YW5jZXMtYW5kLW5ldy1pbnNpZ2h0cy1pbnRvLWFkdmVyc2UtZXZlbnRz0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Pivotal Years: Abivax's Obefazimod Faces Phase III Test - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL3Bpdm90YWwteWVhcnMtYWJpdmF4cy1vYmVmYXppbW9kLWZhY2VzLXBoYXNlLWlpaS10ZXN0L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "PRIME\u00ae Online Activity - Evidence-Based Strategies for Integrating ... - PRIME Education",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vcHJpbWVpbmMub3JnL29ubGluZS9ldmlkZW5jZS1iYXNlZC1zdHJhdGVnaWVzLWludGVncmF0aW5nLWNhci10LWNlbGwtdGhlcmFweS1pbnRvLW5vbi1ob2Rna2lu0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Study: Survivors of Hodgkin Lymphoma Show Signs of Dementia in ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvc3R1ZHktc3Vydml2b3JzLW9mLWhvZGdraW4tbHltcGhvbWEtc2hvdy1zaWducy1vZi1kZW1lbnRpYS1pbi1lYXJseS1hZHVsdGhvb2TSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/16/2022": {
        "artical1": {
            "title": "CAR T Cell Therapy Breyanzi\u00ae Approved as Relapsed or Refractory ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMipQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9DQVItVC1DZWxsLVRoZXJhcHktQnJleWFuemktQXBwcm92ZWQtYXMtUmVsYXBzZWQtb3ItUmVmcmFjdG9yeS1MYXJnZS1CLWNlbGwtTHltcGhvbWEtU2Vjb25kLUxpbmUtVGhlcmFweS1pbi1KYXBhbi9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Cancer center leaders lay bare CAR-T makers' struggles - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2pvaG5zb24tam9obnNvbi1icmlzdG9sLW15ZXJzLWtpdGUtcGhhcm1hLWNhci10LWNlbGwtdGhlcmFweS1zdHJ1Z2dsZS1zbG9hbi1rZXR0ZXJpbmfSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Remarkably, interest in BCMA continues - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy10cmlhbC1yZXN1bHRzL3JlbWFya2FibHktaW50ZXJlc3QtYmNtYS1jb250aW51ZXPSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODQ4NS9hbXA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Kathryn Reda, '23 - jepson - University of Richmond - University of Richmond",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL2plcHNvbi5yaWNobW9uZC5lZHUvZmVhdHVyZXMvYXJ0aWNsZS8tLzIyNTQ1L2thdGhyeW4tcmVkYS0yMy5odG1sP3V0bV9zb3VyY2U9YXMmdXRtX21lZGl1bT1yZWZlcnJhbCZ1dG1fY2FtcGFpZ249ZmVhdHVyZXMtc3RvcnnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Off-the-shelf T-cell therapy wins world-first approval - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2F0YXJhLW1ha2VzLWhpc3Rvcnktd29ybGQtZmlyc3Qtbm9kLWFsbG9nZW5laWMtdC1jZWxsLXRoZXJhcHktZWJ2YWxsb9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Exelixis Announces Initiation of the STELLAR-304 Phase 3 Pivotal ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMizwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMTIyMTAwNTU4OS9lbi9FeGVsaXhpcy1Bbm5vdW5jZXMtSW5pdGlhdGlvbi1vZi10aGUtU1RFTExBUi0zMDQtUGhhc2UtMy1QaXZvdGFsLVRyaWFsLUV2YWx1YXRpbmctWmFuemFsaW50aW5pYi1pbi1QYXRpZW50cy13aXRoLUFkdmFuY2VkLU5vbi1DbGVhci1DZWxsLUtpZG5leS1DYW5jZXLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "First-Line Nivolumab/Ipilimumab vs EXTREME Regimen in ... - The ASCO Post",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigFodHRwczovL2FzY29wb3N0LmNvbS9uZXdzL2RlY2VtYmVyLTIwMjIvZmlyc3QtbGluZS1uaXZvbHVtYWJpcGlsaW11bWFiLXZzLWV4dHJlbWUtcmVnaW1lbi1pbi1yZWN1cnJlbnQtb3ItbWV0YXN0YXRpYy1oZWFkLWFuZC1uZWNrLWNhbmNlci_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/09/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces First ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtRmlyc3QtRGlzY2xvc3VyZXMtYW5kLU5ldy1EYXRhLWF0LUFTSC0yMDIyLURlbW9uc3RyYXRpbmctQ29tbWl0bWVudC10by1SYWlzaW5nLVN0YW5kYXJkcy1pbi1UcmVhdG1lbnQtVGhyb3VnaC1Ccm9hZC1NdWx0aXBsZS1NeWVsb21hLVBvcnRmb2xpby9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "PZC approves warehouse at former Bristol Myers site - Meriden Record-Journal",
            "link": "https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5teXJlY29yZGpvdXJuYWwuY29tL05ld3MvV2FsbGluZ2ZvcmQvV2FsbGluZ2ZvcmQtTmV3cy9XYWxsaW5nZm9yZC1QLVotYXBwcm92ZXMtZGV2ZWxvcG1lbnQtZm9yLWZvcm1lci1CcmlzdG9sLU1leWVyLVNxdWliYi1wcm9wZXJ0eS5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb to Report Results for Fourth Quarter 2022 on ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1SZXBvcnQtUmVzdWx0cy1mb3ItRm91cnRoLVF1YXJ0ZXItMjAyMi1vbi1GZWJydWFyeS0yLTIwMjMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb patents new TYK2 inhibitors - BioWorld Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LmJpb3dvcmxkLmNvbS9hcnRpY2xlcy82OTIzNTQtYnJpc3RvbC1teWVycy1zcXVpYmItcGF0ZW50cy1uZXctdHlrMi1pbmhpYml0b3Jz0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Lyfebulb Announces Finalists for the 2022 Innovation Challenge, in ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMi1gFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2x5ZmVidWxiLWFubm91bmNlcy1maW5hbGlzdHMtZm9yLXRoZS0yMDIyLWlubm92YXRpb24tY2hhbGxlbmdlLWluLWNvbGxhYm9yYXRpb24td2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi10by1hZGRyZXNzLXVubWV0LW5lZWRzLWluLWluZmxhbW1hdG9yeS1ib3dlbC1kaXNlYXNlLTMwMTY5ODk5MS5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Takeda bets $4B upfront on Nimbus' phase 3-ready prospect to ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvdGFrZWRhLWJldHMtNGItdXBmcm9udC1uaW1idXMtcGhhc2UtMy1yZWFkeS1wcm9zcGVjdC1jaGFsbGVuZ2UtYnJpc3RvbC1teWVycy1wc29yaWFzaXPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Ash 2022 \u2013 following in talquetamab\u2019s slipstream - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy10cmlhbC1yZXN1bHRzL2FzaC0yMDIyLWZvbGxvd2luZy10YWxxdWV0YW1hYnMtc2xpcHN0cmVhbdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE4NDUyL2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/02/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb Announces Dividend Increase - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIyL0JyaXN0b2wtTXllcnMtU3F1aWJiLUFubm91bmNlcy1EaXZpZGVuZC1JbmNyZWFzZS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Replimune\u2019s melanoma success looks more than skin deep - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9yZXBsaW11bmVzLW1lbGFub21hLXN1Y2Nlc3MtbG9va3MtbW9yZS1za2luLWRlZXDSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODQ0Mi9hbXA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS' Zeposia, AbbVie drugs shake up early IBD market - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtc3F1aWJicy16ZXBvc2lhLWFiYnZpZXMtc2t5cml6aS1yaW52b3Etc2hha2luZy1lYXJseS1pYmQtdHJlYXRtZW50LW1hcmtldNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "J&J drops out of hunt for Horizon, leaving Sanofi and Amgen to bid - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaG9yaXpvbi1hY3F1aXNpdGlvbi10YWxrcy1qYW5zc2VuLWRyb3BzLW91dC82Mzc5NzAv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "High-Dose Cytarabine and Autologous Stem-Cell Transplantation in ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDE3ODDSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Dragonfly Therapeutics Announces First Patient Dosed in Phase 1 ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2RyYWdvbmZseS10aGVyYXBldXRpY3MtYW5ub3VuY2VzLWZpcnN0LXBhdGllbnQtZG9zZWQtaW4tcGhhc2UtMS1zdHVkeS1vZi1pdHMtZWdmci10YXJnZXRpbmctdHJpbmtldC0zMDE2OTc5MjkuaHRtbNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Cell and Gene Therapy Industry Feels Growing Pains - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2luc2lnaHRzL2NlbGwtYW5kLWdlbmUtdGhlcmFweS1pbmR1c3RyeS1mZWVscy1ncm93aW5nLXBhaW5zL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/25/2022": {
        "artical1": {
            "title": "Envisagenics Announces Research Collaboration with Bristol Myers ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvZW52aXNhZ2VuaWNzLWFubm91bmNlcy1yZXNlYXJjaC1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItMzAxNjg3MzIwLmh0bWzSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS Terminates 2015 Gene Therapy Pact with uniQure - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jtcy10ZXJtaW5hdGVzLTIwMTUtZ2VuZS10aGVyYXB5LXBhY3Qtd2l0aC11bmlxdXJlL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Lyvgen Announces Phase 2 Clinical Collaboration with Bristol ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMizgFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy9seXZnZW4tYW5ub3VuY2VzLXBoYXNlLTItY2xpbmljYWwtY29sbGFib3JhdGlvbi13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLXRvLWV2YWx1YXRlLWx2Z243NDA5LWluLWNvbWJpbmF0aW9uLXdpdGgtbml2b2x1bWFiLWluLW5vbi1zbWFsbC1jZWxsLWx1bmctY2FuY2VyLXBhdGllbnRzL9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "After falling flat weeks ago, BMS is knocking on the Supreme Court's ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jtcy10YWtlcy1jdWUtYW1nZW4taXQtcmUtYXBwZWFscy1zdXByZW1lLWNvdXJ0LWNlbGwtdGhlcmFweS1zY3VmZmxlLWdpbGVhZNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "BMS Supports $96M Launch for Neurodegenerative Newcomer ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2NhamFsLW51ZXJvc2NpZW5jZS1sYXVuY2hlcy13aXRoLTk2bS10by1nZXQtdG8tdGhlLXJvb3Qtb2YtbmV1cm9kZWdlbmVyYXRpdmUtZGlzZWFzZXMv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "With Positive Phase II Data, Nimbus' Psoriasis Therapeutic Poised to ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL25pbWJ1cy10aGVyYXBldXRpY3MtdHlrMi1pbmhpYml0b3Itc2hvd3MtcHJvbWlzZS1pbi1waGFzZS1paWItZm9yLXBsYXF1ZS1wc29yaWFzaXMv0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "UK Study Finds Pfizer/Bristol Myers Clotting Drug Does Not Help COVID-19 Patients - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy91ay1zdHVkeS1maW5kcy1wZml6ZXItYnJpc3RvbC0xMTA4NDE2OTcuaHRtbNIBU2h0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL3VrLXN0dWR5LWZpbmRzLXBmaXplci1icmlzdG9sLTExMDg0MTY5Ny5odG1s?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/18/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb warns US price reforms will dent drug ... - Financial Times",
            "link": "https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50L2E3NjNiYTBkLWU0OGUtNDdlNC1hYmEwLWE3MWVlN2UxOGQxZtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS, generics companies face new suit over Revlimid 'monopoly' - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25ldy1hbnRpdHJ1c3QtbGF3c3VpdC1zYXlzLW1vbm9wbG95LWFsbG93ZWQtYnJpc3RvbC1teWVycy1hbmQtZ2VuZXJpY3MtbWFrZXJzLXN0ZWFsLTMwYtIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Merck opens its mind to epigenetics with Imago buy - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvZGVhbHMvbWVyY2stb3BlbnMtaXRzLW1pbmQtZXBpZ2VuZXRpY3MtaW1hZ28tYnV50gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTg0MDAvYW1w?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Overall Survival With Daratumumab, Bortezomib, and ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI3MzTSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Safety of anti\u2010SARS\u2010CoV\u20102 messenger RNA vaccine in lung cancer ... - John Wiley",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMTExLzE3NTktNzcxNC4xNDczN9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Merck's Keytruda tees up BMS stomach cancer fight with new trial win - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL21lcmNrcy1rZXl0cnVkYS1iYWNrLXN0b21hY2gtY2FuY2VyLWdhbWUtc2NvcmluZy1wb3NpdGl2ZS1yZXN1bHRzLXBoYXNlLTMtdHJpYWwtaGVyLTLSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Three-Year Update of Tisagenlecleucel in Pediatric and Young ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjIuMDA2NDLSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/11/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb warns UK medicines levy threatens investment - Financial Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50LzY3MWJmZTE5LTJlZjAtNGYzYy04NGU0LWE1NzNiODU2NzM0NdIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "How landlocked Lesotho's 1st and only oncology clinic addresses cancer crisis - ABC News",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vYWJjbmV3cy5nby5jb20vSW50ZXJuYXRpb25hbC9sYW5kbG9ja2VkLWxlc290aG9zLTFzdC1vbmNvbG9neS1jbGluaWMtYWRkcmVzc2VzLWNhbmNlci1jcmlzaXMvc3Rvcnk_aWQ9OTI1NjcyMDnSAXpodHRwczovL2FiY25ld3MuZ28uY29tL2FtcC9JbnRlcm5hdGlvbmFsL2xhbmRsb2NrZWQtbGVzb3Rob3MtMXN0LW9uY29sb2d5LWNsaW5pYy1hZGRyZXNzZXMtY2FuY2VyLWNyaXNpcy9zdG9yeT9pZD05MjU2NzIwOQ?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb and PicnicHealth partner on real-world data - OutSourcing-Pharma.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3Lm91dHNvdXJjaW5nLXBoYXJtYS5jb20vQXJ0aWNsZS8yMDIyLzExLzE3L2JyaXN0b2wtbXllcnMtc3F1aWJiLWFuZC1waWNuaWNoZWFsdGgtcGFydG5lci1vbi1yZWFsLXdvcmxkLWRhdGHSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb opens 125-acre biologics campus in Dublin - PharmaTimes",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2JyaXN0b2xfbXllcnNfc3F1aWJiX29wZW5zXzEyNS1hY3JlX2Jpb2xvZ2ljc19jYW1wdXNfaW5fZHVibGluXzE0ODA2NzXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "FDA Warning Letter Cites Abraxane Manufacturing Sterility Issues - Medscape",
            "link": "https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85ODQwODbSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "2022's Fiercest Women in Life Sciences - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzLzIwMjJzLWZpZXJjZXN0LXdvbWVuLWxpZmUtc2NpZW5jZXPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Phase II Randomized Study of Salvage Radiation Therapy Plus ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDE2NjLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "11/04/2022": {
        "artical1": {
            "title": "Welcome to Bristol Myers Squibb - Singapore - Bristol Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMiFmh0dHBzOi8vd3d3LmJtcy5jb20vc2fSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL3VzLXN1cHJlbWUtY291cnQtcmVqZWN0cy1icmlzdG9sLW15ZXJzLWNhbmNlci1kcnVnLXBhdGVudC1maWdodC13aXRoLWdpbGVhZC0yMDIyLTExLTA3L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers hit with warning at AZ plant - BioProcess Insider - BioProcess Insider",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vYmlvcHJvY2Vzc2ludGwuY29tL2Jpb3Byb2Nlc3MtaW5zaWRlci9yZWd1bGF0aW9ucy9icmlzdG9sLW15ZXJzLWhpdC13aXRoLXdhcm5pbmctbGV0dGVyLWF0LWF6LWZpbGwtZmluaXNoLXBsYW50L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Supreme Court rejects BMS bid to revive $1.2B patent fine - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2dpbGVhZHMta2l0ZS1kb2RnZXMtc3VwcmVtZS1jb3VydC1oZWFkd2luZHMtYW5kLTEyYi1maW5lLWNhci10LXBhdGVudC1mZXVkLWJyaXN0b2zSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb keen to contribute more to China's development - China Daily",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LmNoaW5hZGFpbHkuY29tLmNuL2EvMjAyMjExLzA1L1dTNjM2NWRmZGVhMzEwNWNhMWYyMjc0MzgwLmh0bWzSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Ionis gets a double whammy - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy1zbmlwcGV0cy9pb25pcy1nZXRzLWRvdWJsZS13aGFtbXnSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODM2MS9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Time for GSK to stop dreaming about Blenrep - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy1zbmlwcGV0cy90aW1lLWdzay1zdG9wLWRyZWFtaW5nLWFib3V0LWJsZW5yZXDSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODM2Mi9hbXA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/28/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces Positive ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtUG9zaXRpdmUtVG9wbGluZS1SZXN1bHRzLW9mLVBoYXNlLTMtQ09NTUFORFMtVHJpYWwvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Kura Oncology Announces Financing Transactions with Bristol ... - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMizwFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMi8xMS8wMy8yNTQ3NDI1LzM1MTg2L2VuL0t1cmEtT25jb2xvZ3ktQW5ub3VuY2VzLUZpbmFuY2luZy1UcmFuc2FjdGlvbnMtd2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYi1hbmQtSGVyY3VsZXMtQ2FwaXRhbC1Qcm92aWRpbmctQWNjZXNzLXRvLXVwLXRvLTE1MC1NaWxsaW9uLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Durvalumab With or Without Tremelimumab in Combination With ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDA5NzXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Nimbus hopes to best Bristol\u2019s Sotyktu - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb21wYW55LWV2ZW50cy1pbnRlcnZpZXdzL25pbWJ1cy1ob3Blcy1iZXN0LWJyaXN0b2xzLXNvdHlrdHXSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODMwNi9hbXA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Alkermes set to break in two, spinning off its oncology sector - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Fsa2VybWVzLXdpbGwtcm9jay1zcGlub2ZmLWl0cy1vbmNvbG9neS1idXNpbmVzc9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Prognostic Impact of Early Treatment and Oxaliplatin ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI3MjbSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Oncopeptides says trial data good, but not enough to sway FDA - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FmdGVyLWZkYS1kZWZlYXQtb25jb3BlcHRpZGVzLXNob3dzLXJlc3VsdHMtc21hbGwtc3R1ZHktc2hvd3MtYmVuZWZpdC1zaWRlbGluZWQtcGVwYXh0b9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/21/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Reports Third Quarter ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIyL0JyaXN0b2wtTXllcnMtU3F1aWJiLVJlcG9ydHMtVGhpcmQtUXVhcnRlci1GaW5hbmNpYWwtUmVzdWx0cy1mb3ItMjAyMi9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb (BMY) Q3 2022 Earnings Call Transcript - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMi8xMC8yNi9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktcTMtMjAyMi1lYXJuaW5ncy1jYWxsLXRyYS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Q3 sales fall on Revlimid, forex pressure - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2JyaXN0b2wtbXllcnMtcTMtc2FsZXMtZmFsbC1yZXZsaW1pZC1mb3JleC1wcmVzc3VyZS0yMDIyLTEwLTI1L9IBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "New Zeposia (ozanimod) Data Highlight COVID-19 Outcomes and ... - news.bms.com",
            "link": "https://news.google.com/rss/articles/CBMi6AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9OZXctWmVwb3NpYS1vemFuaW1vZC1EYXRhLUhpZ2hsaWdodC1DT1ZJRC0xOS1PdXRjb21lcy1hbmQtUHJlc2VydmF0aW9uLW9mLUxvbmctVGVybS1Db2duaXRpdmUtRnVuY3Rpb24tZnJvbS1TZXBhcmF0ZS1BbmFseXNlcy1pbi1QYXRpZW50cy13aXRoLVJlbGFwc2luZy1Gb3Jtcy1vZi1NdWx0aXBsZS1TY2xlcm9zaXMvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "U.S. Food and Drug Administration (FDA) Accepts Supplemental ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tRkRBLUFjY2VwdHMtU3VwcGxlbWVudGFsLU5ldy1EcnVnLUFwcGxpY2F0aW9uLWZvci1DQU1aWU9TLW1hdmFjYW10ZW4taW4tU3ltcHRvbWF0aWMtT2JzdHJ1Y3RpdmUtSHlwZXJ0cm9waGljLUNhcmRpb215b3BhdGh5LXRvLVJlZHVjZS10aGUtTmVlZC1mb3ItU2VwdGFsLVJlZHVjdGlvbi1UaGVyYXB5L2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers keeps Obsidian cell therapy pact rocking with multiyear ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy1rZWVwcy1jZWxsLXRoZXJhcHktb2JzaWRpYW4tcGFjdC1yb2NraW5nLW11bHRpLXllYXItZXh0ZW5zaW9u0gEA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "The Robert A. Winn Diversity in Clinical Trials Award Program ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiyAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL3BoaWxhbnRocm9weS8yMDIyL1RoZS1Sb2JlcnQtQS4tV2lubi1EaXZlcnNpdHktaW4tQ2xpbmljYWwtVHJpYWxzLUF3YXJkLVByb2dyYW0tQW5ub3VuY2VzLXRoZS1TZWNvbmQtR3JvdXAtb2YtUGh5c2ljaWFucy10by1iZS1UcmFpbmVkLWluLXRoZS0xMTQtTWlsbGlvbi1Qcm9ncmFtL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/14/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Presents Data from ... - news.bms.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi_wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1QcmVzZW50cy1EYXRhLWZyb20tQ2hlY2tNYXRlLS03NkstU2hvd2luZy1PcGRpdm8tbml2b2x1bWFiLVJlZHVjZWQtdGhlLVJpc2stb2YtUmVjdXJyZW5jZS1vci1EZWF0aC1ieS01OC1WZXJzdXMtUGxhY2Viby1pbi1QYXRpZW50cy13aXRoLUNvbXBsZXRlbHktUmVzZWN0ZWQtU3RhZ2UtSUlCLW9yLUlJQy1NZWxhbm9tYS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb Taps Morgan Lewis in Employee Class Action ... - Law.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5sYXcuY29tL25qbGF3am91cm5hbC8yMDIyLzEwLzE4L2JyaXN0b2wtbXllcnMtc3F1aWJiLXRhcHMtbW9yZ2FuLWxld2lzLWluLWVtcGxveWVlLWNsYXNzLWFjdGlvbi1vdmVyLWNvdmlkLTE5LXZhY2NpbmF0aW9uLXBvbGljeS_SAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDIzMDPSAQA?oc%3D5&gl=DE&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "J&J\u2019s $5bn projects have much to prove - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvY29ycG9yYXRlLXN0cmF0ZWd5L2pqcy01Ym4tcHJvamVjdHMtaGF2ZS1tdWNoLXByb3Zl0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTgyOTcvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Treatment of Metastatic Colorectal Cancer: ASCO Guideline ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDE2OTDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Travere Anticipates 3-Month PDUFA Setback for IgA Nephropathy ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RyYXZlcmUtYW50aWNpcGF0ZXMtMy1tb250aC1zZXRiYWNrLWluLWlnYS1uZXBocm9wYXRoeS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "'In vivo' cell therapy: expanding beyond CAR-T - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW4tdml2by1jZWxsLXRoZXJhcHktY2FyLXQtYmlvdGVjaC1zdGFydHVwcy82MzQyODcv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/07/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb Announces Change to Earnings Conference ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMixgFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtQ2hhbmdlLXRvLUVhcm5pbmdzLUNvbmZlcmVuY2UtQ2FsbC1EaWFsLUluLUluZm9ybWF0aW9uLWZvci1UaGlyZC1RdWFydGVyLTIwMjItUmVzdWx0cy1TY2hlZHVsZWQtZm9yLU9jdG9iZXItMjYtMjAyMi9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "New TYK2 inhibitors: a growing race to top Bristol Myers - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHlrMi1pbmhpYml0b3JzLWphay1wcm90ZWluLXN0YXJ0dXBzLWJpb3RlY2gvNjMzNjM1L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "BMS-backed Immatics' cell therapy shows early promise in small ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvaW1tYXRpY3MtY2VsbC10aGVyYXB5LXNob3dzLXByb21pc2UtYW1vbmctaGFuZGZ1bC1waGFzZS0xLXBhdGllbnRzLXByb21wdGluZy0xMTAtbWlsbGlvbtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "VCU Massey Cancer Center to lead $114 million initiative for ... - Richmond Times-Dispatch",
            "link": "https://news.google.com/rss/articles/CBMitAFodHRwczovL3JpY2htb25kLmNvbS9uZXdzL2xvY2FsL3ZjdS1tYXNzZXktY2FuY2VyLWNlbnRlci10by1sZWFkLTExNC1taWxsaW9uLWluaXRpYXRpdmUtZm9yLWV4cGFuZGluZy1kaXZlcnNpdHktaW4tY2xpbmljYWwtdHJpYWxzL2FydGljbGVfMGEwYzE3ZDUtOTUyYS01OTMxLTlkODktOTlkZTdmNmFjZDk2Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Pembrolizumab With or Without Chemotherapy in Recurrent or ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI1MDjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Table 1 | Selected FDA new drug approvals in Q3 2022 - Nature.com",
            "link": "https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvZDQxNTczLTAyMi0wMDE3NC0z0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Schr\u00f6dinger, Eli Lilly Strike $425M Small Molecule Deal - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3NjaHJvZWRpbmdlci1lbGktbGlsbHktc3RyaWtlLTQyNW0tc21hbGwtbW9sZWN1bGUtZGVhbC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/30/2022": {
        "artical1": {
            "title": "SyntheX and Bristol Myers Squibb Enter Into a Research ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMiwgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3N5bnRoZXgtYW5kLWJyaXN0b2wtbXllcnMtc3F1aWJiLWVudGVyLWludG8tYS1yZXNlYXJjaC1jb2xsYWJvcmF0aW9uLXRvLWRpc2NvdmVyLWFuZC1kZXZlbG9wLXRhcmdldGVkLXByb3RlaW4tZGVncmFkYXRpb24tdHBkLXRoZXJhcGV1dGljcy0zMDE2NDAxMTcuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS inks 2nd biotech deal in one day, this time with Autolus - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYm1zLXdhbnRzLWxpZ2h0YnVsYi1tb21lbnQtcGVucy1kZWFsLWFjY2Vzcy1hdXRvbHVzcy1jZWxsLXRoZXJhcHktc3dpdGNo0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb\u2019s active ulcerative colitis treatment bags NICE ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYnJpc3RvbF9teWVyc19zcXVpYmJzX2FjdGl2ZV91bGNlcmF0aXZlX2NvbGl0aXNfdHJlYXRtZW50X2JhZ3NfbmljZV9yZWNvbW1lbmRhdGlvbl8xNDU2MzYz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb Facing Suit From Workers Fired for Refusing ... - Law.com",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3Lmxhdy5jb20vbmpsYXdqb3VybmFsLzIwMjIvMTAvMDMvYnJpc3RvbC1teWVycy1zcXVpYmItZmFjaW5nLXN1aXQtZnJvbS13b3JrZXJzLWZpcmVkLWZvci1yZWZ1c2luZy1jb3ZpZC12YWNjaW5lL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb plots Wirral expansion - Place North West",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vd3d3LnBsYWNlbm9ydGh3ZXN0LmNvLnVrL2JyaXN0b2wtbXllcnMtc3F1aWJiLXBsb3RzLXdpcnJhbC1leHBhbnNpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Lotte Biologics victimized by a post from a fake BMS exec account - KBR",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiPWh0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3Lmh0bWw_aWR4bm89MTQ3NDnSAUBodHRwczovL3d3dy5rb3JlYWJpb21lZC5jb20vbmV3cy9hcnRpY2xlVmlld0FtcC5odG1sP2lkeG5vPTE0NzQ5?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "BMS was first but startup Sudo Bio aims to be best at blocking key ... - MedCity News",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjIvMTAvYm1zLXdhcy1maXJzdC1idXQtc3RhcnR1cC1zdWRvLWJpby1haW1zLXRvLWJlLWJlc3QtYXQtYmxvY2tpbmcta2V5LWF1dG9pbW11bmUtdGFyZ2V0L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/23/2022": {
        "artical1": {
            "title": "Adjuvant Therapy of Nivolumab Combined With Ipilimumab Versus ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjIuMDA1MzPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb and ConcertAI Advance Novel Oncology ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWFuZC1jb25jZXJ0YWktYWR2YW5jZS1ub3ZlbC1vbmNvbG9neS1hY2NlbGVyYXRlZC1kaWdpdGFsLWNsaW5pY2FsLXRyaWFsLXNvbHV0aW9uLTMwMTYzNjIzMi5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Must Face Celgene Deal Suit In NJ State Court - Law360",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmxhdzM2MC5jb20vYXJ0aWNsZXMvMTUzMzQyMy9icmlzdG9sLW15ZXJzLW11c3QtZmFjZS1jZWxnZW5lLWRlYWwtc3VpdC1pbi1uai1zdGF0ZS1jb3VydNIBK2h0dHBzOi8vd3d3LmxhdzM2MC5jb20vYW1wL2FydGljbGVzLzE1MzM0MjM?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Sudo joins a wave of startups taking aim at Bristol Myers' new skin ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3Vkby1iaW9zY2llbmNlcy10eWsyLWluaGliaXRvci1pbmZsYW1tYXRvcnktZGlzZWFzZS82MzI4MTIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb joins Meta as offtaker of 240 MW Cattlemen ... - pv magazine USA",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vcHYtbWFnYXppbmUtdXNhLmNvbS8yMDIyLzA5LzI2L2JyaXN0b2wtbXllcnMtc3F1aWJiLWpvaW5zLW1ldGEtYXMtb2ZmdGFrZXItb2YtMjQwLW13LWNhdHRsZW1lbi1zb2xhci1wYXJrL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "The most productive biopharma workforces of 2021 - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzL3RvcC0xMC1tb3N0LXByb2R1Y3RpdmUtYmlvcGhhcm1hLWNvbXBhbmllc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Genentech pays $70M to access Arsenal's armory of T-cell tools in ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZ2VuZW50ZWNoLXBheXMtNzBtLWFjY2Vzcy1hcnNlbmFscy1hcm1vdXJ5LXQtY2VsbC10b29scy1xdWVzdC1zb2xpZC10dW1vci1jYXItdNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/16/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMilQJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLWZvci1MQUctMy1CbG9ja2luZy1BbnRpYm9keS1Db21iaW5hdGlvbi1PcGR1YWxhZy1uaXZvbHVtYWItYW5kLXJlbGF0bGltYWItZm9yLXRoZS1UcmVhdG1lbnQtb2YtVW5yZXNlY3RhYmxlLW9yLU1ldGFzdGF0aWMtTWVsYW5vbWEtd2l0aC1UdW1vci1DZWxsLVBELUwxLUV4cHJlc3Npb24tLTEvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers' Opdualag adds EU to its market approvals - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9icmlzdG9sLW15ZXJzLW9wZHVhbGFnLWFkZHMtZXUtdG8taXRzLW1hcmtldC1hcHByb3ZhbHPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Adjuvant Treatment With Nivolumab Shows Positive Results in ... - Dermatology Times",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmRlcm1hdG9sb2d5dGltZXMuY29tL3ZpZXcvYWRqdXZhbnQtdHJlYXRtZW50LXdpdGgtbml2b2x1bWFiLXNob3dzLXBvc2l0aXZlLXJlc3VsdHMtaW4tcGhhc2UtMy10cmlhbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb and AbbVie to Cut 360 Jobs Across CA - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWFuZC1hYmJ2aWUtY3V0dGluZy1qb2JzLWluLWNhbGlmb3JuaWEv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Prescription drug disruptions may arise in Puerto Rico amid Fiona\u2019s damage - Fox Weather",
            "link": "https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmZveHdlYXRoZXIuY29tL2V4dHJlbWUtd2VhdGhlci9wdWVydG8tcmljby1wcmVzY3JpcHRpb24tZHJ1Z3MtbWVkdGVjaC1leHBvcnRzLWZpb25h0gFjaHR0cHM6Ly93d3cuZm94d2VhdGhlci5jb20vZXh0cmVtZS13ZWF0aGVyL3B1ZXJ0by1yaWNvLXByZXNjcmlwdGlvbi1kcnVncy1tZWR0ZWNoLWV4cG9ydHMtZmlvbmEuYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Capital Health Launches Trenton Neighborhood Initiative in ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMizgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2NhcGl0YWwtaGVhbHRoLWxhdW5jaGVzLXRyZW50b24tbmVpZ2hib3Job29kLWluaXRpYXRpdmUtaW4tcGFydG5lcnNoaXAtd2l0aC10cmVudG9uLWhlYWx0aC10ZWFtLWxldmVyYWdpbmctMTAtbWlsbGlvbi1vZi1pbnZlc3RtZW50LWluLWxvY2FsLWNvbW11bml0eS0zMDE2MzAzNzEuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "BMS on Breyanzi capacity issues - BioProcess InsiderBioProcess ... - BioProcess Insider",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vYmlvcHJvY2Vzc2ludGwuY29tL2Jpb3Byb2Nlc3MtaW5zaWRlci9nbG9iYWwtbWFya2V0cy9ibXMtY29uZmlkZW50LWJyZXlhbnppLWNhcGFjaXR5LWlzc3Vlcy13aWxsLWJlLXJlc29sdmVkLWluLTIwMjMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/09/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces New Sotyktu ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi9wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtTmV3LVNvdHlrdHUtZGV1Y3JhdmFjaXRpbmliLUxvbmctVGVybS1EYXRhLVNob3dpbmctQ2xpbmljYWwtRWZmaWNhY3ktTWFpbnRhaW5lZC1mb3ItVXAtdG8tVHdvLVllYXJzLXdpdGgtQ29udGludW91cy1UcmVhdG1lbnQtaW4tTW9kZXJhdGUtdG8tU2V2ZXJlLVBsYXF1ZS1Qc29yaWFzaXMvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS's deucravacitinib approved for plaque psoriasis - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJicy1kZXVjcmF2YWN0aW5pYi1zY29yZXMtZmRhLWFwcHJvdmFsLXBsYXF1ZS1wc29yaWFzaXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS Wins Landmark Approval in Plaque Psoriasis, Avoids Black ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jtcy13aW5zLWNsZWFuLWxhYmVsLWFwcHJvdmFsLWZvci1maXJzdC1wbGFxdWUtcHNvcmlhc2lzLW9yYWwtaW5ub3ZhdGlvbi1pbi1hLWRlY2FkZS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces Adjuvant ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMiqQJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtQWRqdXZhbnQtVHJlYXRtZW50LXdpdGgtT3BkaXZvLW5pdm9sdW1hYi1EZW1vbnN0cmF0ZWQtU3RhdGlzdGljYWxseS1TaWduaWZpY2FudC1hbmQtQ2xpbmljYWxseS1NZWFuaW5nZnVsLUltcHJvdmVtZW50LWluLVJlY3VycmVuY2UtRnJlZS1TdXJ2aXZhbC1SRlMtaW4tUGF0aWVudHMtd2l0aC1TdGFnZS1JSUJDLU1lbGFub21hLWluLXRoZS1DaGVja01hdGUtLTc2Sy1UcmlhbC9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Short-course neoadjuvant immunotherapy confers high response ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMDkxNS9zaG9ydGNvdXJzZS1uZW9hZGp1dmFudC1pbW11bm90aGVyYXB5LWNvbmZlcnMtaGlnaC1yZXNwb25zZS1yYXRlcy1pbi1jb2xvbi1jYW5jZXItc3Vic2V00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb Announces Dividend - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIyL0JyaXN0b2wtTXllcnMtU3F1aWJiLUFubm91bmNlcy1EaXZpZGVuZC1hMzk5NzlkZjkvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Transforming Patient Lives Through Scientific Innovation: A Q&A ... - massbio.org",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5tYXNzYmlvLm9yZy9uZXdzL3JlY2VudC1uZXdzL3RyYW5zZm9ybWluZy1wYXRpZW50LWxpdmVzLXRocm91Z2gtc2NpZW50aWZpYy1pbm5vdmF0aW9uLWEtcWEtd2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/02/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb Employees to Relay Nearly 3000 Miles Cross ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMixQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1FbXBsb3llZXMtdG8tUmVsYXktTmVhcmx5LTMwMDAtTWlsZXMtQ3Jvc3MtQ291bnRyeS1Bc3BpcmluZy10by1SYWlzZS1PdmVyLTEtTWlsbGlvbi1mb3ItdGhlLVYtRm91bmRhdGlvbi1mb3ItQ2FuY2VyLVJlc2VhcmNoL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Backed by Bristol Myers, ArsenalBio raises $220M for its cell therapy ... - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXJzZW5hbC1iaW8tc2VyaWVzLWItY2VsbC10aGVyYXB5LWJyaXN0b2wtbXllcnMvNjMxMzI4L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Research at ESMO ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZXNlYXJjaC1hdC1FU01PLUNvbmdyZXNzLTIwMjItSGlnaGxpZ2h0cy1EZXB0aC1vZi1EZXZlbG9wbWVudC1Qcm9ncmFtLUFjcm9zcy1FYXJseS0tYW5kLUxhdGUtU3RhZ2VzLW9mLUNhbmNlci9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb to Participate in the Morgan Stanley 20th ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilgFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1QYXJ0aWNpcGF0ZS1pbi10aGUtTW9yZ2FuLVN0YW5sZXktMjB0aC1Bbm51YWwtR2xvYmFsLUhlYWx0aGNhcmUtQ29uZmVyZW5jZS9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol-Myers Squibb HIV cART drugs antitrust $10.8M class action ... - Top Class Actions",
            "link": "https://news.google.com/rss/articles/CBMijwFodHRwczovL3RvcGNsYXNzYWN0aW9ucy5jb20vbGF3c3VpdC1zZXR0bGVtZW50cy9jbG9zZWQtc2V0dGxlbWVudHMvYnJpc3RvbC1teWVycy1zcXVpYmItaGl2LWNhcnQtZHJ1Z3MtYW50aXRydXN0LTEwLThtLWNsYXNzLWFjdGlvbi1zZXR0bGVtZW50L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb\u2019s acute myeloid leukaemia oral maintenance ... - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5wbWxpdmUuY29tL3BoYXJtYV9uZXdzL2JyaXN0b2xfbXllcnNfc3F1aWJic19hY3V0ZV9teWVsb2lkX2xldWthZW1pYV9vcmFsX21haW50ZW5hbmNlX3RoZXJhcHlfcmVjb21tZW5kZWRfYnlfbmljZV8xNDU0NDgx0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Cipla set to ship its version of BMS drug Revlimid in the US - BusinessLine",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy50aGVoaW5kdWJ1c2luZXNzbGluZS5jb20vbmV3cy9zY2llbmNlL2NpcGxhLXNldC10by1zaGlwLWl0cy12ZXJzaW9uLW9mLWJtcy1kcnVnLXJldmxpbWlkLWluLXRoZS11cy9hcnRpY2xlNjU4NjIwNzAuZWNl0gGHAWh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9uZXdzL3NjaWVuY2UvY2lwbGEtc2V0LXRvLXNoaXAtaXRzLXZlcnNpb24tb2YtYm1zLWRydWctcmV2bGltaWQtaW4tdGhlLXVzL2FydGljbGU2NTg2MjA3MC5lY2UvYW1wLw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/26/2022": {
        "artical1": {
            "title": "Late-Breaking Results From Phase 2 AXIOMATIC-SSP Study of ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi-AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9MYXRlLUJyZWFraW5nLVJlc3VsdHMtRnJvbS1QaGFzZS0yLUFYSU9NQVRJQy1TU1AtU3R1ZHktb2YtTWlsdmV4aWFuLWFuLUludmVzdGlnYXRpb25hbC1PcmFsLUZhY3Rvci1YSWEtSW5oaWJpdG9yLVNob3ctRmF2b3JhYmxlLUFudGl0aHJvbWJvdGljLVByb2ZpbGUtaW4tQ29tYmluYXRpb24tV2l0aC1EdWFsLUFudGlwbGF0ZWxldC1UaGVyYXB5L2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS' secondary stroke med doesn't stick the phase 2 landing - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYm1zLXNlY29uZGFyeS1zdHJva2UtbWVkLWRvZXNudC1zdGljay1waC0yLWxhbmRpbmctZW5jb3VyYWdpbmctZGF0YS10ZWVzLWZ1dHVyZS10cmlhbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "ESC 2022 \u2013 factor XI inhibitors crash - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9lc2MtMjAyMi1mYWN0b3IteGktaW5oaWJpdG9ycy1jcmFzaNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE4MTM5L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Down 6% In A Day, Will Bristol Myers Squibb Stock Rebound? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8wOC8zMS9kb3duLTYtaW4tYS1kYXktd2lsbC1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay1yZWJvdW5kL9IBdmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8wOC8zMS9kb3duLTYtaW4tYS1kYXktd2lsbC1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay1yZWJvdW5kL2FtcC8?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Why Bristol Myers Squibb Stock Is Slumping Today - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA4LzI5L3doeS1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay1pcy1zbHVtcGluZy10b2RheS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers, Bayer study results seed doubt about an emerging ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1teWVycy1qb2huc29uLWpvaG5zb24tbWlsdmV4aWFuLXN0cm9rZS1kYXRhLzYzMDcwMi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "PathAI and Bristol Myers Squibb Expand AI Pact in Drug Discovery ... - Inside Precision Medicine",
            "link": "https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5pbnNpZGVwcmVjaXNpb25tZWRpY2luZS5jb20vbmV3cy1hbmQtZmVhdHVyZXMvcGF0aGFpLWFuZC1icmlzdG9sLW15ZXJzLXNxdWliYi1leHBhbmQtYWktcGFjdC1pbi1kcnVnLWRpc2NvdmVyeS1hbmQtZGV2ZWxvcG1lbnQv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/19/2022": {
        "artical1": {
            "title": "PathAI Announces Extension of Multi-Year Collaboration Agreement ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDgyNTAwNTA2My9lbi9QYXRoQUktQW5ub3VuY2VzLUV4dGVuc2lvbi1vZi1NdWx0aS1ZZWFyLUNvbGxhYm9yYXRpb24tQWdyZWVtZW50LXdpdGgtQnJpc3RvbC1NeWVycy1TcXVpYmLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Aktis Oncology Nabs A Rare Upround of $84M In Extension Funding - Crunchbase News",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vbmV3cy5jcnVuY2hiYXNlLmNvbS9oZWFsdGgtd2VsbG5lc3MtYmlvdGVjaC9ha3Rpcy1jYW5jZXItc3RhcnR1cC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "A pill that treats lupus and repairs its damage is in phase 2 trials - Medical News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3Lm1lZGljYWxuZXdzdG9kYXkuY29tL2FydGljbGVzL2x1cHVzLXBpbGwtaW4tcGhhc2UtMi10cmlhbHMtbWF5LXByZXZlbnQtc3ltcHRvbXMtcmV2ZXJzZS1kYW1hZ2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Motivated by loss of his grandfather, Glastonbury man to be part of ... - Hartford Courant",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipAFodHRwczovL3d3dy5jb3VyYW50LmNvbS8yMDIyLzA4LzE5L21vdGl2YXRlZC1ieS1sb3NzLW9mLWhpcy1ncmFuZGZhdGhlci1nbGFzdG9uYnVyeS1tYW4tdG8tYmUtcGFydC1vZi1jb2FzdC10by1jb2FzdC1iaWtlLXJpZGUtZm9yLXYtZm91bmRhdGlvbi1mb3ItY2FuY2VyLXJlc2VhcmNoL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Long-Term Efficacy and Safety of Luspatercept for Anemia ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI0NzbSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "CSRWire - From Numbers to Knowledge: Unlocking the Predictive ... - CSRwire.com",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmNzcndpcmUuY29tL3ByZXNzX3JlbGVhc2VzLzc1MzE1Ni1udW1iZXJzLWtub3dsZWRnZS11bmxvY2tpbmctcHJlZGljdGl2ZS1wb3dlci1kYXRhLWFjY2VsZXJhdGUtdHJhbnNmb3JtYXRpdmXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "ESC 2022 preview \u2013 who\u2019s got the XI factor? - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9lc2MtMjAyMi1wcmV2aWV3LXdob3MtZ290LXhpLWZhY3RvctIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE4MDY3L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/12/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Completes Acquisition ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiowFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Db21wbGV0ZXMtQWNxdWlzaXRpb24tb2YtVHVybmluZy1Qb2ludC1UaGVyYXBldXRpY3MtRXhwYW5kaW5nLVByZWNpc2lvbi1PbmNvbG9neS1Qb3J0Zm9saW8vZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb acquires Turning Point for $4.1bn - Pharmaceutical Business Review",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLWJ1c2luZXNzLXJldmlldy5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi10dXJuaW5nLXBvaW50L9IBW2h0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLWJ1c2luZXNzLXJldmlldy5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi10dXJuaW5nLXBvaW50L2FtcC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb successfully completes acquisition of Turning ... - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5wbWxpdmUuY29tL3BoYXJtYV9uZXdzL2JyaXN0b2xfbXllcnNfc3F1aWJiX3N1Y2Nlc3NmdWxseV9jb21wbGV0ZXNfYWNxdWlzaXRpb25fb2ZfdHVybmluZ19wb2ludF90aGVyYXBldXRpY3NfMTQ1MzUxNdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD ... - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYnJpc3RvbF9teWVyc19zcXVpYmJfYW5kX2dlbnRpYmlvX2luXyQxLjlibl9kZWFsX3RvX2RldmVsb3BfaWJkX3RoZXJhcGllc18xNDUzMjc20gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI4MTXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Abbvie leaves I-Mab out in the cold - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvY29ycG9yYXRlLXN0cmF0ZWd5LXNuaXBwZXRzL2FiYnZpZS1sZWF2ZXMtaS1tYWItb3V0LWNvbGTSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xODExNC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Drugmaker Moves To Include People With Disabilities In Clinical Trials - Disability Scoop",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmRpc2FiaWxpdHlzY29vcC5jb20vMjAyMi8wOC8xNi9kcnVnbWFrZXItbW92ZXMtdG8taW5jbHVkZS1wZW9wbGUtd2l0aC1kaXNhYmlsaXRpZXMtaW4tY2xpbmljYWwtdHJpYWxzLzI5OTgyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/05/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb and 2seventy bio ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiogJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1hbmQtMnNldmVudHktYmlvLUFubm91bmNlLVRvcGxpbmUtUmVzdWx0cy1mcm9tLUthck1NYS0zLVRyaWFsLVNob3dpbmctQWJlY21hLWlkZWNhYnRhZ2VuZS12aWNsZXVjZWwtU2lnbmlmaWNhbnRseS1JbXByb3Zlcy1Qcm9ncmVzc2lvbi1GcmVlLVN1cnZpdmFsLVZlcnN1cy1TdGFuZGFyZC1SZWdpbWVucy1pbi1SZWxhcHNlZC1hbmQtUmVmcmFjdG9yeS1NdWx0aXBsZS1NeWVsb21hL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "GentiBio Announces Collaboration with Bristol Myers Squibb to ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2dlbnRpYmlvLWFubm91bmNlcy1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tcGlvbmVlci1lbmdpbmVlcmVkLXRyZWctdGhlcmFwaWVzLWZvci1pbmZsYW1tYXRvcnktYm93ZWwtZGlzZWFzZXMtMzAxNjAzMDkyLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb launches new website, tools to help companies ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtc3F1aWJiLWxhdW5jaGVzLW5ldy13ZWJzaXRlLXRvb2xzLWhlbHAtY29tcGFuaWVzLXN1cHBvcnQtd29ya2Vycy1tc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Manufacturing success rate holds back sales of Bristol Myers' CD19 ... - BioPharma-Reporter.com",
            "link": "https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5iaW9waGFybWEtcmVwb3J0ZXIuY29tL0FydGljbGUvMjAyMi8wOC8wOC9tYW51ZmFjdHVyaW5nLXN1Y2Nlc3MtcmF0ZS1ob2xkcy1iYWNrLXNhbGVzLW9mLWJyaXN0b2wtbXllcnMtY2QxOS1jYXItdC1jZWxsLXRoZXJhcHnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "US drug pricing reform happens at last - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvcG9saWN5LWFuZC1yZWd1bGF0aW9uL3VzLWRydWctcHJpY2luZy1yZWZvcm0taGFwcGVucy1sYXN00gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTgwODUvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Peregrine Ventures announces new consortium to invest over $90 ... - CTech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOGh0dHBzOi8vd3d3LmNhbGNhbGlzdGVjaC5jb20vY3RlY2huZXdzL2FydGljbGUvYmptc3JqMWNj0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Six-Year Results From RELEVANCE: Lenalidomide Plus Rituximab ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDA4NDPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/29/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Provides Update on ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi2wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Qcm92aWRlcy1VcGRhdGUtb24tQ2hlY2tNYXRlLS05MTQtVHJpYWwtRXZhbHVhdGluZy1PcGRpdm8tbml2b2x1bWFiLVBsdXMtWWVydm95LWlwaWxpbXVtYWItYXMtQWRqdXZhbnQtVHJlYXRtZW50LW9mLUxvY2FsaXplZC1SZW5hbC1DZWxsLUNhcmNpbm9tYS9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb to Host Virtual Investor Event to Discuss ESC ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMihgFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1Ib3N0LVZpcnR1YWwtSW52ZXN0b3ItRXZlbnQtdG8tRGlzY3Vzcy1FU0MtMjAyMi1IaWdobGlnaHRzL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb partners with Jack and Jill of America to boost ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Jtcy1wYXJ0bmVycy1mYW1pbHktb3JnYW5pemF0aW9uLWphY2stYW5kLWppbGwtYW1lcmljYS1ib29zdC1kaXZlcnNpdHktcGhhcm1hLXdvcmtmb3JjZdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Decision Applies to Plaintiffs in FLSA Collective ... - Jackson Lewis",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmphY2tzb25sZXdpcy5jb20vaW5zaWdodHMvYnJpc3RvbC1teWVycy1kZWNpc2lvbi1hcHBsaWVzLXBsYWludGlmZnMtZmxzYS1jb2xsZWN0aXZlLWFjdGlvbnMtdGhpcmQtY2lyY3VpdC1ob2xkc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers' Opdivo-Yervoy combo joins Roche on the postsurgery ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtb3BkaXZvLXllcnZveS1jb21iby1qb2lucy1yb2NoZS1wb3N0c3VyZ2VyeS1raWRuZXktY2FuY2VyLWZsb3AtbGlzdNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "The top 10 Big Pharmas for diversity, equity and inclusion in 2022 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzL3RvcC0xMC1lcXVhbGl0eS1kaXZlcnNpdHktYW5kLWluY2x1c2lvbi1waGFybWFzLTIwMjHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Dr Reddy's gearing up to get substantial slice of Revlimid generic opportunity in US - Economic Times",
            "link": "https://consent.google.com/m?continue=https://news.google.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?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/22/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives Positive ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tUmVjb21tZW5kaW5nLUFwcHJvdmFsLWZvci1MQUctMy1CbG9ja2luZy1BbnRpYm9keS1Db21iaW5hdGlvbi1PcGR1YWxhZy1uaXZvbHVtYWItYW5kLXJlbGF0bGltYWItZm9yLVRyZWF0bWVudC1vZi1QYXRpZW50cy13aXRoLVVucmVzZWN0YWJsZS1vci1NZXRhc3RhdGljLU1lbGFub21hL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "These New Blockbusters Could Fill Bristol-Myers Squibb's Revenue ... - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA3LzI4L3RoZXNlLW5ldy1ibG9ja2J1c3RlcnMtY291bGQtZmlsbC1icmlzdG9sLW15ZXJzLXNxL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Amid generic attack, BMS's Revlimid shows it can take a punch - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vdC1zby1mYXN0LXJldmxpbWlkcy1mYWRlLWJyaXN0b2wtbXllcnMtcmVwb3J0cy1zYWxlcy1zdXJwcmlzZS1hbWlkLWdlbmVyaWMtY29tcGV0aXRpb2lu0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "The Future of Diversity in Clinical Trials - CSRwire.com",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmNzcndpcmUuY29tL3ByZXNzX3JlbGVhc2VzLzc1MDUxNi1mdXR1cmUtZGl2ZXJzaXR5LWNsaW5pY2FsLXRyaWFsc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Opdualag off to a flying start, says BMS CEO - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL29wZHVhbGFnLW9mZi10by1hLWZseWluZy1zdGFydC1zYXlzLWJtcy1jZW_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Pfizer, BMS vet hits Replay with $55M seed financing - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvcmVwbGF5LXNuYXRjaGVzLTU1bS1zZWVkLWZ1bmRpbmctYXV0aG9yLW5leHQtZ2VuLWdlbm9tZS1tZWRpY2luZXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Phase II Study of Enzalutamide for Patients With Androgen Receptor ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDAyMjnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/15/2022": {
        "artical1": {
            "title": "What To Expect From Bristol Myers Squibb Stock After Q2 Results? - Forbes",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8wNy8xOS93aGF0LXRvLWV4cGVjdC1mcm9tLWJyaXN0b2wtbXllcnMtc3F1aWJiLXN0b2NrLWFmdGVyLXEyLXJlc3VsdHMv0gF-aHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9ncmVhdHNwZWN1bGF0aW9ucy8yMDIyLzA3LzE5L3doYXQtdG8tZXhwZWN0LWZyb20tYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2stYWZ0ZXItcTItcmVzdWx0cy9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Launches Disability ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMixgFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1MYXVuY2hlcy1EaXNhYmlsaXR5LURpdmVyc2l0eS1pbi1DbGluaWNhbC1UcmlhbHMtRERpQ1QtSW5pdGlhdGl2ZS10by1JbXByb3ZlLUhlYWx0aGNhcmUtT3V0Y29tZXMtZm9yLVBlb3BsZS13aXRoLURpc2FiaWxpdGllcy9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Oxford Biomedica, Juno Therapeutics Expand LentiVector Platform ... - Contract Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5jb250cmFjdHBoYXJtYS5jb20vY29udGVudHMvdmlld19icmVha2luZy1uZXdzLzIwMjItMDctMjEvb3hmb3JkLWJpb21lZGljYS1qdW5vLXRoZXJhcGV1dGljcy1leHBhbmQtbGVudGl2ZWN0b3ItcGxhdGZvcm0tcGFjdC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Dr. Giovanni Caforio, Bristol-Myers Squibb (BMS) Chairman and CEO - SurvivorNet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LnN1cnZpdm9ybmV0LmNvbS9hcnRpY2xlcy9zbi1jb25uZWN0LWRyLWdpb3Zhbm5pLWNhZm9yaW8tYnJpc3RvbC1teWVycy1zcXVpYmItYm1zLWNoYWlybWFuLWFuZC1jZW8v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Clinical Outcomes and Risk Stratification of Early-Stage Melanoma ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI0ODjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "There are too many blood cancer cell therapies in development ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FidW5kYW5jZS1jYXItdHMtMzdiLWNlbGwtdGhlcmFweS1jYW5jZXItbWFya2V0LWNhbnQtc3VwcG9ydC1jb25nZXN0ZWQtcGlwZWxpbmUtcmVwb3J00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Merck's Keytruda posts rare flop in head and neck cancer trial - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL21lcmNrcy1tZWdhYmxvY2tidXN0ZXIta2V5dHJ1ZGEtZmxvcHMtaGVhZC1hbmQtbmVjay1jYW5jZXItdHJpYWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/08/2022": {
        "artical1": {
            "title": "Biohaven Commences Phase 3 Study of Taldefgrobep Alfa in Spinal ... - Neurology Live",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3Lm5ldXJvbG9neWxpdmUuY29tL3ZpZXcvYmlvaGF2ZW4tY29tbWVuY2VzLXBoYXNlLTMtc3R1ZHktdGFsZGVmZ3JvYmVwLWFsZmEtc3BpbmFsLW11c2N1bGFyLWF0cm9waHnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Overall Survival Results From the POLO Trial: A Phase III Study of ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDE2MDTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "BioIVT Launches New Scientific Advisory Board - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3ByZXNzLXJlbGVhc2UvMjAyMjA3MTEtYmlvaXZ0LWxhdW5jaGVzLW5ldy1zY2llbnRpZmljLWFkdmlzb3J5LWJvYXJkL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Long-Term Benefits of Tagraxofusp for Patients With Blastic ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDAwMzTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Rethinking DE&I for Growth and Agility: Pamela Fisher - The HR Digest",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LnRoZWhyZGlnZXN0LmNvbS9yZXRoaW5raW5nLWRlaS1mb3ItZ3Jvd3RoLWFuZC1hZ2lsaXR5LXBhbWVsYS1maXNoZXIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Exelixis trots out combo win for Cabometyx and BMS meds in kidney ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2V4ZWxpeGlzLXRyb3Qtb3V0LW9wZGl2by15ZXJ2b3ktY2Fib21ldHl4LWNvbWJvLXdpbi1raWRuZXktY2FuY2VyLXdpbGwtZmRhLWFjY2VwdNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bladder Cancer Drugs Global Market Report 2022-2027: Featuring Key Players Pfizer, AstraZeneca, Bristol-Myers Squibb & Others - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ibGFkZGVyLWNhbmNlci1kcnVncy1nbG9iYWwtbWFya2V0LTExMTgwMDU4MS5odG1s0gFYaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvYmxhZGRlci1jYW5jZXItZHJ1Z3MtZ2xvYmFsLW1hcmtldC0xMTE4MDA1ODEuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/01/2022": {
        "artical1": {
            "title": "Lotte to invest $77M, add jobs to expand Bristol pharma plant in East Syracuse - syracuse.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnN5cmFjdXNlLmNvbS9idXNpbmVzcy8yMDIyLzA3L2xvdHRlLXRvLWludmVzdC03N20tYWRkLWpvYnMtdG8tZXhwYW5kLWJyaXN0b2wtcGhhcm1hLXBsYW50LWluLWVhc3Qtc3lyYWN1c2UuaHRtbNIBigFodHRwczovL3d3dy5zeXJhY3VzZS5jb20vYnVzaW5lc3MvMjAyMi8wNy9sb3R0ZS10by1pbnZlc3QtNzdtLWFkZC1qb2JzLXRvLWV4cGFuZC1icmlzdG9sLXBoYXJtYS1wbGFudC1pbi1lYXN0LXN5cmFjdXNlLmh0bWw_b3V0cHV0VHlwZT1hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "With chance to take on Bristol Myers' $13B heart drug, Cytokinetics ... - Endpoints News",
            "link": "https://news.google.com/rss/articles/CBMigwFodHRwczovL2VuZHB0cy5jb20vd2l0aC1jaGFuY2UtdG8tdGFrZS1vbi1icmlzdG9sLW15ZXJzLTEzYi1oZWFydC1kcnVnLWN5dG9raW5ldGljcy1wcmVwcy1mb3ItcGl2b3RhbC1zdHVkaWVzLXdpdGgtNDUwbS1kZWJ0LXJhaXNlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Relevance of Bone Marrow Biopsies for Response Assessment in ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDIzMDHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Awards & Accolades: June 2022 - Penn Medicine",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnBlbm5tZWRpY2luZS5vcmcvbmV3cy9uZXdzLXJlbGVhc2VzLzIwMjIvanVseS9hd2FyZHMtYW5kLWFjY29sYWRlcy1qdW5lLTIwMjLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "La FDA aprueba Breyanzi\u00ae, la terapia CAR-T de Bristol Myers Squibb para el linfoma de c\u00e9lulas B gr - vademecum.es",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi9QFodHRwczovL3d3dy52YWRlbWVjdW0uZXMvbm90aWNpYS0yMjA3MDUtbGErZmRhK2FwcnVlYmErYnJleWFuemkrcmVnKyUyQytsYSt0ZXJhcGlhK2Nhci10K2RlK2JyaXN0b2wrbXllcnMrc3F1aWJiK3BhcmErZWwrbGluZm9tYStkZStjK2VhY3V0ZStsdWxhcytiK2dyYW5kZXMrJTI4bGNnYiUyOStlbityZWNhK2lhY3V0ZStkYStvK3JlZnJhY3RhcmlvK2Rlc3B1K2VhY3V0ZStzK2RlK3VuK3RyYXRhbWllbnRvK3ByZXZpb18xNjY1NtIB-QFodHRwczovL3d3dy52YWRlbWVjdW0uZXMvYW1wL25vdGljaWEtMjIwNzA1LWxhK2ZkYSthcHJ1ZWJhK2JyZXlhbnppK3JlZyslMkMrbGErdGVyYXBpYStjYXItdCtkZSticmlzdG9sK215ZXJzK3NxdWliYitwYXJhK2VsK2xpbmZvbWErZGUrYytlYWN1dGUrbHVsYXMrYitncmFuZGVzKyUyOGxjZ2IlMjkrZW4rcmVjYStpYWN1dGUrZGErbytyZWZyYWN0YXJpbytkZXNwdStlYWN1dGUrcytkZSt1bit0cmF0YW1pZW50bytwcmV2aW9fMTY2NTY?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "TPTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the ... - Lawyer Monthly Magazine",
            "link": "https://news.google.com/rss/articles/CBMipQFodHRwczovL3d3dy5sYXd5ZXItbW9udGhseS5jb20vMjAyMi8wNy90cHR4LXN0b2NrLWFsZXJ0LWhhbHBlci1zYWRlaC1sbHAtaXMtaW52ZXN0aWdhdGluZy13aGV0aGVyLXRoZS1zYWxlLW9mLXR1cm5pbmctcG9pbnQtdGhlcmFwZXV0aWNzLWluYy1pcy1mYWlyLXRvLXNoYXJlaG9sZGVycy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Daily OTC Pearl: Sacubitril and Valsartan (Entresto) - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZGFpbHktb3RjLXBlYXJsLXNhY3ViaXRyaWwtYW5kLXZhbHNhcnRhbi1lbnRyZXN0by3SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/24/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Presents New Data ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi6AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1QcmVzZW50cy1OZXctRGF0YS1TaG93aW5nLUVmZmVjdC1vZi1FYXJseS1aZXBvc2lhLW96YW5pbW9kLVRyZWF0bWVudC1pbi1JbXByb3ZpbmctYW5kLVByZXNlcnZpbmctQ29nbml0aXZlLUZ1bmN0aW9uLWluLVBlb3BsZS1XaXRoLVJlbGFwc2luZy1NdWx0aXBsZS1TY2xlcm9zaXMvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Ensuring lentivirus supply key for J&J and BMS - BioProcess Insider - BioProcess Insider",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vYmlvcHJvY2Vzc2ludGwuY29tL2Jpb3Byb2Nlc3MtaW5zaWRlci9nbG9iYWwtbWFya2V0cy9jb21tZXJjaWFsLWNhci10cy1lbnN1cmluZy1sZW50aXZpcnVzLXN1cHBseS1rZXktZm9yLWpqLWFuZC1ibXMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "U.S. FDA Approves Bristol Myers Squibb's CAR T Cell Therapy ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMivQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9VUy1GREEtQXBwcm92ZXMtQnJpc3RvbC1NeWVycy1TcXVpYmJzLUNBUi1ULUNlbGwtVGhlcmFweS1CcmV5YW56aWZvci1SZWxhcHNlZC1vci1SZWZyYWN0b3J5LUxhcmdlLUItY2VsbC1MeW1waG9tYS1BZnRlci1PbmUtUHJpb3ItVGhlcmFweS9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "New Data Highlight Immune Response to COVID-19 Vaccines in ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMiwwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9OZXctRGF0YS1IaWdobGlnaHQtSW1tdW5lLVJlc3BvbnNlLXRvLUNPVklELTE5LVZhY2NpbmVzLWluLUluZGl2aWR1YWxzLXdpdGgtUmVsYXBzaW5nLUZvcm1zLW9mLU11bHRpcGxlLVNjbGVyb3Npcy1UcmVhdGVkLXdpdGgtWmVwb3NpYS1vemFuaW1vZC9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "CVS Health returns BMS, Pfizer's Eliquis to formulary - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9lbGlxdWlzLXdpbGwtcmV0dXJuLWN2cy1mb3JtdWxhcnktYWZ0ZXItd2F2ZS1jcml0aWNpc20tY2l0ZXMtbG93ZXItbmV0LWNvc3QtbmVnb3RpYXRpb25zLWJtc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "FDA expands Breyanzi approval for relapsed or refractory large B ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMDYyNy9mZGEtZXhwYW5kcy1icmV5YW56aS1hcHByb3ZhbC1mb3ItcmVsYXBzZWQtb3ItcmVmcmFjdG9yeS1sYXJnZS1iY2VsbC1seW1waG9tYdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Long-term Data Show Zeposia May Help Cognitive Function in MS... - Multiple Sclerosis News Today",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vbXVsdGlwbGVzY2xlcm9zaXNuZXdzdG9kYXkuY29tL25ld3MtcG9zdHMvMjAyMi8wNi8zMC9sb25nLXRlcm0tZGF0YS16ZXBvc2lhLWhlbHAtY29nbml0aXZlLWZ1bmN0aW9uLXBhdGllbnRzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/17/2022": {
        "artical1": {
            "title": "European Medicines Agency Validates Bristol Myers Squibb's ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi4gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9FdXJvcGVhbi1NZWRpY2luZXMtQWdlbmN5LVZhbGlkYXRlcy1CcmlzdG9sLU15ZXJzLVNxdWliYnMtQXBwbGljYXRpb24tZm9yLUNBUi1ULUNlbGwtVGhlcmFweS1CcmV5YW56aS1pbi1SZWxhcHNlZC1vci1SZWZyYWN0b3J5LUxhcmdlLUItY2VsbC1MeW1waG9tYS1BZnRlci1GaXJzdC1MaW5lLVRoZXJhcHkvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS, Pfizer and Merck face steep patent cliffs but all have the ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Jtcy1wZml6ZXItbWVyY2stZmFjZS1leHRyZW1lLXBhdGVudC1leHBvc3VyZS1hbGwtaGF2ZS1maW5hbmNpYWwtZmxleGliaWxpdHktbWEtc2NvcmVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI1NDPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "CVS Caremark returns Eliquis to formulary after outcry - Modern Healthcare",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3Lm1vZGVybmhlYWx0aGNhcmUuY29tL3BhdGllbnQtY2FyZS9jdnMtY2FyZW1hcmstcmV0dXJucy1lbGlxdWlzLWZvcm11bGFyeS1hZnRlci1vdXRjcnnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Neoadjuvant Chemotherapy Plus Immunotherapy in Early-Stage ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjIuMDA4NzPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Cryoport Opens Life Sciences Logistics Center in Morris Plains - njbmagazine.com",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vbmpibWFnYXppbmUuY29tL25qYi1uZXdzLW5vdy9jcnlvcG9ydC1vcGVucy1saWZlLXNjaWVuY2VzLWxvZ2lzdGljcy1jZW50ZXItaW4tbW9ycmlzLXBsYWlucy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "5 Stocks Warren Buffett Has Aggressively Sold Since 2022 Began - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA2LzE3LzUtc3RvY2tzLXdhcnJlbi1idWZmZXR0LWhhcy1zb2xkLXNpbmNlLTIwMjItYmVnYW4v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/10/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Elects Deepak L. Bhatt ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1FbGVjdHMtRGVlcGFrLUwuLUJoYXR0LU0uRC4tTS5QLkguLXRvLUJvYXJkLW9mLURpcmVjdG9ycy9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers asks Supreme Court to revive $1.2 bln cancer-drug ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL2xpdGlnYXRpb24vYnJpc3RvbC1teWVycy1hc2tzLXN1cHJlbWUtY291cnQtcmV2aXZlLTEyLWJsbi1jYW5jZXItZHJ1Zy1wYXRlbnQtd2luLTIwMjItMDYtMTQv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS Enlists Owkin's AI/ML Tech to Improve Clinical Trials - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWlua3MtYWktZGVhbC1vZi11cC10by0xODBtLXdpdGgtb3draW4v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Relatlimab plus nivolumab confers benefit across key subgroups in ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMDYxMC9yZWxhdGxpbWFiLXBsdXMtbml2b2x1bWFiLWNvbmZlcnMtYmVuZWZpdC1hY3Jvc3Mta2V5LXN1Ymdyb3Vwcy1pbi1hZHZhbmNlZC1tZWxhbm9tYdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Prognosis of Patients With Primary Melanoma Stage I and II ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDAyMDLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjIuMDAzODDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI4MjPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/03/2022": {
        "artical1": {
            "title": "Kirkland Represents Bristol Myers Squibb on $4.1 Billion Acquisition ... - Kirkland & Ellis LLP",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmtpcmtsYW5kLmNvbS9uZXdzL3ByZXNzLXJlbGVhc2UvMjAyMi8wNi9raXJrbGFuZC1yZXByZXNlbnRzLWJtcy1vbi10dXJuaW5nLXBvaW500gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb to buy Turning Point Therapeutics for $4.1 ... - STAT",
            "link": "https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5zdGF0bmV3cy5jb20vMjAyMi8wNi8wMy9icmlzdG9sLW15ZXJzLXNxdWliYi10by1idXktdHVybmluZy1wb2ludC10aGVyYXBldXRpY3MtZm9yLTQtMS1iaWxsaW9uLXRvLWdhaW4tZHJ1Z3MtdGFyZ2V0aW5nLXJhcmUtY2FuY2VyLW11dGF0aW9ucy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb to Acquire Turning Point Therapeutics, a ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMimAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDYwMzAwNTE5OC9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1BY3F1aXJlLVR1cm5pbmctUG9pbnQtVGhlcmFwZXV0aWNzLWEtTGVhZGluZy1QcmVjaXNpb24tT25jb2xvZ3ktQ29tcGFuedIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "UPDATE: Bristol Myers strikes up Roche rivalry with $4.1B Turning ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYm1zLXN0cmlrZXMtcm9jaGUtcml2YWxyeS00MWItYWNxdWlzaXRpb24tdHVybmluZy1wb2ludNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Immatics and Editas join up to bring CRISPR to 'gamma delta' cell ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW1tYXRpY3MtZWRpdGFzLWNyaXNwci1nYW1tYS1kZWx0YS1jZWxsLXRoZXJhcHkvNjI1MDE2L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Withdraws ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi1AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1XaXRoZHJhd3MtU3VwcGxlbWVudGFsLUJpb2xvZ2ljcy1MaWNlbnNlLUFwcGxpY2F0aW9uLXNCTEEtZm9yLVJlYmxvenlsLWx1c3BhdGVyY2VwdC1hYW10LWZvci1Ob24tdHJhbnNmdXNpb24tRGVwZW5kZW50LU5URC1CZXRhLVRoYWxhc3NlbWlhL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Landmark Five-Year Data from Phase 3 CheckMate -227 Trial ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimAJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9MYW5kbWFyay1GaXZlLVllYXItRGF0YS1mcm9tLVBoYXNlLTMtQ2hlY2tNYXRlLS0yMjctVHJpYWwtRGVtb25zdHJhdGUtTG9uZy1UZXJtLUR1cmFibGUtU3Vydml2YWwtT3V0Y29tZXMtd2l0aC1PcGRpdm9uaXZvbHVtYWItUGx1cy1ZZXJ2b3ktaXBpbGltdW1hYi1pbi1GaXJzdC1MaW5lLVRyZWF0bWVudC1vZi1QYXRpZW50cy13aXRoLU1ldGFzdGF0aWMtTm9uLVNtYWxsLUNlbGwtTHVuZy1DYW5jZXIvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/27/2022": {
        "artical1": {
            "title": "BMS, Immatics Launch Up-to-$4.2B Expanded Cancer Cell Therapy ... - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvYm1zLWltbWF0aWNzLWxhdW5jaC11cC10by00LTJiLWV4cGFuZGVkLWNhbmNlci1jZWxsLXRoZXJhcHktY29sbGFib3JhdGlvbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers, J&J drugs reduce COVID death rates in NIH study - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2JyaXN0b2wtbXllcnMtZHJ1Zy1mYWlscy1tZWV0LW1haW4tZ29hbC1jb3ZpZC1zdHVkeS0yMDIyLTA2LTAyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS Preps Lupus Treatment to Become Third Approval in Space - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jtcy1kYXRhLXNjb3Jlcy13ZWxsLWZvci1pdHMtc2xlLWRydWctZGV1Y3JhdmFjaXRpbmliL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb is first foreign pharma to leave Russia - The Pharma Letter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9icmlzdG9sLW15ZXJzLXNxdWliYi1pcy1maXJzdC1mb3JlaWduLXBoYXJtYS10by1sZWF2ZS1ydXNzaWHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "U.S. Food and Drug Administration Approves Two Opdivo ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi5gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQXBwcm92ZXMtVHdvLU9wZGl2by1uaXZvbHVtYWItQmFzZWQtUmVnaW1lbnMtYXMtRmlyc3QtTGluZS1UcmVhdG1lbnRzLWZvci1VbnJlc2VjdGFibGUtQWR2YW5jZWQtb3ItTWV0YXN0YXRpYy1Fc29waGFnZWFsLVNxdWFtb3VzLUNlbGwtQ2FyY2lub21hL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Opened during WWII, Bristol Myers in Syracuse was the world\u2019s biggest penicillin maker by 1950 - syracuse.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5zeXJhY3VzZS5jb20vbGl2aW5nLzIwMjIvMDYvb3BlbmVkLWR1cmluZy13d2lpLWJyaXN0b2wtbXllcnMtaW4tc3lyYWN1c2Utd2FzLXRoZS13b3JsZHMtYmlnZ2VzdC1wZW5pY2lsbGluLW1ha2VyLWJ5LTE5NTAuaHRtbNIBmAFodHRwczovL3d3dy5zeXJhY3VzZS5jb20vbGl2aW5nLzIwMjIvMDYvb3BlbmVkLWR1cmluZy13d2lpLWJyaXN0b2wtbXllcnMtaW4tc3lyYWN1c2Utd2FzLXRoZS13b3JsZHMtYmlnZ2VzdC1wZW5pY2lsbGluLW1ha2VyLWJ5LTE5NTAuaHRtbD9vdXRwdXRUeXBlPWFtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "From the Township: Working to revitalize the former BMS campus - Community News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipAFodHRwczovL3d3dy5jb21tdW5pdHluZXdzLm9yZy90b3ducy9ob3Bld2VsbC1leHByZXNzL2Zyb20tdGhlLXRvd25zaGlwLXdvcmtpbmctdG8tcmV2aXRhbGl6ZS10aGUtZm9ybWVyLWJtcy1jYW1wdXMvYXJ0aWNsZV82MzE1NzAxNi1lMTFkLTExZWMtYTRjOC1kN2MwYzQyYjIyOGYuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/20/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb sues Novartis for royalties surrounding the use ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vZW5kcHRzLmNvbS9icmlzdG9sLW15ZXJzLXNxdWliYi1zdWVzLW5vdmFydGlzLWZvci1yb3lhbHRpZXMtc3Vycm91bmRpbmctdGhlLXVzZS1vZi10cmFuc2dlbmljLW1pY2Uv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers pulling out of Russia, closing trials - BioCentury",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmJpb2NlbnR1cnkuY29tL2FydGljbGUvNjQzNzI1L2JyaXN0b2wtbXllcnMtcHVsbGluZy1vdXQtb2YtcnVzc2lhLWNsb3NpbmctdHJpYWxz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Why Did Warren Buffett Just Sell 1 of His Best Stocks of 2022? - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA1LzI2L3doeS1kaWQtd2FycmVuLWJ1ZmZldHQtanVzdC1zZWxsLTEtb2YtaGlzLWJlc3Qtc3RvL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers moves to enforce transgenic mice award - GAR",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZ2xvYmFsYXJiaXRyYXRpb25yZXZpZXcuY29tL2FydGljbGUvYnJpc3RvbC1teWVycy1tb3Zlcy1lbmZvcmNlLXRyYW5zZ2VuaWMtbWljZS1hd2FyZNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Second Revision of the International Staging System (R2-ISS) for ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI2MTTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Pfizer seeks to put etrasimod first - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy1zbmlwcGV0cy9wZml6ZXItc2Vla3MtcHV0LWV0cmFzaW1vZC1maXJzdNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE3ODc2L2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "How do you expand cell therapy manufacturing to reach more ... - BioPharma-Reporter.com",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5iaW9waGFybWEtcmVwb3J0ZXIuY29tL0FydGljbGUvMjAyMi8wNS8yMy9Ib3ctZG8teW91LWV4cGFuZC1jZWxsLXRoZXJhcHktbWFudWZhY3R1cmluZy10by1yZWFjaC1tb3JlLXBhdGllbnRzLXBlci15ZWFy0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/13/2022": {
        "artical1": {
            "title": "South Korean company Lotte to buy Bristol Myers Squibb plant in East Syracuse - syracuse.com",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LnN5cmFjdXNlLmNvbS9idXNpbmVzcy8yMDIyLzA1L3NvdXRoLWtvcmVhbi1jb21wYW55LWxvdHRlLXRvLWJ1eS1icmlzdG9sLW15ZXJzLXNxdWliYi1wbGFudC1pbi1lYXN0LXN5cmFjdXNlLmh0bWzSAYsBaHR0cHM6Ly93d3cuc3lyYWN1c2UuY29tL2J1c2luZXNzLzIwMjIvMDUvc291dGgta29yZWFuLWNvbXBhbnktbG90dGUtdG8tYnV5LWJyaXN0b2wtbXllcnMtc3F1aWJiLXBsYW50LWluLWVhc3Qtc3lyYWN1c2UuaHRtbD9vdXRwdXRUeXBlPWFtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "LOTTE to Purchase Bristol Myers Squibb Manufacturing Facility in ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDUxMjAwNjEzMi9lbi9MT1RURS10by1QdXJjaGFzZS1CcmlzdG9sLU15ZXJzLVNxdWliYi1NYW51ZmFjdHVyaW5nLUZhY2lsaXR5LWluLUVhc3QtU3lyYWN1c2UtTmV3LVlvcmvSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Baker McKenzie Advises Bristol Myers Squibb on Sale of ... - Baker McKenzie",
            "link": "https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LmJha2VybWNrZW56aWUuY29tL2VuL25ld3Nyb29tLzIwMjIvMDUvYnJpc3RvbC1teWVycy1zcXVpYmItbG90dGXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "BridgeBio Pharma Inks Licensing Deal With Bristol Myers Squibb ... - Equities News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmVxdWl0aWVzLmNvbS9uZXdzL2JyaWRnZWJpby1waGFybWEtaW5rcy1saWNlbnNpbmctZGVhbC13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLXdvcnRoLXVwLXRvLTkwNS1taWxsaW9uL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "BridgeBio Announces Exclusive License Agreement with Bristol ... - Goodwin Procter",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3Lmdvb2R3aW5sYXcuY29tL2VuL25ld3MtYW5kLWV2ZW50cy9uZXdzLzIwMjIvMDUvMDVfMTMtYnJpZGdlYmlvLWFubm91bmNlcy1leGNsdXNpdmUtbGljZW5zZdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Busy dealing-making days for BridgeBio - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9idXN5LWRlYWxpbmctbWFraW5nLWRheXMtZm9yLWJyaWRnZWJpb9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Veeva launches Vault CTMS with Bristol Myers Squibb - OutSourcing-Pharma.com",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3Lm91dHNvdXJjaW5nLXBoYXJtYS5jb20vQXJ0aWNsZS8yMDIyLzA1LzE3L1ZlZXZhLWxhdW5jaGVzLVZhdWx0LUNUTVMtd2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/06/2022": {
        "artical1": {
            "title": "Evotec and Bristol Myers Squibb extend and expand strategic ... - Evotec",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5ldm90ZWMuY29tL2VuL2ludmVzdG9yLXJlbGF0aW9ucy9uZXdzL3AvZXZvdGVjLWFuZC1icmlzdG9sLW15ZXJzLXNxdWliYi1leHRlbmQtYW5kLWV4cGFuZC1zdHJhdGVnaWMtcGFydG5lcnNoaXAtaW4tcHJvdGVpbi1kZWdyYWRhdGlvbi02MTcz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BridgeBio Announces Exclusive License Agreement with Bristol ... - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMi7QFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMi8wNS8xMi8yNDQxODQxLzAvZW4vQnJpZGdlQmlvLUFubm91bmNlcy1FeGNsdXNpdmUtTGljZW5zZS1BZ3JlZW1lbnQtd2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYi10by1EZXZlbG9wLWFuZC1Db21tZXJjaWFsaXplLUJCUC0zOTgtYS1Qb3RlbnRpYWxseS1CZXN0LWluLUNsYXNzLVNIUDItSW5oaWJpdG9yLWluLU9uY29sb2d5Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Unit Sues Jiangsu Hengrui to Block Abraxane Copies - Bloomberg Law",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcuY29tL2lwLWxhdy9icmlzdG9sLW15ZXJzLXVuaXQtc3Vlcy1qaWFuZ3N1LWhlbmdydWktdG8tYmxvY2stYWJyYXhhbmUtY29waWVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Nuvig Launches to Develop Novel Immune Therapeutics for Chronic ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDUxMTAwNTA0MS9lbi9OdXZpZy1MYXVuY2hlcy10by1EZXZlbG9wLU5vdmVsLUltbXVuZS1UaGVyYXBldXRpY3MtZm9yLUNocm9uaWMtSW5mbGFtbWF0b3J5LWFuZC1BdXRvaW1tdW5lLURpc2Vhc2Vz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Pfizer Adds Migraine Drugs with Planned $11.6B Biohaven Acquisition - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvcGZpemVyLWFkZHMtbWlncmFpbmUtZHJ1Z3Mtd2l0aC1wbGFubmVkLTExLTZiLWJpb2hhdmVuLWFjcXVpc2l0aW9uL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Fed's Mester: road ahead will be bumpy for economy in inflation fight - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2ZlZHMtbWVzdGVyLXJvYWQtYWhlYWQtd2lsbC1iZS1idW1weS1lY29ub215LWluZmxhdGlvbi1maWdodC0yMDIyLTA1LTEwL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Cullinan Oncology and Taiho Reunite to Co-Develop NSCLC Drug - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2N1bGxpbmFuLW9uY29sb2d5LWFuZC10YWloby1iYWNrLXRvZ2V0aGVyLW9uLWx1bmctY2FuY2VyLWRydWctaW4tYWNxdWlzaXRpb24tZGVhbC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/29/2022": {
        "artical1": {
            "title": "Amphista Therapeutics Enters Strategic Collaboration with Bristol ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi0QFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FtcGhpc3RhLXRoZXJhcGV1dGljcy1lbnRlcnMtc3RyYXRlZ2ljLWNvbGxhYm9yYXRpb24td2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi1mb3ItZGlzY292ZXJ5LWFuZC1kZXZlbG9wbWVudC1vZi10YXJnZXRlZC1wcm90ZWluLWRlZ3JhZGF0aW9uLXRoZXJhcGV1dGljcy0zMDE1MzkxODguaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb (BMY) Q1 2022 Earnings Call Transcript - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmZvb2wuY29tL2Vhcm5pbmdzL2NhbGwtdHJhbnNjcmlwdHMvMjAyMi8wNC8yOS9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktcTEtMjAyMi1lYXJuaW5ncy1jYWxsLXRyYS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA approvals, Revlimid LOE and Opdivo's label expansion ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vZW5kcHRzLmNvbS9mZGEtYXBwcm92YWxzLXJldmxpbWlkLWxvZS1hbmQtb3BkaXZvcy1sYWJlbC1leHBhbnNpb24taGVhZGxpbmUtYnJpc3RvbC1teWVycy1zdGFydC10by0yMDIyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers first-quarter sales up on Eliquis, Opdivo - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2JyaXN0b2wtbXllcnMtMXN0LXF1YXJ0ZXItc2FsZXMtdXAtZWxpcXVpcy1vcGRpdm8tMjAyMi0wNC0yOS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Potential blockbuster BMS cardio drug gets FDA nod, first in rare ... - MedCity News",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjIvMDQvcG90ZW50aWFsLWJsb2NrYnVzdGVyLWJtcy1jYXJkaW8tZHJ1Zy1nZXRzLWZkYS1ub2QtZmlyc3QtaW4tcmFyZS1oZWFydC1kaXNlYXNlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Reports First Quarter ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIyL0JyaXN0b2wtTXllcnMtU3F1aWJiLVJlcG9ydHMtRmlyc3QtUXVhcnRlci1GaW5hbmNpYWwtUmVzdWx0cy1mb3ItMjAyMi9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Kinexions22 - how Bristol Myers Squibb shifted to a continuous improvement approach to supply chain planning - diginomica",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vZGlnaW5vbWljYS5jb20va2luZXhpb25zMjItaG93LWJyaXN0b2wtbXllcnMtc3F1aWJiLXNoaWZ0ZWQtY29udGludW91cy1pbXByb3ZlbWVudC1hcHByb2FjaC1zdXBwbHktY2hhaW4tcGxhbm5pbmfSAX1odHRwczovL2RpZ2lub21pY2EuY29tL2tpbmV4aW9uczIyLWhvdy1icmlzdG9sLW15ZXJzLXNxdWliYi1zaGlmdGVkLWNvbnRpbnVvdXMtaW1wcm92ZW1lbnQtYXBwcm9hY2gtc3VwcGx5LWNoYWluLXBsYW5uaW5nP2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/22/2022": {
        "artical1": {
            "title": "FDA approves Bristol Myers' oral heart disease drug - Reuters",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2ZkYS1hcHByb3Zlcy1icmlzdG9sLW15ZXJzLWhlYXJ0LWRpc2Vhc2UtZHJ1Zy0yMDIyLTA0LTI5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "UPDATE: Nektar guts workforce, weeks after $3.6B Bristol Myers ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvbmVrdGFyLWd1dHMtd29ya2ZvcmNlLXdlZWtzLWFmdGVyLTM2Yi1icmlzdG9sLW15ZXJzLWltbXVuby1vbmNvbG9neS1jb2xsYWJvcmF0aW9uLWVuZHPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "COAST: An Open-Label, Phase II, Multidrug Platform Study of ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjIuMDAyMjfSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "40 Under 40: Ashley Koegel, Bristol Myers Squibb - San Francisco ... - The Business Journals",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zYW5mcmFuY2lzY28vbmV3cy8yMDIyLzA0LzIyLzQwLXVuZGVyLTQwLWNsYXNzLW9mLTIwMjIta29lZ2VsLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Randomized Phase II Study of Nivolumab With or Without ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDI1MTHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Big Pharma's top advertisers - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzL3RvcC1hZHZlcnRpc2Vycy1pbi1iaWctcGhhcm1h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Walmex 1st quarter revenue jumps, yet growth trails sector - Reuters",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL3JldGFpbC1jb25zdW1lci93YWxtYXJ0cy1tZXhpY28tdW5pdC1zYXlzLXF1YXJ0ZXJseS1uZXQtcHJvZml0LXVwLTEwLTIwMjItMDQtMjYv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/15/2022": {
        "artical1": {
            "title": "Game over: Bristol Myers, Nektar end $3.6B immuno-oncology ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZ2FtZS1vdmVyLWJyaXN0b2wtbXllcnMtbmVrdGFyLWVuZC0zNmItaW1tdW5vLW9uY29sb2d5LXByb2dyYW0tYWZ0ZXItMi1tb3JlLWxhdGUtc3RhZ2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "IL-2 program falls flat for Nektar and Bristol Myers Squibb - Chemical & Engineering News",
            "link": "https://news.google.com/rss/articles/CBMiPGh0dHBzOi8vY2VuLmFjcy5vcmcvYnVzaW5lc3MvSUwtMi1wcm9ncmFtLWZhbGxzLWZsYXQvMTAwL2kxNNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Nektar (NKTR) Ends Bempeg Plus Opdivo Program on Study Failures - Zacks Investment Research",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzE5MDE1OTYvbmVrdGFyLW5rdHItZW5kcy1iZW1wZWctcGx1cy1vcGRpdm8tcHJvZ3JhbS1vbi1zdHVkeS1mYWlsdXJlc9IBamh0dHBzOi8vd3d3LnphY2tzLmNvbS9hbXAvc3RvY2svbmV3cy8xOTAxNTk2L25la3Rhci1ua3RyLWVuZHMtYmVtcGVnLXBsdXMtb3BkaXZvLXByb2dyYW0tb24tc3R1ZHktZmFpbHVyZXM?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Why Nektar Therapeutics Stock Is Crashing Today - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzA0LzE4L3doeS1uZWt0YXItdGhlcmFwZXV0aWNzLXN0b2NrLWlzLWNyYXNoaW5nLXRvZGF5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Veeva Vault CTMS Launched at Bristol Myers Squibb to Simplify ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3ZlZXZhLXZhdWx0LWN0bXMtbGF1bmNoZWQtYXQtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tc2ltcGxpZnktY2xpbmljYWwtdHJpYWwtcHJvY2Vzc2VzLWdsb2JhbGx5LTMwMTUyOTg4MS5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Octant Raises $80 Million Series B Round to Support Expansion of ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMi5wFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDQyMDAwNjI0Mi9lbi9PY3RhbnQtUmFpc2VzLTgwLU1pbGxpb24tU2VyaWVzLUItUm91bmQtdG8tU3VwcG9ydC1FeHBhbnNpb24tb2YtTmV4dC1HZW5lcmF0aW9uLURydWctRGlzY292ZXJ5LVBsYXRmb3JtLUFubm91bmNlcy1Db2xsYWJvcmF0aW9uLXdpdGgtQnJpc3RvbC1NeWVycy1TcXVpYmItYW5kLUtleS1BcHBvaW50bWVudHPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "'We Take Care of Our BMS Family' - Bristol Myers Squibb Canc - CSRwire.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmNzcndpcmUuY29tL3ByZXNzX3JlbGVhc2VzLzc0MTcyNi13ZS10YWtlLWNhcmUtb3VyLWJtcy1mYW1pbHktYnJpc3RvbC1teWVycy1zcXVpYmItY2FuY2VyLXN1cHBvcnQtbmV0d29ya9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/08/2022": {
        "artical1": {
            "title": "Nektar and Bristol Myers Squibb Announce Update on Clinical ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiyQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL25la3Rhci1hbmQtYnJpc3RvbC1teWVycy1zcXVpYmItYW5ub3VuY2UtdXBkYXRlLW9uLWNsaW5pY2FsLWRldmVsb3BtZW50LXByb2dyYW0tZm9yLWJlbXBlZ2FsZGVzbGV1a2luLWJlbXBlZy1pbi1jb21iaW5hdGlvbi13aXRoLW9wZGl2by1uaXZvbHVtYWItMzAxNTI2MjIyLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "AACR: Bristol Myers details Opdivo's presurgery lung cancer win ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FhY3ItYnJpc3RvbC1teWVycy1kZXRhaWxzLW9wZGl2b3MtcHJlc3VyZ2VyeS1sdW5nLWNhbmNlci13aW4tZWFybHktc2lnbi1zdXJ2aXZhbC1iZW5lZml00gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Foundation Honors Diversity and Health - CSRwire.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmNzcndpcmUuY29tL3ByZXNzX3JlbGVhc2VzLzc0MTIyNi1icmlzdG9sLW15ZXJzLXNxdWliYi1mb3VuZGF0aW9uLWhvbm9ycy1kaXZlcnNpdHktYW5kLWhlYWx0aC1lcXVpdHktbGVhZGVy0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Neoadjuvant Opdivo (nivolumab) with Chemotherapy Significantly ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi5AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9OZW9hZGp1dmFudC1PcGRpdm8tbml2b2x1bWFiLXdpdGgtQ2hlbW90aGVyYXB5LVNpZ25pZmljYW50bHktSW1wcm92ZXMtRXZlbnQtRnJlZS1TdXJ2aXZhbC1pbi1QYXRpZW50cy13aXRoLVJlc2VjdGFibGUtTm9uLVNtYWxsLUNlbGwtTHVuZy1DYW5jZXItaW4tUGhhc2UtMy1DaGVja01hdGUtLTgxNi1UcmlhbC9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Sandoz and Teva invalidate blockbuster apixaban patent and SPC - JUVE Patent",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3Lmp1dmUtcGF0ZW50LmNvbS9jYXNlcy9zYW5kb3otYW5kLXRldmEtaW52YWxpZGF0ZS1ibG9ja2J1c3Rlci1hcGl4YWJhbi1wYXRlbnQtYW5kLXNwYy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "The top 20 pharma companies by 2021 revenue - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzL3RvcC0yMC1waGFybWEtY29tcGFuaWVzLTIwMjEtcmV2ZW51ZdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Neoadjuvant nivolumab plus chemotherapy extends EFS in non ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMDQxMi9uZW9hZGp1dmFudC1uaXZvbHVtYWItcGx1cy1jaGVtb3RoZXJhcHktZXh0ZW5kcy1lZnMtaW4tbm9uc21hbGwtY2VsbC1sdW5nLWNhbmNlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/01/2022": {
        "artical1": {
            "title": "Evotec achieves programme designation in neuroscience ... - Evotec",
            "link": "https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5ldm90ZWMuY29tL2VuL2ludmVzdG9yLXJlbGF0aW9ucy9uZXdzL3AvZXZvdGVjLWFjaGlldmVzLXByb2dyYW1tZS1kZXNpZ25hdGlvbi1pbi1uZXVyb3NjaWVuY2UtY29sbGFib3JhdGlvbi13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLTYxNjHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces Data from ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMirAJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtRGF0YS1mcm9tLUVYUExPUkVSLUxURS1EZW1vbnN0cmF0aW5nLVN1c3RhaW5lZC1JbXByb3ZlbWVudHMtaW4tQ2xpbmljYWxseS1NZWFuaW5nZnVsLUNhcmRpb3Zhc2N1bGFyLU91dGNvbWVzLWF0LVdlZWtzLTQ4LWFuZC04NC1pbi1QYXRpZW50cy13aXRoLVN5bXB0b21hdGljLU9ic3RydWN0aXZlLUh5cGVydHJvcGhpYy1DYXJkaW9teW9wYXRoeS1SZWNlaXZpbmctTWF2YWNhbXRlbi9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives European ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMixAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1FdXJvcGVhbi1Db21taXNzaW9uLUFwcHJvdmFsLWZvci1PcGRpdm8tbml2b2x1bWFiLVBsdXMtWWVydm95LWlwaWxpbXVtYWItYXMtRmlyc3QtTGluZS1UcmVhdG1lbnQtZm9yLVBhdGllbnRzLXdpdGgvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Mavacamten Demonstrated Significant Reduction in Need for Septal ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMixQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9NYXZhY2FtdGVuLURlbW9uc3RyYXRlZC1TaWduaWZpY2FudC1SZWR1Y3Rpb24taW4tTmVlZC1mb3ItU2VwdGFsLVJlZHVjdGlvbi1UaGVyYXB5LWluLVN5bXB0b21hdGljLU9ic3RydWN0aXZlLUhDTS1QYXRpZW50cy1pbi1QaGFzZS0zLVZBTE9SLVRyaWFsL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Cleveland Clinic-Led Trial Shows Drug Effective in Nearly 80% of Patients with Hypertrophic Cardiomyopathy - Cleveland Clinic Newsroom",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimgFodHRwczovL25ld3Nyb29tLmNsZXZlbGFuZGNsaW5pYy5vcmcvMjAyMi8wNC8wMi9jbGV2ZWxhbmQtY2xpbmljLWxlZC10cmlhbC1zaG93cy1kcnVnLWVmZmVjdGl2ZS1pbi1uZWFybHktODAtb2YtcGF0aWVudHMtd2l0aC1oeXBlcnRyb3BoaWMtY2FyZGlvbXlvcGF0aHkv0gGeAWh0dHBzOi8vbmV3c3Jvb20uY2xldmVsYW5kY2xpbmljLm9yZy8yMDIyLzA0LzAyL2NsZXZlbGFuZC1jbGluaWMtbGVkLXRyaWFsLXNob3dzLWRydWctZWZmZWN0aXZlLWluLW5lYXJseS04MC1vZi1wYXRpZW50cy13aXRoLWh5cGVydHJvcGhpYy1jYXJkaW9teW9wYXRoeS9hbXAv?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Chairman's News | Newsroom | The United States Senate ... - Hearing | Hearings | The United States Senate Committee on Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpbmFuY2Uuc2VuYXRlLmdvdi9jaGFpcm1hbnMtbmV3cy9zZW5hdG9yLXd5ZGVuLWNvbnRpbnVlcy1pbnZlc3RpZ2F0aW9uLWludG8tYmlnLXBoYXJtYS10YXgtcHJhY3RpY2Vz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Middle of the road for CEOs: Bristol Myers' Giovanni Caforio secured ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vZW5kcHRzLmNvbS9taWRkbGUtb2YtdGhlLXJvYWQtZm9yLWNlb3MtYnJpc3RvbC1teWVycy1naW92YW5uaS1jYWZvcmlvLXNlY3VyZWQtYWxtb3N0LTIwbS1pbi0yMDIxLWNvbXBlbnNhdGlvbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/25/2022": {
        "artical1": {
            "title": "5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIyLzAzLzMwLzUtY2hhcnRzLXRoYXQtc2hvdy13aHktYnJpc3RvbC1teWVycy1zcXVpYmItaXMtYS1uL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Roche, Bristol Myers partner to develop digital pathology AI to ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvcm9jaGUtYnJpc3RvbC1teWVycy1wYXJ0bmVyLWRldmVsb3AtZGlnaXRhbC1wYXRob2xvZ3ktYWktYW5hbHl6ZS1jbGluaWNhbC10cmlhbC1hc3NheXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Japan's Ministry of Health, Labour and Welfare Accepts Bristol ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi-gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9KYXBhbnMtTWluaXN0cnktb2YtSGVhbHRoLUxhYm91ci1hbmQtV2VsZmFyZS1BY2NlcHRzLUJyaXN0b2wtTXllcnMtU3F1aWJicy1BcHBsaWNhdGlvbi1mb3ItQnJleWFuemktbGlzb2NhYnRhZ2VuZS1tYXJhbGV1Y2VsLWFzLWEtU2Vjb25kLUxpbmUtVGhlcmFweS1mb3ItUmVsYXBzZWQtb3ItUmVmcmFjdG9yeS1MYXJnZS1CLWNlbGwtTHltcGhvbWEvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "European Medicines Agency Validates Bristol Myers Squibb's ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4wFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9FdXJvcGVhbi1NZWRpY2luZXMtQWdlbmN5LVZhbGlkYXRlcy1CcmlzdG9sLU15ZXJzLVNxdWliYnMtQXBwbGljYXRpb24tZm9yLU9wZGl2by1uaXZvbHVtYWItd2l0aC1DaGVtb3RoZXJhcHktYXMtTmVvYWRqdXZhbnQtVHJlYXRtZW50LWZvci1SZXNlY3RhYmxlLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb Announces New Prescription Drug User Fee ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMiyQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtTmV3LVByZXNjcmlwdGlvbi1EcnVnLVVzZXItRmVlLUFjdC1Hb2FsLURhdGUtZm9yLVJlYmxvenlsLWx1c3BhdGVyY2VwdC1hYW10LVN1cHBsZW1lbnRhbC1CaW9sb2dpY3MtTGljZW5zZS1BcHBsaWNhdGlvbi9kZWZhdWx0LmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Roche Diagnostics taps Bristol Myers Squibb for digital pathology ... - BioWorld Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJpb3dvcmxkLmNvbS9hcnRpY2xlcy81MTczMTQtcm9jaGUtZGlhZ25vc3RpY3MtdGFwcy1icmlzdG9sLW15ZXJzLXNxdWliYi1mb3ItZGlnaXRhbC1wYXRob2xvZ3ktY29sbGFib3JhdGlvbtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "BMS's Busy Week: a Milestone Approval, Reblozyl Delay and Action ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLXMtYnVzeS13ZWVrLWRlbGF5ZWQtcGR1ZmEtZGF0ZS1tb3ZlbWVudC1pbi1qYXBhbi1hbmQtZHJ1Zy1hcHByb3ZhbC0v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/18/2022": {
        "artical1": {
            "title": "U.S. FDA approves new Bristol Myers cancer immunotherapy - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL3VzLWZkYS1hcHByb3Zlcy1uZXctYnJpc3RvbC1teWVycy1jYW5jZXItaW1tdW5vdGhlcmFweS0yMDIyLTAzLTE4L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Transcenta Announces Global Clinical Collaboration with Bristol ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAJodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3RyYW5zY2VudGEtYW5ub3VuY2VzLWdsb2JhbC1jbGluaWNhbC1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tZXZhbHVhdGUtdHN0MDAxLWluLWNvbWJpbmF0aW9uLXdpdGgtb3BkaXZvLWluLXBhdGllbnRzLXdpdGgtbG9jYWxseS1hZHZhbmNlZC1vci1tZXRhc3RhdGljLWdhc3RyaWMtLWdhc3Ryb2Vzb3BoYWdlYWwtanVuY3Rpb24tY2FuY2VyLTMwMTUwNzIxNy5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Volastra Therapeutics Announces Drug Discovery Collaboration ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMijwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDMyMTAwNTAzNi9lbi9Wb2xhc3RyYS1UaGVyYXBldXRpY3MtQW5ub3VuY2VzLURydWctRGlzY292ZXJ5LUNvbGxhYm9yYXRpb24td2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Roche announces collaboration with Bristol Myers Squibb to ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3JvY2hlLWFubm91bmNlcy1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tYWR2YW5jZS1wZXJzb25hbGlzZWQtaGVhbHRoY2FyZS10aHJvdWdoLWRpZ2l0YWwtcGF0aG9sb2d5LXNvbHV0aW9ucy0zMDE1MTA0MDEuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Huge UTC Life Science Building Leased to Bristol Myers Squibb - San Diego Business Journal",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LnNkYmouY29tL25ld3MvZW5ld3MvaHVnZS11dGMtbGlmZS1zY2llbmNlLWJ1aWxkaW5nLWxlYXNlZC1icmlzdG9sLW15ZXIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "U.S. Food and Drug Administration Approves First LAG-3-Blocking ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi8gFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQXBwcm92ZXMtRmlyc3QtTEFHLTMtQmxvY2tpbmctQW50aWJvZHktQ29tYmluYXRpb24tT3BkdWFsYWctbml2b2x1bWFiLWFuZC1yZWxhdGxpbWFiLXJtYnctYXMtVHJlYXRtZW50LWZvci1QYXRpZW50cy13aXRoLVVucmVzZWN0YWJsZS1vci1NZXRhc3RhdGljLU1lbGFub21hL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "FDA approves Opdualag for unresectable or metastatic melanoma - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjIwMzIxL2ZkYS1hcHByb3Zlcy1vcGR1YWxhZy1mb3ItdW5yZXNlY3RhYmxlLW9yLW1ldGFzdGF0aWMtbWVsYW5vbWHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/11/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb and Nektar Announce ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihgJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1hbmQtTmVrdGFyLUFubm91bmNlLVVwZGF0ZS1vbi1QaGFzZS0zLVBJVk9ULUlPLTAwMS1UcmlhbC1FdmFsdWF0aW5nLUJlbXBlZ2FsZGVzbGV1a2luLUJFTVBFRy1pbi1Db21iaW5hdGlvbi13aXRoLU9wZGl2by1uaXZvbHVtYWItaW4tUHJldmlvdXNseS1VbnRyZWF0ZWQtVW5yZXNlY3RhYmxlLW9yLU1ldGFzdGF0aWMtTWVsYW5vbWEvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Temedica announces cooperation with Bristol Myers Squibb for the ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS90ZW1lZGljYS1hbm5vdW5jZXMtY29vcGVyYXRpb24td2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi1mb3ItdGhlLWRldmVsb3BtZW50LW9mLWEtZGlnaXRhbC1jb21wYW5pb24tZm9yLXBzb3JpYXNpcy1wYXRpZW50cy0v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol, Nektar to terminate melanoma therapy trials after study fails (March 14) - Yahoo News",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vbmV3cy55YWhvby5jb20vYnJpc3RvbC1teWVycy1uZWt0YXItbWVsYW5vbWEtY29tYm8tMTEzMTU2MTA5Lmh0bWzSAVFodHRwczovL25ld3MueWFob28uY29tL2FtcGh0bWwvYnJpc3RvbC1teWVycy1uZWt0YXItbWVsYW5vbWEtY29tYm8tMTEzMTU2MTA5Lmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Top 10 pharma R&D budgets in 2021 - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3NwZWNpYWwtcmVwb3J0cy90b3AtMTAtcGhhcm1hLXJkLWJ1ZGdldHMtMjAyMdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Enveda Biosciences Adds New Leaders to Expand & Accelerate ... - Contract Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5jb250cmFjdHBoYXJtYS5jb20vY29udGVudHMvdmlld19icmVha2luZy1uZXdzLzIwMjItMDMtMTcvZW52ZWRhLWJpb3NjaWVuY2VzLWFkZHMtbmV3LWxlYWRlcnMtdG8tZXhwYW5kLWFjY2VsZXJhdGUtcGlwZWxpbmUv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Angioimmunoblastic T-Cell Lymphoma Market Growth \u2013 In Depth ... - Medgadget",
            "link": "https://news.google.com/rss/articles/CBMiwQFodHRwczovL3d3dy5tZWRnYWRnZXQuY29tLzIwMjIvMDMvYW5naW9pbW11bm9ibGFzdGljLXQtY2VsbC1seW1waG9tYS1tYXJrZXQtZ3Jvd3RoLWluLWRlcHRoLXN0dWR5LWFuZC1odWdlLWRlbWFuZC1pbi1mdXR1cmUtMjAyMi10by0yMDI4LWJyaXN0b2wtbXllcnMtc3F1aWJiLW1pbGxlbm5pdW0tcGhhcm1hY2V1dGljYWxzLWluYy5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Phase 2 Trial of Iberdomide in Systemic Lupus Erythematosus | NEJM - nejm.org",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLjEwNTYvTkVKTW9hMjEwNjUzNdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/04/2022": {
        "artical1": {
            "title": "FDA approves expanded use of Bristol Myers cancer drug Opdivo - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9mZGEtYXBwcm92ZXMtZXhwYW5kZWQtdXNlLWJyaXN0b2wtbXllcnMtY2FuY2VyLWRydWctb3BkaXZvLTIwMjItMDMtMDQv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "U.S. Food and Drug Administration Approves Opdivo\u00ae (nivolumab ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4AFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQXBwcm92ZXMtT3BkaXZvLW5pdm9sdW1hYi13aXRoLUNoZW1vdGhlcmFweS1hcy1OZW9hZGp1dmFudC1UcmVhdG1lbnQtZm9yLUNlcnRhaW4tQWR1bHQtUGF0aWVudHMtd2l0aC1SZXNlY3RhYmxlLU5vbi1TbWFsbC1DZWxsLUx1bmctQ2FuY2VyL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "In ultrafast FDA nod, Bristol Myers' Opdivo catapults I-O therapy to ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy91bHRyYS1mYXN0LWZkYS1ub2QtYnJpc3RvbC1teWVycy1zcXVpYmItb3BkaXZvLWNhdGFwdWx0cy1pLW8tcHJlc3VyZ2VyeS1sdW5nLWNhbmNlci1maXJzdNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb's Revlimid finally faces competition in the U.S. ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJicy1yZXZsaW1pZC1maW5hbGx5LWZhY2VzLWNvbXBldGl0aW9uLXVzLXRldmFzLWdlbmVyaWMtbGF1bmNo0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol-Myers Squibb: Eliquis and Opdivo Are Shining Stars - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1lbGlxdWlzLW9wZGl2by0xNTM5MjAwNzEuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWVsaXF1aXMtb3BkaXZvLTE1MzkyMDA3MS5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "New Generic will Cut into BMS's Top-Earning Cancer Drug - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL25ldy1nZW5lcmljLWN1dHMtaW50by1icmlzdG9sLW15ZXJzLXNxdWliYi1zLXRvcC1lYXJuaW5nLWNhbmNlci1kcnVnL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "The top 10 drugs losing US exclusivity in 2022 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnRzL3RvcC0xMC1kcnVncy1sb3NpbmctdXMtZXhjbHVzaXZpdHktMjAyMtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/25/2022": {
        "artical1": {
            "title": "Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMivQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2Jpb2hhdmVuLWxpY2Vuc2VzLXRhbGRlZmdyb2JlcC1hbGZhLWEtcGhhc2UtMy1yZWFkeS1hbnRpLW15b3N0YXRpbi1hZG5lY3Rpbi1mb3Itc3BpbmFsLW11c2N1bGFyLWF0cm9waHktc21hLWZyb20tYnJpc3RvbC1teWVycy1zcXVpYmItMzAxNDkwMzQxLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinwJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tZm9yLU9wZGl2by1uaXZvbHVtYWItcGx1cy1DaGVtb3RoZXJhcHktZm9yLUZpcnN0LUxpbmUtVHJlYXRtZW50LW9mLVBhdGllbnRzLXdpdGgtVW5yZXNlY3RhYmxlLUFkdmFuY2VkLVJlY3VycmVudC1vci1NZXRhc3RhdGljLUVzb3BoYWdlYWwtU3F1YW1vdXMtQ2VsbC1DYXJjaW5vbWEtd2l0aC1UdW1vci1DZWxsLVBELUwxL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Alexandria Real Estate Equities, Inc. Announces Long-Term Lease ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQJodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FsZXhhbmRyaWEtcmVhbC1lc3RhdGUtZXF1aXRpZXMtaW5jLWFubm91bmNlcy1sb25nLXRlcm0tbGVhc2Utd2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi1mb3ItYS1uZXctNDI3LTAwMC1yc2YtaW5ub3ZhdGl2ZS1yZXNlYXJjaC1odWItYXQtdGhlLWFsZXhhbmRyaWEtcG9pbnQtbWVnYS1jYW1wdXMtaW4tdGhlLXNhbi1kaWVnby1jbHVzdGVyLW1hcmtldC0zMDE0OTMwMTEuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb Receives Positive CHMP Opinion ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinwJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tUmVjb21tZW5kaW5nLUFwcHJvdmFsLWZvci1PcGRpdm8tbml2b2x1bWFiLWFzLUFkanV2YW50LVRyZWF0bWVudC1mb3ItUGF0aWVudHMtd2l0aC1SYWRpY2FsbHktUmVzZWN0ZWQtSGlnaC1SaXNrLU11c2NsZS1JbnZhc2l2ZS1Vcm90aGVsaWFsLUNhcmNpbm9tYS13aXRoLVR1bW9yLUNlbGwtUEQtTDEtRXhwcmVzc2lvbi0xL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb Takes 427 KSF at San Diego Campus - Commercial Property Executive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmNvbW1lcmNpYWxzZWFyY2guY29tL25ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItdGFrZXMtNDI3LWtzZi1hdC1zYW4tZGllZ28tY2FtcHVzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "U.S. Food and Drug Administration Accepts for Priority Review ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMi_QFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9VLlMuLUZvb2QtYW5kLURydWctQWRtaW5pc3RyYXRpb24tQWNjZXB0cy1mb3ItUHJpb3JpdHktUmV2aWV3LUJyaXN0b2wtTXllcnMtU3F1aWJicy1BcHBsaWNhdGlvbi1mb3ItT3BkaXZvLW5pdm9sdW1hYi1QbHVzLUNoZW1vdGhlcmFweS1hcy1OZW9hZGp1dmFudC1UcmVhdG1lbnQtZm9yLVJlc2VjdGFibGUtTm9uLVNtYWxsLUNlbGwtTHVuZy1DYW5jZXIvZGVmYXVsdC5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb Receives Positive CHMP Opinion ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipAJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tUmVjb21tZW5kaW5nLUFwcHJvdmFsLWZvci1PcGRpdm8tbml2b2x1bWFiLXBsdXMtWWVydm95LWlwaWxpbXVtYWItZm9yLUZpcnN0LUxpbmUtVHJlYXRtZW50LW9mLVBhdGllbnRzLXdpdGgtVW5yZXNlY3RhYmxlLUFkdmFuY2VkLVJlY3VycmVudC1vci1NZXRhc3RhdGljLUVzb3BoYWdlYWwtU3F1YW1vdXMtQ2VsbC1DYXJjaW5vbWEvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/18/2022": {
        "artical1": {
            "title": "Sandoz launches generic Revlimid in 19 countries in Europe ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NhbmRvei1sYXVuY2hlcy1nZW5lcmljLXJldmxpbWlkLTE5LWNvdW50cmllcy1ldXJvcGUtb3BlbmluZy1hLWZsb29kLWNvbXBldGl0aW9uLWZvci1ibXMtc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb, GRYT Health double down on diversity in cancer - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Jtcy1hbmQtZ3J5dC1oZWFsdGgtY29udGludWUtcHJvZ3JhbS10by1pbmNyZWFzZS1kaXZlcnNpdHktYWxsLWFyZWFzLW9uY29sb2d50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "TYK2 Kinase Inhibitors - Pipeline Insight 2022: Key Players Include ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiygFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDIyMjAwNTY4NS9lbi9UWUsyLUtpbmFzZS1JbmhpYml0b3JzLS0tUGlwZWxpbmUtSW5zaWdodC0yMDIyLUtleS1QbGF5ZXJzLUluY2x1ZGUtQnJpc3RvbC1NeWVycy1TcXVpYmItT25jb3N0ZWxsYWUtUGZpemVyLWFuZC1HYWxhcGFnb3MtLS1SZXNlYXJjaEFuZE1hcmtldHMuY29t0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjEuMDIxODjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Mnemo Taps Pharma Veteran LaCaze in Quest to Become Global ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL21uZW1vLXRhcHMtcGhhcm1hLXZldGVyYW4tbGFjYXplLWluLXF1ZXN0LXRvLWJlY29tZS1nbG9iYWwtbGVhZGVyLS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Italy reports 60029 coronavirus cases on Tuesday, 322 deaths - Reuters",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9pdGFseS1yZXBvcnRzLTYwMDI5LWNvcm9uYXZpcnVzLWNhc2VzLXR1ZXNkYXktMzIyLWRlYXRocy0yMDIyLTAyLTIyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Selumetinib Plus Adjuvant Radioactive Iodine in Patients With High ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjEuMDA3MTTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/11/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb Prices $6 Billion of Senior Unsecured Notes - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vbmV3cy5ibXMuY29tL25ld3MvZGV0YWlscy8yMDIyL0JyaXN0b2wtTXllcnMtU3F1aWJiLVByaWNlcy02LUJpbGxpb24tb2YtU2VuaW9yLVVuc2VjdXJlZC1Ob3Rlcy9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Opdivo\u00ae (nivolumab) in Combination with CABOMETYX ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQJodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9PcGRpdm8tbml2b2x1bWFiLWluLUNvbWJpbmF0aW9uLXdpdGgtQ0FCT01FVFlYLWNhYm96YW50aW5pYi1EZW1vbnN0cmF0ZXMtQ29udGludWVkLVN1cnZpdmFsLUJlbmVmaXRzLXdpdGgtT3Zlci1Ud28tWWVhcnMtb2YtRm9sbG93LVVwLWluLXRoZS1DaGVja01hdGUtLTlFUi1UcmlhbC1pbi1GaXJzdC1MaW5lLUFkdmFuY2VkLVJlbmFsLUNlbGwtQ2FyY2lub21hL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Announces Tender ... - Bristol-Myers Squibb",
            "link": "https://news.google.com/rss/articles/CBMilQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZXMtVGVuZGVyLU9mZmVycy1mb3ItYW4tQWdncmVnYXRlLVB1cmNoYXNlLVByaWNlLW9mLVVwLXRvLTQuMC1CaWxsaW9uL2RlZmF1bHQuYXNweNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb Company -- Moody's assigns A2 to Bristol-Myers notes; stable outlook - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55LW1vb2R5cy0xNzExMDYyODguaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBhbnktbW9vZHlzLTE3MTEwNjI4OC5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "'Big Short' Michael Burry Reveals New Stocks, Exited CVS Health in ... - Markets Insider",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vbWFya2V0cy5idXNpbmVzc2luc2lkZXIuY29tL25ld3Mvc3RvY2tzL2JpZy1zaG9ydC1taWNoYWVsLWJ1cnJ5LXNjaW9uLXE0LXN0b2NrLXBvcnRmb2xpby1jdnMtYm1zLTIwMjItMtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "FDA grants priority review to Breyanzi for second-line treatment of ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMDIxNy9mZGEtZ3JhbnRzLXByaW9yaXR5LXJldmlldy10by1icmV5YW56aS1mb3Itc2Vjb25kbGluZS10cmVhdG1lbnQtb2YtbGFyZ2UtYmNlbGwtbHltcGhvbWHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Adam Lenkowsky, Senior Vice President and General Manager, US ... - The CEO Magazine",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LnRoZWNlb21hZ2F6aW5lLmNvbS9leGVjdXRpdmUtaW50ZXJ2aWV3cy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2FsL2FkYW0tbGVua293c2t5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/04/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb doles out $8M in new grants to improve health ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy1zcXVpYmItYW5ub3VuY2VzLW5lYXJseS04LW1pbGxpb24tbmV3LWdyYW50cy10by1hZGRyZXNzLWhlYWx0aC1lcXVpdHnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers posts slightly better-than-expected fourth-quarter results - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLXBvc3RzLXNsaWdodGx5LWJldHRlci10aGFuLWV4cGVjdGVkLTR0aC1xdHItcmVzdWx0cy0yMDIyLTAyLTA0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol busy boosting supply of Breyanzi, Abecma as massive ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtYnVzeS1ib29zdGluZy1zdXBwbHktYnJleWFuemktYWJlY21hLWFzLW1hc3NpdmUtcGF0ZW50LWNsaWZmLWZvci1yZXZsaW1pZC1sb29tc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Reports Fourth Quarter ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZXBvcnRzLUZvdXJ0aC1RdWFydGVyLWFuZC1GdWxsLVllYXItRmluYW5jaWFsLVJlc3VsdHMtZm9yLTIwMjEvZGVmYXVsdC5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Awards Nearly $8 ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMixQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL3BoaWxhbnRocm9weS8yMDIyL0JyaXN0b2wtTXllcnMtU3F1aWJiLUF3YXJkcy1OZWFybHktOC1NaWxsaW9uLWluLU5ldy1IZWFsdGgtRXF1aXR5LUdyYW50cy10by1JbXByb3ZlLUFjY2Vzcy10by1DYXJlLWZvci1NZWRpY2FsbHktVW5kZXJzZXJ2ZWQtUGF0aWVudHMtaW4tVS5TL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "$8M Grant to Improve Care Access Through Community Health ... - PatientEngagementHIT.com",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vcGF0aWVudGVuZ2FnZW1lbnRoaXQuY29tL25ld3MvOG0tZ3JhbnQtdG8taW1wcm92ZS1jYXJlLWFjY2Vzcy10aHJvdWdoLWNvbW11bml0eS1oZWFsdGgtd29ya2Vyc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "First Circuit Creates Split Regarding Federal Court Jurisdiction Over ... - Ogletree Deakins",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinAFodHRwczovL29nbGV0cmVlLmNvbS9pbnNpZ2h0cy1yZXNvdXJjZXMvYmxvZy1wb3N0cy9maXJzdC1jaXJjdWl0LWNyZWF0ZXMtc3BsaXQtcmVnYXJkaW5nLWZlZGVyYWwtY291cnQtanVyaXNkaWN0aW9uLW92ZXItZmxzYS1tdWx0aXN0YXRlLWNvbGxlY3RpdmUtYWN0aW9ucy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/28/2022": {
        "artical1": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb Receives Positive ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMizwFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi1SZWNlaXZlcy1Qb3NpdGl2ZS1DSE1QLU9waW5pb24tZm9yLUNBUi1ULUNlbGwtVGhlcmFweS1CcmV5YW56aS1saXNvY2FidGFnZW5lbWFyYWxldWNlbC1mb3ItUmVsYXBzZWQtb3ItUmVmcmFjdG9yeS1ETEJDTC1QTUJDTC1hbmQtRkwzQi9kZWZhdWx0LmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Appeals Court Creates Circuit Split on Whether Bristol-Myers ... - Jackson Lewis",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmphY2tzb25sZXdpcy5jb20vaW5zaWdodHMvYXBwZWFscy1jb3VydC1jcmVhdGVzLWNpcmN1aXQtc3BsaXQtd2hldGhlci1icmlzdG9sLW15ZXJzLWFwcGxpZXMtY29sbGVjdGl2ZS1hY3Rpb25z0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "25 Investigates: Family of woman murdered in Worcester settles suit against her former employer - Boston 25 News",
            "link": "https://news.google.com/rss/articles/CBMipAFodHRwczovL3d3dy5ib3N0b24yNW5ld3MuY29tL25ld3MvbWFzc2FjaHVzZXR0cy8yNS1pbnZlc3RpZ2F0ZXMtZmFtaWx5LXdvbWFuLW11cmRlcmVkLXdvcmNlc3Rlci1zZXR0bGVzLXN1aXQtYWdhaW5zdC1oZXItZm9ybWVyLWVtcGxveWVyL1dGNVdYVEo0M1JDWTdGNllVTUpFTFBQUVNNL9IBswFodHRwczovL3d3dy5ib3N0b24yNW5ld3MuY29tL25ld3MvbWFzc2FjaHVzZXR0cy8yNS1pbnZlc3RpZ2F0ZXMtZmFtaWx5LXdvbWFuLW11cmRlcmVkLXdvcmNlc3Rlci1zZXR0bGVzLXN1aXQtYWdhaW5zdC1oZXItZm9ybWVyLWVtcGxveWVyL1dGNVdYVEo0M1JDWTdGNllVTUpFTFBQUVNNLz9vdXRwdXRUeXBlPWFtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "\u2018We\u2019re not going to get the all clear\u2019: More employers need to learn ... - The Boston Globe",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmJvc3Rvbmdsb2JlLmNvbS8yMDIyLzAyLzAyL2J1c2luZXNzL3dlcmUtbm90LWdvaW5nLWdldC1hbGwtY2xlYXItbW9yZS1lbXBsb3llcnMtbmVlZC1sZWFybi1saXZlLXdpdGgtY292aWQv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "State AGs Lead the Way in False Advertising Enforcement - Troutman Pepper",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LnRyb3V0bWFuLmNvbS9pbnNpZ2h0cy9zdGF0ZS1hZ3MtbGVhZC10aGUtd2F5LWluLWZhbHNlLWFkdmVydGlzaW5nLWVuZm9yY2VtZW50Lmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "The Future Of Medicine: Fighting Deadly Diseases With Smart Devices And Digital Biomarkers - Forbes",
            "link": "https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dhbmVza2VzYXJpLzIwMjIvMDEvMzEvdGhlLWZ1dHVyZS1vZi1tZWRpY2luZS1maWdodGluZy1kZWFkbHktZGlzZWFzZXMtd2l0aC1zbWFydC1kZXZpY2VzLWFuZC1kaWdpdGFsLWJpb21hcmtlcnMv0gGSAWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ2FuZXNrZXNhcmkvMjAyMi8wMS8zMS90aGUtZnV0dXJlLW9mLW1lZGljaW5lLWZpZ2h0aW5nLWRlYWRseS1kaXNlYXNlcy13aXRoLXNtYXJ0LWRldmljZXMtYW5kLWRpZ2l0YWwtYmlvbWFya2Vycy9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Inflection Point: Abivax Challenges Pharma Giants in Ulcerative Colitis - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL2luZmxlY3Rpb24tcG9pbnQtYWJpdmF4LWNoYWxsZW5nZXMtcGhhcm1hLWdpYW50cy1pbi11bGNlcmF0aXZlLWNvbGl0aXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/21/2022": {
        "artical1": {
            "title": "Fierce JPM Week: Bristol Myers' next-gen autoimmune med not just ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtcy1uZXh0LWdlbi1hdXRvaW1tdW5lLW1lZC1ub3QtanVzdC1hbm90aGVyLWphay1kcnVnLWV4ZWMtc2F5c9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Apixaban Market See Incredible Growth 2022-2028 | Bristol-Myers ... - Medgadget",
            "link": "https://news.google.com/rss/articles/CBMingFodHRwczovL3d3dy5tZWRnYWRnZXQuY29tLzIwMjIvMDEvYXBpeGFiYW4tbWFya2V0LXNlZS1pbmNyZWRpYmxlLWdyb3d0aC0yMDIyLTIwMjgtYnJpc3RvbC1teWVycy1zcXVpYmItcG9ydG9sYS1waGFybWFjZXV0aWNhbHMtYy1oLWJvZWhyaW5nZXItc29obi1wZml6ZXIuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Edgewell hires Havas Media as U.S. media agency for sun, shave ... - Ad Age",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vYWRhZ2UuY29tL2FydGljbGUvYWdlbmN5LW5ld3MvZWRnZXdlbGwtaGlyZXMtaGF2YXMtbWVkaWEtdXMtbWVkaWEtYWdlbmN5LXN1bi1zaGF2ZS1hbmQtaHlnaWVuZS1icmFuZHMvMjM5NDk4NtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Imaging techniques detect counterfeit medications - Laser Focus World",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3Lmxhc2VyZm9jdXN3b3JsZC5jb20vc2NpZW5jZS1yZXNlYXJjaC9hcnRpY2xlLzE0MjIzOTIyL2ltYWdpbmctdGVjaG5pcXVlcy1kZXRlY3QtY291bnRlcmZlaXQtbWVkaWNhdGlvbnPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Pharma Chips Away at Discount Drugs While Battling HHS in Court - Bloomberg Law",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcuY29tL2hlYWx0aC1sYXctYW5kLWJ1c2luZXNzL3BoYXJtYS1jaGlwcy1hd2F5LWF0LWRpc2NvdW50LWRydWdzLXdoaWxlLWJhdHRsaW5nLWhocy1pbi1jb3VydNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Vaccine\u2010induced immune thrombotic thrombocytopenia (VITT ... - John Wiley",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Z1bGwvMTAuMTExMS9qdGguMTU2MTnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "S&P 500 Follows Nasdaq Into Correction Territory as Fear Index Rises - Investopedia",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vcy1hbmQtcC01MDAtaGl0cy1jb3JyZWN0aW9uLTUyMTY4NDnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/14/2022": {
        "artical1": {
            "title": "Bristol Myers, VCs launch new RNA therapeutics biotech Ceptur ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy12Y3MtbGF1bmNoLW5ldy1ybmEtdGhlcmFwZXV0aWNzLWJpb3RlY2gtY2VwdHVyLTc1bS10by1zaWxlbmNlLXByZS1tcm5h0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb becomes 12th drugmaker to announce 340B ... - FierceHealthcare",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZWhlYWx0aGNhcmUuY29tL2hvc3BpdGFscy9icmlzdG9sLW15ZXJzLXNxdWliYi1iZWNvbWVzLTEydGgtZHJ1Zy1tYWtlci10by1hbm5vdW5jZS0zNDBiLWNvbnRyYWN0LXBoYXJtYWN50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Is Bristol Myers Squibb Stock A Better Pick Over This Vaccine Company? - Forbes",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjIvMDEvMTgvaXMtYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2stYS1iZXR0ZXItcGljay1vdmVyLXRoaXMtdmFjY2luZS1jb21wYW55L9IBhAFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMjIvMDEvMTgvaXMtYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2stYS1iZXR0ZXItcGljay1vdmVyLXRoaXMtdmFjY2luZS1jb21wYW55L2FtcC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Lilly and Evotec Aim $1B Deal at Kidney Disease and Diabetes - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9lbGktbGlsbHktZXZvdGVjLXN0cmlrZS1kaWFiZXRlcy1hbmQtbWV0YWJvbGljLWRpc2Vhc2UtY29sbGFib3JhdGlvbi12YWx1ZWQtYXQtdXAtdG8tMS1iaWxsaW9uL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Neoadjuvant nivolumab plus ipilimumab active in subset of patients ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIyMDEyMC9uZW9hZGp1dmFudC1uaXZvbHVtYWItcGx1cy1pcGlsaW11bWFiLWFjdGl2ZS1pbi1zdWJzZXQtb2YtcGF0aWVudHMtd2l0aC1nYXN0cmljLWNhbmNlcnPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Idiopathic Pulmonary Fibrosis Treatment Market Report 2022 ... - Medgadget",
            "link": "https://news.google.com/rss/articles/CBMi3AFodHRwczovL3d3dy5tZWRnYWRnZXQuY29tLzIwMjIvMDEvaWRpb3BhdGhpYy1wdWxtb25hcnktZmlicm9zaXMtdHJlYXRtZW50LW1hcmtldC1yZXBvcnQtMjAyMi1nZW5lcmF0ZS1uZXctY2hhbGxlbmdlcy1hbmQtb3Bwb3J0dW5pdGllcy13aXRoLXRvcC1jb21wYW55LXByb2ZpbGVzLWJpb2dlbi1ib2VocmluZ2VyLWluZ2VsaGVpbS1icmlzdG9sLW15ZXJzLXNxdWliYi1jaXBsYS5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "The top 10 biopharma M&A deals in 2021 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTEwLWJpb3BoYXJtYS1tLWEtZGVhbHMtMjAyMdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/07/2022": {
        "artical1": {
            "title": "Century Therapeutics and Bristol Myers Squibb Enter into a ... - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMizAFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMi8wMS8xMC8yMzYzNzYyLzAvZW4vQ2VudHVyeS1UaGVyYXBldXRpY3MtYW5kLUJyaXN0b2wtTXllcnMtU3F1aWJiLUVudGVyLWludG8tYS1TdHJhdGVnaWMtQ29sbGFib3JhdGlvbi10by1EZXZlbG9wLWlQU0MtZGVyaXZlZC1BbGxvZ2VuZWljLUNlbGwtVGhlcmFwaWVzLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS puts $150M on the table in off-the-shelf cell therapy alliance ... - MedCity News",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjIvMDEvYm1zLXB1dHMtMTUwbS1vbi10aGUtdGFibGUtaW4tb2ZmLXRoZS1zaGVsZi1jZWxsLXRoZXJhcHktYWxsaWFuY2Utd2l0aC1jZW50dXJ5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Here\u2019s A Better Pharmaceutical Pick Over Merck Stock - Forbes",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMi8wMS8xMS9oZXJlcy1hLWJldHRlci1waGFybWFjZXV0aWNhbC1waWNrLW92ZXItbWVyY2stc3RvY2sv0gFyaHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9ncmVhdHNwZWN1bGF0aW9ucy8yMDIyLzAxLzExL2hlcmVzLWEtYmV0dGVyLXBoYXJtYWNldXRpY2FsLXBpY2stb3Zlci1tZXJjay1zdG9jay9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "JPM 2022: Bristol Myers plots 3 blockbuster launches to counter ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RocmVlLWxhdW5jaGVzLXRhcC1mb3IteWVhci1icmlzdG9sLW15ZXJzLXBsYW5zLXRvLWdyb3ctdGhyb3VnaC1yZXZsaW1pZC1zLXBhdGVudC1jbGlmZtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "BioAtla Announces Clinical Collaboration with Bristol Myers Squibb ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMi_wFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2Jpb2F0bGEtYW5ub3VuY2VzLWNsaW5pY2FsLWNvbGxhYm9yYXRpb24td2l0aC1icmlzdG9sLW15ZXJzLXNxdWliYi10by1zdHVkeS1tZWNib3RhbWFiLXZlZG90aW4tYmEzMDExLWFuZC1venVyaWZ0YW1hYi12ZWRvdGluLWJhMzAyMS1pbi1jb21iaW5hdGlvbi13aXRoLW9wZGl2by1uaXZvbHVtYWItZm9yLXRyZWF0bWVudC1vZi1zb2xpZC10dW1vcnMtMzAxNDU3NDc1Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb - Bristol Myers Squibb to Highlight Long-Term ... - Bristol-Myers Squibb",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMioQFodHRwczovL25ld3MuYm1zLmNvbS9uZXdzL2RldGFpbHMvMjAyMi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1IaWdobGlnaHQtTG9uZy1UZXJtLUdyb3d0aC1TdHJhdGVneS1hdC1KLlAuLU1vcmdhbnMtNDB0aC1Bbm51YWwtSGVhbHRoY2FyZS1Db25mZXJlbmNlL2RlZmF1bHQuYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Biomica Announces Clearance for First-in-Human Phase I Study of ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMiugFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2Jpb21pY2EtYW5ub3VuY2VzLWNsZWFyYW5jZS1mb3ItZmlyc3QtaW4taHVtYW4tcGhhc2UtaS1zdHVkeS1vZi1ibWMtMTI4LWluLWNvbWJpbmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmJzLWFudGktcGQtMS1vcGRpdm8tMzAxNDU4MTIxLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/31/2021": {
        "artical1": {
            "title": "Raising the profile of women and diversity at Bristol Myers Squibb - Security Magazine",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LnNlY3VyaXR5bWFnYXppbmUuY29tL2FydGljbGVzLzk2Nzg2LXJhaXNpbmctdGhlLXByb2ZpbGUtb2Ytd29tZW4tYW5kLWRpdmVyc2l0eS1hdC1icmlzdG9sLW15ZXJzLXNxdWliYtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Selects ZS To Support Global ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIyMDEwNTAwNTAzMy9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi1TZWxlY3RzLVpTLVRvLVN1cHBvcnQtR2xvYmFsLUNvbW1lcmNpYWxpemF0aW9uLWFuZC1BbmFseXRpY3MtQ2FwYWJpbGl0aWVz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Nimbus, Bristol-Myers Drop Psoriasis Drug Dispute - Law360",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmxhdzM2MC5jb20vYXJ0aWNsZXMvMTQ1MjQxMC9uaW1idXMtYnJpc3RvbC1teWVycy1kcm9wLXBzb3JpYXNpcy1kcnVnLWRpc3B1dGXSAStodHRwczovL3d3dy5sYXczNjAuY29tL2FtcC9hcnRpY2xlcy8xNDUyNDEw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Biohaven and Pfizer Complete Collaboration Transaction for ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2Jpb2hhdmVuLWFuZC1wZml6ZXItY29tcGxldGUtY29sbGFib3JhdGlvbi10cmFuc2FjdGlvbi1mb3ItY29tbWVyY2lhbGl6YXRpb24tb2YtcmltZWdlcGFudC1hbmQtemF2ZWdlcGFudC1vdXRzaWRlLXVuaXRlZC1zdGF0ZXMtMzAxNDU0MDc3Lmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "2021 drug approvals: In a year dominated by COVID, biopharma ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvMjAyMS1zLW5ldy1kcnVnLWFwcHJvdmFsc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Merck KGaA takes 4th option on Big Pharma darling F-star's ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvbWVyY2stdGFrZXMtNHRoLW9wdGlvbi1iaWctcGhhcm1hLWRhcmxpbmctZi1zdGFyLXMtYmlzcGVjaWZpYy1pbW11bm90aGVyYXBpZXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Daily Medication Pearl: Rivaroxaban (Xarelto) - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZGFpbHktbWVkaWNhdGlvbi1wZWFybC1yaXZhcm94YWJhbi14YXJlbHRvLdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/24/2021": {
        "artical1": {
            "title": "COVID\u201019 infection in patients with late\u2010onset Pompe disease - John Wiley",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMDAyL211cy4yNzQ4MtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "What Are the Most Effective Treatments for Insomnia? - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvd2hhdC1hcmUtdGhlLW1vc3QtZWZmZWN0aXZlLXRyZWF0bWVudHMtZm9yLWluc29tbmlhLdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Sutro Biopharma and Tasly Biopharmaceuticals Enter into Exclusive ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiqQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3N1dHJvLWJpb3BoYXJtYS1hbmQtdGFzbHktYmlvcGhhcm1hY2V1dGljYWxzLWVudGVyLWludG8tZXhjbHVzaXZlLWxpY2Vuc2UtYWdyZWVtZW50LWZvci1zdHJvLTAwMi1pbi1ncmVhdGVyLWNoaW5hLTMwMTQ1MDc5OC5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Updated C. Difficile Infection Guidelines Incorporate New Trials - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvdXBkYXRlZC1jLWRpZmZpY2lsZS1pbmZlY3Rpb24tZ3VpZGVsaW5lcy1pbmNvcnBvcmF0ZS1uZXctdHJpYWxz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Biden says he's open to shorter quarantine requirements - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2JpZGVuLXNheXMtaGVzLW9wZW4tc2hvcnRlci1xdWFyYW50aW5lLXJlcXVpcmVtZW50cy0yMDIxLTEyLTI3L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Biogen's roller coaster 2021 takes another surprising turn with report ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NhbXN1bmctZ3JvdXAtdGFsa3MtdG8tYnV5LWJpb2dlbi1hLWRlYWwtY291bGQtYmUtd29ydGgtNDItYmlsbGlvbtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Apixaban Appears Safer, More Effective Than Rivaroxaban in ... - TCTMD",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2FwaXhhYmFuLWFwcGVhcnMtc2FmZXItbW9yZS1lZmZlY3RpdmUtcml2YXJveGFiYW4tbWVkaWNhcmUtc3R1ZHnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/17/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb Stock: Bull vs. Bear - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2slM0EtYnVsbC12cy4tYmVhctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Blood thinner drug Xarelto tied to higher rate of major side effects ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9ibG9vZC10aGlubmVyLWRydWcteGFyZWx0by10aWVkLW1vcmUtbWFqb3Itc2lkZS1lZmZlY3RzLXN0dWR5LTIwMjEtMTItMjEv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Adaptive Dosing of Nivolumab + Ipilimumab Immunotherapy Based ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDE1NzDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "2022 forecast: Cell, gene therapy makers push past regulatory ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2NlbGwtYW5kLWdlbmUtdGhlcmFweS1tYWtlcnMtcHVzaC1wYXN0LXJlZ3VsYXRvcnktcGF5ZXItaHVyZGxlcy10by1zZXQtdXAtaGlnaC1ob3Blcy1mb3LSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "GSK-Vir antibody COVID-19 therapy to be tested in large UK study - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9nc2stdmlyLWFudGlib2R5LWNvdmlkLTE5LXRoZXJhcHktYmUtdGVzdGVkLWxhcmdlLXVrLXN0dWR5LTIwMjEtMTItMjMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Next Steps in Assessing BOVen Therapy in Patients With Previously ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvbmV4dC1zdGVwcy1pbi1hc3Nlc3NpbmctYm92ZW4tdGhlcmFweS1pbi1wYXRpZW50cy13aXRoLXByZXZpb3VzbHktdW50cmVhdGVkLWNsbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Fierce Biotech's top 10 data readouts in 2022 - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3NwZWNpYWwtcmVwb3J0L2ZpZXJjZS1iaW90ZWNoLXMtdG9wLTEwLWRhdGEtcmVhZG91dHMtMjAyMtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/10/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb Drops $920 Million to Broaden Partnership ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9icmlzdG9sLW15ZXJzLXNxdWliYi1icm9hZGVuLWl0cy1wYXJ0bmVyc2hpcC13aXRoLWltbWF0aWNzLWRyb3BwaW5nLTkyMC1tbG4tZGVhbC10by1hY3F1aXJlLXJpZ2h0cy10by1hLWNhbmNlci1kcnVnLXByb2dyYW0v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Gilead, Bristol jaw over superiority of CAR-T treatments for blood ... - STAT",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDIxLzEyLzExL2dpbGVhZC1icmlzdG9sLWphdy1vdmVyLXRoZS1zdXBlcmlvcml0eS1vZi1yaXZhbC1jYXItdC10cmVhdG1lbnRzLWZvci1ibG9vZC1jYW5jZXIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "In its old age, Bristol Myers' Orencia becomes first drug approved for ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2l0cy1vbGQtYWdlLWJyaXN0b2wtbXllcnMtb3JlbmNpYS1iZWNvbWVzLWZpcnN0LWRydWctYXBwcm92ZWQtZm9yLXByZXZlbnRpbmctZ3JhZnQtdmVyc3Vz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Ash 2021 \u2013 Bristol reveals its sons of Revlimid - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2gtMjAyMS1icmlzdG9sLXJldmVhbHMtaXRzLXNvbnMtcmV2bGltaWTSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNzQ1MS9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Ash 2021 \u2013 why Breyanzi and Yescarta might refresh the parts Kymriah cannot reach - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2gtMjAyMS13aHktYnJleWFuemktYW5kLXllc2NhcnRhLW1pZ2h0LXJlZnJlc2gtcGFydHMta3ltcmlhaNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE3NDQ5L2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "AbbVie ends enrollment in Idera collab as the biotech winds down ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWJidmllLWVuZHMtZW5yb2xsbWVudC1pZGVyYS1jb2xsYWJvcmF0aW9uLWFzLWlkZXJhLWVuZHMtaXRzLW93bi1jb2xvcmVjdGFsLWNhbmNlci10cmlhbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Mavacamten for symptomatic obstructive hypertrophic cardiomyopathy - Healio",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9jYXJkaW9sb2d5LzIwMjExMjA4L21hdmFjYW10ZW4tZm9yLXN5bXB0b21hdGljLW9ic3RydWN0aXZlLWh5cGVydHJvcGhpYy1jYXJkaW9teW9wYXRoedIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/03/2021": {
        "artical1": {
            "title": "Family of Webster woman murdered two years ago files suit against pharmaceutical giant - Boston 25 News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMioQFodHRwczovL3d3dy5ib3N0b24yNW5ld3MuY29tL25ld3MvMjUtaW52ZXN0aWdhdGVzL2ZhbWlseS13ZWJzdGVyLXdvbWFuLW11cmRlcmVkLXR3by15ZWFycy1hZ28tZmlsZXMtc3VpdC1hZ2FpbnN0LXBoYXJtYWNldXRpY2FsLWdpYW50L1BQNENGM0xJNkJDQlJKVEJPQzVQTjZJNENRL9IBsAFodHRwczovL3d3dy5ib3N0b24yNW5ld3MuY29tL25ld3MvMjUtaW52ZXN0aWdhdGVzL2ZhbWlseS13ZWJzdGVyLXdvbWFuLW11cmRlcmVkLXR3by15ZWFycy1hZ28tZmlsZXMtc3VpdC1hZ2FpbnN0LXBoYXJtYWNldXRpY2FsLWdpYW50L1BQNENGM0xJNkJDQlJKVEJPQzVQTjZJNENRLz9vdXRwdXRUeXBlPWFtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Disease Burden Affects Outcomes in Pediatric and Young Adult B ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjAuMDM1ODXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "A Great Example Of Stopping Volume On The Bristol-Myers Squibb ... - Investing.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmludmVzdGluZy5jb20vYW5hbHlzaXMvYS1ncmVhdC1leGFtcGxlLW9mLXN0b3BwaW5nLXZvbHVtZS1vbi10aGUtYnJpc3RvbG15ZXJzLXNxdWliYi1kYWlseS1zdG9jay1jaGFydC0yMDA2MTA2ODHSAYQBaHR0cHM6Ly9tLmludmVzdGluZy5jb20vYW5hbHlzaXMvYS1ncmVhdC1leGFtcGxlLW9mLXN0b3BwaW5nLXZvbHVtZS1vbi10aGUtYnJpc3RvbG15ZXJzLXNxdWliYi1kYWlseS1zdG9jay1jaGFydC0yMDA2MTA2ODE_YW1wTW9kZT0x?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Adicet scores the first hit for gamma-delta - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9hZGljZXQtc2NvcmVzLWZpcnN0LWhpdC1nYW1tYS1kZWx0YdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE3NDI4L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Roche, Genentech, Recursion Launch Up-to-$12B AI Drug ... - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3Mvcm9jaGUtZ2VuZW50ZWNoLXJlY3Vyc2lvbi1sYXVuY2gtdXAtdG8tMTJiLWFpLWRydWctZGlzY292ZXJ5LWVmZm9ydC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Barcode-Enabled Liquid Dosage Dispense Preparation Process ... - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L2JhcmNvZGUtZW5hYmxlZC1saXF1aWQtZG9zYWdlLWRpc3BlbnNlLXByZXBhcmF0aW9uLXByb2Nlc3MtbWF5LWltcHJvdmUtc2FmZXR5LXF1YWxpdHktb2YtcGhhcm1hY3ktc2VydmljZXPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Fetus brains unharmed by non-severe COVID-19; cancer patients ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9mZXR1cy1icmFpbnMtdW5oYXJtZWQtYnktbm9uLXNldmVyZS1jb3ZpZC0xOS1jYW5jZXItcGF0aWVudHMtZ2V0LWJlbmVmaXQtbXJuYS0yMDIxLTEyLTAzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/26/2021": {
        "artical1": {
            "title": "Bristol Myers is sued for refusing COVID-19 vaccine religious ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLWlzLXN1ZWQtcmVmdXNpbmctY292aWQtMTktdmFjY2luZS1yZWxpZ2lvdXMtZXhlbXB0aW9ucy0yMDIxLTEyLTAxL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Amgen's Otezla notches win in genital psoriasis, snagging possible ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXMtb3RlemxhLW5vdGNoZXMtd2luLWdlbml0YWwtcHNvcmlhc2lzLXN0dWR5LXNuYWdnaW5nLXBvc3NpYmxlLWVkZ2UtYWdhaW5zdC1ibXPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Scholarship 2022 (Fully Funded to attend the ... - Opportunities For Africans",
            "link": "https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3Lm9wcG9ydHVuaXRpZXNmb3JhZnJpY2Fucy5jb20vYnJpc3RvbC1teWVycy1zcXVpYmItc2Nob2xhcnNoaXAtMjAyMi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Emergency Department Visits Rise for Those With Depression ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZW1lcmdlbmN5LWRlcGFydG1lbnQtdmlzaXRzLXJpc2UtZm9yLXRob3NlLXdpdGgtZGVwcmVzc2lvbi1kdXJpbmctcGFuZGVtaWPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "CDC says no cases of Omicron identified in U.S. so far - Reuters",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2NkYy1zYXlzLW5vLWNhc2VzLW9taWNyb24taWRlbnRpZmllZC11cy1zby1mYXItMjAyMS0xMS0yNy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Singapore close to vaccinating all eligible people against COVID-19 - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9zaW5nYXBvcmUtY2xvc2UtdmFjY2luYXRpbmctYWxsLWVsaWdpYmxlLXBlb3BsZS1hZ2FpbnN0LWNvdmlkLTE5LTIwMjEtMTItMDEv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Kremlin warns against U.S. pressure over Nord Stream 2 certification - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2VuZXJneS9rcmVtbGluLXdhcm5zLWFnYWluc3QtdXMtcHJlc3N1cmUtb3Zlci1ub3JkLXN0cmVhbS0yLWNlcnRpZmljYXRpb24tMjAyMS0xMS0yOS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/19/2021": {
        "artical1": {
            "title": "3 Undervalued Warren Buffett Stocks - Morningstar",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3Lm1vcm5pbmdzdGFyLmNvLnVrL3VrL25ld3MvMjE3MDQ1LzMtdW5kZXJ2YWx1ZWQtd2FycmVuLWJ1ZmZldHQtc3RvY2tzLmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Merck buzzes Dragonfly for 2nd immunotherapy candidate in $700M ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvbWVyY2stYnV6emVzLWRyYWdvbmZseS1mb3Itc2Vjb25kLWltbXVub3RoZXJhcHktY2FuZGlkYXRlLTcwMG0tcGFjdC1tb250aC1hZnRlci1icmlzdG9s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Califf, Biden's FDA pick, has millions invested in pharma, tech ... - STAT",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDIxLzExLzIzL2NhbGlmZi1taWxsaW9ucy1waGFybWEtdGVjaC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Japan to release a few hundred thousand kilolitres of oil from reserve - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2VuZXJneS9qYXBhbi1yZWxlYXNlLWZldy1odW5kcmVkLXRob3VzYW5kLWtpbG9saXRyZXMtb2lsLXJlc2VydmUtMjAyMS0xMS0yNC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "3 Pharma Stocks That Are Too Cheap to Ignore - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzExLzI1LzMtcGhhcm1hLXN0b2Nrcy10aGF0LWFyZS10b28tY2hlYXAtdG8taWdub3JlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "AbbVie Stock Rises on Upgrade to Buy from Hold by SocGen - TheStreet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaW52ZXN0aW5nL2FiYnZpZS1zaGFyZXMtcmlzZS11cGdyYWRlLWJ1eS1zb2NnZW7SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Elizabeth Holmes Rebuts Prosecution's Key Argument In Trial - The New York Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjEvMTEvMjIvdGVjaG5vbG9neS9ob2xtZXMtYmxvb2QtdGVzdGluZy1wZml6ZXItYXN0cmF6ZW5lY2EuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/12/2021": {
        "artical1": {
            "title": "AHA: Bristol Myers' $13B MyoKardia heart drug gets along with beta ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2ViaW90ZWNoLmNvbS9iaW90ZWNoL2JyaXN0b2wtbXllcnMtMTNiLW15b2thcmRpYS1oZWFydC1kcnVnLWdldHMtYWxvbmctYmV0YS1ibG9ja2Vycy1hcy1jbG9jay10aWNrcy1kb3duLXRvLWZkYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers and Janssen race toward PhIII with a next-gen blood ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZW5kcHRzLmNvbS9icmlzdG9sLW15ZXJzLWFuZC1qYW5zc2VuLXJhY2UtdG93YXJkLXBoaWlpLXdpdGgtYS1uZXh0LWdlbi1ibG9vZC10aGlubmVyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Launching Nine New Drugs After Bulking Up Pipeline - Bloomberg",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTExLTE2L2JyaXN0b2wtbXllcnMtbGF1bmNoaW5nLW5ldy1kcnVncy1hZnRlci1idWxraW5nLXVwLXBpcGVsaW5l0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "J&J sees potential for 14 new multibillion-dollar drugs by 2025 - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9qai1zZWVzLXBvdGVudGlhbC0xNC1uZXctbXVsdGliaWxsaW9uLWRvbGxhci1kcnVncy1ieS0yMDI1LTIwMjEtMTEtMTgv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "2021's Fiercest Women in Life Sciences - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvd29tZW4tbGlmZS1zY2llbmNlcy0yMDIx0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Study Suggests a Better Blood Thinner Could Be Near - HealthDay",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5oZWFsdGhkYXkuY29tL2hlYWx0aC1uZXdzL2hlYWx0aC10ZWNobm9sb2d5L2ItMTEtMTYtbmV3LWRydWctY291bGQtaGVscC1wcmV2ZW50LWJsb29kLWNsb3RzLWFmdGVyLWtuZWUtcmVwbGFjZW1lbnQtMjY1NTUzNzgzMy5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Pegbelfermin improves markers of fibrosis in NASH - Healio",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZXBhdG9sb2d5LzIwMjExMTE2L3BlZ2JlbGZlcm1pbi1pbXByb3Zlcy1tYXJrZXJzLW9mLWZpYnJvc2lzLWluLW5hc2jSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "11/05/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb invests $20m in Compugen cancer drug - Globes",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vZW4uZ2xvYmVzLmNvLmlsL2VuL2FydGljbGUtYnJpc3RvbC1teWVycy1zcXVpYmItaW52ZXN0cy0yMG0taW4tY29tcHVnZW4tMTAwMTM5MDY4M9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Abraxane cancer drug shortage forces patients in Columbus to adjust - The Columbus Dispatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5kaXNwYXRjaC5jb20vc3RvcnkvbmV3cy9oZWFsdGhjYXJlLzIwMjEvMTEvMDkvYWJyYXhhbmUtY2FuY2VyLWRydWctc2hvcnRhZ2UtZm9yY2VzLXBhdGllbnRzLWNvbHVtYnVzLWFkanVzdC10cmVhdG1lbnQvNjIzOTU5MzAwMS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Motorcycle Motorcade Delivers Toys, Hope at Children's Hospital in ... - TAPinto.net",
            "link": "https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy50YXBpbnRvLm5ldC90b3ducy9uZXctYnJ1bnN3aWNrL3NlY3Rpb25zL2dpdmluZy1iYWNrL2FydGljbGVzL21vdG9yY3ljbGUtbW90b3JjYWRlLWRlbGl2ZXJzLXRveXMtaG9wZS1hdC1jaGlsZHJlbi1zLWhvc3BpdGFsLWluLW5ldy1icnVuc3dpY2vSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Biohaven and Pfizer Enter Strategic Collaboration for the ... - Pfizer",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LnBmaXplci5jb20vbmV3cy9wcmVzcy1yZWxlYXNlL3ByZXNzLXJlbGVhc2UtZGV0YWlsL2Jpb2hhdmVuLWFuZC1wZml6ZXItZW50ZXItc3RyYXRlZ2ljLWNvbGxhYm9yYXRpb27SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "SITC 2021 \u2013 ALX Oncology's unpleasant double dip - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9zaXRjLTIwMjEtYWx4LW9uY29sb2d5cy11bnBsZWFzYW50LWRvdWJsZS1kaXDSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNzM3NS9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Quality of Life in Men With Prostate Cancer Randomly Allocated to ... - ASCO Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9qY28uMjEuMDA3MjjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "bluebird bio splits to create new oncology firm 2seventy bio - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYmx1ZWJpcmRfYmlvX3NwbGl0c190b19jcmVhdGVfbmV3X29uY29sb2d5X2Zpcm1fMnNldmVudHlfYmlvXzEzODMxNjHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/29/2021": {
        "artical1": {
            "title": "Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia ... - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzExLzAzL2hlcmVzLXdoeS1icmlzdG9sLW15ZXJzLXNxdWliYi1jYW50LW1pc3Mtb3V0LW9uLWF1L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Stand Up To Cancer With Support From Bristol Myers Squibb ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMiuAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3N0YW5kLXVwLXRvLWNhbmNlci13aXRoLXN1cHBvcnQtZnJvbS1icmlzdG9sLW15ZXJzLXNxdWliYi11bnZlaWxzLW5ldy1sdW5nLWNhbmNlci1wc2EtZmVhdHVyaW5nLWFydGlzdC1hY3Rvci1hbmQtYWN0aXZpc3QtY29tbW9uLTMwMTQxNjQ0Mi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "AbbVie-backed Nitrome adds BMS as investor in $45M series A ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWJidmllLWJhY2tlZC1uaXRyb21lLWFkZHMtYm1zLWFzLWludmVzdG9yLXNuYWdzLW51cml4LWNiby1hcy1jZW8tYW5kLXJlYnJhbmRzLXRvLW5pdHJhc2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Pfizer bows out of the Tyk2 race - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvcGZpemVyLWJvd3Mtb3V0LXR5azItcmFjZdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE3MzQ4L2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Management of Immune-Related Adverse Events in Patients ... - ASCO Journals",
            "link": "https://news.google.com/rss/articles/CBMiMWh0dHBzOi8vYXNjb3B1YnMub3JnL2RvaS9hYnMvMTAuMTIwMC9KQ08uMjEuMDE0NDDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Corporate Climate Pledges Often Ignore a Key Component: Supply ... - The New York Times",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjEvMTEvMDIvYnVzaW5lc3MvY29ycG9yYXRlLWNsaW1hdGUtcGxlZGdlLXN1cHBseS1jaGFpbi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Hopewell's ex-BMS site coming alive with new tenants, new ... - Community News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5jb21tdW5pdHluZXdzLm9yZy9idXNpbmVzcy9ob3Bld2VsbHMtZXgtYm1zLXNpdGUtY29taW5nLWFsaXZlLXdpdGgtbmV3LXRlbmFudHMtbmV3LXRlY2hub2xvZ2llcy9hcnRpY2xlX2EwODNmZmNjLTNiNDUtMTFlYy1iMjE4LTQzNTI4OTNlZjAzZS5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/22/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb, after passing on Acceleron, now eyes Aurinia ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLWFmdGVyLXBhc3NpbmctYWNjZWxlcm9uLW5vdy1leWVzLWF1cmluaWEtdGFrZW91dC1ibG9vbWJlcmfSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers interested in buying Aurinia Pharma - Bloomberg News - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLWludGVyZXN0ZWQtYnV5aW5nLWF1cmluaWEtcGhhcm1hLWJsb29tYmVyZy1uZXdzLTIwMjEtMTAtMjIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "AUPH Stock Rockets To Record On Rumored Bristol Myers Takeover - Investor's Business Daily",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L2F1cGgtc3RvY2stcG9wcy1iZWZvcmUtYmVpbmctaGFsdGVkLW9uLXJlcG9ydHMtb2YtbG9vbWluZy1icmlzdG9sLW15ZXJzLXRha2VvdmVyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers reports 10% quarterly sales growth as cancer drugs ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLXJlcG9ydHMtMTAtcXVhcnRlcmx5LXNhbGVzLWdyb3d0aC1jYW5jZXItZHJ1Z3MtcmVib3VuZC0yMDIxLTEwLTI3L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "BMS Buyout Rumors Send Canadian Biopharma\u2019s Stock Soaring - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2J1eW91dC1ydW1vcnMtc2VuZC1jYW5hZGlhbi1iaW9waGFybWEtcy1zdG9jay1zb2FyaW5nLS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Pacific Trader: Why Aurinia Pharmaceuticals is the belle of the ... - BCBusiness",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmJjYnVzaW5lc3MuY2EvUGFjaWZpYy1UcmFkZXItV2h5LUF1cmluaWEtUGhhcm1hY2V1dGljYWxzLWlzLXRoZS1iZWxsZS1vZi10aGUtYmlvdGVjaC1iYWxs0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Acceleron Announces Third Quarter 2021 REBLOZYL\u00ae Net Sales - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjExMDI3MDA1NTMwL2VuL0FjY2VsZXJvbi1Bbm5vdW5jZXMtVGhpcmQtUXVhcnRlci0yMDIxLVJFQkxPWllMJUMyJUFFLU5ldC1TYWxlc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/15/2021": {
        "artical1": {
            "title": "Dragonfly Therapeutics Announces Sixth Dragonfly Drug to be ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMi9AFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2RyYWdvbmZseS10aGVyYXBldXRpY3MtYW5ub3VuY2VzLXNpeHRoLWRyYWdvbmZseS1kcnVnLXRvLWJlLWxpY2Vuc2VkLWJ5LWJyaXN0b2wtbXllcnMtc3F1aWJiLWFuZC1yZWNlaXB0LW9mLW1pbGVzdG9uZS1wYXltZW50cy1mb2xsb3dpbmctZmlyc3QtcGF0aWVudC1kb3Npbmctb2YtdHdvLXRyaW5rZXQtaW1tdW5vdGhlcmFwaWVzLTMwMTQwMjI5MS5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "More activist pressure for Merck's $11.5B Acceleron deal as another ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FjdGl2aXN0LXByZXNzdXJlLWZvci1tZXJjay1zLTExLTViLWFjY2VsZXJvbi1kZWFsLWhlZGdlLWZ1bmQtYXNrcy1mb3ItdHdpY2UtcHJpY2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb (BMY) Reports Next Week: Wall Street Expects Earnings Growth - Zacks Investment Research",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LnphY2tzLmNvbS9zdG9jay9uZXdzLzE4MTM1ODMvYnJpc3RvbC1teWVycy1zcXVpYmItYm15LXJlcG9ydHMtbmV4dC13ZWVrLXdhbGwtc3RyZWV0LWV4cGVjdHMtZWFybmluZ3MtZ3Jvd3Ro0gF7aHR0cHM6Ly93d3cuemFja3MuY29tL2FtcC9zdG9jay9uZXdzLzE4MTM1ODMvYnJpc3RvbC1teWVycy1zcXVpYmItYm15LXJlcG9ydHMtbmV4dC13ZWVrLXdhbGwtc3RyZWV0LWV4cGVjdHMtZWFybmluZ3MtZ3Jvd3Ro?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb's Zeposia Launch Trajectories Diverge in ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMi9QFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2JyaXN0b2wtbXllcnMtc3F1aWJicy16ZXBvc2lhLWxhdW5jaC10cmFqZWN0b3JpZXMtZGl2ZXJnZS1pbi1nZXJtYW55LWFuZC10aGUtdWstZm9sbG93aW5nLW5lZ2F0aXZlLW5pY2UtZGVjaXNpb24tamFuc3NlbnMtcG9udm9yeS1jb3VsZC1saWtld2lzZS1zdHVtYmxlLWFjY29yZGluZy10by1zcGhlcml4LWdsb2JhbC1pbnNpZ2h0cy0zMDE0MDQ3OTkuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia\u2014and ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2ViaW90ZWNoLmNvbS9iaW90ZWNoL3ZlbnR5eC1uYWJzLXVwc2l6ZWQtaXBvLXRvLWNoYWxsZW5nZS1icmlzdG9sLXMtemVwb3NpYS1hbmQtYS1iYWNrZXItaW50aW1hdGUta25vd2xlZGdlLWl0c9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Some cancer patients now have to find other options as Bristol ... - Endpoints News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijQFodHRwczovL2VuZHB0cy5jb20vc29tZS1jYW5jZXItcGF0aWVudHMtbm93LWhhdmUtdG8tZmluZC1vdGhlci1vcHRpb25zLWFzLWJyaXN0b2wtbXllcnMtYWJyYXhhbmUtZmFsbHMtaW50by1zaG9ydGFnZS1mcm9tLW1hbnVmYWN0dXJpbmctd29lcy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Intelsat judge aims to delay key bankruptcy plan hearing - Reuters",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2xlZ2FsL3RyYW5zYWN0aW9uYWwvaW50ZWxzYXQtanVkZ2UtYWltcy1kZWxheS1rZXktYmFua3J1cHRjeS1wbGFuLWhlYXJpbmctMjAyMS0xMC0yMC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/08/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb engaged in Acceleron buyout talks but couldn't ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLWVuZ2FnZWQtYWNjZWxlcm9uLWJ1eW91dC10YWxrcy1idXQtY291bGRuLXQtanVzdGlmeS1wcmljZS1yZXBvcnTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Kills China Abraxane Deal with BeiGene - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWtpbGxzLWNoaW5hLWFicmF4YW5lLWRlYWwtd2l0aC1iZWlnZW5lL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS gives notice of termination of Abraxane deal with BeiGene - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9ibXMtZ2l2ZXMtbm90aWNlLW9mLXRlcm1pbmF0aW9uLW9mLWFicmF4YW5lLWRlYWwtd2l0aC1iZWlnZW5l0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Agenus Earns $20M BMS Milestone In Antibody Alliance - Contract Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmNvbnRyYWN0cGhhcm1hLmNvbS9jb250ZW50cy92aWV3X2JyZWFraW5nLW5ld3MvMjAyMS0xMC0xMy9hZ2VudXMtZWFybnMtMjBtLWJtcy1taWxlc3RvbmUtaW4tYW50aWJvZHktYWxsaWFuY2Uv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "GRYT Health and Bristol Myers Squibb Team Up to Launch Diversity in Oncology Initiative - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ncnl0LWhlYWx0aC1icmlzdG9sLW15ZXJzLXNxdWliYi0xNTUyNDcxNzYuaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2dyeXQtaGVhbHRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLTE1NTI0NzE3Ni5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Ocrevus data of 8 years to defend multiple sclerosis leadership - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VjdHJpbXMtcm9jaGUtdG91dHMtOC15ZWFyLW9jcmV2dXMtZGF0YS10by1kZWZlbmQtbXVsdGlwbGUtc2NsZXJvc2lzLWxlYWRlcnNoaXDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Transition Bio, Inc., Expands Leadership Team, Names CEO, CTO ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjExMDEyMDA1NTI3L2VuL1RyYW5zaXRpb24tQmlvLUluYy4tRXhwYW5kcy1MZWFkZXJzaGlwLVRlYW0tTmFtZXMtQ0VPLUNUTy1DT0_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/01/2021": {
        "artical1": {
            "title": "Bristol Myers' top autoimmune drug prospect takes a hit in mid-stage ... - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1teWVycy1kZXVjcmF2YWNpdGluaWItdHlrMi11bGNlcmF0aXZlLWNvbGl0aXMvNjA3ODU1L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Springworks seeks cancer win as a prelude to something bigger - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb21wYW55LWV2ZW50cy9zcHJpbmd3b3Jrcy1zZWVrcy1jYW5jZXItd2luLXByZWx1ZGUtc29tZXRoaW5nLWJpZ2dlctIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE3MjcwL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "The unfavorable effects of COVID\u201019 on Dutch advanced melanoma ... - John Wiley",
            "link": "https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMDAyL2lqYy4zMzgzM9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Amazon appealing denial of development permit in Wallingford - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vTmV3cy9XYWxsaW5nZm9yZC9XYWxsaW5nZm9yZC1OZXdzL0FtYXpvbi1hcHBlYWxzLWRlbmlhbC1vZi1sYW5kLXVzZS1wZXJtaXQtaW4tV2FsbGluZ2ZvcmQuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Lawmakers seek details on accounting firms after a New York Times ... - The New York Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjEvMTAvMDUvYnVzaW5lc3MvYWNjb3VudGluZy1maXJtcy10cmVhc3VyeS13YXJyZW4tamF5YXBhbC5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol-Myers Sues Alembic to Block Generic Versions of Sprycel - Bloomberg Law",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vbmV3cy5ibG9vbWJlcmdsYXcuY29tL2lwLWxhdy9icmlzdG9sLW15ZXJzLXN1ZXMtYWxlbWJpYy10by1ibG9jay1nZW5lcmljLXZlcnNpb25zLW9mLXNwcnljZWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Medication Pearl of the Day: Tisotumab Vedotin (Tivdak) for Cervical ... - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvbWVkaWNhdGlvbi1wZWFybC1vZi10aGUtZGF5LXRpc290dW1hYi12ZWRvdGluLXRpdmRhay1mb3ItY2VydmljYWwtY2FuY2Vy0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/24/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb previews new 'transformation' corporate brand ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtc3F1aWJiLXByZXZpZXdzLWZpcnN0LXBvc3QtY2VsZ2VuZS1tZXJnZXItY29ycG9yYXRlLWJyYW5kLWNhbXBhaWduLWF00gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Mystery suitor lines up $11B Acceleron acquisition: report - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvbXlzdGVyeS1zdWl0b3ItbGluZXMtdXAtMTFiLWFjY2VsZXJvbi1hY3F1aXNpdGlvbi1yZXBvcnTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Communications and Commercialisation | Interview: Catherine ... - Pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vZGVlcC1kaXZlLnBoYXJtYXBob3J1bS5jb20vbWFnYXppbmUvY29tbXVuaWNhdGlvbnMtYW5kLWNvbW1lcmNpYWxpc2F0aW9uL2JyaXN0b2wtbXllcnMtc3F1aWJiLWJtcy1jYXRoZXJpbmUtb3dlbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Speck Design and Bristol-Myers-Squibb Partner to Create O+Y Tool - Dexigner",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiI2h0dHBzOi8vd3d3LmRleGlnbmVyLmNvbS9uZXdzLzMzODc50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Merck & Co justifies paying up for Acceleron - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvZGVhbHMvbWVyY2stY28tanVzdGlmaWVzLXBheWluZy1hY2NlbGVyb27SASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNzI1NC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Botswana - Baylor College of Medicine News",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmJjbS5lZHUvbmV3cy9ib3Rzd2FuYS1iYXlsb3ItY29sbGVnZS1vZi1tZWRpY2luZS1yZW5ldy1wYXJ0bmVyc2hpcNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Merck's reported $11B Acceleron buy could help it diversify beyond ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2J1eWluZy1hY2NlbGVyb24tZm9yLTExYi1hLWdvb2QtZml0LWZvci1tZXJjay10by1kaXZlcnNpZnktZnJvbS1rZXl0cnVkYS1idXQtYW50aXRydXN00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/17/2021": {
        "artical1": {
            "title": "ESMO: Bristol Myers' Opdivo-Yervoy, Pfizer-Merck KGaA's Bavencio ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtb3BkaXZvLXllcnZveS1wZml6ZXItbWVyY2sta2dhYS1zLWJhdmVuY2lvLWhpdC13YWxscy1oZWFkLWFuZC1uZWNrLWNhbmNlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Alexandria sells stake in South Lake Union building for near-record ... - The Business Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9zZWF0dGxlL25ld3MvMjAyMS8wOS8yMS80MDAtZGV4dGVyLXN0YWtlLXNlbGxzLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Immunotherapy combination maintains OS advantage in malignant ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDkxNy9pbW11bm90aGVyYXB5LWNvbWJpbmF0aW9uLW1haW50YWlucy1vcy1hZHZhbnRhZ2UtaW4tbWFsaWduYW50LXBsZXVyYWwtbWVzb3RoZWxpb21h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "ESMO: Regeneron, Sanofi take another stab at lung cancer with ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9yZWdlbmVyb24tc2Fub2ZpLXRha2UtYW5vdGhlci1zdGFiLWF0LWx1bmctY2FuY2VyLWxpYnRheW8tY2hlbW8tY29tYm8td2luLXNob3VsZC1tZXJjay13b3JyedIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Use of novel antithrombotic agents for COVID\u201019: Systematic ... - John Wiley",
            "link": "https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMTExL2p0aC4xNTUzM9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "TreeFrog Raises $75M to Develop Parkinson's Stem Cell Therapies - Parkinson's News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vcGFya2luc29uc25ld3N0b2RheS5jb20vbmV3cy90cmVlZnJvZy1yYWlzZXMtNzVtLWRldmVsb3AtcGFya2luc29ucy1zdGVtLWNlbGwtdGhlcmFwaWVzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Nivolumab-ipilimumab combination confers durable benefit in ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDkxNy9uaXZvbHVtYWJpcGlsaW11bWFiLWNvbWJpbmF0aW9uLWNvbmZlcnMtZHVyYWJsZS1iZW5lZml0LWluLWFkdmFuY2VkLXJlbmFsLWNlbGwtY2FyY2lub21h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/10/2021": {
        "artical1": {
            "title": "Nivolumab plus ipilimumab confers sustained OS benefit in ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDkxMy9uaXZvbHVtYWItcGx1cy1pcGlsaW11bWFiLWNvbmZlcnMtc3VzdGFpbmVkLW9zLWJlbmVmaXQtaW4tbWFsaWduYW50LXBsZXVyYWwtbWVzb3RoZWxpb21h0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Oligonucleotide synthesis gets an overhaul - Chemical & Engineering News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vY2VuLmFjcy5vcmcvc3ludGhlc2lzL21lZGljaW5hbC1jaGVtaXN0cnkvT2xpZ29udWNsZW90aWRlLXN5bnRoZXNpcy1vdmVyaGF1bC85OS93ZWIvMjAyMS8wOdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Raytheon CEO expects inflation pressure in coming years - Reuters",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2Flcm9zcGFjZS1kZWZlbnNlL3JheXRoZW9uLWNlby1leHBlY3RzLWluZmxhdGlvbi1wcmVzc3VyZS1jb21pbmcteWVhcnMtMjAyMS0wOS0xNS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Money on the Move: September 8 \u2013 14 - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL21vbmV5LW9uLXRoZS1tb3ZlLXNlcHRlbWJlci04LTE0LS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "China's IASO nets $108M to advance cell therapies, antibodies for ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvY2hpbmEtcy1pYXNvLW5ldHMtMTA4bS10by1hZHZhbmNlLWNlbGwtdGhlcmFwaWVzLWFudGlib2RpZXMtZm9yLWNhbmNlci1hdXRvaW1tdW5lLWRpc2Vhc2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Fierce Pharma Asia\u2014Takeda's AbbVie drug supply lawsuit ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvZmllcmNlLXBoYXJtYS1hc2lhLXRha2VkYS1zLWFiYnZpZS1kcnVnLXN1cHBseS1sYXdzdWl0LW5vdmF2YXgtY292aWQtdmFjY2luZS1kZWFsLWp1bm_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Pharmacy Quiz: Test Your Knowledge on C. Difficile Infection - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvcGhhcm1hY3ktcXVpei10ZXN0LXlvdXIta25vd2xlZGdlLW9uLWMtZGlmZmljaWxlLWluZmVjdGlvbtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/03/2021": {
        "artical1": {
            "title": "With approval for China's 2nd CAR-T therapy, Juno, WuXi joint ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvanVuby13dXhpLWp2LWdvZXMtdXAtYWdhaW5zdC15ZXNjYXJ0YS1jaGluYS1ub2QtZm9yLWNhci10LXRoZXJhcHnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "More than 230 Bristol Myers Squibb Employees Pedal Across the ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMixAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDkwODAwNTAyNy9lbi9Nb3JlLXRoYW4tMjMwLUJyaXN0b2wtTXllcnMtU3F1aWJiLUVtcGxveWVlcy1QZWRhbC1BY3Jvc3MtdGhlLVUuUy4tdG8tQWR2YW5jZS1DYW5jZXItUmVzZWFyY2gtaW4tU2V2ZW50aC1Bbm51YWwtQ29hc3QtMi1Db2FzdC00LUNhbmNlci1SaWRl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "JW Therapeutics Announces NMPA Approval of Relmacabtagene ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9pbi9uZXdzLXJlbGVhc2VzL2p3LXRoZXJhcGV1dGljcy1hbm5vdW5jZXMtbm1wYS1hcHByb3ZhbC1vZi1yZWxtYWNhYnRhZ2VuZS1hdXRvbGV1Y2VsLWluamVjdGlvbi1pbi1jaGluYS04Mzc2NTE0NTguaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Obsidian Therapeutics Announces Closing of $115 Million Series B ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL29ic2lkaWFuLXRoZXJhcGV1dGljcy1hbm5vdW5jZXMtY2xvc2luZy1vZi0xMTUtbWlsbGlvbi1zZXJpZXMtYi1maW5hbmNpbmctMzAxMzcyMTk1Lmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Drug giants line up for Irish legal battle over patents - Irish Independent",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmluZGVwZW5kZW50LmllL2J1c2luZXNzL2lyaXNoL2RydWctZ2lhbnRzLWxpbmUtdXAtZm9yLWlyaXNoLWxlZ2FsLWJhdHRsZS1vdmVyLXBhdGVudHMvNDA4MzUyMTMuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "WCLC: AstraZeneca's detailed Imfinzi, tremelimumab data in ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3djbGMtYXN0cmF6ZW5lY2Etcy1kZXRhaWxlZC1pbWZpbnppLXRyZW1lbGltdW1hYi1kYXRhLW1ldGFzdGF0aWMtbnNjbGMtYXJlLWZhci1mcm9tLWHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "mAbs in multiple myeloma: first-to-market advantage will be strong - Pharmaceutical Technology",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL2ZlYXR1cmVzL21hYnMtbXVsdGlwbGUtbXllbG9tYS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/27/2021": {
        "artical1": {
            "title": "Gilead Wins a Patent Battle in CAR-T War with BMS - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2luLXRoZS1jYXItdC13YXItYmV0d2Vlbi1naWxlYWQtYW5kLWJtcy1naWxlYWQtd2lucy1hLXBhdGVudC1iYXR0bGUv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "5 top stocks Warren Buffett recently sold \u2014 why he could be dead wrong - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy81LXRvcC1zdG9ja3Mtd2FycmVuLWJ1ZmZldHQtMTcxMDAwMjIwLmh0bWzSAVFodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy81LXRvcC1zdG9ja3Mtd2FycmVuLWJ1ZmZldHQtMTcxMDAwMjIwLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Servier's beefing up in oncology through dealmaking and Tibsovo ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NlcnZpZXItYnVpbGRzLW9uY29sb2d5LWFtYml0aW9uLXNlcmllcy1kZWFsbWFraW5nLWFuZC10aWJzb3ZvLXdpbnMtdS1zLWNlb9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Novavax COVID-19 vaccine U.S. trial participants count as fully ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9ub3ZhdmF4LWNvdmlkLTE5LXZhY2NpbmUtdXMtdHJpYWwtcGFydGljaXBhbnRzLWNvdW50LWZ1bGx5LXZhY2NpbmF0ZWQtdHdvLXdlZWtzLTIwMjEtMDgtMzAv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Modeling Inaccessible Cells from Induced Stem Cells Heralds Hope ... - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvbW9kZWxpbmctaW5hY2Nlc3NpYmxlLWNlbGxzLWZyb20taW5kdWNlZC1zdGVtLWNlbGxzLWhlcmFsZHMtaG9wZS1mb3ItdW50cmVhdGFibGUtbHVuZy1kaXNlYXNlcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Roche withdraws drug for a type of breast cancer in United States - Reuters",
            "link": "https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9yb2NoZS13aXRoZHJhd3MtZHJ1Zy1icmVhc3QtY2FuY2VyLWluZGljYXRpb24tdW5pdGVkLXN0YXRlcy0yMDIxLTA4LTI3L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Afghanistan central bank board member urges Biden, IMF to release ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2FmZ2hhbmlzdGFuLWNlbnRyYWwtYmFuay1ib2FyZC1tZW1iZXItdXJnZXMtYmlkZW4taW1mLXJlbGVhc2UtZnVuZHMtMjAyMS0wOS0wMS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/20/2021": {
        "artical1": {
            "title": "Gilead Sciences wins reversal of $1.2 billion award in patent case with Bristol Myers - Yahoo News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vbmV3cy55YWhvby5jb20vYW1waHRtbC9naWxlYWQtc2NpZW5jZXMtd2lucy1yZXZlcnNhbC0xLTE1NDc1NzQ1My5odG1s0gFNaHR0cHM6Ly9uZXdzLnlhaG9vLmNvbS9hbXBodG1sL2dpbGVhZC1zY2llbmNlcy13aW5zLXJldmVyc2FsLTEtMTU0NzU3NDUzLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-backed Cardior gets $75M to run midphase antisense heart ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1iYWNrZWQtY2FyZGlvci1nZXRzLTc1bS10by1ydW4tbWlkcGhhc2UtYW50aXNlbnNlLWhlYXJ0LWZhaWx1cmUtdHJpYWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA Approves Opdivo for Adjuvant Treatment of Patients with High ... - PharmaLive",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LnBoYXJtYWxpdmUuY29tL2ZkYS1hcHByb3Zlcy1vcGRpdm8tZm9yLWFkanV2YW50LXRyZWF0bWVudC1vZi1wYXRpZW50cy13aXRoLWhpZ2gtcmlzay11cm90aGVsaWFsLWNhcmNpbm9tYS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Abecma is the first treatment approved by EC for multiple myeloma - European Pharmaceutical Review",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmV1cm9wZWFucGhhcm1hY2V1dGljYWxyZXZpZXcuY29tL25ld3MvMTYwODY3L2FiZWNtYS1pcy10aGUtZmlyc3QtdHJlYXRtZW50LWFwcHJvdmVkLWJ5LWVjLWZvci1tdWx0aXBsZS1teWVsb21hL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Wall St rebounds on tech support, but heads for weekly losses - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL3NwLTUwMC1kb3ctdHJhY2std29yc3Qtd2Vlay0yLW1vbnRocy1yZWNvdmVyeS10YXBlci1mZWFycy0yMDIxLTA4LTIwL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Novartis falls behind rivals in race to bring CAR-T to early lymphoma - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMta3ltcmlhaC1zZWNvbmQtbGluZS1jYXItdC1seW1waG9tYS82MDU0NTYv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Cardior Raises \u20ac64M Series B to Advance Clinical Pipeline of RNA ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDgyNTAwNTMxNC9lbi9DYXJkaW9yLVJhaXNlcy0lRTIlODIlQUM2NE0tU2VyaWVzLUItdG8tQWR2YW5jZS1DbGluaWNhbC1QaXBlbGluZS1vZi1STkEtVGhlcmFwZXV0aWNzLXRvLVRyZWF0LUNhcmRpYWMtRGlzZWFzZdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/13/2021": {
        "artical1": {
            "title": "BMS advances AI-designed drug candidate into development - PharmaTimes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2Jtc19hZHZhbmNlc19haS1kZXNpZ25lZF9kcnVnX2NhbmRpZGF0ZV9pbnRvX2RldmVsb3BtZW50XzEzNzU0MjLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Next-gen psoriasis drug rivalry between Bristol Myers and Nimbus ... - Endpoints News",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vZW5kcHRzLmNvbS9uZXh0LWdlbi1wc29yaWFzaXMtZHJ1Zy1yaXZhbHJ5LWJldHdlZW4tYnJpc3RvbC1teWVycy1hbmQtbmltYnVzLXNwaWxscy1pbnRvLWEtbGVnYWwtYmF0dGxlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen \u2014 How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2 - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9hcHBsZS1nbS1rcm9nZXItYWJidmllLW1lcmNrLTA2MTIzOTM5Mi5odG1s0gFSaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvYXBwbGUtZ20ta3JvZ2VyLWFiYnZpZS1tZXJjay0wNjEyMzkzOTIuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "BRIEF\u2014Scott Cooke named BMS' GM for UK and Ireland - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vaW4tYnJpZWYvYnJpZWYtc2NvdHQtY29va2UtbmFtZWQtYm1zLWdtLWZvci11ay1hbmQtaXJlbGFuZNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Incidence of and factors associated with SARS\u2010CoV\u20102 infection ... - John Wiley",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMTExL3RiZWQuMTQyOTPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Pharmacy Clinical Pearl of the Day: Comprehensive Metabolic ... - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L3BoYXJtYWN5LWNsaW5pY2FsLXBlYXJsLW9mLXRoZS1kYXktY29tcHJlaGVuc2l2ZS1tZXRhYm9saWMtcGFuZWwtdnMtY29tcGxldGUtYmxvb2QtY291bnQtbGFic9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Improving Outcomes and Mitigating Costs Associated With CAR T ... - AJMC.com Managed Markets Network",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvaW1wcm92aW5nLW91dGNvbWVzLWFuZC1taXRpZ2F0aW5nLWNvc3RzLWFzc29jaWF0ZWQtd2l0aC1jYXItdC1jZWxsLXRoZXJhcHnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/06/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb and Five Leading Historically Black Colleges ... - The Dig",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3RoZWRpZy5ob3dhcmQuZWR1L2FsbC1zdG9yaWVzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWFuZC1maXZlLWxlYWRpbmctaGlzdG9yaWNhbGx5LWJsYWNrLWNvbGxlZ2VzLWFuZC11bml2ZXJzaXRpZXMtbGF1bmNoLXRvbW9ycm93c9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "A Global Vision for Access - Pharmaceutical Executive",
            "link": "https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy9hLWdsb2JhbC12aXNpb24tZm9yLWFjY2Vzc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "A World View | Touro College of Pharmacy | Touro University - Touro University",
            "link": "https://news.google.com/rss/articles/CBMiNGh0dHBzOi8vdGNvcC50b3Vyby5lZHUvbmV3cy9zdG9yaWVzL2Etd29ybGQtdmlldy5waHDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Gilead Foundation bounces back with a bang\u2014$200M in the bank ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2dpbGVhZC1mb3VuZGF0aW9uLWJvdW5jZXMtYmFjay1hLWJhbmctMjAwLW1pbGxpb24tYmFuay1hbmQtYW1iaXRpb3VzLWdvYWxz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Drugmakers partner with Black colleges to diversify talent, clinical trials - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9kcnVnbWFrZXJzLXBhcnRuZXItd2l0aC1ibGFjay1jb2xsZWdlcy10by1kaXZlcnNpZnktdGFsZW50LWNsaW5pY2FsLXRyaWFscy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "J&J's Ponvory may be late to the multiple sclerosis market, but ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy9qLWotcy1wb252b3J5LW1heS1iZS1sYXRlLXRvLW11bHRpcGxlLXNjbGVyb3Npcy1tYXJrZXQtYnV0LWRvY3Mtc3RpbGwtc2VlLXBvdGVudGlhbC1zdHVkedIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "McDonald's to require US office workers to get vaccinated ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL3JldGFpbC1jb25zdW1lci9tY2RvbmFsZHMtcmVxdWlyZS11cy1vZmZpY2Utd29ya2Vycy1nZXQtdmFjY2luYXRlZC1ueXQtMjAyMS0wOC0xMS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/30/2021": {
        "artical1": {
            "title": "WuXi STA Completes Acquisition of Bristol Myers Squibb ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMimwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3d1eGktc3RhLWNvbXBsZXRlcy1hY3F1aXNpdGlvbi1vZi1icmlzdG9sLW15ZXJzLXNxdWliYi1tYW51ZmFjdHVyaW5nLWZhY2lsaXR5LWluLWNvdXZldC1zd2l0emVybGFuZC0zMDEzNDY1NDguaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers pulls an Istodax lymphoma use 10 years after FDA ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtcHVsbHMtaXN0b2RheC1seW1waG9tYS11c2UtMTAteWVhcnMtYWZ0ZXItZmRhLWFjY2VsZXJhdGVkLWFwcHJvdmFs0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Servier scores a win in bid to expand Tibsovo in acute myeloid ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NlcnZpZXItY2xhaW1zLXdpbi10by1leHBhbmQtdGlic292by1hbWwtYW5kLXRvLXJlYWNoLWV1LXdoZXJlLWFnaW9zLWZhaWxlZNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Zai Lab to pay Schr\u00f6dinger up to $338M in biobucks for oncology ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvemFpLWxhYi10by1wYXktc2Nocm9kaW5nZXItdXAtdG8tMzM4bS1iaW9idWNrcy1mb3Itb25jb2xvZ3ktci1kLWNvbGxhYtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bayer acquires small molecule startup Vividion Therapeutics for up ... - Chemical & Engineering News",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vY2VuLmFjcy5vcmcvcGhhcm1hY2V1dGljYWxzL2RydWctZGlzY292ZXJ5L0JheWVyLWFjcXVpcmVzLXNtYWxsLW1vbGVjdWxlLXN0YXJ0dXAtVml2aWRpb24tVGhlcmFwZXV0aWNzLzk5L3dlYi8yMDIxLzA40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Lenalidomide and Pomalidomide: Immunomodulating Drug ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvbGVuYWxpZG9taWRlLWFuZC1wb21hbGlkb21pZGUtaW1tdW5vbW9kdWxhdGluZy1kcnVnLXRoZXJhcGllcy1pbi1tdWx0aXBsZS1teWVsb21h0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "AstraZeneca\u2019s FDA Approval Brings New Hope to the Lupus ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FzdHJhemVuZWNhLXMtZmRhLWFwcHJvdmFsLWJyaW5ncy1uZXctaG9wZS10by10aGUtbHVwdXMtY29tbXVuaXR5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/23/2021": {
        "artical1": {
            "title": "BridgeBio Announces Clinical Collaboration with Bristol Myers ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigJodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2JyaWRnZWJpby1hbm5vdW5jZXMtY2xpbmljYWwtY29sbGFib3JhdGlvbi13aXRoLWJyaXN0b2wtbXllcnMtc3F1aWJiLXRvLXN0dWR5LWJicC0zOTgtYS1wb3RlbnRpYWxseS1iZXN0LWluLWNsYXNzLXNocDItaW5oaWJpdG9yLWluLWNvbWJpbmF0aW9uLXdpdGgtb3BkaXZvLW5pdm9sdW1hYi1pbi1hZHZhbmNlZC1zb2xpZC10dW1vcnMtd2l0aC1rcmFzLW11dGF0aW9ucy0zMDEzNDE2MDUuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Withdraws Single-Agent Nivolumab Post ... - OncLive",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5vbmNsaXZlLmNvbS92aWV3L2JyaXN0b2wtbXllcnMtc3F1aWJiLXdpdGhkcmF3cy1zaW5nbGUtYWdlbnQtbml2b2x1bWFiLXBvc3Qtc29yYWZlbmliLWhjYy1pbmRpY2F0aW9uLWluLXRoZS11bml0ZWQtc3RhdGVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "New Jersey STEM Innovation Fellowship Expands to Science with ... - Montclaire News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5tb250Y2xhaXIuZWR1L25ld3NjZW50ZXIvMjAyMS8wNy8yOS9uZXctamVyc2V5LXN0ZW0taW5ub3ZhdGlvbi1mZWxsb3dzaGlwLWV4cGFuZHMtdG8tc2NpZW5jZS13aXRoLWZ1bmRpbmctZnJvbS1zdGF0ZS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "IMIDomicsTM Closes $16.5 Million Series A Financing to Advance ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiwQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDcyNzAwNTI1Ny9lbi9JTUlEb21pY3NUTS1DbG9zZXMtMTYuNS1NaWxsaW9uLVNlcmllcy1BLUZpbmFuY2luZy10by1BZHZhbmNlLWl0cy1QcmVjaXNpb24tRGlzY292ZXJ5LVBsYXRmb3JtLWZvci1JbW11bmUtTWVkaWF0ZWQtSW5mbGFtbWF0b3J5LURpc2Vhc2Vz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Prothena rolls out preclinical data for anti-amyloid Alzheimer's ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3Jlc2VhcmNoL3Byb3RoZW5hLXNheXMtcHJlY2xpbmljYWwtYWx6aGVpbWVyLXMtZHJ1Zy1jYW5kaWRhdGUtYmluZHMtYWJvdXQtMTEtdGltZXMtbW9yZS10aGFu0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Their First Kiss Missed the Mark, But Their Connection Was Spot On ... - The New York Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiR2h0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjEvMDcvMjMvc3R5bGUvYW15LWxlZS1yeWFuLXRzb3Utd2VkZGluZy5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Straight talk: Pfizer translates high science into plain language to ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3N0cmFpZ2h0LXRhbGstcGZpemVyLXRyYW5zbGF0ZXMtaGlnaC1zY2llbmNlLWludG8tcGxhaW4tbGFuZ3VhZ2UtZm9yLWV2ZXJ5ZGF5LWFjY2Vzcy10b9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/16/2021": {
        "artical1": {
            "title": "Bristol Myers Squibb Co. stock rises Wednesday, still underperforms market - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3RvcnkvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stcmlzZXMtd2VkbmVzZGF5LXN0aWxsLXVuZGVycGVyZm9ybXMtbWFya2V0LTAxNjI2OTAwMDYzLTIzNGY1ZjA0ODBmNtIBiwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL2RhdGEtbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jby1zdG9jay1yaXNlcy13ZWRuZXNkYXktc3RpbGwtdW5kZXJwZXJmb3Jtcy1tYXJrZXQtMDE2MjY5MDAwNjMtMjM0ZjVmMDQ4MGY2?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Cytokinetics stock soars on heart drug data that sets stage for Phase ... - MedCity News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjEvMDcvY3l0b2tpbmV0aWNzLXN0b2NrLXNvYXJzLW9uLWhlYXJ0LWRydWctZGF0YS10aGF0LXNldHMtc3RhZ2UtZm9yLXBoYXNlLTMtc3R1ZGllcy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Catalent invests $100m in Italian facility - BioProcess Insider - BioProcess Insider",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL2Jpb3Byb2Nlc3NpbnRsLmNvbS9iaW9wcm9jZXNzLWluc2lkZXIvZmFjaWxpdGllcy1jYXBhY2l0eS9jYXRhbGVudC1wbG91Z2hzLTEwMG0taW4taXRhbGlhbi1mYWNpbGl0eS10by11cC1kcnVnLXN1YnN0YW5jZS1wcm9kdWN0aW9uL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "IBD: Caring for your patients through life's stages - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9nYXN0cm9lbnRlcm9sb2d5LzIwMjEwNzEzL2liZC1jYXJpbmctZm9yLXlvdXItcGF0aWVudHMtdGhyb3VnaC1saWZlcy1zdGFnZXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL25la3Rhci1hcHBvaW50cy1kaW1pdHJ5LXNhLW51eXRlbi1tZC1waGQtYXMtc2VuaW9yLXZpY2UtcHJlc2lkZW50LWFuZC1jaGllZi1tZWRpY2FsLW9mZmljZXItMzAxMzM2MjA0Lmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Bristol-Myers Squibb accused of misusing market power with cancer ... - Lawyerly",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3Lmxhd3llcmx5LmNvbS5hdS9icmlzdG9sLW15ZXJzLXNxdWliYi1hY2N1c2VkLW9mLW1pc3VzaW5nLW1hcmtldC1wb3dlci13aXRoLW1lbGFub21hLXRyZWF0bWVudC1wcm9ncmFtL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "The key to psoriasis innovation? Dispelling the shadow of the JAK ... - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMitgFodHRwczovL3d3dy5wbWxpdmUuY29tL3BtaHViL21lZGljYWxfY29tbXVuaWNhdGlvbnMvRmlzaGF3YWNrX0dyb3VwX29mX0NvbXBhbmllcy93aGl0ZV9wYXBlcnNfYW5kX3Jlc291cmNlcy90aGVfa2V5X3RvX3Bzb3JpYXNpc19pbm5vdmF0aW9uX2Rpc3BlbGxpbmdfdGhlX3NoYWRvd19vZl90aGVfamFrX2luaGliaXRvctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/09/2021": {
        "artical1": {
            "title": "State to get $1.2 million as part of Bristol-Myers Medicaid settlement ... - WTVQ",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3Lnd0dnEuY29tL3N0YXRlLXRvLWdldC0xLTItbWlsbGlvbi1hcy1wYXJ0LW9mLWJyaXN0b2wtbXllcnMtbWVkaWNhaWQtc2V0dGxlbWVudC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "The top 15 blockbuster patent expirations coming this decade - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTE1LWJsb2NrYnVzdGVyLXBhdGVudC1leHBpcmF0aW9ucy1jb21pbmctZGVjYWRl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "After getting ditched by Big Pharma veteran, FibroGen hopes it has ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5maWVyY2ViaW90ZWNoLmNvbS9iaW90ZWNoL2ZpYnJvZ2VuLW5hYnMtc2Vjb25kLWNoaWVmLXNjaWVudGlmaWMtb2ZmaWNlci1sZXNzLXRoYW4tYS15ZWFyLXNuYWdnaW5nLWZvcm1lci1jb21wdWdlbi1jc2_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "'Persistent' ECB won't tighten too early, Lagarde says - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL3BlcnNpc3RlbnQtZWNiLXdvbnQtdGlnaHRlbi10b28tZWFybHktbGFnYXJkZS1zYXlzLTIwMjEtMDctMTMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Novartis leads and Bristol lags on novel drug approvals - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2luc2lnaHRzL25tZS1hcHByb3ZhbHMvbm92YXJ0aXMtbGVhZHMtYW5kLWJyaXN0b2wtbGFncy1ub3ZlbC1kcnVnLWFwcHJvdmFsc9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE2OTcyL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "The CoVID\u2010TE risk assessment model for venous thromboembolism ... - John Wiley",
            "link": "https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMTExL2p0aC4xNTQ2M9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "FDA approves Darzalex Faspro for use in relapsed multiple myeloma - Healio",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjEwNzEyL2ZkYS1hcHByb3Zlcy1kYXJ6YWxleC1mYXNwcm8tZm9yLXVzZS1pbi1yZWxhcHNlZC1tdWx0aXBsZS1teWVsb21h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/02/2021": {
        "artical1": {
            "title": "COVID Delta variant worries bubble to the surface in some asset ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2NvdmlkLWRlbHRhLXZhcmlhbnQtd29ycmllcy1idWJibGUtc3VyZmFjZS1zb21lLWFzc2V0LXByaWNlcy0yMDIxLTA3LTAyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Company-wide vacations could be the future of paid time off - Axios",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3LmF4aW9zLmNvbS8yMDIxLzA3LzAyL2J1cm5vdXQtc2FtZS12YWNhdGlvbi1wYWlkLXRpbWUtb2Zm0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Saudi Arabia pushes back on UAE opposition to OPEC+ deal - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2VuZXJneS9zYXVkaS1lbmVyZ3ktbWluaXN0ZXItcHVzaGVzLWJhY2stdWFlLXJlcXVlc3Qtb3Zlci1iYXNlbGluZS1vaWwtb3V0cHV0LXNheXMtMjAyMS0wNy0wNC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "GSK rejects Elliott's demands for board change, consumer sale - Reuters",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2JyaXRhaW5zLWdzay1iYWNrcy1jZW8tYWZ0ZXItcHJlc3N1cmUtYWN0aXZpc3QtZWxsaW90dC0yMDIxLTA3LTAyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Plasma Cell\u2010Free DNA Genotyping: From an Emerging Concept to a ... - The Oncologist",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzODg50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "With European recovery in sight, property investors bank on the office - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL3dpdGgtZXVyb3BlYW4tcmVjb3Zlcnktc2lnaHQtcHJvcGVydHktaW52ZXN0b3JzLWJhbmstb2ZmaWNlLTIwMjEtMDctMDYv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "The 2021 MM+M Awards: The Shortlist - MM+M - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL21tbS1hd2FyZHMvdGhlLTIwMjEtbW1tLWF3YXJkcy10aGUtc2hvcnRsaXN0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/25/2021": {
        "artical1": {
            "title": "GlaxoSmithKline taps Goldman, Citi to advise on consumer unit ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2dsYXhvc21pdGhrbGluZS10YXBzLWdvbGRtYW4tY2l0aS1hZHZpc2UtY29uc3VtZXItdW5pdC1zcGlub2ZmLWJsb29tYmVyZy1uZXdzLTIwMjEtMDYtMjUv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Dollar set for best month since March, payrolls test looms - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2RvbGxhci1zZXQtYmVzdC1tb250aC1zaW5jZS1tYXJjaC1wYXlyb2xscy10ZXN0LWxvb21zLTIwMjEtMDYtMzAv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Nivolumab/Ipilimumab Approved in Europe for dMMR or MSI-H ... - OncLive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvbml2b2x1bWFiLWlwaWxpbXVtYWItYXBwcm92ZWQtaW4tZXVyb3BlLWZvci1kbW1yLW9yLW1zaS1oLW1ldGFzdGF0aWMtY29sb3JlY3RhbC1jYW5jZXLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "AstraZeneca names Galbraith as Baselga successor in cancer R&D - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYXN0cmF6ZW5lY2EtbmFtZXMtZ2FsYnJhaXRoLWFzLWJhc2VsZ2Etc3VjY2Vzc29yLWNhbmNlci1yLWTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "DivcoWest Breaks Ground on a New Life Science Building at ... - Boston Real Estate Times",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vYm9zdG9ucmVhbGVzdGF0ZXRpbWVzLmNvbS9kaXZjb3dlc3QtYnJlYWtzLWdyb3VuZC1vbi1hLW5ldy1saWZlLXNjaWVuY2UtYnVpbGRpbmctYXQtY2FtYnJpZGdlLWNyb3NzaW5nL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Sunitinib and Evofosfamide (TH\u2010302) in Systemic Treatment\u2010Na\u00efve ... - The Oncologist",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzODg10gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Dominican Republic giving third COVID-19 vaccine dose in move to ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9kb21pbmljYW4tcmVwdWJsaWMtZ2l2aW5nLXRoaXJkLWNvdmlkLTE5LXZhY2NpbmUtZG9zZS1tb3ZlLXN0YXZlLW9mZi1uZXctdmlydXMtMjAyMS0wNy0wMS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/18/2021": {
        "artical1": {
            "title": "BMS Bets Big on Eisai's ADC for Solid Tumors in Potential $3 Billion ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jtcy1wYXJ0bmVycy13aXRoLWVpc2FpLXRvLWRldmVsb3AtYW50aWJvZHktZHJ1Zy1jb25qdWdhdGUtZm9yLXNvbGlkLXR1bW9ycy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "After Immunogen and Sutro, Bristol buys into the folate story - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvZGVhbHMvYWZ0ZXItaW1tdW5vZ2VuLWFuZC1zdXRyby1icmlzdG9sLWJ1eXMtZm9sYXRlLXN0b3J50gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTY5NjUvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS and Eisai to collaborate in deal worth up to $3.1bn - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYm1zX2FuZF9laXNhaV90b19jb2xsYWJvcmF0ZV9pbl9kZWFsX3dvcnRoX3VwX3RvXyQyLjQ1Ym5fMTM3MTgzNtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Prothena Announces Bristol Myers Squibb Opt-in of Anti-Tau ... - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMi4gFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMS8wNi8yNC8yMjUyNjEwLzI0MDQxL2VuL1Byb3RoZW5hLUFubm91bmNlcy1CcmlzdG9sLU15ZXJzLVNxdWliYi1PcHQtaW4tb2YtQW50aS1UYXUtUFJYMDA1LWFzLXRoZS1GaXJzdC1Qcm9ncmFtLWZyb20tR2xvYmFsLU5ldXJvc2NpZW5jZS1SZXNlYXJjaC1hbmQtRGV2ZWxvcG1lbnQtQ29sbGFib3JhdGlvbi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "With pandemic easing, Bristol Myers Squibb takes its GRYT ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Jtcy1leGNoYW5nZXMtcGFuZGVtaWMtdGhlbWUtdG8tanVzdC1hZHZvY2FjeS1vbmxpbmUtcGF0aWVudC1wbGF0Zm9ybdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol Myers Squibb Noise Issue Complaints, Leaf Blower Ban ... - TAPinto.net",
            "link": "https://news.google.com/rss/articles/CBMixwFodHRwczovL3d3dy50YXBpbnRvLm5ldC90b3ducy9zdW1taXQvc2VjdGlvbnMvZ292ZXJubWVudC9hcnRpY2xlcy9icmlzdG9sLW15ZXJzLXNxdWliYi1ub2lzZS1pc3N1ZS1jb21wbGFpbnRzLWxlYWYtYmxvd2VyLWJhbi1kaWFsb2d1ZS1jb250aW51ZS10by1zd2lybC1hdC1zdW1taXQtY29tbW9uLWNvdW5jaWwtcy1zZWNvbmQtanVuZS1tZWV0aW5n0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Sun Pharma, Celgene to settle patent row over anti-cancer drug - The Hindu",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LnRoZWhpbmR1LmNvbS9idXNpbmVzcy9zdW4tcGhhcm1hLWNlbGdlbmUtdG8tc2V0dGxlLXBhdGVudC1yb3ctb3Zlci1hbnRpLWNhbmNlci1kcnVnL2FydGljbGUzNDkxOTc2OS5lY2XSAXhodHRwczovL3d3dy50aGVoaW5kdS5jb20vYnVzaW5lc3Mvc3VuLXBoYXJtYS1jZWxnZW5lLXRvLXNldHRsZS1wYXRlbnQtcm93LW92ZXItYW50aS1jYW5jZXItZHJ1Zy9hcnRpY2xlMzQ5MTk3NjkuZWNlL2FtcC8?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/11/2021": {
        "artical1": {
            "title": "How Big Is Bristol Myers Squibb's Latest FDA Approval? - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaG93LWJpZy1pcy1icmlzdG9sLW15ZXJzLXNxdWliYnMtbGF0ZXN0LWZkYS1hcHByb3ZhbC0yMDIxLTA2LTEz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "The top 10 highest paid biopharma R&D executives in 2020 - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3NwZWNpYWwtcmVwb3J0L3RvcC0xMC1oaWdoZXN0LXBhaWQtYmlvcGhhcm1hLXItZC1leGVjdXRpdmVzLTIwMjDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "GSK pays iTeos $625M upfront to join Merck, Roche and the rest in ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZ3NrLXBheXMtaXRlb3MtNjI1bS11cGZyb250LXRvLWpvaW4tbWVyY2stcm9jaGUtYW5kLXJlc3QtdGlnaXQtaW1tdW5vLW9uY29sb2d5LXJhY2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "The big approvals still on the cards for 2021 - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2luc2lnaHRzL25tZS1hcHByb3ZhbHMvYmlnLWFwcHJvdmFscy1zdGlsbC1jYXJkcy0yMDIx0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTY5NTEvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Aid groups to G7: honour pledges or risk failure at climate summit - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2Vudmlyb25tZW50L2FpZC1ncm91cHMtZzctaG9ub3VyLXBsZWRnZXMtb3Itcmlzay1mYWlsdXJlLWNsaW1hdGUtc3VtbWl0LTIwMjEtMDYtMTEv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "ArrowMark Partners Lends $76M for New Jersey Life Sciences ... - Commercial Observer",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vY29tbWVyY2lhbG9ic2VydmVyLmNvbS8yMDIxLzA2L2Fycm93bWFyay1wYXJ0bmVycy1sZW5kcy03Nm0tZm9yLW5ldy1qZXJzZXktbGlmZS1zY2llbmNlcy1hY3F1aXNpdGlvbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "U.S. has administered 308.1 mln doses of COVID-19 vaccines, CDC ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy91cy1oYXMtYWRtaW5pc3RlcmVkLTMwODEtbWxuLWRvc2VzLWNvdmlkLTE5LXZhY2NpbmVzLWNkYy1zYXlzLTIwMjEtMDYtMTIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/04/2021": {
        "artical1": {
            "title": "Fitch Affirms Bristol-Myers Squibb's IDR at 'A-'; Withdraws Ratings ... - Fitch Ratings",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimgFodHRwczovL3d3dy5maXRjaHJhdGluZ3MuY29tL3Jlc2VhcmNoL2NvcnBvcmF0ZS1maW5hbmNlL2ZpdGNoLWFmZmlybXMtYnJpc3RvbC1teWVycy1zcXVpYmItaWRyLWF0LWEtd2l0aGRyYXdzLXJhdGluZ3Mtb3V0bG9vay1yZXZpc2VkLXRvLXN0YWJsZS0wNy0wNi0yMDIx0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb hires Michelle Weese to lead corporate affairs - PR Week",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnByd2Vlay5jb20vYXJ0aWNsZS8xNzE4NTM4L2JyaXN0b2wtbXllcnMtc3F1aWJiLWhpcmVzLW1pY2hlbGxlLXdlZXNlLWxlYWQtY29ycG9yYXRlLWFmZmFpcnPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb launches Diversity in Clinical Trials Program - WHYY",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd2h5eS5vcmcvYXJ0aWNsZXMvbGFjay1vZi1kaXZlcnNpdHktaW4tY2xpbmljYWwtdHJpYWxzLWhhcy1odXJ0LXBhdGllbnRzLW9mLWNvbG9yLWEtbmV3LXByb2dyYW0tYWltcy10by1jaGFuZ2UtdGhhdC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "New approvals for liver cancer mark 'golden age' of treatment - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjEwNjA4L25ldy1hcHByb3ZhbHMtZm9yLWxpdmVyLWNhbmNlci1tYXJrLWdvbGRlbi1hZ2Utb2YtdHJlYXRtZW500gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Umoja Biopharma Announces Appointment of David Fontana, Ph.D ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3Vtb2phLWJpb3BoYXJtYS1hbm5vdW5jZXMtYXBwb2ludG1lbnQtb2YtZGF2aWQtZm9udGFuYS1waGQtYXMtY2hpZWYtYnVzaW5lc3MtYW5kLXN0cmF0ZWd5LW9mZmljZXItMzAxMzA3NjA0Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Adding nivolumab to neoadjuvant chemotherapy does not impede ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDYwOS9hZGRpbmctbml2b2x1bWFiLXRvLW5lb2FkanV2YW50LWNoZW1vdGhlcmFweS1kb2VzLW5vdC1pbXBlZGUtc3VyZ2VyeS1pbi1yZXNlY3RhYmxlLW5zY2xj0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Research Pharmacists Have Unique Responsibilities - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvcmVzZWFyY2gtcGhhcm1hY2lzdHMtaGF2ZS11bmlxdWUtcmVzcG9uc2liaWxpdGllc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/28/2021": {
        "artical1": {
            "title": "It had to happen: Ex-Celgene shareholders sue Bristol Myers ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FzLWV4cGVjdGVkLWZvcm1lci1jZWxnZW5lLXNoYXJlaG9sZGVycy1zdWUtYnJpc3RvbC1teWVycy1zcXVpYmItZm9yLTYtNGItY2xhaW1pbmctYmxhdGFudNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers' multiple sclerosis drug Zeposia snags first-in-class ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtbXVsdGlwbGUtc2NsZXJvc2lzLWRydWctemVwb3NpYS1zbmFncy1maXJzdC1jbGFzcy1ub2QtdG8tdHJlYXQtdWxjZXJhdGl2ZdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Training for success | UDaily - UDaily",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LnVkZWwuZWR1L3VkYWlseS8yMDIxL2p1bmUvYmlvcGhhcm1hLXNjaWVuY2VzLW1hc3Rlci_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "ASCO: Bristol Myers touts 2 Opdivo esophageal cancer wins, but the ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtdG91dHMtMi1vcGRpdm8tZXNvcGhhZ2VhbC1jYW5jZXItd2lucy1idXQteWVydm95LWNvbWJvLXNlZXMtYS1jYXZlYXTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "FDA Approves Zeposia for Treatment of Ulcerative Colitis - Gastroenterology & Endoscopy News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5nYXN0cm9lbmRvbmV3cy5jb20vRkRBLVVwZGF0ZS1hbmQtUHJvZHVjdC1OZXdzL0FydGljbGUvMDYtMjEvRkRBLUFwcHJvdmVzLVplcG9zaWEtZm9yLVRyZWF0bWVudC1vZi1VbGNlcmF0aXZlLUNvbGl0aXMvNjM3MjXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Health Canada Approves OPDIVO\u00ae (nivolumab) plus YERVOY ... - Canada NewsWire",
            "link": "https://news.google.com/rss/articles/CBMi6gFodHRwczovL3d3dy5uZXdzd2lyZS5jYS9uZXdzLXJlbGVhc2VzL2hlYWx0aC1jYW5hZGEtYXBwcm92ZXMtb3BkaXZvLXItbml2b2x1bWFiLXBsdXMteWVydm95LXItaXBpbGltdW1hYi1hcy10aGUtZmlyc3QtYW5kLW9ubHktaW1tdW5vdGhlcmFweS10cmVhdG1lbnQtZm9yLXByZXZpb3VzbHktdW50cmVhdGVkLXVucmVzZWN0YWJsZS1tYWxpZ25hbnQtcGxldXJhbC1tZXNvdGhlbGlvbWEtODM3MDA2MDI5Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "J&J, Legend Biotech's multiple myeloma CAR-T scores FDA priority ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2otai1sZWdlbmQtYmlvdGVjaC1zLW11bHRpcGxlLW15ZWxvbWEtY2FyLXQtc2NvcmVzLWZkYS1wcmlvcml0eS1yZXZpZXctc2V0dGluZy11cC1wb3RlbnRpYWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/21/2021": {
        "artical1": {
            "title": "BMS' Opdivo/Yervoy improves long-term survival for melanoma ... - PharmaTimes",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2Jtc19vcGRpdm95ZXJ2b3lfaW1wcm92ZXNfbG9uZy10ZXJtX3N1cnZpdmFsX2Zvcl9tZWxhbm9tYV9wYXRpZW50c18xMzcwNTM10gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Lilly leads the big pharma pack on pipeline value - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9saWxseS1sZWFkcy1iaWctcGhhcm1hLXBhY2stcGlwZWxpbmUtdmFsdWXSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNjkwNi9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Mercuria-backed Tailwind buys BP stake in Shearwater UK oilfield - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2VuZXJneS9tZXJjdXJpYS1iYWNrZWQtdGFpbHdpbmQtYnV5cy1icC1zdGFrZS1zaGVhcndhdGVyLXVrLW9pbGZpZWxkLTIwMjEtMDUtMjQv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "The Vaccine Rollout Is Changing How We Think about Prescription ... - Scientific American",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LnNjaWVudGlmaWNhbWVyaWNhbi5jb20vYXJ0aWNsZS90aGUtdmFjY2luZS1yb2xsb3V0LWlzLWNoYW5naW5nLWhvdy13ZS10aGluay1hYm91dC1wcmVzY3JpcHRpb24tbWVkcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Jim Simons' Firm's Top Trades of the 1st Quarter - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9qaW0tc2ltb25zLWZpcm1zLXRvcC10cmFkZXMtMjA1MjMzNDYyLmh0bWzSAVFodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9qaW0tc2ltb25zLWZpcm1zLXRvcC10cmFkZXMtMjA1MjMzNDYyLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Lyell aims to follow Juno, Sana as Wall Street cools to biotech IPOs - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbHllbGwtaXBvLWNlbGwtdGhlcmFweS1jYW5jZXIvNjAwODQ3L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Pembrolizumab shows promise in metastatic breast cancer with high ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikgFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDUyNS9wZW1icm9saXp1bWFiLXNob3dzLXByb21pc2UtaW4tbWV0YXN0YXRpYy1icmVhc3QtY2FuY2VyLXdpdGgtaGlnaC10dW1vci1tdXRhdGlvbmFsLWJ1cmRlbtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/14/2021": {
        "artical1": {
            "title": "Agenus and Bristol Myers Squibb Announce Exclusive Global ... - GlobeNewswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMivgFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMS8wNS8xOC8yMjMxNDc4LzgwNjAvZW4vQWdlbnVzLWFuZC1CcmlzdG9sLU15ZXJzLVNxdWliYi1Bbm5vdW5jZS1FeGNsdXNpdmUtR2xvYmFsLUxpY2Vuc2UtZm9yLUFnZW51cy1BbnRpLVRJR0lULUJpc3BlY2lmaWMtQW50aWJvZHktUHJvZ3JhbS5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Exscientia announces multi-target, AI-driven drug discovery ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDUxOTAwNTE4MC9lbi9FeHNjaWVudGlhLWFubm91bmNlcy1tdWx0aS10YXJnZXQtQUktZHJpdmVuLWRydWctZGlzY292ZXJ5LWNvbGxhYm9yYXRpb24td2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "New Bristol Myers immunotherapy combo better than Opdivo alone ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9uZXctYnJpc3RvbC1teWVycy1pbW11bm90aGVyYXB5LWNvbWJvLWJldHRlci10aGFuLW9wZGl2by1hbG9uZS1tZWxhbm9tYS1zdHVkeS0yMDIxLTA1LTE5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb Elects Manuel Hidalgo Medina, M.D., Ph.D. to ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDUyMDAwNTI4NS9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi1FbGVjdHMtTWFudWVsLUhpZGFsZ28tTWVkaW5hLU0uRC4tUGguRC4tdG8tQm9hcmQtb2YtRGlyZWN0b3Jz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "ACC 2021: BMS unveils more data for mavacamten, nabbed in $13 ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWNjLTIwMjEtYm1zLXVudmVpbHMtbW9yZS1kYXRhLWZvci1tYXZhY2FtdGVuLW5hYmJlZC0xM2ItbXlva2FyZGlhLWJ1eW91dNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Blue Spark Technologies Announces Observational Trial Using ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMirwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDUxOTAwNTEyNC9lbi9CbHVlLVNwYXJrLVRlY2hub2xvZ2llcy1Bbm5vdW5jZXMtT2JzZXJ2YXRpb25hbC1UcmlhbC1Vc2luZy1UZW1wVHJhcSVDMiVBRS1XZWFyYWJsZS1EZXZpY2UtaW4tQ0FSLVQtUGF0aWVudC1Nb25pdG9yaW5n0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Blueprint adds another BMS vet to its roster with new CSO - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYmx1ZXByaW50LWFkZHMtYW5vdGhlci1ibXMtdmV0LXRvLWl0cy1yb3N0ZXItbmV3LWNzb9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/07/2021": {
        "artical1": {
            "title": "PZC holds hearing on Amazon plan for former BMS site in Wallingford - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vTmV3cy9XYWxsaW5nZm9yZC9XYWxsaW5nZm9yZC1OZXdzL1dhbGxpbmdmb3JkLUFtYXpvbi1hdC1CTVMtcHVibGljLWhlYXJpbmcuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Exelixis' Cabometyx scores backing from Ipsen in thyroid cancer ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9mb2xsb3dpbmctcHJvbWlzaW5nLXRyaWFsLWRhdGEtZnJhbmNlLXMtaXBzZW4tam9pbnMtcmVndWxhdG9yeS1hcHByb3ZhbC1lZmZvcnRzLWZvci1leGVsaXhpc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Working Mothers Are Essential in the Pharmacy Workforce - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvd29ya2luZy1tb3RoZXJzLWFyZS1lc3NlbnRpYWwtaW4tdGhlLXBoYXJtYWN5LXdvcmtmb3JjZdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Keros' Phase II KER-050 to treat anaemia in myelodysplastic ... - Clinical Trials Arena",
            "link": "https://news.google.com/rss/articles/CBMirwFodHRwczovL3d3dy5jbGluaWNhbHRyaWFsc2FyZW5hLmNvbS9jb21tZW50L2tlcm9zLXBoYXNlLWlpLWtlci0wNTAtdG8tdHJlYXQtYW5hZW1pYS1pbi1teWVsb2R5c3BsYXN0aWMtc3luZHJvbWUtaGFzLXBvdGVudGlhbC10by1leGNlZWQtbG93LXRyYW5zZnVzaW9uLWluZGVwZW5kZW5jZS1iZW5jaG1hcmsv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Dr. Jill Lacy Named 2021 ASCO Fellow - OncLive",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvZHItamlsbC1sYWN5LW5hbWVkLTIwMjEtYXNjby1mZWxsb3fSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Intravenous Immunoglobulin Offers New Treatment Opportunities for ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvaW50cmF2ZW5vdXMtaW1tdW5vZ2xvYnVsaW4tb2ZmZXJzLW5ldy10cmVhdG1lbnQtb3Bwb3J0dW5pdGllcy1mb3ItbmV1cm9sb2dpY2FsLWRpc2Vhc2Vz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Cosmos (ATOM) Price Predictions: Where Will the ATOM Crypto Go ... - InvestorPlace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vaW52ZXN0b3JwbGFjZS5jb20vMjAyMS8wNS9jb3Ntb3MtYXRvbS1wcmljZS1wcmVkaWN0aW9ucy13aGVyZS13aWxsLXRoZS1hdG9tLWNyeXB0by1nby1hZnRlci1pdHMtcmVjb3JkLWhpZ2gv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/30/2021": {
        "artical1": {
            "title": "DarwinHealth Announces a Research Collaboration with Bristol ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2RhcndpbmhlYWx0aC1hbm5vdW5jZXMtYS1yZXNlYXJjaC1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItZm9yLWEtbm92ZWwtY2FuY2VyLXRhcmdldC1kaXNjb3ZlcnktbmN0aS1pbml0aWF0aXZlLTMwMTI4NTYwNi5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers sees automation, virtual reality on the horizon for pair ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9icmlzdG9sLW15ZXJzLXNlZXMtYXV0b21hdGlvbi1hbmQtdmlydHVhbC1yZWFsaXR5LWhvcml6b24tYXQtaXRzLWR1YWwtY2VsbC10aGVyYXB50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "DivcoWest's 250 Water St. at Cambridge Crossing fully leases to ... - New England Real Estate Journal Online",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vbmVyZWouY29tL2RpdmNvd2VzdHMtMjUwLXdhdGVyLXN0LWF0LWN4LWZ1bGx5LWxlYXNlcy10by1icmlzdG9sLW15ZXJzLXNxdWliYtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Esker Therapeutics launches with $70M and a focused approach for ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2ViaW90ZWNoLmNvbS9iaW90ZWNoL2Vza2VyLXRoZXJhcGV1dGljcy1sYXVuY2hlcy03MG0tYW5kLWEtZm9jdXNlZC1hcHByb2FjaC1mb3ItYXV0b2ltbXVuZS1kaXNlYXNlcy1iZXlvbmQtamFrc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Social Distancing, Health Care Disruptions, Telemedicine Use, and ... - John Wiley",
            "link": "https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vb25saW5lbGlicmFyeS53aWxleS5jb20vZG9pL2Ficy8xMC4xMDAyL2FjcjIuMTEyMznSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Pfizer TV ad aims for clinical trial diversity, with a special invite to the ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3BmaXplci10di1hZC1hZGRyZXNzZXMtaGVhbHRoLWluZXF1aXRpZXMtY2xpbmljYWwtdHJpYWxzLWhpZ2hsaWdodGluZy1uZXctaHViLWZvci1kcnVn0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and ... - The Oncologist",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzODEw0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/23/2021": {
        "artical1": {
            "title": "Bristol Myers first-quarter earnings miss expectations as cancer ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMimAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9icmlzdG9sLW15ZXJzLWZpcnN0LXF1YXJ0ZXItZWFybmluZ3MtbWlzcy1leHBlY3RhdGlvbnMtY2FuY2VyLWRydWdzLXVuZGVycGVyZm9ybS0yMDIxLTA0LTI5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers' deucravacitinib beats out exiled Otezla, plots 2022 ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy1kZXVjcmF2YWNpdGluaWItYmVhdHMtb3V0LWV4aWxlZC1vdGV6bGEtZXllcy0yMDIyLWxhdW5jaNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Syngene, BMS Extend Long Term Research Alliance Until 2030 - Contract Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmNvbnRyYWN0cGhhcm1hLmNvbS9jb250ZW50cy92aWV3X2JyZWFraW5nLW5ld3MvMjAyMS0wNC0yOC9zeW5nZW5lLWJtcy1leHRlbmQtbG9uZy10ZXJtLXJlc2VhcmNoLWFsbGlhbmNlL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "BMS to build fifth cell therapy plant - BioProcess Insider - BioProcess Insider",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vYmlvcHJvY2Vzc2ludGwuY29tL2Jpb3Byb2Nlc3MtaW5zaWRlci9ibXMtdG8tYnVpbGQtZmlmdGgtY2VsbC10aGVyYXB5LXBsYW50LWluLXJlc3BvbnNlLXRvLWNhci10LXN1Y2Nlc3Mv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "John C. Martin, 69, Dies; Led Drugmaker in Breakthroughs ... - The New York Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjEvMDQvMjcvYnVzaW5lc3Mvam9obi1jLW1hcnRpbi02OS1kaWVzLWxlZC1kcnVnbWFrZXItaW4tYnJlYWt0aHJvdWdocy5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Oral Azacitidine Recommended for EU Approval in AML - OncLive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvb3JhbC1hemFjaXRpZGluZS1yZWNvbW1lbmRlZC1mb3ItZXUtYXBwcm92YWwtaW4tYW1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Exscientia Announces Investment of up to $525M - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjEwNDI3MDA1OTA1L2VuL0V4c2NpZW50aWEtQW5ub3VuY2VzLUludmVzdG1lbnQtb2YtdXAtdG8tNTI1TdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/16/2021": {
        "artical1": {
            "title": "Bristol Myers' Opdivo wins landmark FDA nod as first I-O therapy for ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtb3BkaXZvLXdpbnMtbGFuZG1hcmstZmRhLW5vZC1hcy1maXJzdC1pLW8tdGhlcmFweS1mb3ItZnJvbnQtbGluZS1zdG9tYWNo0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Expands into Remaining Space at Cambridge ... - Boston Real Estate Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vYm9zdG9ucmVhbGVzdGF0ZXRpbWVzLmNvbS9icmlzdG9sLW15ZXJzLXNxdWliYi1leHBhbmRzLWludG8tcmVtYWluaW5nLXNwYWNlLWF0LWNhbWJyaWRnZS1jcm9zc2luZ3MtMjUwLXdhdGVyLXN0cmVldC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA Approves First Immunotherapy for Initial Treatment of Gastric ... - FDA.gov",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZkYS5nb3YvbmV3cy1ldmVudHMvcHJlc3MtYW5ub3VuY2VtZW50cy9mZGEtYXBwcm92ZXMtZmlyc3QtaW1tdW5vdGhlcmFweS1pbml0aWFsLXRyZWF0bWVudC1nYXN0cmljLWNhbmNlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb Plans Cell Therapy Manufacturing Site in the ... - BioPharm International",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJpb3BoYXJtaW50ZXJuYXRpb25hbC5jb20vdmlldy9icmlzdG9sLW15ZXJzLXNxdWliYi1wbGFucy1jZWxsLXRoZXJhcHktbWFudWZhY3R1cmluZy1zaXRlLWluLXRoZS1uZXRoZXJsYW5kc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Eli Lilly retakes innovation crown, while Bristol Myers rates most ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2VsaS1saWxseS1yZXRha2VzLWlubm92YXRpb24tY3Jvd24td2hpbGUtYm1zLXJhdGVzLW1vc3QtaW52ZW50aXZlLXBoYXJtYS1hbm51YWwtc3R1ZHnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "IDEA Pharma's 10th annual Pharmaceutical Innovation Index: Eli ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMioAFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy9pZGVhLXBoYXJtYS1zLTEwdGgtYW5udWFsLXBoYXJtYWNldXRpY2FsLWlubm92YXRpb24taW5kZXgtZWxpLWxpbGx5LWlzLXRoZS1tb3N0LWlubm92YXRpdmUtY29tcGFueS1mb3ItdGhlLWZpcnN0LXRpbWUv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "The V Foundation Announces New Category of V Scholar Grant for ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDQxOTAwNTY3Ni9lbi9UaGUtVi1Gb3VuZGF0aW9uLUFubm91bmNlcy1OZXctQ2F0ZWdvcnktb2YtVi1TY2hvbGFyLUdyYW50LWZvci1CbGFja0FmcmljYW4tQW1lcmljYW4tUmVzZWFyY2hlcnPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/09/2021": {
        "artical1": {
            "title": "Why This Bristol-Myers Squibb Stock Analyst Is Turning Bullish On The Pharma Company's Pipeline - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy93aHktYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2stMTYwMzA2NDk4Lmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy93aHktYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2stMTYwMzA2NDk4Lmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Immune-boosting drug may help before lung cancer surgery - Medical Xpress",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vbWVkaWNhbHhwcmVzcy5jb20vbmV3cy8yMDIxLTA0LWltbXVuZS1ib29zdGluZy1kcnVnLWx1bmctY2FuY2VyLXN1cmdlcnkuaHRtbNIBU2h0dHBzOi8vbWVkaWNhbHhwcmVzcy5jb20vbmV3cy8yMDIxLTA0LWltbXVuZS1ib29zdGluZy1kcnVnLWx1bmctY2FuY2VyLXN1cmdlcnkuYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb expands local footprint at Cambridge Crossing ... - The Business Journals",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9ib3N0b24vbmV3cy8yMDIxLzA0LzE1L2JyaXN0b2wtbXllcnMtc3F1aWJiLWV4cGFuZGluZy1sb2NhbC1mb290cHJpbnQtYXQuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "The Right Approach To Personal Jurisdiction In Class Actions - Law360",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmxhdzM2MC5jb20vYXJ0aWNsZXMvMTM3MzcyMy90aGUtcmlnaHQtYXBwcm9hY2gtdG8tcGVyc29uYWwtanVyaXNkaWN0aW9uLWluLWNsYXNzLWFjdGlvbnPSAStodHRwczovL3d3dy5sYXczNjAuY29tL2FtcC9hcnRpY2xlcy8xMzczNzIz?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Fattman, McKenna push domestic violence bill protecting survivors ... - Worcester Telegram",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy50ZWxlZ3JhbS5jb20vc3RvcnkvbmV3cy9sb2NhbC8yMDIxLzA0LzEwL2ZhdHRtYW4tbWNrZW5uYS1wdXNoLWRvbWVzdGljLXZpb2xlbmNlLWJpbGwtcHJvdGVjdGluZy1zdXJ2aXZvcnMtd29ya2luZy1jb250cmFjdC1qb2JzLzcxNTI0ODEwMDIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Precision BioSciences Appoints Stanley R. Frankel, M.D. to Board of ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDQxMjAwNTQ4NS9lbi9QcmVjaXNpb24tQmlvU2NpZW5jZXMtQXBwb2ludHMtU3RhbmxleS1SLi1GcmFua2VsLU0uRC4tdG8tQm9hcmQtb2YtRGlyZWN0b3Jz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Virtual meeting delivers first time drug structures - Chemical & Engineering News",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vY2VuLmFjcy5vcmcvYWNzLW5ld3MvYWNzLW1lZXRpbmctbmV3cy9WaXJ0dWFsLW1lZXRpbmctZGVsaXZlcnMtZmlyc3QtdGltZS1kcnVnLXN0cnVjdHVyZXMvOTkvd2ViLzIwMjEvMDTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "04/02/2021": {
        "artical1": {
            "title": "PsiOxus Therapeutics Updates Agreement with Bristol Myers Squibb ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMitwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDQwNzAwNTMwMC9lbi9Qc2lPeHVzLVRoZXJhcGV1dGljcy1VcGRhdGVzLUFncmVlbWVudC13aXRoLUJyaXN0b2wtTXllcnMtU3F1aWJiLXRvLUFkdmFuY2UtdGhlaXItQ2xpbmljYWwtU3RhZ2UtSW1tdW5vLU9uY29sb2d5LUNvbGxhYm9yYXRpb27SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol's new myeloma CAR-T needs a hefty discount to be cost ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtcy1uZXctbXllbG9tYS1jYXItdC1uZWVkcy1hLWJpZy1kaXNjb3VudC10by1iZS1jb3N0LWVmZmVjdGl2ZS13YXRjaGRvZ3Mtc2F5LXdoaWxl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Funding the Next Generation of Cancer Therapies - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2luc2lnaHRzL2Z1bmRpbmctdGhlLW5leHQtZ2VuZXJhdGlvbi1vZi1jYW5jZXItdGhlcmFwaWVzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Pfizer Expanding Operations in Fast-Growing Tampa and Restarting ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3BmaXplci1leHBhbmRpbmctb3BlcmF0aW9ucy1pbi1mbG9yaWRhLWFuZC1taWNoaWdhbi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Costa Rica to wait on European agency decision before starting ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9jb3N0YS1yaWNhLXdhaXQtZXVyb3BlYW4tYWdlbmN5LWRlY2lzaW9uLWJlZm9yZS1zdGFydGluZy1hc3RyYXplbmVjYS12YWNjaW5lcy0yMDIxLTA0LTA3L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "John C. Martin, pioneer of single-pill HIV treatment, dies unexpectedly - Palo Alto Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LnBhbG9hbHRvb25saW5lLmNvbS9uZXdzLzIwMjEvMDQvMDUvam9obi1jLW1hcnRpbi1waW9uZWVyLW9mLXNpbmdsZS1waWxsLWhpdi10cmVhdG1lbnQtZGllcy11bmV4cGVjdGVkbHnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Merck's Keytruda, on the heels of a first-line kidney cancer win ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL21lcmNrLXMta2V5dHJ1ZGEtaGVlbHMtYS1maXJzdC1saW5lLWtpZG5leS1jYW5jZXItd2luLXRhcmdldHMtZWFybGllci1wb3N0LXN1cmdlcnktdXNl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/26/2021": {
        "artical1": {
            "title": "Bristol Myers, Bluebird bio set multiple myeloma therapy list price at ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9ibHVlYmlyZC1iaW8tc2V0cy1saXN0LXByaWNlLW11bHRpcGxlLW15ZWxvbWEtdGhlcmFweS00MTk1MDAtMjAyMS0wMy0yOS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "After Many Delays, BMS and bluebird Win Approval for Multiple ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FmdGVyLWRlbGF5cy1ibXMtYW5kLWJsdWViaXJkLXdpbi1hcHByb3ZhbC1mb3ItbXVsdGlwbGUtbXllbG9tYS1jYXItdC10aGVyYXB5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA Approves First Cell-Based Gene Therapy for Adult Patients with ... - FDA.gov",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZkYS5nb3YvbmV3cy1ldmVudHMvcHJlc3MtYW5ub3VuY2VtZW50cy9mZGEtYXBwcm92ZXMtZmlyc3QtY2VsbC1iYXNlZC1nZW5lLXRoZXJhcHktYWR1bHQtcGF0aWVudHMtbXVsdGlwbGUtbXllbG9tYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Here\u2019s Why Bristol Myers Squibb Stock Is Undervalued At $63 - Forbes",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMS8wMy8yOS9oZXJlcy13aHktYnJpc3RvbC1teWVycy1zcXVpYmItc3RvY2staXMtdW5kZXJ2YWx1ZWQtYXQtNjMv0gF4aHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9ncmVhdHNwZWN1bGF0aW9ucy8yMDIxLzAzLzI5L2hlcmVzLXdoeS1icmlzdG9sLW15ZXJzLXNxdWliYi1zdG9jay1pcy11bmRlcnZhbHVlZC1hdC02My9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Key Takeaways From the Supreme Court's Personal Jurisdiction ... - Dechert",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmRlY2hlcnQuY29tL2tub3dsZWRnZS9vbnBvaW50LzIwMjEvMy9rZXktdGFrZWF3YXlzLWZyb20tdGhlLXN1cHJlbWUtY291cnQtcy1wZXJzb25hbC1qdXJpc2RpY3Rpb24tZGVjLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "BMS CEO Earned $20 Million in 2020, a 7% Increase Amidst a ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNlby1jYWZvcmlvLWdyZXctdGhlLWNvbXBhbnktYW5kLWhpcy1zYWxhcnktYnktNy1wZXJjZW50LWluLTIwMjAtL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Servier Completes Acquisition of Agios Pharmaceuticals' Oncology ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3NlcnZpZXItY29tcGxldGVzLWFjcXVpc2l0aW9uLW9mLWFnaW9zLXBoYXJtYWNldXRpY2Fscy1vbmNvbG9neS1idXNpbmVzcy0zMDEyNTk5NjAuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/19/2021": {
        "artical1": {
            "title": "In a MedCity Pivot podcast, a Bristol Myers Squibb scientist talks ... - MedCity News",
            "link": "https://news.google.com/rss/articles/CBMinAFodHRwczovL21lZGNpdHluZXdzLmNvbS8yMDIxLzAzL2luLW1lZGNpdHktcGl2b3QtcG9kY2FzdC1iaW9waGFybWEtcmVzZWFyY2hlci10YWxrcy1hYm91dC10aGUtbGVzc29ucy1vZi1kcnVnLWRpc2NvdmVyeS1hbmQtcmVjZW50LXN1Y2Nlc3MtdGllZC10by1jb3ZpZC0xOS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2otai1uYWJzLWZkYS1ub2QtZm9yLXBvbnZvcnktam9pbmluZy1ub3ZhcnRpcy1icmlzdG9sLW15ZXJzLWFuZC1vdGhlcnMtY3Jvd2RlZC1tcy1tYXJrZXTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA accepts BMS' investigational cardiovascular drug mavacamten ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvZmRhX2FjY2VwdHNfYm1zX2ludmVzdGlnYXRpb25hbF9jYXJkaW92YXNjdWxhcl9kcnVnX21hdmFjYW10ZW5fZm9yX3Jldmlld18xMzY1NTcz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Perdue Farms taps Clark as chief HR officer - Food Business News",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmZvb2RidXNpbmVzc25ld3MubmV0L2FydGljbGVzLzE4MjEyLXBlcmR1ZS1mYXJtcy10YXBzLWNsYXJrLWFzLWNoaWVmLWhyLW9mZmljZXLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "O'Neal Cancer Center at UAB partners in study to improve Black ... - Alabama NewsCenter",
            "link": "https://news.google.com/rss/articles/CBMiiwFodHRwczovL2FsYWJhbWFuZXdzY2VudGVyLmNvbS8yMDIxLzAzLzIxL29uZWFsLWNhbmNlci1jZW50ZXItYXQtdWFiLXBhcnRuZXJzLWluLXN0dWR5LXRvLWltcHJvdmUtYmxhY2stcGFydGljaXBhdGlvbi1pbi1sdW5nLWNhbmNlci10cmlhbHMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Online trading platform AvaTrade places bet on \u00a3700m London float - Sky News",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vbmV3cy5za3kuY29tL3N0b3J5L29ubGluZS10cmFkaW5nLXBsYXRmb3JtLWF2YXRyYWRlLXBsYWNlcy1iZXQtb24tNzAwbS1sb25kb24tZmxvYXQtMTIyNTYxNTfSAWhodHRwczovL25ld3Muc2t5LmNvbS9zdG9yeS9hbXAvb25saW5lLXRyYWRpbmctcGxhdGZvcm0tYXZhdHJhZGUtcGxhY2VzLWJldC1vbi03MDBtLWxvbmRvbi1mbG9hdC0xMjI1NjE1Nw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Cancer drugs show big sales rise in 2020; AbbVie's Humira again ... - spglobal.com",
            "link": "https://news.google.com/rss/articles/CBMipAFodHRwczovL3d3dy5zcGdsb2JhbC5jb20vbWFya2V0aW50ZWxsaWdlbmNlL2VuL25ld3MtaW5zaWdodHMvbGF0ZXN0LW5ld3MtaGVhZGxpbmVzL2NhbmNlci1kcnVncy1zaG93LWJpZy1zYWxlcy1yaXNlLWluLTIwMjAtYWJidmllLXMtaHVtaXJhLWFnYWluLXRvcHMtbGlzdC02MzI0OTg5ONIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/12/2021": {
        "artical1": {
            "title": "Aktis Oncology Announces $72M Series A Financing To Advance ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMiqgFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FrdGlzLW9uY29sb2d5LWFubm91bmNlcy03Mm0tc2VyaWVzLWEtZmluYW5jaW5nLXRvLWFkdmFuY2UtYnJlYWt0aHJvdWdoLXJhZGlvcGhhcm1hY2V1dGljYWxzLXRvLXRyZWF0LXNvbGlkLXR1bW9ycy0zMDEyNDk3NjMuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Nivolumab plus tivozanib explored in phase 3 kidney cancer trial - Urology Times",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy9uaXZvbHVtYWItcGx1cy10aXZvemFuaWItZXhwbG9yZWQtaW4tcGhhc2UtMy1raWRuZXktY2FuY2VyLXRyaWFs0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "insitro Raises $400 Million in Series C Financing - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjEwMzE1MDA1MjE0L2VuL2luc2l0cm8tUmFpc2VzLTQwMC1NaWxsaW9uLWluLVNlcmllcy1DLUZpbmFuY2luZ9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Cancer immunotherapy approach targets common genetic alteration - EurekAlert",
            "link": "https://news.google.com/rss/articles/CBMiQWh0dHBzOi8vd3d3LmV1cmVrYWxlcnQub3JnL3B1Yl9yZWxlYXNlcy8yMDIxLTAzL2pobS1jaWEwMzE1MjEucGhw0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Six important updates for Colorectal Cancer Awareness Month - Healio",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjEwMzExL3NpeC1pbXBvcnRhbnQtdXBkYXRlcy1mb3ItY29sb3JlY3RhbC1jYW5jZXItYXdhcmVuZXNzLW1vbnRo0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Air China to buy 18 Airbus A320neo jets from GECAS subsidiary - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2F1dG9zLXRyYW5zcG9ydGF0aW9uL2Fpci1jaGluYS1idXktMTgtYWlyYnVzLWEzMjBuZW8tamV0cy1nZWNhcy1zdWJzaWRpYXJ5LTIwMjEtMDMtMTgv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Wary of blood clots, some Spanish regions hold back AstraZeneca ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy93YXJ5LWJsb29kLWNsb3RzLXNvbWUtc3BhbmlzaC1yZWdpb25zLWhvbGQtYmFjay1hc3RyYXplbmVjYS1zaG90cy0yMDIxLTAzLTEyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/05/2021": {
        "artical1": {
            "title": "At Bristol Myers Squibb People are our Greatest Resource - sxsw.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LnN4c3cuY29tL25ld3MvMjAyMS9icmlzdG9sLW15ZXJzLXNxdWliYi1wZW9wbGUtYXJlLW91ci1ncmVhdGVzdC1yZXNvdXJjZS0yL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Co. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMingFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3RvcnkvYnJpc3RvbC1teWVycy1zcXVpYmItY28tc3RvY2stdW5kZXJwZXJmb3Jtcy1tb25kYXktd2hlbi1jb21wYXJlZC10by1jb21wZXRpdG9ycy1kZXNwaXRlLWRhaWx5LWdhaW5zLTAxNjE1MjQyMzMyLWNkMDQ1OGRmZjBhYdIBpgFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL2RhdGEtbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jby1zdG9jay11bmRlcnBlcmZvcm1zLW1vbmRheS13aGVuLWNvbXBhcmVkLXRvLWNvbXBldGl0b3JzLWRlc3BpdGUtZGFpbHktZ2FpbnMtMDE2MTUyNDIzMzItY2QwNDU4ZGZmMGFh?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Statement on NIH starting enrollment for third trial of blood clotting ... - National Institutes of Health (.gov)",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3Lm5paC5nb3YvbmV3cy1ldmVudHMvbmV3cy1yZWxlYXNlcy9zdGF0ZW1lbnQtbmloLXN0YXJ0aW5nLWVucm9sbG1lbnQtdGhpcmQtdHJpYWwtYmxvb2QtY2xvdHRpbmctdHJlYXRtZW50cy1jb3ZpZC0xOdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Novartis exec says Kymriah's ready to square off with Bristol Myers ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JlYWR5LXRvLXNxdWFyZS1vZmYtYm1zLWJyZXlhbnppLW5vdmFydGlzLWV4ZWMtc2F5cy1oZS1zLXdlbGNvbWluZy1jYXItdC1jb21wZXRpdGlvbtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Gilead's CAR-T med Yescarta gets a leg up on Novartis rival with ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2dpbGVhZC1zLXllc2NhcnRhLWdldHMtYS1sZWctdXAtbm92YXJ0aXMtcml2YWwtZmRhLWFwcHJvdmFsLXRoaXJkLWxpbmUtZm9sbGljdWxhci1seW1waG9tYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Seres stops microbiome cancer trial, deprioritizes drug as COVID-19 ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvc2VyZXMtc3RvcHMtbWljcm9iaW9tZS1jYW5jZXItdHJpYWwtZGVwcmlvcml0aXplcy1kcnVnLWFzLWNvdmlkLXRocm90dGxlcy1lbnJvbGxtZW500gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "The top 10 drugs losing U.S. exclusivity in 2021 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTEwLWRydWdzLWxvc2luZy11LXMtZXhjbHVzaXZpdHktMjAyMdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/26/2021": {
        "artical1": {
            "title": "Bill Gates-backed Oxford biotech totals $100M funding to discover ... - UKTN (UK Technology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiR2h0dHBzOi8vd3d3LnVrdGVjaC5uZXdzL25ld3MvZXhzY2llbnRpYS1veGZvcmQtYmlvdGVjaC1mdW5kaW5nLTIwMjEwMzA00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Presage Sets the Stage for Commercial Expansion with Closing of ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMi2AFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3ByZXNhZ2Utc2V0cy10aGUtc3RhZ2UtZm9yLWNvbW1lcmNpYWwtZXhwYW5zaW9uLXdpdGgtY2xvc2luZy1vZi0xM20tZmluYW5jaW5nLWFuZC1leGVjdXRpb24tb2YtbmV3LXBoYXNlLTAtdHJpYWwtYWdyZWVtZW50cy13aXRoLW1lcmNrLWFuZC1tYXZlcmljay10aGVyYXBldXRpY3MtMzAxMjM4MDU0Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "TRACE-STL: Stemming a fourth COVID-19 wave at the local level ... - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvc3RlbW1pbmctYS1mb3VydGgtd2F2ZS1hdC10aGUtbG9jYWwtbGV2ZWwv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Ben Platt and Sister-in-Law Courtney on Using Music Therapy to ... - PEOPLE",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vcGVvcGxlLmNvbS9oZWFsdGgvYmVuLXBsYXR0LXNpc3Rlci1pbi1sYXctY291cnRuZXktdGFsay1tcy1pbi1oYXJtb255L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "London could lose out to New York under draft EU finance deal ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2ZpbmFuY2UvbG9uZG9uLWNvdWxkLWxvc2Utb3V0LW5ldy15b3JrLXVuZGVyLWRyYWZ0LWV1LWZpbmFuY2UtZGVhbC1kb2N1bWVudC0yMDIxLTAyLTI2L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Matrix Essentials Founder Sells Palm Beach Lot - The Real Deal",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vdGhlcmVhbGRlYWwuY29tL21pYW1pLzIwMjEvMDMvMDEvZmFjZWxpZnQtcmVxdWlyZWQtYmVhdXR5LW1vZ3VsLXNlbGxzLXBhbG0tYmVhY2gtbG90LWZvci00Mm0v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Temporal Trends and Predictors in the Use of Stereotactic Body ... - The Oncologist",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzNzM20gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/19/2021": {
        "artical1": {
            "title": "Bristol Myers Inches Toward the Future of Cell Therapy with New ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWluY2hlcy10b3dhcmQtdGhlLWZ1dHVyZS1vZi1jZWxsLXRoZXJhcHktd2l0aC1uZXctbWFudWZhY3R1cmluZy1wbGFudC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9icmlzdG9sLW15ZXJzLWhvdC1vZmYtYnJleWFuemktbm9kLXBsb3RzLW5ldy1jZWxsLXRoZXJhcHktZmFjdG9yeS1tYXNzYWNodXNldHRz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers Squibb Co. stock falls Tuesday, underperforms market - MarketWatch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9zdG9yeS9icmlzdG9sLW15ZXJzLXNxdWliYi1jby1zdG9jay1mYWxscy10dWVzZGF5LXVuZGVycGVyZm9ybXMtbWFya2V0LTAxNjE0MTE5MTE3LWU0YjU3ZWNlYjNkMNIBgwFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vYW1wL2RhdGEtbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jby1zdG9jay1mYWxscy10dWVzZGF5LXVuZGVycGVyZm9ybXMtbWFya2V0LTAxNjE0MTE5MTE3LWU0YjU3ZWNlYjNkMA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "BMS ups Breyanzi production with cell therapy plant - BioProcess ... - BioProcess Insider",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vYmlvcHJvY2Vzc2ludGwuY29tL2Jpb3Byb2Nlc3MtaW5zaWRlci9ibXMtdXBzLWJyZXlhbnppLXByb2R1Y3Rpb24td2l0aC1tYXNzYWNodXNldHRzLWNlbGwtdGhlcmFweS1wbGFudC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Orna Therapeutics Circles Success With $100 Million Launch - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL29ybmEtdGhlcmFwZXV0aWNzLWNpcmNsZXMtc3VjY2Vzcy13aXRoLTEwMC1taWxsaW9uLWxhdW5jaC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Durvalumab FDA indication for bladder cancer voluntarily withdrawn - Urology Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy9kdXJ2YWx1bWFiLWZkYS1pbmRpY2F0aW9uLWZvci1ibGFkZGVyLWNhbmNlci12b2x1bnRhcmlseS13aXRoZHJhd27SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Opdivo Effective as Bladder Cancer Post-surgery Therapy, Data Show - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMS8wMi8xOS9wb3N0LXN1cmdlcnktdGhlcmFweS1vcGRpdm8tYWR2YW5jZWQtYmxhZGRlci1jYW5jZXItcGhhc2UtMy1jbGluaWNhbC10cmlhbC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/12/2021": {
        "artical1": {
            "title": "Bristol-Myers, Sanofi ordered to pay Hawaii $834 million over Plavix ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWJyaXN0b2wtbXllcnMtc2Fub2ZpLXBsYXZpeC9icmlzdG9sLW15ZXJzLXNhbm9maS1vcmRlcmVkLXRvLXBheS1oYXdhaWktODM0LW1pbGxpb24tb3Zlci1wbGF2aXgtd2FybmluZy1sYWJlbC1pZFVTS0JOMkFGMVlJ0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Plavix partners Sanofi, Bristol Myers vow to appeal Hawaii's $834M ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3BsYXZpeC1wYXJ0bmVycy1zYW5vZmktYm1zLXZvdy10by1hcHBlYWwtaGF3YWlpLXMtODM0bS1tYXJrZXRpbmctdmVyZGljdNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers, Sanofi Must Pay $834 Million Over Plavix - Bloomberg",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIxLTAyLTE1L2JyaXN0b2wtbXllcnMtc2Fub2ZpLW9yZGVyZWQtdG8tcGF5LTgzNC1taWxsaW9uLW92ZXItcGxhdml40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol Myers Squibb pens $1.3B biobucks pact with Molecular ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy1zcXVpYmItcGVucy0xLTNiLWJpb2J1Y2tzLXBhY3QtbW9sZWN1bGFyLXRlbXBsYXRlcy1heGVzLWNlbGdlbmUtY2FyLXQtYXNzZXTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS - Life Sciences Intellectual Property Review",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmxpZmVzY2llbmNlc2lwcmV2aWV3LmNvbS9uZXdzL2FudGl0cnVzdC1oaXYtZHJ1Z3MtY2FzZS1zaG91bGQtYmUtYXJiaXRyYXRlZC1hcmd1ZS1naWxlYWQtYm1zLTQzNjfSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Health Canada Approves REBLOZYL\u00ae (luspatercept), New Class of ... - Canada NewsWire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiswFodHRwczovL3d3dy5uZXdzd2lyZS5jYS9uZXdzLXJlbGVhc2VzL2hlYWx0aC1jYW5hZGEtYXBwcm92ZXMtcmVibG96eWwtci1sdXNwYXRlcmNlcHQtbmV3LWNsYXNzLW9mLXRyZWF0bWVudC1mb3ItYWR1bHQtcGF0aWVudHMtbGl2aW5nLXdpdGgtbXllbG9keXNwbGFzdGljLXN5bmRyb21lcy04NzM4MDc1NzEuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "ASCO GU: Merck, Eisai turn up the heat in kidney cancer with ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FzY28tZ3UtbWVyY2stZWlzYWktdHVybi11cC1oZWF0LWtpZG5leS1jYW5jZXItY29tcGV0aXRpdmUtc3Vydml2YWwtZGF0YdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/05/2021": {
        "artical1": {
            "title": "FDA approves Bristol Myers Squibb's CAR-T therapy - MarketWatch",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9zdG9yeS9mZGEtYXBwcm92ZXMtYnJpc3RvbC1teWVycy1zcXVpYmJzLWNhci10LXRoZXJhcHktMjAyMS0wMi0wONIBYWh0dHBzOi8vd3d3Lm1hcmtldHdhdGNoLmNvbS9hbXAvc3RvcnkvZmRhLWFwcHJvdmVzLWJyaXN0b2wtbXllcnMtc3F1aWJicy1jYXItdC10aGVyYXB5LTIwMjEtMDItMDg?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "New Hope for B-Cell Lymphoma Patients as FDA Approves BMS ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2ZkYS1ncmVlbmxpZ2h0cy1icmlzdG9sLW15ZXJzLXNxdWliYi1zLWJyZXlhbnppLWZvci1iLWNlbGwtbHltcGhvbWEv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "ASCO GU: Bristol Myers touts first-in-class Opdivo win in muscle ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2FzY28tZ3UtYnJpc3RvbC1teWVycy10b3V0cy1maXJzdC1jbGFzcy1vcGRpdm8td2luLW11c2NsZS1pbnZhc2l2ZS1ibGFkZGVyLWNhbmNlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "FDA approves Bristol-Myers' gene therapy for white blood cell cancer - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWJyaXN0b2wtbXllcnMtZmRhLWFwcHJvdmFsL2ZkYS1hcHByb3Zlcy1icmlzdG9sLW15ZXJzLWdlbmUtdGhlcmFweS1mb3Itd2hpdGUtYmxvb2QtY2VsbC1jYW5jZXItaWRVS0tCTjJBNTJMVi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Takes $470 Million Write-off and Scraps Orva-Cel CAR ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWFiYW5kb24tcy1vcnZhLWNlbC1wcm9ncmFtL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "CAR T-cell Therapy Breyanzi Approved for Large B-cell Lymphomas - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMS8wMi8xMC9jYXItdC1jZWxsLXRoZXJhcHktYnJleWFuemktYXBwcm92ZWQtbGFyZ2UtYi1jZWxsLWx5bXBob21hcy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Another domestic Chinese PD-1 inhibitor enters the race for US ... - Clinical Trials Arena",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5jbGluaWNhbHRyaWFsc2FyZW5hLmNvbS9jb21tZW50L2RvbWVzdGljLWNoaW5lc2UtcGQtMS1pbmhpYml0b3ItdXMtYXBwcm92YWwtY29oZXJ1cy1iaW9zY2llbmNlcy1zaGFuZ2hhaS1qdW5zaGktYmlvc2NpZW5jZXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/29/2021": {
        "artical1": {
            "title": "Bristol Myers' psoriasis drug strikes again, beating Amgen's Otezla ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy1wc29yaWFzaXMtZHJ1Zy1zdHJpa2VzLWFnYWluLWJlYXRpbmctYW1nZW4tcy1vdGV6bGEtYS0ybmQtcGl2b3RhbC10cmlhbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "WuXi STA to buy Bristol Myers Squibb's Couvet, Switzerland ... - BioPharma-Reporter.com",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5iaW9waGFybWEtcmVwb3J0ZXIuY29tL0FydGljbGUvMjAyMS8wMi8wMi9XdVhpLVNUQS10by1idXktQnJpc3RvbC1NeWVycy1TcXVpYmItcy1tYW51ZmFjdHVyaW5nLWZhY2lsaXR5LWluLVN3aXR6ZXJsYW5k0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Acceleron Announces Fourth Quarter and Full Year 2020 ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDIwNDAwNTYwMS9lbi9BY2NlbGVyb24tQW5ub3VuY2VzLUZvdXJ0aC1RdWFydGVyLWFuZC1GdWxsLVllYXItMjAyMC1SRUJMT1pZTCVDMiVBRS1OZXQtU2FsZXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "An MS drug for ulcerative colitis? Bristol Myers steps in FDA fast ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL21zLWRydWctZm9yLXVsY2VyYXRpdmUtY29saXRpcy1icmlzdG9sLW15ZXJzLXN0ZXBzLWZkYS1mYXN0LWxhbmUtdG8ta25vdy1mYXRlLXplcG9zaWHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "FDA blasts Lonza facility in Form 483 that derailed Bristol Myers ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9mZGEtYmxhc3RzLWxvbnphLWZhY2lsaXR5LWZvcm0tNDgzLWRlcmFpbGVkLWJyaXN0b2wtbXllcnMtcGxhbi1saXNvLWNlbC1ub2QtYnktMjAyMNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "World Lung 2020 \u2013 Yervoy\u2019s front-line impotence laid bare - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy93b3JsZC1sdW5nLTIwMjAteWVydm95cy1mcm9udC1saW5lLWltcG90ZW5jZS1sYWlkLWJhcmXSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNjU3Ni9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Merck's Keytruda Proves Better Alone in Combination Trial With ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FkZGluZy1icmlzdG9sLW15ZXJzLXNxdWliYi1zLXllcnZveS10by1tZXJjay1zLWtleXRydWRhLWluLWx1bmctY2FuY2VyLW5vLWltcHJvdmVtZW50L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/22/2021": {
        "artical1": {
            "title": "Abatacept, placebo yield similarly low opportunistic infection rates in ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9yaGV1bWF0b2xvZ3kvMjAyMTAxMjcvYWJhdGFjZXB0LXBsYWNlYm8teWllbGQtc2ltaWxhcmx5LWxvdy1vcHBvcnR1bmlzdGljLWluZmVjdGlvbi1yYXRlcy1pbi1yYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Exelixis Announces U.S. FDA Approval of CABOMETYX ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi1wFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy9leGVsaXhpcy1hbm5vdW5jZXMtdS1zLWZkYS1hcHByb3ZhbC1vZi1jYWJvbWV0eXgtY2Fib3phbnRpbmliLWluLWNvbWJpbmF0aW9uLXdpdGgtb3BkaXZvLW5pdm9sdW1hYi1hcy1hLWZpcnN0LWxpbmUtdHJlYXRtZW50LWZvci1wYXRpZW50cy13aXRoLWFkdmFuY2VkLXJlbmFsLWNlbGwtY2FyY2lub21hL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA Agrees to Priority Review of Opdivo for Gastric, Esophageal ... - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMS8wMS8yMi9mZGEtcHJpb3JpdHktcmV2aWV3LW9wZGl2by1nYXN0cmljLWVzb3BoYWdlYWwtY2FuY2Vycy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "The year immuno-oncology could break into perioperative settings - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb21wYW55LWV2ZW50cy95ZWFyLWltbXVuby1vbmNvbG9neS1jb3VsZC1icmVhay1wZXJpb3BlcmF0aXZlLXNldHRpbmdz0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTY1NTAvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Taiwan to put 5000 into quarantine over hospital COVID-19 cluster - Reuters",
            "link": "https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy90YWl3YW4tcHV0LTUwMDAtaW50by1xdWFyYW50aW5lLW92ZXItaG9zcGl0YWwtY292aWQtMTktY2x1c3Rlci0yMDIxLTAxLTI0L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "3 Top Healthcare Stocks That Can Make You Richer in 2021 (and ... - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzAxLzI0LzMtdG9wLWhlYWx0aGNhcmUtc3RvY2tzLXRoYXQtY2FuLW1ha2UteW91LXJpY2hlci1pL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Pembrolizumab prolongs PFS vs. chemotherapy for certain patients ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijwFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDEyMi9wZW1icm9saXp1bWFiLXByb2xvbmdzLXBmcy12cy1jaGVtb3RoZXJhcHktZm9yLWNlcnRhaW4tcGF0aWVudHMtd2l0aC1jb2xvcmVjdGFsLWNhbmNlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/15/2021": {
        "artical1": {
            "title": "Is Bristol-Myers Squibb (BMY) Stock a Buy For 2021? - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktc3RvY2stMTcxOTQxODIxLmh0bWzSAVRodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1ibXktc3RvY2stMTcxOTQxODIxLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Hedging Risk and Optimizing Potential in a Large Pension Risk Transfer - Treasury & Risk",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LnRyZWFzdXJ5YW5kcmlzay5jb20vMjAyMS8wMS8yMS9oZWRnaW5nLXJpc2stYW5kLW9wdGltaXppbmctcG90ZW50aWFsLWluLWEtbGFyZ2UtcGVuc2lvbi1yaXNrLXRyYW5zZmVyL9IBeGh0dHBzOi8vd3d3LnRyZWFzdXJ5YW5kcmlzay5jb20vMjAyMS8wMS8yMS9oZWRnaW5nLXJpc2stYW5kLW9wdGltaXppbmctcG90ZW50aWFsLWluLWEtbGFyZ2UtcGVuc2lvbi1yaXNrLXRyYW5zZmVyLz9hbXA9MQ?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "The top 10 largest biopharma M&A deals in 2020 - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTEwLWxhcmdlc3QtYmlvcGhhcm1hLW0tYS1kZWFscy0yMDIw0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Merck KGaA\u2019s dual immuno-oncology weapon misfires - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9tZXJjay1rZ2Fhcy1kdWFsLWltbXVuby1vbmNvbG9neS13ZWFwb24tbWlzZmlyZXPSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNjU0OC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Avapritinib in Patients With Advanced Gastrointestinal Stromal ... - The Oncologist",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzNjc00gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Aclaris MK2 bears fruit - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9hY2xhcmlzLW1rMi1iZWFycy1mcnVpdNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE2NTQzL2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Triplet demonstrates activity in metastatic colorectal cancer - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZW1hdG9sb2d5LW9uY29sb2d5LzIwMjEwMTE5L3RyaXBsZXQtZGVtb25zdHJhdGVzLWFjdGl2aXR5LWluLW1ldGFzdGF0aWMtY29sb3JlY3RhbC1jYW5jZXLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/08/2021": {
        "artical1": {
            "title": "Avidity Biosciences Announces 2021 Pipeline Updates and ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2F2aWRpdHktYmlvc2NpZW5jZXMtYW5ub3VuY2VzLTIwMjEtcGlwZWxpbmUtdXBkYXRlcy1hbmQtcmVzZWFyY2gtY29sbGFib3JhdGlvbi13aXRoLW15b2thcmRpYS0zMDEyMDMxNzAuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Health Canada Approves ONUREG\u00ae (azacitidine tablets), First ... - Canada NewsWire",
            "link": "https://news.google.com/rss/articles/CBMiuAFodHRwczovL3d3dy5uZXdzd2lyZS5jYS9uZXdzLXJlbGVhc2VzL2hlYWx0aC1jYW5hZGEtYXBwcm92ZXMtb251cmVnLXItYXphY2l0aWRpbmUtdGFibGV0cy1maXJzdC1tYWludGVuYW5jZS10aGVyYXB5LWZvci1wYXRpZW50cy1pbi1yZW1pc3Npb24tZnJvbS1hY3V0ZS1teWVsb2lkLWxldWtlbWlhLTgzMTYzOTYwNi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "JPM: Illumina inks multiple cancer diagnostic partnerships to ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvanBtLWlsbHVtaW5hLWlua3MtbXVsdGlwbGUtY2FuY2VyLWRpYWdub3N0aWMtcGFydG5lcnNoaXBzLXRvLWNvbXBsZW1lbnQtdXBjb21pbmctZ3JhaWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bluebird bio plans to spin off cancer drugs unit - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiRmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtYmx1ZWJpcmQtYmlvLXNwaW5vZmYtaWRVU0tCTjI5RzE1TC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "EXCLUSIVE Goldman eyes deals to boost Marcus-sources - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2V4Y2x1c2l2ZS1nb2xkbWFuLWV5ZXMtZGVhbHMtYm9vc3QtbWFyY3VzLXNvdXJjZXMtMjAyMS0wMS0xNS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "bluebird bio's Oncology Business Leaves the Nest to Form New ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JsdWViaXJkLWJpby1zcGlucy1vdXQtb25jb2xvZ3ktYnVzaW5lc3MtaW50by1uZXctY29tcGFueS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "CAR-T a 'fantastic improvement' over available therapies for ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIxMDExMS9jYXJ0LWEtZmFudGFzdGljLWltcHJvdmVtZW50LW92ZXItYXZhaWxhYmxlLXRoZXJhcGllcy1mb3ItYWR2YW5jZWQtbXVsdGlwbGUtbXllbG9tYdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/01/2021": {
        "artical1": {
            "title": "ArsenalBio Announces Multi-Program Discovery Collaboration with ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMiygFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIxMDEwNzAwNTIzNC9lbi9BcnNlbmFsQmlvLUFubm91bmNlcy1NdWx0aS1Qcm9ncmFtLURpc2NvdmVyeS1Db2xsYWJvcmF0aW9uLXdpdGgtQnJpc3RvbC1NeWVycy1TcXVpYmItdG8tQWR2YW5jZS1OZXh0LUdlbmVyYXRpb24tVC1jZWxsLVRoZXJhcGllcy1mb3ItU29saWQtVHVtb3Jz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Withdraws Nivolumab Indication for Treatment ... - Cancer Network",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvYnJpc3RvbC1teWVycy1zcXVpYmItd2l0aGRyYXdzLW5pdm9sdW1hYi1pbmRpY2F0aW9uLWZvci10cmVhdG1lbnQtb2Ytc2NsY9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers M&A strategy leader enters 2021 with 'stronger sense ... - spglobal.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiqAFodHRwczovL3d3dy5zcGdsb2JhbC5jb20vbWFya2V0aW50ZWxsaWdlbmNlL2VuL25ld3MtaW5zaWdodHMvbGF0ZXN0LW5ld3MtaGVhZGxpbmVzL2JyaXN0b2wtbXllcnMtbS1hLXN0cmF0ZWd5LWxlYWRlci1lbnRlcnMtMjAyMS13aXRoLXN0cm9uZ2VyLXNlbnNlLW9mLXVyZ2VuY3ktNjE5ODA5MjfSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Pfizer, AbbVie, BMS, Teva, Sanofi, Gilead and others ring in 2021 ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3BmaXplci1hYmJ2aWUtYm1zLXRldmEtc2Fub2ZpLWdpbGVhZC1hbmQtb3RoZXItY29tcGFuaWVzLXJpbmctMjAyMS1uZWFybHktNjAwLXByaWNlLWhpa2Vz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "3 Dividend Stocks That Pay You Better Than Coca-Cola Does - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIxLzAxLzA3LzMtZGl2aWRlbmQtc3RvY2tzLXRoYXQtcGF5LXlvdS1iZXR0ZXItdGhhbi1jb2NhLWNvL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Drugmakers kick off 2021 with 500 U.S. price hikes - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2hlYWx0aGNhcmUtcGhhcm1hY2V1dGljYWxzL2RydWdtYWtlcnMta2ljay1vZmYtMjAyMS13aXRoLTUwMC11cy1wcmljZS1oaWtlcy0yMDIxLTAxLTA0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Ikena bags $120M to advance growing pipeline of cancer drugs - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvaWtlbmEtYmFncy0xMjBtLXRvLWFkdmFuY2UtZ3Jvd2luZy1waXBlbGluZS1jYW5jZXItZHJ1Z3PSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/25/2020": {
        "artical1": {
            "title": "Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvcGQtMS1sMS1kcnVnbWFrZXJzLW1lcmNrLWJyaXN0b2wtbXllcnMtYXN0cmF6ZW5lY2EtYW5kLXJvY2hlLWxvc2UtYmlkLXRvLWV4cGFuZC1yZWFjaNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BP well comes up empty at promising Ironbark gas prospect off ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2J1c2luZXNzL2VuZXJneS9icC13ZWxsLWNvbWVzLXVwLWVtcHR5LXByb21pc2luZy1pcm9uYmFyay1nYXMtcHJvc3BlY3Qtb2ZmLWF1c3RyYWxpYS0yMDIwLTEyLTI5L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "MAXIMISE: Secukinumab significantly improves signs, symptoms of ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvcmhldW1hdG9sb2d5LzIwMjAxMjI4L21heGltaXNlLXNlY3VraW51bWFiLXNpZ25pZmljYW50bHktaW1wcm92ZXMtc2lnbnMtc3ltcHRvbXMtb2YtYXhpYWwtZGlzZWFzZS1pbi1wc2HSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "A Collaborative Approach to Specialty Pharmacy at an Academic ... - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvYS1jb2xsYWJvcmF0aXZlLWFwcHJvYWNoLXRvLXNwZWNpYWx0eS1waGFybWFjeS1hdC1hbi1hY2FkZW1pYy1tZWRpY2FsLWNlbnRlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Governor DeSantis Appoints Nanette Rivera to Big Cypress Basin ... - coastalbreezenews.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5jb2FzdGFsYnJlZXplbmV3cy5jb20vbmV3cy9nb3Zlcm5vci1kZXNhbnRpcy1hcHBvaW50cy1uYW5ldHRlLXJpdmVyYS10by1iaWctY3lwcmVzcy1iYXNpbi1ib2FyZC9hcnRpY2xlXzAzYmFmZjg0LWVlM2ItNTY4Ni1iMDIxLWVlMTRmNmNjOGFjZS5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Lakewood baby death: Fractured ribs, brain bleeds, skull fractures - Asbury Park Press",
            "link": "https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5hcHAuY29tL3N0b3J5L25ld3MvY3JpbWUvamVyc2V5LW1heWhlbS8yMDIwLzEyLzI4L2RhdmlkLWEtc21pdGgtaG9taWNpZGUtcG9saWNlLXJlY29yZHMtc2hha2VuLWJhYnktc3luZHJvbWUvNDAzOTY5NTAwMS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Boston doctor has severe allergic reaction to Moderna COVID ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMinQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWhlYWx0aC1jb3JvbmF2aXJ1cy12YWNjaW5lcy1tb2Rlcm5hL2Jvc3Rvbi1kb2N0b3ItaGFzLXNldmVyZS1hbGxlcmdpYy1yZWFjdGlvbi10by1tb2Rlcm5hLWNvdmlkLXZhY2NpbmUtbnl0LWlkVVNLQk4yOTAwMFcv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/18/2020": {
        "artical1": {
            "title": "Analysis of the Role of Plasma 25\u2010Hydroxyvitamin D Levels in ... - The Oncologist",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzNjQ10gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS says CheckMate -548 trial of Opdivo in glioblastoma will not ... - The Pharma Letter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9ibXMtc2F5cy1jaGVja21hdGUtNTQ4LXRyaWFsLW9mLW9wZGl2by1pbi1nbGlvYmxhc3RvbWEtd2lsbC1ub3QtbWVldC1nb2Fs0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Germany to start first COVID-19 vaccination in elderly homes on Dec ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2hlYWx0aC1jb3JvbmF2aXJ1cy1ldS12YWNjaW5lL2dlcm1hbnktdG8tc3RhcnQtZmlyc3QtY292aWQtMTktdmFjY2luYXRpb24taW4tZWxkZXJseS1ob21lcy1vbi1kZWMtMjctaWRVU0w4TjJISjZaTi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Summit Council Concludes 2020 with Flurry of Resolutions ... - TAPinto.net",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy50YXBpbnRvLm5ldC90b3ducy9zdW1taXQvc2VjdGlvbnMvZ292ZXJubWVudC9hcnRpY2xlcy9zdW1taXQtY291bmNpbC1jb25jbHVkZXMtMjAyMC13aXRoLWZsdXJyeS1vZi1yZXNvbHV0aW9ucy1vcmRpbmFuY2Vz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "New national lockdown in Britain not inevitable, says minister - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9idXNpbmVzcy9oZWFsdGhjYXJlLXBoYXJtYWNldXRpY2Fscy9uZXctbmF0aW9uYWwtbG9ja2Rvd24tYnJpdGFpbi1ub3QtaW5ldml0YWJsZS1zYXlzLW1pbmlzdGVyLTIwMjAtMTItMjAv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Opdivo and Medicare: Coverage, options, and costs - Medical News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3Lm1lZGljYWxuZXdzdG9kYXkuY29tL2FydGljbGVzL2RvZXMtbWVkaWNhcmUtY292ZXItb3BkaXZv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "How CBO should score the Medicare MFN drug rule - Brookings Institution",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5icm9va2luZ3MuZWR1L2FydGljbGVzL2hvdy1zaG91bGQtY2JvLXRyZWF0LXRoZS1tb3N0LWZhdm9yZWQtbmF0aW9uLW1vZGVsLWludGVyaW0tZmluYWwtcnVsZS1mb3ItbWVkaWNhcmUtcGFydC1iLWRydWdzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/11/2020": {
        "artical1": {
            "title": "Cipla settles blood cancer drug litigation with Bristol Myers in US - Business Standard",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5idXNpbmVzcy1zdGFuZGFyZC5jb20vYXJ0aWNsZS9jb21wYW5pZXMvY2lwbGEtc2V0dGxlcy1ibG9vZC1jYW5jZXItZHJ1Zy1saXRpZ2F0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1pbi11cy0xMjAxMjExMDEyMjdfMS5odG1s0gGPAWh0dHBzOi8vd3d3LmJ1c2luZXNzLXN0YW5kYXJkLmNvbS9hbXAvYXJ0aWNsZS9jb21wYW5pZXMvY2lwbGEtc2V0dGxlcy1ibG9vZC1jYW5jZXItZHJ1Zy1saXRpZ2F0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1pbi11cy0xMjAxMjExMDEyMjdfMS5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Cipla Gains Nearly 5% On Settlement of US Patent Litigation - NDTV Profit",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3Lm5kdHYuY29tL2J1c2luZXNzL2NpcGxhLWdhaW5zLW5lYXJseS01LW9uLXNldHRsZW1lbnQtb2YtcGF0ZW50LWxpdGlnYXRpb24td2l0aC1jZWxnZW5lLWNvcnBvcmF0aW9uLXVzYS0yMzM4MjQ40gGAAWh0dHBzOi8vd3d3Lm5kdHYuY29tL2J1c2luZXNzL2NpcGxhLWdhaW5zLW5lYXJseS01LW9uLXNldHRsZW1lbnQtb2YtcGF0ZW50LWxpdGlnYXRpb24td2l0aC1jZWxnZW5lLWNvcnBvcmF0aW9uLXVzYS0yMzM4MjQ4L2FtcC8x?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "No Surface buyout, but Glaxo picks another cancer target - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvbm8tc3VyZmFjZS1idXlvdXQtZ2xheG8tcGlja3MtYW5vdGhlci1jYW5jZXItdGFyZ2V00gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTY0NzAvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Hall of med-ad legends elects Bernstein, Souza and Schilling to '21 ... - MM+M Online",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9oYWxsLW9mLW1lZC1hZC1sZWdlbmRzLWVsZWN0cy1iZXJuc3RlaW4tc291emEtYW5kLXNjaGlsbGluZy10by0yMS1jbGFzcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bluebird Bio, Biomarin Tabbed as Top Acquisition Targets - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ibHVlYmlyZC1iaW8tYmlvbWFyaW4tdGFiYmVkLXRvcC0xNTAwNDQyNzAuaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JsdWViaXJkLWJpby1iaW9tYXJpbi10YWJiZWQtdG9wLTE1MDA0NDI3MC5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Lockheed Martin to help Japan build stealth fighter - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtamFwYW4tZGVmZW5jZS1sb2NraGVlZC1pZFVTS0JOMjhTME42L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Foldax to Initiate FDA Clinical Study of Biopolymer Mitral Heart Valve - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9mb2xkYXgtaW5pdGlhdGUtZmRhLWNsaW5pY2FsLXN0dWR5LWJpb3BvbHltZXItbWl0cmFsLWhlYXJ0LXZhbHZl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/04/2020": {
        "artical1": {
            "title": "Howard President And Bristol Myers Squibb CEO: Achieving ... - Forbes",
            "link": "https://news.google.com/rss/articles/CBMipQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2JyaWFubmVnYXJyZXR0LzIwMjAvMTIvMDQvaG93YXJkLXByZXNpZGVudC1hbmQtYnJpc3RvbC1teWVycy1zcXVpYmItY2VvLWFjaGlldmluZy1oZWFsdGhjYXJlLWVxdWl0eS1tZWFucy1jaGFuZ2luZy10aGUtd2F5LXBlb3BsZS10aGluay_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Ash 2020 \u2013 efficacy and deaths mark the Car-T multiple myeloma race - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2gtMjAyMC1lZmZpY2FjeS1hbmQtZGVhdGhzLW1hcmstY2FyLXQtbXVsdGlwbGUtbXllbG9tYS1yYWNl0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTY0MjMvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Pentwater Solicits Holders of Bristol-Myers Squibb Contingent Value ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiqQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTIwOTAwNTMwMC9lbi9QZW50d2F0ZXItU29saWNpdHMtSG9sZGVycy1vZi1CcmlzdG9sLU15ZXJzLVNxdWliYi1Db250aW5nZW50LVZhbHVlLVJpZ2h0cy10by1Qcm92aWRlLUNvbnNlbnQtdG8tUmVwbGFjZS1UcnVzdGVl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Corporate Affairs Head Kathryn Metcalfe Departs Bristol Myers Squibb - PRovoke Media",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5wcm92b2tlbWVkaWEuY29tL2xhdGVzdC9hcnRpY2xlL2Jlbi10cm91bnNvbi1sZWF2ZXMtdGNzLWZvci1jb3Jwb3JhdGUtYWZmYWlycy1sZWFkZXJzaGlwLXJvbGUtYXQtYnJpc3RvbC1teWVycy1zcXVpYmLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "The Benefit of Maintaining the Expression of the Anti-sickling ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiuQFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L2NvbmZlcmVuY2VzYXNodGhlLWJlbmVmaXQtb2YtbWFpbnRhaW5pbmctdGhlLWV4cHJlc3Npb24tb2YtdGhlLWFudGktc2lja2xpbmctZGFtbWEtb3J0aG9sb2ctaW4tcGF0aWVudHMtd2l0aC1zaWNrbGUtY2VsbC1kaXNlYXNlLWFuZC1iZXRhLXRoYWxhc3NlbWlhc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "McArthur Fellow Jin-Quan Yu Named to Newly-Endowed Chemistry ... - Times of San Diego",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHA6Ly90aW1lc29mc2FuZGllZ28uY29tL3RlY2gvMjAyMC8xMi8wOC9tY2FydGh1ci1mZWxsb3ctamluLXF1YW4teXUtbmFtZWQtdG8tbmV3bHktZW5kb3dlZC1jaGVtaXN0cnktY2hhaXIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Effects of the COVID\u201019 Pandemic on Patients Living With Vasculitis - acrjournals.onlinelibrary.wiley.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQmh0dHBzOi8vYWNyam91cm5hbHMub25saW5lbGlicmFyeS53aWxleS5jb20vZG9pLzEwLjEwMDIvYWNyMi4xMTIwNNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/27/2020": {
        "artical1": {
            "title": "Glioblastoma Multiforme Treatment Market : Size, Insights, Trends ... - PharmiWeb.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5waGFybWl3ZWIuY29tL3ByZXNzLXJlbGVhc2UvMjAyMC0xMi0wMS9nbGlvYmxhc3RvbWEtbXVsdGlmb3JtZS10cmVhdG1lbnQtbWFya2V0LXNpemUtaW5zaWdodHMtdHJlbmRzLW91dGxvb2stdG8tMjAyNy10b3AtcGxheWVycy1h0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Zanidatamab Gets FDA Breakthrough Designation for HER2 Gene ... - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvemFuaWRhdGFtYWItZ2V0cy1mZGEtYnJlYWt0aHJvdWdoLWRlc2lnbmF0aW9uLWZvci1oZXIyLWdlbmVhbXBsaWZpZWQtYmlsaWFyeS10cmFjdC1jYW5jZXLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Opdivo Approved in EU as 2nd-line Advanced Esophageal Cancer ... - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8xMS8zMC9vcGRpdm8tYXBwcm92ZWQtZXVyb3BlLXNlY29uZC1saW5lLXRoZXJhcHktYWR2YW5jZWQtZXNvcGhhZ2VhbC1jYW5jZXIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Arena Pharma's R&D lead quits 6 months into the job, replaced by ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYXJlbmEtcGhhcm1hLXMtci1kLWxlYWQtcXVpdHMtNi1tb250aHMtaW50by1qb2ItcmVwbGFjZWQtYnktYWxkZXItY21v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Camber Pharma Launches Generic Exalgo - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvY2FtYmVyLXBoYXJtYS1sYXVuY2hlcy1nZW5lcmljLWV4YWxnb9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "La compa\u00f1\u00eda americana Bristol Myers Squibb ampliar\u00e1 sus laboratorios en Sevilla - ABC de Sevilla",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3NldmlsbGEuYWJjLmVzL2Vjb25vbWlhL3NldmktY29tcGFuaWEtYW1lcmljYW5hLWJyaXN0b2wtbXllcnMtc3F1aWJiLWFtcGxpYXJhLWxhYm9yYXRvcmlvcy1zZXZpbGEtMjAyMDExMzAxMzIyX25vdGljaWEuaHRtbNIBhwFodHRwczovL3NldmlsbGEuYWJjLmVzL2Vjb25vbWlhL3NldmktY29tcGFuaWEtYW1lcmljYW5hLWJyaXN0b2wtbXllcnMtc3F1aWJiLWFtcGxpYXJhLWxhYm9yYXRvcmlvcy1zZXZpbGEtMjAyMDExMzAxMzIyX25vdGljaWFfYW1wLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Mexico to introduce tax breaks along southern border, extend in north - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLW1leGljby10YXhlcy9tZXhpY28tdG8taW50cm9kdWNlLXRheC1icmVha3MtYWxvbmctc291dGhlcm4tYm9yZGVyLWV4dGVuZC1pbi1ub3J0aC1pZFVTS0JOMjg3MUxaL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/20/2020": {
        "artical1": {
            "title": "$2.7 billion deal for Schr\u00f6dinger and Bristol Myers Squibb - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS8yLTctYmlsbGlvbi1kZWFsLWZvci1zY2hyb2Rpbmdlci1hbmQtYnJpc3RvbC1teWVycy1zcXVpYmLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Schr\u00f6dinger Announces a Multi-Target Drug Discovery ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMiuwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTEyMzAwNTY2My9lbi9TY2hyJUMzJUI2ZGluZ2VyLUFubm91bmNlcy1hLU11bHRpLVRhcmdldC1EcnVnLURpc2NvdmVyeS1EZXZlbG9wbWVudC1hbmQtQ29tbWVyY2lhbGl6YXRpb24tQ29sbGFib3JhdGlvbi13aXRoLUJyaXN0b2wtTXllcnMtU3F1aWJi0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol-myers Squibb Company (BMY) EVP, Chief Information Officer Autenried Paul Von Sold $1. ... - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jb21wYW55LWJteS0yMzE1MTE0NzcuaHRtbNIBVmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBhbnktYm15LTIzMTUxMTQ3Ny5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "New $100M Program Aims to Improve Diversity in Clinical Trials - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8xMS8yMy9uZXctMTAwbS1wcm9ncmFtLWFpbXMtdG8taW1wcm92ZS1kaXZlcnNpdHktaW4tY2xpbmljYWwtdHJpYWxzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Global Biologics Market 2020:Size,Share,Trends,Covid-19 impact ... - PharmiWeb.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5waGFybWl3ZWIuY29tL3ByZXNzLXJlbGVhc2UvMjAyMC0xMS0yNS9nbG9iYWwtYmlvbG9naWNzLW1hcmtldC0yMDIwc2l6ZS1zaGFyZS10cmVuZHMtY292aWQtMTktaW1wYWN0LXNlZWtpbmctZXhjZWxsZW50LWdyb3d0aC10b3AtcGxheWXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant ... - The Oncologist",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vdGhlb25jb2xvZ2lzdC5vbmxpbmVsaWJyYXJ5LndpbGV5LmNvbS9kb2kvMTAuMTAwMi9vbmNvLjEzNjA40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "FEATURE-Uprooted by war, Armenians face bleak winter in schools ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2FybWVuaWEtYXplcmJhaWphbi1haWQvZmVhdHVyZS11cHJvb3RlZC1ieS13YXItYXJtZW5pYW5zLWZhY2UtYmxlYWstd2ludGVyLWluLXNjaG9vbHMtYW5kLXNhbmF0b3JpdW1zLWlkVVNMOE4ySTU1NDMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/13/2020": {
        "artical1": {
            "title": "The Bristol Myers Squibb Foundation and National Medical ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi1AFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTExNzAwNTIzMC9lbi9UaGUtQnJpc3RvbC1NeWVycy1TcXVpYmItRm91bmRhdGlvbi1hbmQtTmF0aW9uYWwtTWVkaWNhbC1GZWxsb3dzaGlwcy1MYXVuY2gtMTAwLU1pbGxpb24tUHJvZ3JhbS10by1IZWxwLUluY3JlYXNlLURpdmVyc2l0eS1hbmQtSW5jbHVzaW9uLWluLUNsaW5pY2FsLVRyaWFsc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Warren Buffett, Berkshire Bought 4 Pharma Stocks After 20-Year ... - Markets Insider",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQFodHRwczovL21hcmtldHMuYnVzaW5lc3NpbnNpZGVyLmNvbS9uZXdzL3N0b2Nrcy93YXJyZW4tYnVmZmV0dC1iZXJrc2hpcmUtaGF0aGF3YXktYnV5LTQtcGhhcm1hLXN0b2Nrcy0yMC15ZWFycy0yMDIwLTExLTEwMjk4MTU5MzHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Jim Simons' Firm's Top 5 Sells of the 3rd Quarter - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9qaW0tc2ltb25zLWZpcm1zLXRvcC01LTIxMzYyOTUzNy5odG1s0gFMaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvamltLXNpbW9ucy1maXJtcy10b3AtNS0yMTM2Mjk1MzcuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "J&J, following BMS, pledges $100M to address racism and health ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2otai1wbGVkZ2VzLTEwMC1taWxsaW9uLXRvLWFkZHJlc3MtcmFjaXNtLWFuZC1oZWFsdGgtaW5lcXVpdGllc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Alkermes flops FDA's 'remote review' at manufacturing site for ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9hbGtlcm1lcy1mbG9wcy1mZGEtcy1yZW1vdGUtcmV2aWV3LWF0LW1hbnVmYWN0dXJpbmctc2l0ZS1mb3Itc2NoaXpvcGhyZW5pYS1iaXBvbGFy0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Study: People Who Eat Chili Peppers May Live Longer - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvc3R1ZHktcGVvcGxlLXdoby1lYXQtY2hpbGktcGVwcGVycy1tYXktbGl2ZS1sb25nZXLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Turkey to buy 20 mln COVID-19 vaccine doses from China, also ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMimwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2hlYWx0aGNvcm9uYXZpcnVzLXR1cmtleS1jaGluYS90dXJrZXktdG8tYnV5LTIwLW1sbi1jb3ZpZC0xOS12YWNjaW5lLWRvc2VzLWZyb20tY2hpbmEtYWxzby10YWxraW5nLXRvLXBmaXplci1pZElOTDFOMkk1MENJL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "11/06/2020": {
        "artical1": {
            "title": "Wallingford officials review environmental impact of Amazon facility - Meriden Record-Journal",
            "link": "https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5teXJlY29yZGpvdXJuYWwuY29tL05ld3MvV2FsbGluZ2ZvcmQvV2FsbGluZ2ZvcmQtTmV3cy9XYWxsaW5nZm9yZC01LVJlc2VhcmNoLW5ldy1zaXRlLXBsYW4td2V0bGFuZHMtcHVibGljLWhlYXJpbmcuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Merck Announces Out-Licensing Agreement for Investigational ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9pbi9uZXdzLXJlbGVhc2VzL21lcmNrLWFubm91bmNlcy1vdXQtbGljZW5zaW5nLWFncmVlbWVudC1mb3ItaW52ZXN0aWdhdGlvbmFsLWF0YWNpY2VwdC13aXRoLXZlcmEtdGhlcmFwZXV0aWNzLTg3NTUwNzIxNy5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "How a partnership-funded, lung cancer screening saved one ... - Veterans Affairs (.gov)",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vbmV3cy52YS5nb3YvODA5MTUvcGFydG5lcnNoaXAtZnVuZGVkLWx1bmctY2FuY2VyLXNjcmVlbmluZy1zYXZlZC1vbmUtdmV0ZXJhbnMtbGlmZS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Opdivo-Yervoy-Chemo Combo Approved in EU for Advanced NSCLC - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8xMS8wOS9vcGRpdm8teWVydm95LWNoZW1vLWNvbWJvLWFwcHJvdmVkLWV1LWFkdmFuY2VkLW5zY2xjL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Post-surgery Opdivo Found to Extend Survival in High-risk Bladder ... - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikgFodHRwczovL2ltbXVuby1vbmNvbG9neW5ld3MuY29tLzIwMjAvMTEvMTEvcG9zdC1zdXJnZXJ5LW9wZGl2by1mb3VuZC10by1yZWR1Y2Utcmlzay1vZi1yZWN1cnJlbmNlLWluLWhpZ2gtcmlzay1ibGFkZGVyLWNhbmNlci1jaGVja21hdGUtMjc0LXRyaWFsL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Copper edges up as vaccine hopes boost risk appetite - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiPmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvaW5zdGFudC1hcnRpY2xlL2lkVVNMMU4ySFcwNDUv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Movers & Shakers, November 13 | BioSpace - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jpb3NwYWNlLW1vdmVycy1hbmQtc2hha2Vycy1ub3ZlbWJlci0xMy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/30/2020": {
        "artical1": {
            "title": "Amgen's Otezla faces a hit from Bristol's would-be rival, but safety ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLXMtb3RlemxhLWZhY2VzLXRocmVhdC1mcm9tLWJtcy1wc29yaWFzaXMtY2FuZGlkYXRlLWFuYWx5c3RzLXNheS1idXQtc2FmZXR5LWRhdGEtd2lsbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb focuses on innovation at CIIE - SHINE News",
            "link": "https://news.google.com/rss/articles/CBMiLGh0dHBzOi8vd3d3LnNoaW5lLmNuL2Jpei9jb21wYW55LzIwMTEwNjkwOTgv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Collaboration is the best medicine | UDaily - UDaily",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LnVkZWwuZWR1L3VkYWlseS8yMDIwL25vdmVtYmVyL2RhdmlkLWVsa2lucy1jaGFwbGluLXR5bGVyLWxlY3R1cmUtbWVkaWNpbmUtYnVzaW5lc3MtYWNhZGVtaWMtY29sbGFib3JhdGlvbi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Three Biotechs Shutter Clinical Programs After Futility Analysis or ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlLy10aHJlZS1iaW90ZWNocy1zaHV0dGVyLWNsaW5pY2FsLXByb2dyYW1zLWFmdGVyLWZ1dGlsaXR5LWFuYWx5c2lzLW9yLWZhaWxlZC10cmlhbHMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Lifestyle Drugs Market Demand to Increase with the Rise in COVID ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTEwNDAwNTMzNS9lbi9MaWZlc3R5bGUtRHJ1Z3MtTWFya2V0LURlbWFuZC10by1JbmNyZWFzZS13aXRoLXRoZS1SaXNlLWluLUNPVklELTE5LUluZmVjdGlvbnMtVGVjaG5hdmlv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "NOBCChE 2020 goes virtual - Chemical & Engineering News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRmh0dHBzOi8vY2VuLmFjcy5vcmcvY2FyZWVycy9kaXZlcnNpdHkvTk9CQ0NoRS0yMDIwLWdvZXMtdmlydHVhbC85OC9pNDLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Golumbeski, Hasnain join Vertex Ventures HC as executive advisers - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZ29sdW1iZXNraS1oYXNuYWluLWpvaW4tdmVydGV4LXZlbnR1cmVzLWFzLWV4ZWN1dGl2ZS1hZHZpc29yc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/23/2020": {
        "artical1": {
            "title": "insitro Announces Five-Year Discovery Collaboration with Bristol ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi7QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTAyODAwNTI3Ni9lbi9pbnNpdHJvLUFubm91bmNlcy1GaXZlLVllYXItRGlzY292ZXJ5LUNvbGxhYm9yYXRpb24td2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYi10by1EaXNjb3Zlci1hbmQtRGV2ZWxvcC1Ob3ZlbC1UcmVhdG1lbnRzLWZvci1BbXlvdHJvcGhpYy1MYXRlcmFsLVNjbGVyb3Npcy1hbmQtRnJvbnRvdGVtcG9yYWwtRGVtZW50aWHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "insitro inks deal with Bristol Myers worth up to $2.1 billion - The Pharma Letter",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9pbnNpdHJvLWlua3MtZGVhbC13aXRoLWJyaXN0b2wtbXllcnMtd29ydGgtdXAtdG8tMi0xLWJpbGxpb27SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Motley Fool: Bristol Myers Squibb has plenty of potential blockbuster drugs in the pipeline - The Dallas Morning News",
            "link": "https://news.google.com/rss/articles/CBMimwFodHRwczovL3d3dy5kYWxsYXNuZXdzLmNvbS9idXNpbmVzcy9wZXJzb25hbC1maW5hbmNlLzIwMjAvMTAvMjUvbW90bGV5LWZvb2wtYnJpc3RvbC1teWVycy1zcXVpYmItaGFzLXBsZW50eS1vZi1wb3RlbnRpYWwtYmxvY2tidXN0ZXItZHJ1Z3MtaW4tdGhlLXBpcGVsaW5lL9IBqgFodHRwczovL3d3dy5kYWxsYXNuZXdzLmNvbS9idXNpbmVzcy9wZXJzb25hbC1maW5hbmNlLzIwMjAvMTAvMjUvbW90bGV5LWZvb2wtYnJpc3RvbC1teWVycy1zcXVpYmItaGFzLXBsZW50eS1vZi1wb3RlbnRpYWwtYmxvY2tidXN0ZXItZHJ1Z3MtaW4tdGhlLXBpcGVsaW5lLz9vdXRwdXRUeXBlPWFtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "MBX Biosciences Appoints James Cornelius to its Board of Directors - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjAxMDI3MDA1NDcwL2VuL01CWC1CaW9zY2llbmNlcy1BcHBvaW50cy1KYW1lcy1Db3JuZWxpdXMtdG8taXRzLUJvYXJkLW9mLURpcmVjdG9yc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "3 Bargain Stocks You Can Buy Right Now - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzEwLzIzLzMtYmFyZ2Fpbi1zdG9ja3MteW91LWNhbi1idXktcmlnaHQtbm93L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Opdivo Combo Extends Patient Survival in Stomach, Esophageal ... - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL2ltbXVuby1vbmNvbG9neW5ld3MuY29tLzIwMjAvMTAvMjgvb3BkaXZvLWNvbWJvLWV4dGVuZHMtc3Vydml2YWwtYWR2YW5jZWQtc3RvbWFjaC1hbmQtZXNvcGhhZ2VhbC1jYW5jZXJzLXBoYXNlLTMtdHJpYWwtc2hvd3Mv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Opdivo-Cabometyx Gets FDA Priority Review for Advanced Kidney ... - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL2ltbXVuby1vbmNvbG9neW5ld3MuY29tLzIwMjAvMTAvMjYvb3BkaXZvLWNhYm9tZXR5eC1jb21iby1ncmFudGVkLWZkYS1wcmlvcml0eS1yZXZpZXctbmV3bHktZGlhZ25vc2VkLWFkdmFuY2VkLWtpZG5leS1jYW5jZXIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/16/2020": {
        "artical1": {
            "title": "Better Buy: Amgen vs. Bristol Myers Squibb - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzEwLzE4L2JldHRlci1idXktYW1nZW4tdnMtYnJpc3RvbC1teWVycy1zcXVpYmIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Anatomy of a deal: How MyoKardia got BMS to bump up its buyout ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYW5hdG9teS1hLWRlYWwtaG93LW15b2thcmRpYS1nb3QtYm1zLXRvLWJ1bXAtdXAtaXRzLWJ1eW91dC10by0xM2LSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Ransomware Attack on a Major Health Tech Firm Slows Down ... - CPO Magazine",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5jcG9tYWdhemluZS5jb20vY3liZXItc2VjdXJpdHkvcmFuc29td2FyZS1hdHRhY2stb24tYS1tYWpvci1oZWFsdGgtdGVjaC1maXJtLXNsb3dzLWRvd24tc2V2ZXJhbC1jb3ZpZC0xOS1jbGluaWNhbC10cmlhbHMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "NIH begins large clinical trial to test immune modulators for ... - National Institutes of Health (.gov)",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3Lm5paC5nb3YvbmV3cy1ldmVudHMvbmV3cy1yZWxlYXNlcy9uaWgtYmVnaW5zLWxhcmdlLWNsaW5pY2FsLXRyaWFsLXRlc3QtaW1tdW5lLW1vZHVsYXRvcnMtdHJlYXRtZW50LWNvdmlkLTE50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Where to Invest $5000 Right Now - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvd2hlcmUtdG8taW52ZXN0LSQ1MDAwLXJpZ2h0LW5vdy0yMDIwLTEwLTE20gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Mark J. Gerber Named Assistant Director of the Office of Internal ... - Federal Bureau of Investigation",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZiaS5nb3YvbmV3cy9wcmVzcy1yZWxlYXNlcy9tYXJrLWotZ2VyYmVyLW5hbWVkLWFzc2lzdGFudC1kaXJlY3Rvci1vZi10aGUtb2ZmaWNlLW9mLWludGVybmFsLWF1ZGl0aW5n0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Chemotherapy-free induction, consolidation therapy induces ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIwMTAyMS9jaGVtb3RoZXJhcHlmcmVlLWluZHVjdGlvbi1jb25zb2xpZGF0aW9uLXRoZXJhcHktaW5kdWNlcy1tb2xlY3VsYXItcmVzcG9uc2UtaW4tcGgtYWxs0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/09/2020": {
        "artical1": {
            "title": "IONTAS Announces Mammalian Display Licensing Agreement With ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMTAxMzAwNTE3Ny9lbi9JT05UQVMtQW5ub3VuY2VzLU1hbW1hbGlhbi1EaXNwbGF5LUxpY2Vuc2luZy1BZ3JlZW1lbnQtV2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS' Zeposia hits the mark in ulcerative colitis - PharmaTimes",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2Jtc196ZXBvc2lhX2hpdHNfdGhlX21hcmtfaW5fdWxjZXJhdGl2ZV9jb2xpdGlzXzEzNTI5NTHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "BMS to buy MyoKardia for access to late-stage heart disease drug - Chemical & Engineering News",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vY2VuLmFjcy5vcmcvcGhhcm1hY2V1dGljYWxzL2RydWctZGV2ZWxvcG1lbnQvQk1TLWJ1eS1NeW9LYXJkaWEtYWNjZXNzLWxhdGUvOTgvaTM50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "FDA Approves Opdivo-Yervoy Combo for Inoperable Mesothelioma - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8xMC8wOS9mZGEtYXBwcm92ZXMtb3BkaXZvLXllcnZveS1jb21iby1hcy1maXJzdC1saW5lLXRoZXJhcHktZm9yLWlub3BlcmFibGUtbWVzb3RoZWxpb21hL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Global Alumni Profile: Uzair Qadeer - Pennsylvania State University",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LnBzdS5lZHUvbmV3cy9pbXBhY3Qvc3RvcnkvZ2xvYmFsLWFsdW1uaS1wcm9maWxlLXV6YWlyLXFhZGVlci_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Monday Pharmaceutical Mystery: Which Drug Caused a Patient's ... - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvbW9uZGF5LXBoYXJtYWNldXRpY2FsLW15c3Rlcnktd2hpY2gtZHJ1Zy1jYXVzZWQtYS1wYXRpZW50cy1wb3RlbnRpYWxseS1kZWFkbHktYmxvb2QtY2xvdNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Thor adds new property to expanding life science platform | Real ... - Real Estate Weekly",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vcmV3LW9ubGluZS5jb20vdGhvci1hZGRzLW5ldy1wcm9wZXJ0eS10by1leHBhbmRpbmctbGlmZS1zY2llbmNlLXBsYXRmb3JtL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/02/2020": {
        "artical1": {
            "title": "Bristol Myers expands heart drug business with $13 billion deal for ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvbXlva2FyZGlhLW0tYS1icmlzdG9sLW15ZXJzLWlkVVNLQk4yNlExSjPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers to buy heart drugs developer MyoKardia for about $13 billion - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjAvMTAvMDUvYnJpc3RvbC1teWVycy10by1idXktaGVhcnQtZHJ1Z3MtZGV2ZWxvcGVyLW15b2thcmRpYS1mb3ItYWJvdXQtMTMtYmlsbGlvbi5odG1s0gFyaHR0cHM6Ly93d3cuY25iYy5jb20vYW1wLzIwMjAvMTAvMDUvYnJpc3RvbC1teWVycy10by1idXktaGVhcnQtZHJ1Z3MtZGV2ZWxvcGVyLW15b2thcmRpYS1mb3ItYWJvdXQtMTMtYmlsbGlvbi5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS Strengthens Cardiovascular Business with $13.1 Billion ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtc3F1aWJiLWJ1eXMtbXlva2FyZGlhLWZvci0xMy0xLWJpbGxpb24v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "New plan proposed for former Bristol-Myers Squibb site in Wallingford - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5teXJlY29yZGpvdXJuYWwuY29tL05ld3MvV2FsbGluZ2ZvcmQvV2FsbGluZ2ZvcmQtTmV3cy9OZXctcGxhbi1wcm9wb3NlZC1mb3ItZm9ybWVyLUJyaXN0b2wtTXllcnMtU3F1aWJiLXNpdGUtaW4tV2FsbGluZ2ZvcmQuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb snags new Opdivo-Yervoy nod but chalks up ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtc3F1aWJiLXNuYWdzLW5ldy1vcGRpdm8teWVydm95LW5vZC1idXQtY2hhbGtzLXVwLWZhaWx1cmUtbWVsYW5vbWHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "FDA OKs Combo Therapy for First-Line Mesothelioma Treatment - Medscape",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85Mzg1MzDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Fitch Affirms Bristol-Myers Squibb's Long-Term IDR at 'A-'; Outlook ... - Fitch Ratings",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5maXRjaHJhdGluZ3MuY29tL3Jlc2VhcmNoL2NvcnBvcmF0ZS1maW5hbmNlL2ZpdGNoLWFmZmlybXMtYnJpc3RvbC1teWVycy1zcXVpYmItbG9uZy10ZXJtLWlkci1hdC1hLW91dGxvb2stbmVnYXRpdmUtMDgtMTAtMjAyMNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/25/2020": {
        "artical1": {
            "title": "Moving for minutes: Noblesville family gearing up for busy weekend - FOX 59 Indianapolis",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vZm94NTkuY29tL21vcm5pbmctbmV3cy9wYXktaXQtZm9yd2FyZC9tb3ZpbmctZm9yLW1pbnV0ZXMtbm9ibGVzdmlsbGUtZmFtaWx5LWdlYXJpbmctdXAtZm9yLWJ1c3ktd2Vla2VuZC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Nivolumab plus chemotherapy prolongs PFS in gastric ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIwMDkyNS9uaXZvbHVtYWItcGx1cy1jaGVtb3RoZXJhcHktcHJvbG9uZ3MtcGZzLWluLWdhc3RyaWMtZ2FzdHJvZXNvcGhhZ2VhbC1qdW5jdGlvbi1jYW5jZXLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Katie Porter tore into pharma executive for price hikes on cancer drug - Business Insider",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20va2F0aWUtcG9ydGVyLWV4ZWN1dGl2ZS1tYXJrLWFsbGVzLXByaWNlLWhpa2VzLWNhbmNlci1kcnVnLXJldmxpbWlkLTIwMjAtOdIBbWh0dHBzOi8vd3d3LmJ1c2luZXNzaW5zaWRlci5jb20va2F0aWUtcG9ydGVyLWV4ZWN1dGl2ZS1tYXJrLWFsbGVzLXByaWNlLWhpa2VzLWNhbmNlci1kcnVnLXJldmxpbWlkLTIwMjAtOT9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "U.S. Senate's McConnell says Republicans, Democrats \"very far ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2hlYWx0aC1jb3JvbmF2aXJ1cy11c2EtbWNjb25uZWxsL3Utcy1zZW5hdGVzLW1jY29ubmVsbC1zYXlzLXJlcHVibGljYW5zLWRlbW9jcmF0cy12ZXJ5LWZhci1hcGFydC1vbi1jb3JvbmF2aXJ1cy1yZWxpZWYtaWRVU1cxTjJHRTAzWi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "West Side Nut Club's half-pot passes $33K on first day - Courier & Press",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmNvdXJpZXJwcmVzcy5jb20vc3RvcnkvbmV3cy8yMDIwLzA5LzI1L251dC1jbHVicy1oYWxmLXBvdC1wYXNzZXMtMzMtay1maXJzdC1kYXkvMzUyODIxNzAwMS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Nick Duran collects close to $20K, topping Bruno Barreiro in HD 112 - Florida Politics",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vZmxvcmlkYXBvbGl0aWNzLmNvbS9hcmNoaXZlcy8zNzA2MzQtZHVyYW4tY29sbGVjdHMtMjBrLXRvcHBpbmctYmFycmVpcm8v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Fierce Biotech's 2020 Fierce 15 - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL3NwZWNpYWwtcmVwb3J0L2ZpZXJjZS1iaW90ZWNoLXMtMjAyMC1maWVyY2UtMTXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/18/2020": {
        "artical1": {
            "title": "ESMO: Bristol Myers' Opdivo racks up GI cancer data for 2 ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VzbW8tYnJpc3RvbC1teWVycy1vcGRpdm8tcmFja3MtdXAtZ2ktY2FuY2VyLWRhdGEtZm9yLXR3by1wb3RlbnRpYWxseS1wcmFjdGljZS1jaGFuZ2luZy1mZGHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "EMA to Review Opdivo-Yervoy Combo for Untreated, Inoperable ... - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8wOS8xOC9lbWEtdG8tcmV2aWV3LW9wZGl2by15ZXJ2b3ktY29tYm8tZm9yLXVudHJlYXRlZC1pbm9wZXJhYmxlLW1lc290aGVsaW9tYS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Health Canada approves Inrebic for myelofibrosis - The Pharma Letter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9oZWFsdGgtY2FuYWRhLWFwcHJvdmVzLWlucmViaWMtZm9yLW15ZWxvZmlicm9zaXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "ESMO: Merck's Keytruda matches Opdivo on key survival metric for ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VzbW8tbWVyY2stcy1rZXl0cnVkYS1tYXRjaGVzLW9wZGl2by1rZXktcG9zdHN1cmdlcnktbWVsYW5vbWEtc3Vydml2YWwtbWV0cmlj0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Vantage Esmo 2020 roundup - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy92YW50YWdlLWVzbW8tMjAyMC1yb3VuZHVw0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTYyMTAvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Esmo 2020 \u2013 Agenus sees light at the end of the tunnel at last - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9lc21vLTIwMjAtYWdlbnVzLXNlZXMtbGlnaHQtZW5kLXR1bm5lbC1sYXN00gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTYyMDAvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "ESMO: Merck's Keytruda doubles 5-year survival rate for lung ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VzbW8tbWVyY2stcy1rZXl0cnVkYS1kb3VibGVzLTUteWVhci1zdXJ2aXZhbC1yYXRlLWZvci1sdW5nLWNhbmNlci1wYXRpZW50c9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "09/11/2020": {
        "artical1": {
            "title": "Bristol-Myers and Pfizer Win Over Eliquis Patents - JD Supra",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3Lmpkc3VwcmEuY29tL2xlZ2FsbmV3cy9icmlzdG9sLW15ZXJzLWFuZC1wZml6ZXItd2luLW92ZXItMzEyMDIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Esmo 2020 preview \u2013 a kidney cancer showdown gets star billing - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9lc21vLTIwMjAtcHJldmlldy1raWRuZXktY2FuY2VyLXNob3dkb3duLWdldHMtc3Rhci1iaWxsaW5n0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTYxNzYvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Fourth Annual SAAC Career Fair is Thursday - Rensselaer ... - RPI Athletics",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vcnBpYXRobGV0aWNzLmNvbS9uZXdzLzIwMjAvOS8xMi9nZW5lcmFsLWZvdXJ0aC1hbm51YWwtc2FhYy1jYXJlZXItZmFpci1pcy10aHVyc2RheS5hc3B40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Opdivo Shows Benefits for Esophageal, GEJ Cancer Patients, Study ... - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL2ltbXVuby1vbmNvbG9neW5ld3MuY29tLzIwMjAvMDkvMTQvcG9zdC1zdXJnZXJ5LW9wZGl2by1zaG93cy1iZW5lZml0cy1mb3ItZXNvcGhhZ2VhbC1nZWotY2FuY2VyLXBhdGllbnRzLWluLW9uZ29pbmctdHJpYWwv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Esmo 2020 preview \u2013 late-breaking immunotherapy - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9lc21vLTIwMjAtcHJldmlldy1sYXRlLWJyZWFraW5nLWltbXVub3RoZXJhcHnSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNjE3NC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Hospital admissions for acute myocardial infarction before and after ... - The Lancet",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LnRoZWxhbmNldC5jb20vam91cm5hbHMvbGFucHViL2FydGljbGUvUElJUzI0NjgtMjY2NygyMCkzMDE4OC0yL2Z1bGx0ZXh00gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "UPS names new members of board of directors - Air Cargo News",
            "link": "https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LmFpcmNhcmdvbmV3cy5uZXQvcGVvcGxlL3Vwcy1uYW1lcy1uZXctbWVtYmVycy1vZi1ib2FyZC1vZi1kaXJlY3RvcnMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/04/2020": {
        "artical1": {
            "title": "Abbvie looks east for CD47 - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvZGVhbHMvYWJidmllLWxvb2tzLWVhc3QtY2Q0N9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE2MTU5L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "\u201cDeep Dive\u201d into Biology of Kidney Tumors Identifies Markers of ... - On Cancer - Memorial Sloan Kettering",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3Lm1za2NjLm9yZy9uZXdzL2RlZXAtZGl2ZS1iaW9sb2d5LWtpZG5leS10dW1vcnMtaWRlbnRpZmllcy1ub3ZlbC1tYXJrZXJzLXJlc3BvbnNlLWltbXVub3RoZXJhcHnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Columbia Endowment Names Kim Lew CEO | Chief Investment Officer - Chief Investment Officer",
            "link": "https://news.google.com/rss/articles/CBMiQWh0dHBzOi8vd3d3LmFpLWNpby5jb20vbmV3cy9jb2x1bWJpYS1lbmRvd21lbnQtbmFtZXMta2ltLWxldy1jZW8v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Second wave of floating storage triggered by ailing oil market - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtZ2xvYmFsLW9pbC1mbG9hdGluZy1pZFVTS0JOMjYwMkVY0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Multiple Myeloma Market Size Forecast, Epidemiology Analysis ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMitQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL211bHRpcGxlLW15ZWxvbWEtbWFya2V0LXNpemUtZm9yZWNhc3QtZXBpZGVtaW9sb2d5LWFuYWx5c2lzLWVtZXJnaW5nLWRydWctdXB0YWtlLWFuZC1rZXktY29tcGFuaWVzLWFzc2Vzc21lbnQtYnktZGVsdmVpbnNpZ2h0LTMwMTEyODE2Mi5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "GEMINI: Entyvio safety profile favorable in long-term use - Healio",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9nYXN0cm9lbnRlcm9sb2d5LzIwMjAwOTA4L2dlbWluaS1lbnR5dmlvLXNhZmV0eS1wcm9maWxlLWZhdm9yYWJsZS1pbi1sb25ndGVybS11c2XSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "'Enough is enough': Gilead-Morehouse study racial, ethnic disparity ... - spglobal.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMipwFodHRwczovL3d3dy5zcGdsb2JhbC5jb20vbWFya2V0aW50ZWxsaWdlbmNlL2VuL25ld3MtaW5zaWdodHMvbGF0ZXN0LW5ld3MtaGVhZGxpbmVzL2Vub3VnaC1pcy1lbm91Z2gtZ2lsZWFkLW1vcmVob3VzZS1zdHVkeS1yYWNpYWwtZXRobmljLWRpc3Bhcml0eS1pbi1jb3ZpZC0xOS02MDAzNTI1M9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/28/2020": {
        "artical1": {
            "title": "After Bristol snub, Gilead pens $120M upfront, $685M in biobucks ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWZ0ZXItYnJpc3RvbC1zbnViLWdpbGVhZC1wZW5zLTEyMG0tdXBmcm9udC02ODVtLWJpb2J1Y2tzLWZvci1lYXJseS1qb3VuY2UtY2FuY2VyLXByb2dyYW3SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "ESC: Pfizer, BMS' Eliquis tops Xarelto, vitamin K drugs for site ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL3BoYXJtYS9lc2MtcGZpemVyLWJtcy1lbGlxdWlzLWN1dHMtc2l0ZS1zcGVjaWZpYy1ibGVlZGluZy1vdmVyLXZrYXMteGFyZWx0by1mcmVuY2gtcmVhbC13b3JsZC1zdHVkedIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA Approves CC-486 as Maintenance Therapy in Acute Myeloid ... - Targeted Oncology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2ZkYS1hcHByb3Zlcy1jYy00ODYtYXMtbWFpbnRlbmFuY2UtdGhlcmFweS1pbi1hY3V0ZS1teWVsb2lkLWxldWtlbWlh0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Trial clarifies which patients with acute pulmonary embolism can be ... - European Society of Cardiology",
            "link": "https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5lc2NhcmRpby5vcmcvVGhlLUVTQy9QcmVzcy1PZmZpY2UvUHJlc3MtcmVsZWFzZXMvVHJpYWwtY2xhcmlmaWVzLXdoaWNoLXBhdGllbnRzLXdpdGgtYWN1dGUtcHVsbW9uYXJ5LWVtYm9saXNtLWNhbi1iZS1tYW5hZ2VkLWF0LWhvbWXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Abbott Restarts Bioresorbable Stent Clinical Trials With New Esprit ... - Diagnostic and Interventional Cardiology",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vYXJ0aWNsZS9hYmJvdHQtcmVzdGFydHMtYmlvcmVzb3JiYWJsZS1zdGVudC1jbGluaWNhbC10cmlhbHMtbmV3LWVzcHJpdC1iZWxvdy1rbmVlLXNjYWZmb2xk0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "NeuClone Discloses Two Biosimilars Referencing Opdivo\u00ae and ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDkwMTAwNTMwOC9lbi9OZXVDbG9uZS1EaXNjbG9zZXMtVHdvLUJpb3NpbWlsYXJzLVJlZmVyZW5jaW5nLU9wZGl2byVDMiVBRS1hbmQtS2V5dHJ1ZGElQzIlQUXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Multiple Myeloma in 8 Major Markets 2017-2030: United States ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMixwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDkwMTAwNTY1Ni9lbi9NdWx0aXBsZS1NeWVsb21hLWluLTgtTWFqb3ItTWFya2V0cy0yMDE3LTIwMzAtVW5pdGVkLVN0YXRlcy1HZXJtYW55LUZyYW5jZS1JdGFseS1TcGFpbi1Vbml0ZWQtS2luZ2RvbS1KYXBhbi1hbmQtQ2hpbmEtLS1SZXNlYXJjaEFuZE1hcmtldHMuY29t0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/21/2020": {
        "artical1": {
            "title": "Bristol Myers Squibb's targeted AML drug Idhifa fails to extend ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtc3F1aWJiLXMtZXgtY2VsZ2VuZS1hbWwtZHJ1Zy1pZGhpZmEtZmFpbHMtdG8tZXh0ZW5kLXBhdGllbnRzLWxpdmVz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Squibb Enters Agreement to Acquire Forbius, Adding ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDgyNDAwNTE1OS9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi1FbnRlcnMtQWdyZWVtZW50LXRvLUFjcXVpcmUtRm9yYml1cy1BZGRpbmctTGVhZC1UR0YtYmV0YS1Bc3NldC10by1Qb3J0Zm9saW_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Drugmakers slash prices to win China's bulk-buy contracts: state ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiPGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtY2hpbmEtZHJ1Z3MtaWRVU0tCTjI1RzFJWNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Few TGF-\u03b2 assets remain unencumbered after Bristol\u2019s Forbius buy - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvZmV3LXRnZi1iLWFzc2V0cy1yZW1haW4tdW5lbmN1bWJlcmVkLWFmdGVyLWJyaXN0b2xzLWZvcmJpdXMtYnV50gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTYxMzQvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb Leasing Big At Boston Biotech Campus - The Real Deal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vdGhlcmVhbGRlYWwuY29tL25ldy15b3JrLzIwMjAvMDgvMjMvcGhhcm1hLWdpYW50LWlua3MtbWFzc2l2ZS1sZWFzZS1hdC1zcHJhd2xpbmctYm9zdG9uLW1peGVkLXVzZS1jYW1wdXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Filgotinib was set to struggle, market stats show - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvZmlsZ290aW5pYi13YXMtc2V0LXN0cnVnZ2xlLW1hcmtldC1zdGF0cy1zaG930gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTYxMTYvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "BeiGene Appoints Corsee Sanders, Ph.D. to its Board of Directors - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMjAwODI1MDA1MTM2L2VuL0JlaUdlbmUtQXBwb2ludHMtQ29yc2VlLVNhbmRlcnMtUGguRC4tdG8taXRzLUJvYXJkLW9mLURpcmVjdG9yc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/14/2020": {
        "artical1": {
            "title": "Another big drug maker growing in Cambridge - The Boston Globe",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmJvc3Rvbmdsb2JlLmNvbS8yMDIwLzA4LzE5L2J1c2luZXNzL2Fub3RoZXItYmlnLWRydWdtYWtlci1ncm93aW5nLWNhbWJyaWRnZS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS signs $475m licensing deal with Dragonfly Therapeutics - Pharmaceutical Technology",
            "link": "https://news.google.com/rss/articles/CBMiR2h0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL25ld3MvYm1zLWRyYWdvbmZseS1saWNlbnNpbmcv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Should Lilly also take on Merck in lung cancer? - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvc2hvdWxkLWxpbGx5LWFsc28tdGFrZS1tZXJjay1sdW5nLWNhbmNlctIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE2MTE1L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "For Advanced NSCLC, Opdivo-Yervoy-Chemo Combo Approved in ... - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8wOC8xNy9oZWFsdGgtY2FuYWRhLWFwcHJvdmVzLW9wZGl2by15ZXJ2b3ktY2hlbW8tY29tYm8tZm9yLWFkdmFuY2VkLW5zY2xjL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Evoke KYNE promotes Dante DelVecchio to senior VP - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX2FwcG9pbnRtZW50cy9ldm9rZV9reW5lX3Byb21vdGVzX2RhbnRlX2RlbHZlY2NoaW9fdG9fc2VuaW9yX3ZwXzEzNDcwMzXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "New Formulations Benefit Special Populations - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvbmV3LWZvcm11bGF0aW9ucy1iZW5lZml0LXNwZWNpYWwtcG9wdWxhdGlvbnPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Top 10 ways companies cook the books - Accounting Today",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LmFjY291bnRpbmd0b2RheS5jb20vbGlzdC90b3AtMTAtd2F5cy1jb21wYW5pZXMtY29vay10aGUtYm9va3PSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/07/2020": {
        "artical1": {
            "title": "Bristol Myers Squibb, on a roll, touts 2 Opdivo GI cancer wins ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtc3F1aWJiLWEtcm9sbC10b3V0cy0yLW9wZGl2by1naS1jYW5jZXItd2luc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "World Lung 2020 \u2013 Bristol delivers on its mesothelioma promise - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy93b3JsZC1sdW5nLTIwMjAtYnJpc3RvbC1kZWxpdmVycy1pdHMtbWVzb3RoZWxpb21hLXByb21pc2XSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNjA5NC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Health Canada Approves OPDIVO\u00ae (nivolumab) plus YERVOY ... - Canada NewsWire",
            "link": "https://news.google.com/rss/articles/CBMi1QFodHRwczovL3d3dy5uZXdzd2lyZS5jYS9uZXdzLXJlbGVhc2VzL2hlYWx0aC1jYW5hZGEtYXBwcm92ZXMtb3BkaXZvLXItbml2b2x1bWFiLXBsdXMteWVydm95LXItaXBpbGltdW1hYi1jb21iaW5lZC13aXRoLWxpbWl0ZWQtY2hlbW90aGVyYXB5LWZvci10aGUtdHJlYXRtZW50LW9mLW1ldGFzdGF0aWMtbm9uLXNtYWxsLWNlbGwtbHVuZy1jYW5jZXItODk4MjI5NTYyLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Opdivo-Yervoy Combo Prolongs Survival of Patients With ... - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijgFodHRwczovL2ltbXVuby1vbmNvbG9neW5ld3MuY29tLzIwMjAvMDgvMTIvb3BkaXZvLXllcnZveS1jb21iby1wcm9sb25ncy1zdXJ2aXZhbC1vZi1wYXRpZW50cy13aXRoLWlub3BlcmFibGUtbWVzb3RoZWxpb21hLXBoYXNlLTMtdHJpYWwtc2hvd3Mv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Contingent value is back in vogue - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL2NvbnRpbmdlbnQtdmFsdWUtYmFjay12b2d1ZdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE2MTAwL2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Pharm Exec's 19th Annual Industry Audit - Pharmaceutical Executive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy8xOXRoLWFubnVhbC1pbmR1c3RyeS1hdWRpdC12YWx1ZS1ib29zdNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Induction-concurrent chemotherapy sequence shows promise in ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIwMDgwNy9pbmR1Y3Rpb25jb25jdXJyZW50LWNoZW1vdGhlcmFweS1zZXF1ZW5jZS1zaG93cy1wcm9taXNlLWluLW5hc29waGFyeW5nZWFsLWNhcmNpbm9tYdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/31/2020": {
        "artical1": {
            "title": "With Court Win, BMS and Pfizer Stave Off Eliquis Generic ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3dpdGgtY291cnQtd2luLWJtcy1hbmQtcGZpemVyLXN0YXZlLW9mZi1nZW5lcmljLWNoYWxsZW5nZXJzLXRvLWVsaXF1aXMtZm9yLW5vdy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Eppes Professors distinction changed at Florida State University - Tallahassee Democrat",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnRhbGxhaGFzc2VlLmNvbS9zdG9yeS9uZXdzLzIwMjAvMDgvMDQvZXBwZXMtcHJvZmVzc29ycy1kaXN0aW5jdGlvbi1jaGFuZ2VkLWZsb3JpZGEtc3RhdGUtdW5pdmVyc2l0eS81NTc1NzcyMDAyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Roche's Tecentriq claims melanoma OK, but don't expect a sales ... - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL3JvY2hlcy10ZWNlbnRyaXEtY2xhaW1zLW1lbGFub21hLW9rLWJ1dC1kb250LWV4cGVjdC1hLXNhbGVzLXN1cmdl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Princeton's Prud'homme and Yang partner with Genentech to ... - Princeton University",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LnByaW5jZXRvbi5lZHUvbmV3cy8yMDIwLzA3LzMxL3ByaW5jZXRvbnMtcHJ1ZGhvbW1lLWFuZC15YW5nLXBhcnRuZXItZ2VuZW50ZWNoLWRlY29kZS1rZXktcHJvY2Vzcy12YWNjaW5lcy1hbmTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "The Evolution of Specialty Medicine - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRmh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvdGhlLWV2b2x1dGlvbi1vZi1zcGVjaWFsdHktbWVkaWNpbmXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Regeneron pairs with BioNTech on melanoma immunotherapy - pharmaphorum",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL3JlZ2VuZXJvbi1wYWlycy13aXRoLWJpb250ZWNoLW9uLW1lbGFub21hLWltbXVub3RoZXJhcHnSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Brukinsa May Cause Fewer Side Effects Than Other BTK Inhibitors ... - Curetoday.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5jdXJldG9kYXkuY29tL3ZpZXcvYnJ1a2luc2EtbWF5LWNhdXNlLWZld2VyLXNpZGUtZWZmZWN0cy10aGFuLW90aGVyLWJ0ay1pbmhpYml0b3JzLWZvci1wYXRpZW50cy13aXRoLWJjZWxsLW1hbGlnbmFuY2llc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/24/2020": {
        "artical1": {
            "title": "Roche's Tecentriq triplet nabs melanoma OK, but BMS' Opdivo ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JvY2hlLXMtdGVjZW50cmlxLXRyaXBsZXQtbmFicy1tZWxhbm9tYS1vay1idXQtYm1zLW9wZGl2by15ZXJ2b3ktc3RpbGwtcmVpZ25zLXN1cHJlbWXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS Uses Virtual Technology To Empower Patient Communities - Clinical Leader",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmNsaW5pY2FsbGVhZGVyLmNvbS9kb2MvYm1zLXVzZXMtdmlydHVhbC10ZWNobm9sb2d5LXRvLWVtcG93ZXItcGF0aWVudC1jb21tdW5pdGllcy0wMDAx0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "MENTOR Expands Leadership with Addition of Tara Spann as Chief ... - CSRwire.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5jc3J3aXJlLmNvbS9wcmVzc19yZWxlYXNlcy80NTQ5My1tZW50b3ItZXhwYW5kcy1sZWFkZXJzaGlwLXdpdGgtYWRkaXRpb24tb2YtdGFyYS1zcGFubi1hcy1jaGllZi1wZW9wbGUtc3RyYXRlZ3ktb2ZmaWNlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "F-star set to land Nasdaq listing through Spring Bank merger - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZi1zdGFyLXNldC10by1sYW5kLW5hc2RhcS1saXN0aW5nLXRocm91Z2gtc3ByaW5nLWJhbmstbWVyZ2Vy0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Charting the history of immunotherapy, cancer treatment's fourth pillar - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL2ZlYXR1cmVzL2NoYXJ0aW5nLXRoZS1oaXN0b3J5LW9mLWltbXVub3RoZXJhcHktY2FuY2VyLXRyZWF0bWVudHMtZm91cnRoLXBpbGxhci_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "CEOs Asked to Pledge Disability Inclusion at Their Companies - Adweek",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmFkd2Vlay5jb20vcGVyZm9ybWFuY2UtbWFya2V0aW5nL2Nlb3MtZGlzYWJpbGl0eS1pbmNsdXNpb24tcGxlZGdlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Dapagliflozin Meets All Endpoints to Treat Chronic Kidney Disease - Diagnostic and Interventional Cardiology",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9kYXBhZ2xpZmxvemluLW1lZXRzLWFsbC1lbmRwb2ludHMtdHJlYXQtY2hyb25pYy1raWRuZXktZGlzZWFzZdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/17/2020": {
        "artical1": {
            "title": "EMA to Review Liso-cel as CAR T-cell Therapy for Advanced ... - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8wNy8yMi9lbWEtcmV2aWV3aW5nLWxpc28tY2VsbC1jYXItdC1jZWxsLXRoZXJhcHktZm9yLXJlbGFwc2VkLXJlZnJhY3RvcnktbHltcGhvbWFzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "It\u2019s official: \u201cpipeline in a product\u201d is a thing - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9pdHMtb2ZmaWNpYWwtcGlwZWxpbmUtcHJvZHVjdC10aGluZ9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1OTU0L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Georgia Cancer Center program providing blueprint for outreach in ... - The Augusta Chronicle",
            "link": "https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5hdWd1c3RhY2hyb25pY2xlLmNvbS9zdG9yeS9uZXdzLzIwMjAvMDcvMjEvZ2VvcmdpYS1jYW5jZXItY2VudGVyLXByb2dyYW0tcHJvdmlkaW5nLWJsdWVwcmludC1mb3Itb3V0cmVhY2gtaW4tYWZyaWNhLzExNDc4ODUzMi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "With Boeing Pessimistic, Should Spirit Aerosystems' Investors Stay ... - Trefis",
            "link": "https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy50cmVmaXMuY29tL3N0b2NrL3Nwci9hcnRpY2xlcy80OTQxMjIvd2l0aC1ib2VpbmctcGVzc2ltaXN0aWMtc2hvdWxkLXNwaXJpdC1hZXJvc3lzdGVtcy1pbnZlc3RvcnMtc3RheS1pbi1oaWdoLXNwaXJpdHMvMjAyMC0wNy0yMdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol-Myers' (BMY) CAR T Cell Therapy Gets EMA Validation - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLWJteS1jYXItdC0xMzU2MDE3NzQuaHRtbNIBTWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2JyaXN0b2wtbXllcnMtYm15LWNhci10LTEzNTYwMTc3NC5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "European Society of Cardiology Announces Late-Breaking Study ... - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9ldXJvcGVhbi1zb2NpZXR5LWNhcmRpb2xvZ3ktYW5ub3VuY2VzLWxhdGUtYnJlYWtpbmctc3R1ZHktcHJlc2VudGF0aW9ucy1pdHMtMjAyMC12aXJ0dWFs0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Sequential gemcitabine and docetaxel proves efficacious in NMIBC - Urology Times",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy9zZXF1ZW50aWFsLWdlbWNpdGFiaW5lLWFuZC1kb2NldGF4ZWwtcHJvdmVzLWVmZmljYWNpb3VzLWluLW5taWJj0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/10/2020": {
        "artical1": {
            "title": "ReviveMed Announces AI-driven Metabolomics Study with Bristol ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDcxNDAwNTExNS9lbi9SZXZpdmVNZWQtQW5ub3VuY2VzLUFJLWRyaXZlbi1NZXRhYm9sb21pY3MtU3R1ZHktd2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Vir Biotechnology Appoints Elliott Sigal, M.D., Ph.D. to Board of ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3JlbGVhc2VzL3Zpci1iaW90ZWNobm9sb2d5LWFwcG9pbnRzLWVsbGlvdHQtc2lnYWwtbS1kLXBoLWQtdG8tYm9hcmQtb2YtZGlyZWN0b3JzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Stephen Yoder, MD, MBA Named Vice President, Business ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3N0ZXBoZW4teW9kZXItbWQtbWJhLW5hbWVkLXZpY2UtcHJlc2lkZW50LWJ1c2luZXNzLWRldmVsb3BtZW50LWF0LXRhaWhvLW9uY29sb2d5LWluYy0zMDEwOTMzNDkuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "NY Fed's Logan says market functioning has improved but officials ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLXVzYS1mZWQtbG9nYW4vbnktZmVkcy1sb2dhbi1zYXlzLW1hcmtldC1mdW5jdGlvbmluZy1oYXMtaW1wcm92ZWQtYnV0LW9mZmljaWFscy1yZW1haW4tdmlnaWxhbnQtaWRVU0tDTjI0RzJQQy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "FDA approves Tremfya, first IL-23 inhibitor for psoriatic arthritis - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9yaGV1bWF0b2xvZ3kvMjAyMDA3MTQvZmRhLWFwcHJvdmVzLXRyZW1meWEtZmlyc3QtaWwyMy1pbmhpYml0b3ItZm9yLXBzb3JpYXRpYy1hcnRocml0aXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Risankizumab may be superior to secukinumab in psoriasis treatment - Healio",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9kZXJtYXRvbG9neS8yMDIwMDcxNC9yaXNhbmtpenVtYWItbWF5LWJlLXN1cGVyaW9yLXRvLXNlY3VraW51bWFiLWluLXBzb3JpYXNpcy10cmVhdG1lbnTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Genmab locates U.S. headquarters in Princeton - centraljersey.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vY2VudHJhbGplcnNleS5jb20vMjAyMC8wNy8xMC9nZW5tYWItbG9jYXRlcy11LXMtaGVhZHF1YXJ0ZXJzLWluLXByaW5jZXRvbi_SAVZodHRwczovL2NlbnRyYWxqZXJzZXkuY29tLzIwMjAvMDcvMTAvZ2VubWFiLWxvY2F0ZXMtdS1zLWhlYWRxdWFydGVycy1pbi1wcmluY2V0b24vP2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/03/2020": {
        "artical1": {
            "title": "Dragonfly Therapeutics Announces New Research Collaboration ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMi6gFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2RyYWdvbmZseS10aGVyYXBldXRpY3MtYW5ub3VuY2VzLW5ldy1yZXNlYXJjaC1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tZGV2ZWxvcC1ub3ZlbC10aGVyYXBldXRpYy1jYW5kaWRhdGVzLWZvci1tdWx0aXBsZS1zY2xlcm9zaXMtYW5kLW5ldXJvLWluZmxhbW1hdGlvbi10YXJnZXQtMzAxMDg4MjExLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "GSK snags first-in-class FDA nod for Rukobia to treat HIV patients ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2dzay1zbmFncy1maXJzdC1jbGFzcy1mZGEtbm9kLWZvci1ydWtvYmlhLXRvLXRyZWF0LWhpdi1wYXRpZW50cy1mZXctb3B0aW9uc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Healthcare is in the midst of a \u2018paradigm shift\u2019 - Fortune",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vZm9ydHVuZS5jb20vMjAyMC8wNy8wOC9oZWFsdGhjYXJlLWlzLWluLXRoZS1taWRzdC1vZi1hLXBhcmFkaWdtLXNoaWZ0L9IBUmh0dHBzOi8vZm9ydHVuZS5jb20vMjAyMC8wNy8wOC9oZWFsdGhjYXJlLWlzLWluLXRoZS1taWRzdC1vZi1hLXBhcmFkaWdtLXNoaWZ0L2FtcC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Rowan students are researching through a pandemic summer - Rowan Today",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vdG9kYXkucm93YW4uZWR1L25ld3MvMjAyMC8wNy9yZXNlYXJjaGluZy10aHJvdWdoLXBhbmRlbWljLXN1bW1lci5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Citi expects stocks to go sideways for a year, suggests defensives - Reuters",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWNpdGlncm91cC1tYXJrZXRzL2NpdGktZXhwZWN0cy1zdG9ja3MtdG8tZ28tc2lkZXdheXMtZm9yLWEteWVhci1zdWdnZXN0cy1kZWZlbnNpdmVzLWlkVVNLQk4yNDcwS1Ev0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "3 Stocks I'll Be Buying When the Market Crashes Again - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA3LzA5LzMtc3RvY2tzLWlsbC1iZS1idXlpbmctd2hlbi10aGUtbWFya2V0LXRhbmtzLWFnYWluLmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "How to perform office-based blue light cystoscopy - Urology Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy9ob3ctdG8tcGVyZm9ybS1vZmZpY2UtYmFzZWQtYmx1ZS1saWdodC1jeXN0b3Njb3B50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/26/2020": {
        "artical1": {
            "title": "Triple Negative Breast Cancer Trial to Test Cancer Vaccine Combo - Breast Cancer News",
            "link": "https://news.google.com/rss/articles/CBMikgFodHRwczovL2JyZWFzdGNhbmNlci1uZXdzLmNvbS8yMDIwLzA2LzI5L2NhbmNlci12YWNjaW5lLWNvbWJvLWRwdi0wMDEtYm1zLTk4NjE3OC1vcGRpdm8tdHJpcGxlLW5lZ2F0aXZlLWJyZWFzdC1jYW5jZXItdWJpdmFjLWJyaXN0b2wtbXllcnMtc3F1aWJiL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Monopar And Northstar Announce Filing Of Provisional Patent ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMi_AFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2JyaWVmLW1vbm9wYXItYW5kLW5vcnRoc3Rhci1hbm5vdW5jZS1maWwvYnJpZWYtbW9ub3Bhci1hbmQtbm9ydGhzdGFyLWFubm91bmNlLWZpbGluZy1vZi1wcm92aXNpb25hbC1wYXRlbnQtcHJvdGVjdGluZy1kZXZlbG9wbWVudC1hbmQtdXNlLW9mLXJhZGlvLWltbXVuby10aGVyYXBldXRpY3MtdGFyZ2V0aW5nLXNldmVyZS1jb3ZpZC0xOS10aHJvdWdoLXVwYXItaWRVU0ZXTjJFNzBQUC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Takeda and Carmine Enter $900 Million Non-Viral Gene Therapy ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3Rha2VkYS1hbmQtY2FybWluZS10aGVyYXBldXRpY3MtcGFydG5lci1vbi1yYXJlLWRpc2Vhc2Utbm9uLXZpcmFsLWdlbmUtdGhlcmFwaWVzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Helsinn and MEI Discontinue Phase III Trial of Pracinostat in AML - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2hlbHNpbm4tYW5kLW1laS1hYmFuZG9uLXByYWNpbm9zdGF0LWluLWFtbC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Human Microbiome Therapeutics Market 2020-2024 | Growing ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiqAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDYzMDAwNTA4NS9lbi9IdW1hbi1NaWNyb2Jpb21lLVRoZXJhcGV1dGljcy1NYXJrZXQtMjAyMC0yMDI0LUdyb3dpbmctUHJldmFsZW5jZS1vZi1DaHJvbmljLURpc2Vhc2VzLXRvLUJvb3N0LUdyb3d0aC1UZWNobmF2aW_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "IPO Preview: iTeos Therapeutics Starts IPO Effort - IPOs On ... - TheStreet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvaXRlb3MtdGhlcmFwZXV0aWNzLWlwb9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Study: Afib Persistence Shouldn't Be Based on 7-Day Cutoff - Medpage Today",
            "link": "https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vd3d3Lm1lZHBhZ2V0b2RheS5jb20vY2FyZGlvbG9neS9hcnJoeXRobWlhcy84NzM5MtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/19/2020": {
        "artical1": {
            "title": "Lincoln Equities, H.I.G. Realty Purchase Bristol Myers Squibb Campus - njbmagazine.com",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vbmpibWFnYXppbmUuY29tL25qYi1uZXdzLW5vdy9saW5jb2xuLWVxdWl0aWVzLWgtaS1nLXJlYWx0eS1wdXJjaGFzZS1icmlzdG9sLW15ZXJzLXNxdWliYi1jYW1wdXMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "BMS Dublin Site Wins ISPE 'Facility of the Year' Award - Contract Pharma",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmNvbnRyYWN0cGhhcm1hLmNvbS9jb250ZW50cy92aWV3X2JyZWFraW5nLW5ld3MvMjAyMC0wNi0yNC9ibXMtZHVibGluLXNpdGUtd2lucy1pc3BlLWZhY2lsaXR5LW9mLXRoZS15ZWFyLWF3YXJkL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Coronavirus pandemic threatens to delay potentially life-changing new medicines - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMjAvMDYvMTkvY29yb25hdmlydXMtcGFuZGVtaWMtdGhyZWF0ZW5zLXRvLWRlbGF5LXBvdGVudGlhbGx5LWxpZmUtY2hhbmdpbmctbWVkaWNpbmVzLmh0bWzSAXRodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAyMC8wNi8xOS9jb3JvbmF2aXJ1cy1wYW5kZW1pYy10aHJlYXRlbnMtdG8tZGVsYXktcG90ZW50aWFsbHktbGlmZS1jaGFuZ2luZy1tZWRpY2luZXMuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb Hopewell campus sold | Hopewell Express ... - Community News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5jb21tdW5pdHluZXdzLm9yZy90b3ducy9ob3Bld2VsbC1leHByZXNzL2JyaXN0b2wtbXllcnMtc3F1aWJiLWhvcGV3ZWxsLWNhbXB1cy1zb2xkL2FydGljbGVfNGE3ZTJlMzQtMzJjMC01ZjQ2LWFhMGItNmM2ZDk4NTU2YmZjLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol-Myers machine learning to optimize CAR-T - Bioprocess Insider - BioProcess Insider",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL2Jpb3Byb2Nlc3NpbnRsLmNvbS9iaW9wcm9jZXNzLWluc2lkZXIvdGhlcmFwZXV0aWMtY2xhc3MvbmV4LXQtdXAtYnJpc3RvbC1teWVycy11c2luZy1tYWNoaW5lLWxlYXJuaW5nLXRvLW9wdGltaXplLWZ1dHVyZS1jYXItdC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "After Celgene deal, BMS shoots up pharma market cap rankings - pharmaphorum",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL2FmdGVyLWNlbGdlbmUtZGVhbC1ibXMtc2hvb3RzLXVwLXBoYXJtYS1tYXJrZXQtY2FwLXJhbmtpbmdz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "\"Extremely fast-tracked\": Jacobs billion-dollar drugs factory wins ... - Global Construction Review",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3Lmdsb2JhbGNvbnN0cnVjdGlvbnJldmlldy5jb20vZXh0cmVtZWx5LWZhc3QtdHJhY2tlZC1qYWNvYnMtYmlsbGlvbi1kb2xsYXItZHJ1Z3Mv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/12/2020": {
        "artical1": {
            "title": "ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMisAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2FyY2hlcmR4LWVudGVycy1jb2xsYWJvcmF0aW9uLXdpdGgtYnJpc3RvbC1teWVycy1zcXVpYmItdG8tYXBwbHktcGVyc29uYWxpemVkLWNhbmNlci1tb25pdG9yaW5nLXBjbS10by1jbGluaWNhbC1yZXNlYXJjaC0zMDEwNzk0MTMuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Recombinant Antibody Network Partners with Bristol Myers Squibb ... - ucsf.edu",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LnVjc2YuZWR1L25ld3MvMjAyMC8wNi80MTc4NzYvcmVjb21iaW5hbnQtYW50aWJvZHktbmV0d29yay1wYXJ0bmVycy1icmlzdG9sLW15ZXJzLXNxdWliYi1kZXZlbG9wLW5vdmVs0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA Approves Opdivo for Advanced Esophageal Cancer - Immuno-Oncology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8wNi8xMi9mZGEtYXBwcm92ZXMtb3BkaXZvLWZvci1hZHZhbmNlZC1lc29waGFnZWFsLWNhbmNlci_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Maryam Shojaei, trailblazer for women in Iran to watch men's soccer, earns Stuart Scott ENSPIRE Award - ESPN - ESPN India",
            "link": "https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5lc3BuLmluL2VzcHlzL3N0b3J5L18vaWQvMjkzMTQ3OTcvbWFyeWFtLXNob2phZWktYmxhemVkLXRyYWlsLXdvbWVuLWlyYW4td2F0Y2gtbWVuLXNvY2Nlci1lYXJucy1zdHVhcnQtc2NvdHQtZW5zcGlyZS1hd2FyZD9wbGF0Zm9ybT1hbXDSAZMBaHR0cHM6Ly93d3cuZXNwbi5pbi9lc3B5cy9zdG9yeS9fL2lkLzI5MzE0Nzk3L21hcnlhbS1zaG9qYWVpLWJsYXplZC10cmFpbC13b21lbi1pcmFuLXdhdGNoLW1lbi1zb2NjZXItZWFybnMtc3R1YXJ0LXNjb3R0LWVuc3BpcmUtYXdhcmQ_cGxhdGZvcm09YW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "3BL Media Announces 100 Best Corporate Citizens of 2020 - CSRwire.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmNzcndpcmUuY29tL3ByZXNzX3JlbGVhc2VzLzQ1Mjg0LTNibC1tZWRpYS1hbm5vdW5jZXMtMTAwLWJlc3QtY29ycG9yYXRlLWNpdGl6ZW5zLW9mLTIwMjDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Japan's Nichi-Iko jumps on hopes for steroid sales boost to treat ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvaGVhbHRoLWNvcm9uYXZpcnVzLXN0ZXJvaWQtbmljaGktaWtvLWlkVVNMNE4yRFUwVUrSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Novel Antisense Drug Shows Promise in Slowing Fatty Liver Disease - UC San Diego Health",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vaGVhbHRoLnVjc2QuZWR1L25ld3MvcHJlc3MtcmVsZWFzZXMvMjAyMC0wNi0xNi1ub3ZlbC1hbnRpc2Vuc2UtZHJ1Zy1zaG93cy1wcm9taXNlLWluLXNsb3dpbmctZmF0dHktbGl2ZXItZGlzZWFzZS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/05/2020": {
        "artical1": {
            "title": "Opinion | It's time for businesses to finally address racism. Here's how. - The Washington Post",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9vcGluaW9ucy8yMDIwLzA2LzEwL2l0cy10aW1lLWJ1c2luZXNzZXMtZmluYWxseS1hZGRyZXNzLXJhY2lzbS1oZXJlcy1ob3cv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Autobahn Therapeutics Takes Aim at CNS Disorders with $76 ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3dpdGgtNzYtbWlsbGlvbi1mcm9tLWJpb2dlbi1ibXMtYW5kLWFyY2gtdmVudHVyZXMtYXV0b2JhaG4tam9pbnMtdGhlLWh1bnQtZm9yLWNucy10cmVhdG1lbnRzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "IPO Preview: Repare Therapeutics Starts U.S. IPO Plan - IPOs On ... - TheStreet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvcmVwYXJlLXRoZXJhcGV1dGljcy1pcG_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "AstraZeneca Explores Merger With COVID-Drug Developer Gilead ... - Investopedia",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vYXN0cmF6ZW5lY2EtZXhwbG9yZXMtbWVyZ2VyLXdpdGgtY292aWQtZHJ1Zy1kZXZlbG9wZXItZ2lsZWFkLXJlcG9ydC00ODQ3MDk40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Tim Davie appointed as new head of the BBC - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvYnJpdGFpbi1iYmMvdGltLWRhdmllLWFwcG9pbnRlZC1hcy1uZXctaGVhZC1vZi10aGUtYmJjLWlkVVNTOE4yRDQwNE8v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Agency 100 2020: Arteric - MM+M - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiPmh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2FnZW5jeS0xMDAvYWdlbmN5LTEwMC0yMDIwLWFydGVyaWMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Obsidian's SWFT Response to COVID-19 - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL29ic2lkaWFucy1zd2Z0LXJlc3BvbnNlLXRvLWNvdmlkLTE5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/29/2020": {
        "artical1": {
            "title": "Bristol Myers Squibb's Zeposia launches into crowded MS market - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy9icmlzdG9sLW15ZXJzLXNxdWliYi1zLXplcG9zaWEtbGF1bmNoZXMtaW50by1jcm93ZGVkLW11bHRpcGxlLXNjbGVyb3Npcy1tYXJrZXQtYW1pZC1jb3ZpZNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Asco 2020 \u2013 J&J sees multiple myeloma responses deepen - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2NvLTIwMjAtamotc2Vlcy1tdWx0aXBsZS1teWVsb21hLXJlc3BvbnNlcy1kZWVwZW7SASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTg4NC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Asco 2020 \u2013 after Tecentriq\u2019s liver win the spotlight falls on Merck and Astra - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2NvLTIwMjAtYWZ0ZXItdGVjZW50cmlxcy1saXZlci13aW4tc3BvdGxpZ2h0LWZhbGxzLW1lcmNrLWFuZNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1OTAwL2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "China says Canada is an accomplice of U.S. in Huawei case - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VrLXVzYS1odWF3ZWktdGVjaC1jaGluYS1jYW5hZGEvY2hpbmEtc2F5cy1jYW5hZGEtaXMtYW4tYWNjb21wbGljZS1vZi11LXMtaW4taHVhd2VpLWNhc2UtaWRVS0tCTjIzNTEyTy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Google is sued in U.S. for tracking users' 'private' internet browsing - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvYWxwaGFiZXQtZ29vZ2xlLXByaXZhY3ktbGF3c3VpdC1pZFVTTDFOMkRGMjlDL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Roche's Tecentriq gets a green light to challenge Bayer with first-in ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3JvY2hlLXMtdGVjZW50cmlxLWdldHMtYS1ncmVlbi1saWdodC10by1jaGFsbGVuZ2UtYmF5ZXItZmlyc3QtY2xhc3MtbGl2ZXItY2FuY2VyLW5vZNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Coronavirus: Vaccine could be manufactured in Butler County - Hamilton Journal News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmpvdXJuYWwtbmV3cy5jb20vbmV3cy9odWdlLWRvc2VzLWNvcm9uYXZpcnVzLXZhY2NpbmUtY291bGQtbWFkZS13ZXN0LWNoZXN0ZXItd2hhdC1rbm93LW5vdy9nOU56SkxGQXlRQVRDZ2hnazl5b0VPL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/22/2020": {
        "artical1": {
            "title": "BMS Drops $65 Million on Multi-Target Discovery Deal with Repare ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2Jtcy1hbmQtcmVwYXJlLXRoZXJhcGV1dGljcy1mb3JnZS1tdWx0aS10YXJnZXQtZGlzY292ZXJ5LWNvbGxhYm9yYXRpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Repare Therapeutics Announces Multi-Target Discovery ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDUyNjAwNTgwNS9lbi9SZXBhcmUtVGhlcmFwZXV0aWNzLUFubm91bmNlcy1NdWx0aS1UYXJnZXQtRGlzY292ZXJ5LUNvbGxhYm9yYXRpb24td2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol Myers jumps into synthetic lethality with $65M Repare deal - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy1qdW1wcy1pbnRvLXN5bnRoZXRpYy1sZXRoYWxpdHktNjVtLXJlcGFyZS1kZWFs0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Q32 Bio Launches with $46 Million and IL-7 Inhibitor Licensed from ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3EzMi1iaW8tbGF1bmNoZXMtd2l0aC00Ni1taWxsaW9uLWFuZC1pbC03LWluaGliaXRvci1saWNlbnNlZC1mcm9tLWJtcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "UK medtech company Exscientia raises $60 million to apply AI to ... - Tech.eu",
            "link": "https://news.google.com/rss/articles/CBMiLmh0dHBzOi8vdGVjaC5ldS8yMDIwLzA1LzI2L2V4c2NpZW50aWEtZnVuZGluZy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Asco 2020 \u2013 Keytruda a \u201cnew standard\u201d in biomarker-driven cancer - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2NvLTIwMjAta2V5dHJ1ZGEtbmV3LXN0YW5kYXJkLWJpb21hcmtlci1kcml2ZW4tY2FuY2Vy0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTU4ODEvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Follow the Money Behind Anti-Abortion Laws - brennancenter.org",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmJyZW5uYW5jZW50ZXIub3JnL291ci13b3JrL2FuYWx5c2lzLW9waW5pb24vZm9sbG93LW1vbmV5LWJlaGluZC1hbnRpLWFib3J0aW9uLWxhd3PSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/15/2020": {
        "artical1": {
            "title": "Could This Cancer Drug Developer\u2019s Stock Make You Filthy Rich? - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA1LzIwL2NvdWxkLXRoaXMtY2FuY2VyLWRydWctZGV2ZWxvcGVycy1zdG9jay1tYWtlLXlvdS1mLmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Better Buy: Pfizer vs. Bristol Myers Squibb - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA1LzE3L2JldHRlci1idXktcGZpemVyLXZzLWJyaXN0b2wtbXllcnMtc3F1aWJiLmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA approves Pomalyst as first new Kaposi sarcoma treatment in 20 ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDIwMDUxNS9mZGEtYXBwcm92ZXMtcG9tYWx5c3QtYXMtZmlyc3QtbmV3LWthcG9zaS1zYXJjb21hLXRyZWF0bWVudC1pbi0yMC15ZWFyc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "3 Stocks to Buy Ahead of the Next Market Crash - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA1LzE1LzMtc3RvY2tzLXRvLWJ1eS1haGVhZC1vZi10aGUtbmV4dC1tYXJrZXQtY3Jhc2guYXNweNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "J&J holds its own on sales per employee - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9qai1ob2xkcy1pdHMtb3duLXNhbGVzLWVtcGxveWVl0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTU3ODkvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "For Advanced NSCLC, FDA Approves Opdivo-Yervoy as First-line ... - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20vMjAyMC8wNS8xOS9mZGEtYXBwcm92ZXMtb3BkaXZvLXllcnZveS1jb21iby1maXJzdC1saW5lLXRyZWF0bWVudC1hZHZhbmNlZC1uc2NsYy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "UK firms using COVID borrowing scheme face dividend and bonus ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWhlYWx0aC1jb3JvbmF2aXJ1cy1icml0YWluLWJvZS91ay1maXJtcy11c2luZy1jb3ZpZC1ib3Jyb3dpbmctc2NoZW1lLWZhY2UtZGl2aWRlbmQtYW5kLWJvbnVzLWN1cmJzLWlkVVNLQk4yMlYwU0ov0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/08/2020": {
        "artical1": {
            "title": "Is Bristol Myers Squibb Losing Its Edge As A Growth Stock? - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvaXMtYnJpc3RvbC1teWVycy1zcXVpYmItbG9zaW5nLWl0cy1lZGdlLWFzLWEtZ3Jvd3RoLXN0b2NrLTIwMjAtMDUtMTPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "FDA Decision on Liso-cel for Large B-cell Lymphoma Due in ... - Lymphoma News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL2x5bXBob21hbmV3c3RvZGF5LmNvbS8yMDIwLzA1LzExL2ZkYS1kZWNpc2lvbi1vbi1saXNvLWNlbC1jYXItdC1jZWxsLXRoZXJhcHktYWR2YW5jZWQtbGFyZ2UtYi1jZWxsLWx5bXBob21hLWR1ZS1pbi1ub3ZlbWJlci_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "NJ has 17 children with coronavirus-like syndrome like Kawasaki ... - NorthJersey.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5ub3J0aGplcnNleS5jb20vc3RvcnkvbmV3cy9jb3JvbmF2aXJ1cy8yMDIwLzA1LzEzL25qLWhhcy0xOC1jaGlsZHJlbi1jb3JvbmF2aXJ1cy1saWtlLXN5bmRyb21lLWxpa2Uta2F3YXNha2ktZGlzZWFzZS81MTg0MzIzMDAyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Fostering Diversity and Inclusion - njbmagazine.com",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vbmpibWFnYXppbmUuY29tL21vbnRobHktYXJ0aWNsZXMvZm9zdGVyaW5nLWRpdmVyc2l0eS1hbmQtaW5jbHVzaW9uL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Bristol Myers Squibb registra unas p\u00e9rdidas de 716 millones en el ... - PlantaDoce",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LnBsYW50YWRvY2UuY29tL2VtcHJlc2EvYnJpc3RvbC1teWVycy1zcXVpYmItcmVnaXN0cmEtdW5hcy1wZXJkaWRhcy1kZS03MTYtbWlsbG9uZXMtZW4tZWwtcHJpbWVyLXRyaW1lc3RyZS5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Tip of the Week: Medication Dispensing and Storage Technology in ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvdGlwLW9mLXRoZS13ZWVrLW1lZGljYXRpb24tZGlzcGVuc2luZy1hbmQtc3RvcmFnZS10ZWNobm9sb2d5LWluLXRoZS1ob3NwaXRhbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol Myers Squibb \u304c AWS Storage Gateway \u3092\u4f7f\u7528\u3057\u3066 ... - AWS Blog",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vYXdzLmFtYXpvbi5jb20vanAvYmxvZ3MvbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1pbmNyZWFzZXMtcGVyZm9ybWFuY2UtYW5kLWNvc3Qtc2F2aW5ncy11c2luZy1hd3Mtc3RvcmFnZS1nYXRld2F5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/01/2020": {
        "artical1": {
            "title": "Another delay for Bristol Myers cell therapy as FDA extends review - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1teWVycy1saXNvLWNlbC1kZWxheS1mZGEtcmV2aWV3LzU3NzQ4Ni_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Neoadjuvant Nivolumab 'Promising' in Merkel Cell Carcinoma - Medscape",
            "link": "https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85MzAxMTXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "A tale of two drug launches during coronavirus - MM+M Online",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9hLXRhbGUtb2YtdHdvLWRydWctbGF1bmNoZXMtZHVyaW5nLWNvcm9uYXZpcnVzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Golden State Warriors news: ESPN to shift focus of 2020 ESPYs - Golden State of Mind",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LmdvbGRlbnN0YXRlb2ZtaW5kLmNvbS8yMDIwLzUvNS8yMTI0ODY3NC9nb2xkZW4tc3RhdGUtd2FycmlvcnMtbmV3cy1lc3BuLWVzcHlz0gFmaHR0cHM6Ly93d3cuZ29sZGVuc3RhdGVvZm1pbmQuY29tL3BsYXRmb3JtL2FtcC8yMDIwLzUvNS8yMTI0ODY3NC9nb2xkZW4tc3RhdGUtd2FycmlvcnMtbmV3cy1lc3BuLWVzcHlz?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Nivolumab-Based Tx Effective in Early, Unfavorable Hodgkin's - Medpage Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3Lm1lZHBhZ2V0b2RheS5jb20vaGVtYXRvbG9neW9uY29sb2d5L2hlbWF0b2xvZ3kvODYyNjTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "5 Ways to Tell Eli Lilly to Ban Near-Drowning Tests on Mice! - PETA",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiJmh0dHBzOi8vd3d3LnBldGEub3JnL2FjdGlvbi9lbGktbGlsbHkv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Novartis beats Merck KGaA to U.S. finish line with targeted lung ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vdmFydGlzLWJlYXRzLW1lcmNrLWtnYWEtdG8tZmluaXNoLWxpbmUtdGFyZ2V0ZWQtbHVuZy1jYW5jZXItZHJ1Zy1jYXBtYXRpbmli0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/24/2020": {
        "artical1": {
            "title": "Roche looks set to retain its place at the top of big pharma rankings - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9yb2NoZS1sb29rcy1zZXQtcmV0YWluLWl0cy1wbGFjZS10b3AtYmlnLXBoYXJtYS1yYW5raW5nc9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1NzkyL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Payback beyond borders: Philly profs, pharma pros aided China as virus hit. Now PPE arrives, in thanks - The Philadelphia Inquirer",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmlucXVpcmVyLmNvbS9idXNpbmVzcy9waGlsbHlkZWFscy9jb3ZpZC0xOS1jaGluYS1waGlsYWRlbHBoaWEtd3VoYW4tdGVtcGxlLWJyaXN0b2wtbXllcnMtYWlkLW1hc2tzLTIwMjAwNDI3Lmh0bWzSAYsBaHR0cHM6Ly93d3cuaW5xdWlyZXIuY29tL2J1c2luZXNzL3BoaWxseWRlYWxzL2NvdmlkLTE5LWNoaW5hLXBoaWxhZGVscGhpYS13dWhhbi10ZW1wbGUtYnJpc3RvbC1teWVycy1haWQtbWFza3MtMjAyMDA0MjcuaHRtbD9vdXRwdXRUeXBlPWFtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Long term forecasts confirm Keytruda\u2019s dominance - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvbG9uZy10ZXJtLWZvcmVjYXN0cy1jb25maXJtLWtleXRydWRhcy1kb21pbmFuY2XSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTgwMC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "New Technology from Vivtex Accelerates Speed and Accuracy of ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMi8QFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDQyNzAwNTUxNi9lbi9OZXctVGVjaG5vbG9neS1mcm9tLVZpdnRleC1BY2NlbGVyYXRlcy1TcGVlZC1hbmQtQWNjdXJhY3ktb2YtVGVzdGluZy1NZXRob2RzLWFuZC1Gb3JtdWxhdGlvbnMtdG8tSW5jcmVhc2UtRHJ1Zy1BYnNvcnB0aW9uLWluLXRoZS1HSS1UcmFjdC1mb3ItdGhlLURldmVsb3BtZW50LW9mLU5vdmVsLU9yYWwtVGhlcmFwZXV0aWNz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Merrill Lynch-Occupied Complex in Hopewell Township Trades for $95M - Globe St.",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3Lmdsb2Jlc3QuY29tLzIwMjAvMDQvMzAvbWVycmlsbC1seW5jaC1vY2N1cGllZC1jb21wbGV4LWluLWhvcGV3ZWxsLXRvd25zaGlwLXRyYWRlcy1mb3ItOTVtL9IBbGh0dHBzOi8vd3d3Lmdsb2Jlc3QuY29tLzIwMjAvMDQvMzAvbWVycmlsbC1seW5jaC1vY2N1cGllZC1jb21wbGV4LWluLWhvcGV3ZWxsLXRvd25zaGlwLXRyYWRlcy1mb3ItOTVtLz9hbXA9MQ?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Government loses case claiming $325M over generic Plavix delay - Lawyerly",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lmxhd3llcmx5LmNvbS5hdS9jb21tb253ZWFsdGgtbG9zZXMtYmlkLWZvci0zMjVtLW92ZXItZ2VuZXJpYy1wbGF2aXgtZGVsYXkv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "IPO Restart: ADC Therapeutics Refiles For U.S. IPO - IPOs On ... - TheStreet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vd3d3LnRoZXN0cmVldC5jb20vaXBvL25ld3MvYWRjLXRoZXJhcGV1dGljcy11cy1pcG_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/17/2020": {
        "artical1": {
            "title": "Bristol Myers says Opdivo performs well in kidney, lung cancer trials - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtYnJpc3RvbG15ZXJzLWNhbmNlci1pZFVTS0JOMjIyMjVO0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "RPT-Drug trial specialists see coronavirus-fueled spike in demand ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvaGVhbHRoLWNvcm9uYXZpcnVzLXZpcnR1YWx0cmlhbHMtaWRVU0w4TjJDNTNSNdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Drug trial specialists see coronavirus-fueled spike in demand for ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvaGVhbHRoLWNvcm9uYXZpcnVzLXZpcnR1YWx0cmlhbHMtaWRVU0w0TjJCTjVTTC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Atopic Dermatitis Drugs Market: Exponential Growth of Biologic ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2F0b3BpYy1kZXJtYXRpdGlzLWRydWdzLW1hcmtldC1leHBvbmVudGlhbC1ncm93dGgtb2YtYmlvbG9naWMtZHJ1Z3MtZmF2b3ItbWFya2V0LWdyb3d0aC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "PGDx promotes Megan Bailey to CEO - Technical.ly",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vdGVjaG5pY2FsLmx5L3N0YXJ0dXBzL3BnZHgtcGVyc29uYWwtZ2Vub21lLWRpYWdub3N0aWNzLXByb21vdGVzLW1lZ2FuLWJhaWxleS1jZW8tZG91Zy13YXJkLXJlc2lnbnMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Biotech company Amgen expanding its Tampa operations hub - Tampa Bay Times",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnRhbXBhYmF5LmNvbS9uZXdzL2J1c2luZXNzLzIwMjAvMDQvMjMvYmlvdGVjaC1jb21wYW55LWFtZ2VuLWV4cGFuZGluZy1pdHMtdGFtcGEtb3BlcmF0aW9ucy1odWIv0gF6aHR0cHM6Ly93d3cudGFtcGFiYXkuY29tL25ld3MvYnVzaW5lc3MvMjAyMC8wNC8yMy9iaW90ZWNoLWNvbXBhbnktYW1nZW4tZXhwYW5kaW5nLWl0cy10YW1wYS1vcGVyYXRpb25zLWh1Yi8_b3V0cHV0VHlwZT1hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "If You Invested $10,000 in Gilead Sciences' IPO, This Is How Much ... - The Motley Fool",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDIwLzA0LzE5L2lmLXlvdS1pbnZlc3RlZC0xMDAwLWluLWdpbGVhZC1zY2llbmNlcy1pcG8tdGhpcy1pLmFzcHjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/10/2020": {
        "artical1": {
            "title": "Buy, Sell, Or Hold Bristol-Myers Squibb At $60? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMC8wNC8xNS9idXktc2VsbC1vci1ob2xkLWJyaXN0b2wtbXllcnMtc3F1aWJiLWF0LTYwL9IBamh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMC8wNC8xNS9idXktc2VsbC1vci1ob2xkLWJyaXN0b2wtbXllcnMtc3F1aWJiLWF0LTYwL2FtcC8?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Nantkwest And Immunitybio Announce Therapeutics And Vaccines ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMisQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2JyaWVmLW5hbnRrd2VzdC1hbmQtaW1tdW5pdHliaW8tYW5ub3VuY2UvYnJpZWYtbmFudGt3ZXN0LWFuZC1pbW11bml0eWJpby1hbm5vdW5jZS10aGVyYXBldXRpY3MtYW5kLXZhY2NpbmVzLWZvci1jb21iYXR0aW5nLWNvdmlkLTE5LWlkVVNBU0EwMEtOSC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Analysis of COVID-19-Global Antiviral Drugs Market 2020-2024 ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMixAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDQxNTAwNTUyMy9lbi9BbmFseXNpcy1vZi1DT1ZJRC0xOS1HbG9iYWwtQW50aXZpcmFsLURydWdzLU1hcmtldC0yMDIwLTIwMjQtRXZvbHZpbmctT3Bwb3J0dW5pdGllcy13aXRoLUFiYlZpZS1JbmMuLWFuZC1CcmlzdG9sLU15ZXJzLVNxdWliYi1Dby4tVGVjaG5hdmlv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "World's Best Investment Banks 2020: Deals Of The Year - Global Finance",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vZ2ZtYWcuY29tL2F3YXJkL2F3YXJkLXdpbm5lcnMvd29ybGRzLWJlc3QtaW52ZXN0bWVudC1iYW5rcy0yMDIwLWRlYWxzLXllYXIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "World's Best Investment Banks 2020: M&A - Global Finance",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZ2ZtYWcuY29tL2F3YXJkL2F3YXJkLXdpbm5lcnMvd29ybGRzLWJlc3QtaW52ZXN0bWVudC1iYW5rcy0yMDIwLW1lcmdlcnMtYWNxdWlzaXRpb25zL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Boeing to resume Washington airplane production next week - Bothell-Kenmore Reporter",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmJvdGhlbGwtcmVwb3J0ZXIuY29tL2J1c2luZXNzL2JvZWluZy10by1yZXN1bWUtd2FzaGluZ3Rvbi1haXJwbGFuZS1wcm9kdWN0aW9uLW5leHQtd2Vlay_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Rothschild Investment Corp Buys Lockheed Martin Corp, Bristol ... - GuruFocus.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi0QFodHRwczovL3d3dy5ndXJ1Zm9jdXMuY29tL25ld3MvMTEwNjY3NS9yb3Roc2NoaWxkLWludmVzdG1lbnQtY29ycC1idXlzLWxvY2toZWVkLW1hcnRpbi1jb3JwLWJyaXN0b2xteWVycy1zcXVpYmItY29tcGFueS1zeXNjby1jb3JwLXNlbGxzLXJveWFsLWNhcmliYmVhbi1jcnVpc2VzLWNvbnN0ZWxsYXRpb24tYnJhbmRzLWluYy1nb2xkbWFuLXNhY2hzLWdyb3VwLWluY9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/03/2020": {
        "artical1": {
            "title": "Bristol Myers, Acceleron's Reblozyl moves closer to blockbusterland ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2JyaXN0b2wtbXllcnMtYWNjZWxlcm9uLXMtcmVibG96eWwtbW92ZXMtY2xvc2VyLXRvLWJsb2NrYnVzdGVyLWxhbmQtbmV3LWJsb29kLWRpc29yZGVyc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Nivolumab Plus Ipilimumab Under Review for First-Line Treatment ... - Monthly Prescribing Reference",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmVtcHIuY29tL2hvbWUvbmV3cy9kcnVncy1pbi10aGUtcGlwZWxpbmUvbml2b2x1bWFiLXBsdXMtaXBpbGltdW1hYi11bmRlci1yZXZpZXctZm9yLWZpcnN0LWxpbmUtdHJlYXRtZW50LW9mLW5zY2xjL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Certain Vaccines in Children with pJIA on Orencia Maintain ... - Juvenile Arthritis News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vanV2ZW5pbGVhcnRocml0aXNuZXdzLmNvbS8yMDIwLzA0LzAzL2NlcnRhaW4tdmFjY2luZXMtaW4tY2hpbGRyZW4td2l0aC1wamlhLW9uLW9yZW5jaWEtbWFpbnRhaW4tZWZmZWN0aXZlbmVzcy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Aspirin Okay for Up to 30 Days in A-fib Patients After ACS or PCI ... - TCTMD",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2FzcGlyaW4tb2theS0zMC1kYXlzLWZpYi1wYXRpZW50cy1hZnRlci1hY3Mtb3ItcGNpLWF1Z3VzdHVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "These pharmaceutical companies are the top inventors and innovators - Fortune",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vZm9ydHVuZS5jb20vMjAyMC8wNC8wNi90b3AtcGhhcm1hY2V1dGljYWwtY29tcGFuaWVzLWlubm92YXRpb24taW52ZW50aW9uLTIwMjAv0gFaaHR0cHM6Ly9mb3J0dW5lLmNvbS8yMDIwLzA0LzA2L3RvcC1waGFybWFjZXV0aWNhbC1jb21wYW5pZXMtaW5ub3ZhdGlvbi1pbnZlbnRpb24tMjAyMC9hbXAv?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "How the CARES Act affects COVID-19 test pricing | Brookings - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvaG93LXRoZS1jYXJlcy1hY3QtYWZmZWN0cy1jb3ZpZC0xOS10ZXN0LXByaWNpbmcv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Adapting Biopharma Launches in the COVID-19 Landscape - Pharmaceutical Executive",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy9hZGFwdGluZy1iaW9waGFybWEtbGF1bmNoZXMtY292aWQtMTktbGFuZHNjYXBl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/27/2020": {
        "artical1": {
            "title": "Bristol Myers Squibb Says BLA Submission Includes Results From ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiuAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2JyaWVmLWJyaXN0b2wtbXllcnMtc3F1aWJiLXNheXMtYmxhLXN1Ym0vYnJpZWYtYnJpc3RvbC1teWVycy1zcXVpYmItc2F5cy1ibGEtc3VibWlzc2lvbi1pbmNsdWRlcy1yZXN1bHRzLWZyb20tcGl2b3RhbC1waGFzZS0yLWthcm1tYS1zdHVkeS1pZFVTQVNBMDBKSDUv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol Myers Receives Positive CHMP Opinion On Zeposia For ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi4QFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2JyaWVmLWJyaXN0b2wtbXllcnMtcmVjZWl2ZXMtcG9zaXRpdmUtY2gvYnJpZWYtYnJpc3RvbC1teWVycy1yZWNlaXZlcy1wb3NpdGl2ZS1jaG1wLW9waW5pb24tb24temVwb3NpYS1mb3ItdHJlYXRtZW50LW9mLWFkdWx0LXBhdGllbnRzLXdpdGgtbXVsdGlwbGUtc2NsZXJvc2lzLXdpdGgtYWN0aXZlLWRpc2Vhc2UtaWRVS0ZXTjJCSzBVOS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "15 of the Best Dividend Stocks to Buy for 2020 - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy8xNS1iZXN0LWRpdmlkZW5kLXN0b2Nrcy1idXktMTgxOTU1NDMzLmh0bWzSAVFodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy8xNS1iZXN0LWRpdmlkZW5kLXN0b2Nrcy1idXktMTgxOTU1NDMzLmh0bWw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "ACC: J&J, Bayer's blood thinner Xarelto scores in artery disease ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FjYy1qLWotYmF5ZXItcy1ibG9vZC10aGlubmVyLXhhcmVsdG8tc2NvcmVzLXRyaWFsLXdpbi1hcnRlcnktZGlzZWFzZS1hZnRlci1zdXJnZXJ50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Equinor to quit U.S. lobby group over climate policy - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtZXF1aW5vci1sb2JieWluZy1pZFVTS0JOMjFFMktVL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Saudi Arabia approves IPO stock listings of government assets ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMipgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3NhdWRpLWNhYmluZXQtY29tcGFuaWVzL3VwZGF0ZS0xLXNhdWRpLWFyYWJpYS1hcHByb3Zlcy1pcG8tc3RvY2stbGlzdGluZ3Mtb2YtZ292ZXJubWVudC1hc3NldHMtcGxhbm5lZC1mb3ItcHJpdmF0aXNhdGlvbi1pZFVTTDhOMkJPOEJF0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "GE Healthcare Life Sciences is Now Cytiva - Pharmaceutical Technology Magazine",
            "link": "https://news.google.com/rss/articles/CBMiR2h0dHBzOi8vd3d3LnBoYXJtdGVjaC5jb20vdmlldy9nZS1oZWFsdGhjYXJlLWxpZmUtc2NpZW5jZXMtbm93LWN5dGl2YS0w0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/20/2020": {
        "artical1": {
            "title": "What Will Drive Bristol-Myers Squibb\u2019s $42 Billion Revenue In 2020? - Forbes",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMC8wMy8yMy93aGF0LXdpbGwtZHJpdmUtYnJpc3RvbC1teWVycy1zcXVpYmJzLTQyLWJpbGxpb24tcmV2ZW51ZS1pbi0yMDIwL9IBf2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAyMC8wMy8yMy93aGF0LXdpbGwtZHJpdmUtYnJpc3RvbC1teWVycy1zcXVpYmJzLTQyLWJpbGxpb24tcmV2ZW51ZS1pbi0yMDIwL2FtcC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "China suspends Bristol-Myers' cancer drug sales over findings at ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiR2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtYnJpc3RvbC1teWVycy1hYnJheGFuZS1pZFVTS0JOMjFDMjZP0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "China halts import of Bristol Myers cancer drug after inspection at ... - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hpbmEtaGFsdC1pbXBvcnQtYWJyYXhhbmUtYnJpc3RvbC1teWVycy1iZWlnZW5lLzU3NDg3OC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "U.S. FDA approves Bristol-Myers MS drug, launch delayed due to ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWJyaXN0b2wtbXllcnMtZmRhL3Utcy1mZGEtYXBwcm92ZXMtYnJpc3RvbC1teWVycy1tcy1kcnVnLWxhdW5jaC1kZWxheWVkLWR1ZS10by1jb3JvbmF2aXJ1cy1pZElOS0JOMjFEMUdTL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Regenacy Pharma Earns $30 Million Series A to Advance Diabetic ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3JlZ2VuYWN5LXBoYXJtYS1jbG9zZXMtYS0zMC1taWxsaW9uLXNlcmllcy1hL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Logged On From the Laundry Room: How the C.E.O.s of Google ... - The New York Times",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMjAvMDMvMjMvYnVzaW5lc3MvY29ybmVyLW9mZmljZS1jb3JvbmF2aXJ1cy5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "One-fifth of JIA Patients Switch Out 1st Biological Therapy, UK Study ... - Juvenile Arthritis News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL2p1dmVuaWxlYXJ0aHJpdGlzbmV3cy5jb20vMjAyMC8wMy8yMC9vbmUtZmlmdGgtb2YtamlhLXBhdGllbnRzLXByZXNjcmliZWQtc2Vjb25kLWxpbmUtYmlvbG9naWNhbC10aGVyYXB5LXVrLXN0dWR5LXJlcG9ydHMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/13/2020": {
        "artical1": {
            "title": "Bristol Myers nabs M&A pro with $200B in deals under her belt to ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtbmFicy1tLWEtcHJvLTIwMGItZGVhbHMtdW5kZXItaGVyLWJlbHQtdG8taGVsbS1idXNpbmVzcy1kZXZlbG9wbWVudNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb in action to support fight against COVID-19 - SHINE News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiLGh0dHBzOi8vd3d3LnNoaW5lLmNuL2Jpei9jb21wYW55LzIwMDMxNzQ0NTkv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "What are the health coverage provisions in the House coronavirus ... - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvd2hhdC1hcmUtdGhlLWhlYWx0aC1jb3ZlcmFnZS1wcm92aXNpb25zLWluLXRoZS1ob3VzZS1jb3JvbmF2aXJ1cy1iaWxsL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "What do I do if I lose my job-based health insurance? | Brookings - Brookings Institution",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvd2hhdC1kby1pLWRvLWlmLWktbG9zZS1teS1qb2ItYmFzZWQtaGVhbHRoLWluc3VyYW5jZS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "MM&M unveils its 2020 Hall of Femme and Women to Watch honorees - MM+M Online",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5tbW0tb25saW5lLmNvbS9ob21lL2NoYW5uZWwvZmVhdHVyZXMvaGFsbC1vZi1mZW1tZS9tbW0tdW52ZWlscy1pdHMtMjAyMC1tbW0taGFsbC1vZi1mZW1tZS1hbmQtd29tZW4tdG8td2F0Y2gtaG9ub3JlZXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "The Top 25 Biotech CEOs of 2020 - The Healthcare Technology Report.",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vdGhlaGVhbHRoY2FyZXRlY2hub2xvZ3lyZXBvcnQuY29tL3RoZS10b3AtMjUtYmlvdGVjaC1jZW9zLW9mLTIwMjAv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Bowel cancer mum 'facing death sentence' amid drugs uncertainty - BBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiNmh0dHBzOi8vd3d3LmJiYy5jby51ay9uZXdzL3VrLWVuZ2xhbmQtc3VmZm9say01MTg1MjA2MNIBOmh0dHBzOi8vd3d3LmJiYy5jby51ay9uZXdzL3VrLWVuZ2xhbmQtc3VmZm9say01MTg1MjA2MC5hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/06/2020": {
        "artical1": {
            "title": "Bristol Myers Squibb taps Voluntis to build a digital cancer ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvYnJpc3RvbC1teWVycy1zcXVpYmItdGFwcy12b2x1bnRpcy10by1idWlsZC1hLWRpZ2l0YWwtY2FuY2VyLWNvbXBhbmlvbi1hcHDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Empliciti\u2019s front-line flop underlines Darzalex\u2019s dominance - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9lbXBsaWNpdGlzLWZyb250LWxpbmUtZmxvcC11bmRlcmxpbmVzLWRhcnphbGV4cy1kb21pbmFuY2XSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTYzMi9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Takeda's Ninlaro swings and misses in newly diagnosed myeloma - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3Rha2VkYS1zLW5pbmxhcm8tc3dpbmdzLWFuZC1taXNzZXMtbmV3bHktZGlhZ25vc2VkLW15ZWxvbWHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Life Sciences Partners Raises \u20ac528M Life Sciences Investment Fund - Labiotech.eu",
            "link": "https://news.google.com/rss/articles/CBMiRmh0dHBzOi8vd3d3LmxhYmlvdGVjaC5ldS90cmVuZHMtbmV3cy9saWZlLXNjaWVuY2VzLXBhcnRuZXJzLWZ1bmRyYWlzZS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Whole Foods Loses Bid to Trim Employee Class Action - Courthouse News Service",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmNvdXJ0aG91c2VuZXdzLmNvbS93aG9sZS1mb29kcy1sb3Nlcy1iaWQtdG8tdHJpbS1lbXBsb3llZS1jbGFzcy1hY3Rpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "New ARISTOTLE Data 'Reassuring' on Lower Apixaban Dose - TCTMD",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL25ldy1hcmlzdG90bGUtZGF0YS1yZWFzc3VyaW5nLWxvd2VyLWFwaXhhYmFuLWRvc2XSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Another Court Takes A Bite Out Of Forum Shopping: Plaintiffs Must ... - JD Supra",
            "link": "https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3Lmpkc3VwcmEuY29tL2xlZ2FsbmV3cy9hbm90aGVyLWNvdXJ0LXRha2VzLWEtYml0ZS1vdXQtb2YtZm9ydW0tNDM0OTEv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/28/2020": {
        "artical1": {
            "title": "Bristol Myers Squibb unveils new branding, will phase out Celgene ... - MM+M Online",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9icmlzdG9sLW15ZXJzLXNxdWliYi11bnZlaWxzLW5ldy1icmFuZGluZy13aWxsLXBoYXNlLW91dC1jZWxnZW5lLWJyYW5kL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Advanced Ovarian Cancer Therapy COM701 Shows Promise Early ... - Ovarian Cancer News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vb3ZhcmlhbmNhbmNlcm5ld3N0b2RheS5jb20vMjAyMC8wMi8yOC9jb203MDEtc2hvd3MtcHJvbWlzZS1vdmFyaWFuLWNhbmNlci1vdGhlci1zb2xpZC10dW1vcnMtZWFybHktcmVzdWx0cy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "AbbVie, GSK, Sanofi and more limit employee travel as coronavirus ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2RydWdtYWtlcnMtaW1wbGVtZW50cy10cmF2ZWwtcmVzdHJpY3Rpb25zLWFzLWNvcm9uYXZpcnVzLXRocmVhdGVucy1idXNpbmVzc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Pharmacists Can Play Key Role in Drug Repurposing - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvcGhhcm1hY2lzdHMtY2FuLXBsYXkta2V5LXJvbGUtaW4tZHJ1Zy1yZXB1cnBvc2luZ9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Obituary for William Carlton Moore of Pinehurst - Sandhill Sentinel",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vc2FuZGhpbGxzc2VudGluZWwuY29tL29iaXR1YXJ5LWZvci13aWxsaWFtLWNhcmx0b24tbW9vcmUtb2YtcGluZWh1cnN0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Sequential gemcitabine/docetaxel promising for recurrent NMIBC - Urology Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LnVyb2xvZ3l0aW1lcy5jb20vdmlldy9zZXF1ZW50aWFsLWdlbWNpdGFiaW5lZG9jZXRheGVsLXByb21pc2luZy1yZWN1cnJlbnQtbm1pYmPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "JAK inhibitors show promise in psoriasis, atopic dermatitis - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9kZXJtYXRvbG9neS8yMDIwMDIyNy9qYWstaW5oaWJpdG9ycy1zaG93LXByb21pc2UtaW4tcHNvcmlhc2lzLWF0b3BpYy1kZXJtYXRpdGlz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/21/2020": {
        "artical1": {
            "title": "Ex-BMS exec jumps to Gilead to lead research group - PMLiVE - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX2FwcG9pbnRtZW50cy9leC1ibXNfZXhlY19qdW1wc190b19naWxlYWRfdG9fbGVhZF9yZXNlYXJjaF9ncm91cF8xMzI2Njky0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "FDA Approves Generic Albuterol Sulfate Inhalation Aerosol - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvZmRhLWFwcHJvdmVzLWdlbmVyaWMtYWxidXRlcm9sLXN1bGZhdGUtaW5oYWxhdGlvbi1hZXJvc29s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA Clears Bempedoic Acid Non-statin LDL-cholesterol Lowering ... - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vYXJ0aWNsZS9mZGEtY2xlYXJzLWJlbXBlZG9pYy1hY2lkLW5vbi1zdGF0aW4tbGRsLWNob2xlc3Rlcm9sLWxvd2VyaW5nLWRydWfSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Team Dynamics: 15 Life Sciences Organizations Leading the Way - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RlYW0tZHluYW1pY3MtMTUtbGlmZS1zY2llbmNlcy1vcmdhbml6YXRpb25zLWxlYWRpbmctdGhlLXdheS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMi6wFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy9tYXBrdXJlLWJlaWdlbmUtYW5kLXNwcmluZ3dvcmtzLWFubm91bmNlLWluaXRpYXRpb24tb2YtcGhhc2UtMS1jbGluaWNhbC10cmlhbC1vZi1iZ2ItMzI0NS1hLXNlbGVjdGl2ZS1uZXh0LWdlbmVyYXRpb24tYi1yYWYtaW5oaWJpdG9yLWluLWFkdWx0LXBhdGllbnRzLXdpdGgtYWR2YW5jZWQtb3ItcmVmcmFjdG9yeS1zb2xpZC10dW1vcnMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Joint replacement fails to eliminate, prevent ultrasound synovitis in RA - Healio",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9yaGV1bWF0b2xvZ3kvMjAyMDAyMjUvam9pbnQtcmVwbGFjZW1lbnQtZmFpbHMtdG8tZWxpbWluYXRlLXByZXZlbnQtbXJpLXN5bm92aXRpcy1pbi1yYdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Can protein degraders unlock \u2018undruggable\u2019 drug targets? - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX2ludGVsbGlnZW5jZS9DYW5fcHJvdGVpbl9kZWdyYWRlcnNfdW5sb2NrX3VuZHJ1Z2dhYmxlX2RydWdfdGFyZ2V0c18xMzI1NjU20gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/14/2020": {
        "artical1": {
            "title": "Drug at center of $1.7B BMS, Five Prime partnership fails in Phase II ... - MedCity News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjAvMDIvZHJ1Zy1hdC1jZW50ZXItb2YtMS03Yi1ibXMtZml2ZS1wcmltZS1wYXJ0bmVyc2hpcC1mYWlscy1pbi1waGFzZS1paS1wYW5jcmVhdGljLWNhbmNlci1zdHVkeS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "'A gutless decision' - Worcester Telegram",
            "link": "https://news.google.com/rss/articles/CBMiqwFodHRwczovL3d3dy50ZWxlZ3JhbS5jb20vc3RvcnkvbmV3cy9sb2NhbC9ub3J0aC8yMDIwLzAyLzE5L2ZhdGhlci1hbWFuZGEtZGFicm93c2tpLXdvbWFuLXNsYWluLW9jb25ub3JzLXJlc3RhdXJhbnQtd29yY2VzdGVyLWZvY3VzZXMtY2xvc2luZy1sb29waG9sZS1sYWJvci1sYXcvMTY3MjI3NjAwNy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "For Large B-cell Lymphoma, FDA to Review CAR T-cell Therapy ... - Lymphoma News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigwFodHRwczovL2x5bXBob21hbmV3c3RvZGF5LmNvbS8yMDIwLzAyLzE4L2Nhci10LWNlbGwtdGhlcmFweS1saXNvLWNlbC1mZGEtcHJpb3JpdHktcmV2aWV3LXJlbGFwc2VkLXJlZnJhY3RvcnktbGFyZ2UtYi1jZWxsLWx5bXBob21hL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Keytruda stumbles, but remains dominant - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMva2V5dHJ1ZGEtc3R1bWJsZXMtcmVtYWlucy1kb21pbmFudNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1NDk2L2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Asco-GU: confirmation for Seattle and a reminder for Mirati - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2NvLWd1LWNvbmZpcm1hdGlvbi1zZWF0dGxlLWFuZC1yZW1pbmRlci1taXJhdGnSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTU3MC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Opdivo (nivolumab) Plus Yervoy (ipilimumab) Demonstrates ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMi4gFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy9vcGRpdm8tbml2b2x1bWFiLXBsdXMteWVydm95LWlwaWxpbXVtYWItZGVtb25zdHJhdGVzLWNvbnRpbnVlZC1zdXJ2aXZhbC1iZW5lZml0LWF0LTQyLW1vbnRoLWZvbGxvdy11cC1pbi1wYXRpZW50cy13aXRoLXByZXZpb3VzbHktdW50cmVhdGVkLWFkdmFuY2VkLW9yLW1ldGFzdGF0aWMtcmVuYWwtY2VsbC1jYXJjaW5vbWEv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Domestic violence law change would extend job protection for victims - Worcester Telegram",
            "link": "https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy50ZWxlZ3JhbS5jb20vc3RvcnkvbmV3cy9sb2NhbC9zb3V0aC13ZXN0LzIwMjAvMDIvMTgvY2hhbmdlLWluLWxhdy13b3VsZC1leHRlbmQtcHJvdGVjdGlvbi1mb3ItdmljdGltcy1saWtlLXNsYWluLXdlYnN0ZXItd29tYW4vMTY4MjU3OTAwNy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/07/2020": {
        "artical1": {
            "title": "Celgene drugs drive BMS to a buoyant Q4, but Opdivo stalls - PMLiVE - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvY2VsZ2VuZV9kcnVnc19kcml2ZV9ibXNfdG9fYV9idW95YW50X3E0LF9idXRfb3BkaXZvX3N0YWxsc18xMzI0NDk10gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "What Are Bristol-Myers Squibb's Top 3 Drugs? - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvd2hhdC1hcmUtYnJpc3RvbC1teWVycy1zcXVpYmJzLXRvcC0zLWRydWdzLTIwMjAtMDItMTDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Trump Eyes Drug-Price Cuts After His Health-Care Record Is Attacked - Bloomberg",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIwLTAyLTEwL3RydW1wLWV5ZXMtZHJ1Zy1wcmljZS1jdXRzLWFmdGVyLWhpcy1oZWFsdGgtY2FyZS1yZWNvcmQtYXNzYWlsZWTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Merck chases Roche with triple-negative breast cancer data for ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvbWVyY2tfY2hhc2VzX3JvY2hlX3dpdGhfdHJpcGxlLW5lZ2F0aXZlX2JyZWFzdF9jYW5jZXJfZGF0YV9mb3Jfa2V5dHJ1ZGFfMTMyNTYyMdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Media Resources | AACR Newsroom - American Association for Cancer Research (AACR)",
            "link": "https://news.google.com/rss/articles/CBMiPWh0dHBzOi8vd3d3LmFhY3Iub3JnL2Fib3V0LXRoZS1hYWNyL25ld3Nyb29tL21lZGlhLXJlc291cmNlcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Novel drug targets tumor growth in advanced kidney cancer - Harvard Gazette",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vbmV3cy5oYXJ2YXJkLmVkdS9nYXpldHRlL3N0b3J5LzIwMjAvMDIvbm92ZWwtZHJ1Zy10YXJnZXRzLXR1bW9yLWdyb3d0aC1pbi1hZHZhbmNlZC1raWRuZXktY2FuY2VyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Review finds treatments associated with highest PASI response ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvZGVybWF0b2xvZ3kvMjAyMDAyMTAvcmV2aWV3LWZpbmRzLXRyZWF0bWVudHMtYXNzb2NpYXRlZC13aXRoLWhpZ2hlc3QtcGFzaS1yZXNwb25zZS1yYXRlcy1pbi1wbGFxdWUtcHNvcmlhc2lz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/31/2020": {
        "artical1": {
            "title": "CORRECTED-UPDATE 1-Bristol-Myers Squibb pulls Opdivo+ ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2JyaXN0b2wtbXllcnMtb3BkaXZvL2NvcnJlY3RlZC11cGRhdGUtMS1icmlzdG9sLW15ZXJzLXNxdWliYi1wdWxscy1vcGRpdm95ZXJ2b3ktbHVuZy1hcHBsaWNhdGlvbi1pbi1ldXJvcGUtaWRVU0wxTjJBMDIzNy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "What Are Bristol-Myers Squibb's Top 3 Drugs? - Trefis",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LnRyZWZpcy5jb20vc3RvY2svYm15L2FydGljbGVzLzQ4MjEzMi93aGF0LWFyZS1icmlzdG9sLW15ZXJzLXNxdWliYnMtdG9wLTMtZHJ1Z3MvMjAyMC0wMi0wNNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BioMotiv announces appointment of Satish Jindal as CEO - Crain's Cleveland Business",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmNyYWluc2NsZXZlbGFuZC5jb20vaGVhbHRoLWNhcmUvYmlvbW90aXYtYW5ub3VuY2VzLWFwcG9pbnRtZW50LXNhdGlzaC1qaW5kYWwtY2Vv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "After losing its CMO last summer, CytomX Therapeutics finally nabs ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWZ0ZXItbG9zaW5nLWl0cy1jbW8tbGFzdC1zdW1tZXItY3l0b214LXRoZXJhcGV1dGljcy1maW5hbGx5LW5hYnMtYS1yZXBsYWNlbWVudNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Metuchen hires new borough administrator - centraljersey.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vY2VudHJhbGplcnNleS5jb20vMjAyMC8wMi8wNS9tZXR1Y2hlbi1oaXJlcy1uZXctYm9yb3VnaC1hZG1pbmlzdHJhdG9yL9IBUmh0dHBzOi8vY2VudHJhbGplcnNleS5jb20vMjAyMC8wMi8wNS9tZXR1Y2hlbi1oaXJlcy1uZXctYm9yb3VnaC1hZG1pbmlzdHJhdG9yLz9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Global dealmaking gets off to sluggish start in 2020 - Financial Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50LzJmNzk4ZTU0LTQ1NzAtMTFlYS1hZWIzLTk1NTgzOWUwNjQ0MdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Edison official tapped as Metuchen borough administrator - My Central Jersey",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5teWNlbnRyYWxqZXJzZXkuY29tL3N0b3J5L25ld3MvbG9jYWwvbWlkZGxlc2V4LWNvdW50eS8yMDIwLzAyLzA1L2VkaXNvbi1uai1vZmZpY2lhbC10YXBwZWQtbWV0dWNoZW4tYm9yb3VnaC1hZG1pbmlzdHJhdG9yLzQ2NTQ3ODMwMDIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/24/2020": {
        "artical1": {
            "title": "OncoCyte Launches NSCLC Stratification Test, Looks beyond Lung ... - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2dlbi1lZGdlL29uY29jeXRlLWxhdW5jaGVzLW5zY2xjLXN0cmF0aWZpY2F0aW9uLXRlc3QtbG9va3MtYmV5b25kLWx1bmctY2FuY2VyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "DTC Perspectives Announces 2020 Top 25 Marketers of the Year - DTC Perspectives Magazine",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmR0Y3BlcnNwZWN0aXZlcy5jb20vZHRjLXBlcnNwZWN0aXZlcy1hbm5vdW5jZXMtMjAyMC10b3AtMjUtbWFya2V0ZXJzLXllYXIv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Acceleron\u2019s post-Reblozyl plan comes together - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9hY2NlbGVyb25zLXBvc3QtcmVibG96eWwtcGxhbi1jb21lcy10b2dldGhlctIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1NTAwL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Wall St slides on coronavirus fears, Intel offers support - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXNhLXN0b2Nrcy1pZFVTTDROMjlUMlJOL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Understanding Axial Spondyloarthritis: A Primer for Managed Care - AJMC.com Managed Markets Network",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LmFqbWMuY29tL3ZpZXcvYXhpYWwtc3BvbmR5bG9hcnRocml0aXMtcHJpbWVyLWZvci1tYW5hZ2VkLWNhcmXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Rutgers RWJ Medical School partners with The Marisa Tufaro ... - My Central Jersey",
            "link": "https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy5teWNlbnRyYWxqZXJzZXkuY29tL3N0b3J5L25ld3MvaGVhbHRoLzIwMjAvMDEvMzAvcnV0Z2Vycy1yd2otbWVkaWNhbC1zY2hvb2wtcGFydG5lcnMtbWFyaXNhLXR1ZmFyby1mb3VuZGF0aW9uLzQ1OTQxNjYwMDIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "The 34 best hospitals and health systems for diversity, according to ... - The Daily Briefing",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vd3d3LmFkdmlzb3J5LmNvbS9kYWlseS1icmllZmluZy8yMDIwLzAxLzI3L2ZvcmJlcy1kaXZlcnNpdHnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/17/2020": {
        "artical1": {
            "title": "Building A Commons: How Bristol-Myers Squibb And BioTeam Used ... - Bio-IT World",
            "link": "https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5iaW8taXR3b3JsZC5jb20vbmV3cy8yMDIwLzAxLzIyL2J1aWxkaW5nLWEtY29tbW9ucy1ob3ctYnJpc3RvbC1teWVycy1zcXVpYmItYW5kLWJpb3RlYW0tdXNlZC1nZW4zLXRvLWJ1aWxkLWEtbmV3LWRhdGEtcGFyYWRpZ23SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "PBM rebates lower premiums for healthy people, but don't bring ... - MedCity News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMjAvMDEvcGJtLXJlYmF0ZXMtbG93ZXItcHJlbWl1bXMtZm9yLWhlYWx0aHktcGVvcGxlLWJ1dC1kb250LWJyaW5nLWRvd24tZHJ1Zy1jb3N0cy1ibXMtZXhlYy1zYXlzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Notes and Takeaways from JPM 2020 - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRmh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2luc2lnaHRzL25vdGVzLWFuZC10YWtlYXdheXMtZnJvbS1qcG0tMjAyMC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Fitbit rolls out blood oxygen tracking with an eye toward FDA ... - FierceHealthcare",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LmZpZXJjZWhlYWx0aGNhcmUuY29tL3RlY2gvZml0Yml0LXJvbGxzLW91dC1ibG9vZC1veHlnZW4tdHJhY2tpbmctZXllLXRvd2FyZC1mZGEtY2xlYXJhbmNlLWZvci1zbGVlcC1hcG5lYS1kaWFnbm9zaXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Michigan, Tesla reach agreement for direct car delivery: source - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtdGVzbGEtbWljaGlnYW4taWRVU0tCTjFaSzJMUNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "'This Is Us' Star Sterling K. Brown Says He and Randall Pearson ... - Prevention Magazine",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LnByZXZlbnRpb24uY29tL2hlYWx0aC9tZW50YWwtaGVhbHRoL2EzMDYyNzU1MS90aGlzLWlzLXVzLXN0ZXJsaW5nLWstYnJvd24tcmFuZGFsbC1wZWFyc29uLWNvbm5lY3Rpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Patients with moderate PsA disease more likely to meet treatment ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvcmhldW1hdG9sb2d5LzIwMjAwMTIyL3BhdGllbnRzLXdpdGgtbW9kZXJhdGUtcHNhLWRpc2Vhc2UtbW9yZS1saWtlbHktdG8tbWVldC10cmVhdG1lbnQtdGFyZ2V0cy13aXRoLWFwcmVtaWxhc3TSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/10/2020": {
        "artical1": {
            "title": "Evotec, Bristol-Myers Squibb Expand Alliance - Contract Pharma",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmNvbnRyYWN0cGhhcm1hLmNvbS9jb250ZW50cy92aWV3X2JyZWFraW5nLW5ld3MvMjAyMC0wMS0xNC9ldm90ZWMtYnJpc3RvbC1teWVycy1zcXVpYmItZXhwYW5kLWFsbGlhbmNlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Pharma Giant Bristol-Myers Squibb Bans Near-Drowning Test - News - PETA Australia",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LnBldGEub3JnLmF1L25ld3MvYnJpc3RvbC1teWVycy1zcXVpYmItYmFucy1mb3JjZWQtc3dpbS10ZXN0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Global Blood Cancer Therapeutics Market 2019-2023 | Evolving ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMivQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDExNDAwNTMzOC9lbi9HbG9iYWwtQmxvb2QtQ2FuY2VyLVRoZXJhcGV1dGljcy1NYXJrZXQtMjAxOS0yMDIzLUV2b2x2aW5nLU9wcG9ydHVuaXRpZXMtd2l0aC1Ob3ZhcnRpcy1BRy1hbmQtQnJpc3RvbC1NeWVycy1TcXVpYmItQ29tcGFueS1UZWNobmF2aW_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Pharma's 2019 TV spending ticks up\u2014barely\u2014thanks to big Humira ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3BoYXJtYS10di1hZC1zcGVuZGluZy1mb3ItMjAxOS1maW5pc2hlcy1mbGF0LWNvbXBhcmVkLXRvLXByZXZpb3VzLXllYXLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "King's College London Ends a Cruel Test on Animals - PETA",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vd3d3LnBldGEub3JnL2Jsb2cvdmljdG9yeS1raW5ncy1jb2xsZWdlLWxvbmRvbi1lbmRzLWZvcmNlZC1zd2ltLXRlc3Qv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Barer Institute Announces Founding Board Members - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvYmFyZXItaW5zdGl0dXRlLWFubm91bmNlcy1mb3VuZGluZy1ib2FyZC1tZW1iZXJzLTMwMDk4NjA3OC5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Deceptive efforts by opioid makers and distributors intensified crisis of addiction and death in Canada, class action says - Business in Vancouver",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vYml2LmNvbS9hcnRpY2xlLzIwMjAvMDEvZGVjZXB0aXZlLWVmZm9ydHMtb3Bpb2lkLW1ha2Vycy1hbmQtZGlzdHJpYnV0b3JzLWludGVuc2lmaWVkLWNyaXNpcy1hZGRpY3Rpb24tYW5k0gF1aHR0cHM6Ly9iaXYuY29tL2FydGljbGUvMjAyMC8wMS9kZWNlcHRpdmUtZWZmb3J0cy1vcGlvaWQtbWFrZXJzLWFuZC1kaXN0cmlidXRvcnMtaW50ZW5zaWZpZWQtY3Jpc2lzLWFkZGljdGlvbi1hbmQ_YW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/03/2020": {
        "artical1": {
            "title": "We Did It! Bristol-Myers Squibb Bans Forced Swim Test - PETA",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LnBldGEub3JnL2Jsb2cvYnJpc3RvbC1teWVycy1zcXVpYmItZW5kcy1mb3JjZWQtc3dpbS10ZXN0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers, Sanofi Sue Hawaii Over Plavix Marketing Case - Bloomberg",
            "link": "https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDIwLTAxLTA4L2JyaXN0b2wtbXllcnMtc2Fub2ZpLXN1ZS1oYXdhaWktb3Zlci1wbGF2aXgtbWFya2V0aW5nLWNhc2XSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Dr. Thomas J. Lynch Jr. named new president and director of Fred ... - Fred Hutchinson Cancer Center",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmZyZWRodXRjaC5vcmcvZW4vbmV3cy9jZW50ZXItbmV3cy8yMDIwLzAxL2RyLXRob21hcy1qLWx5bmNoLW5hbWVkLW5ldy1wcmVzaWRlbnQtYW5kLWRpcmVjdG9yLWZyZWQtaHV0Y2guaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Global Neuroblastoma Drugs Market 2019-2023 | Evolving ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiswFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDIwMDEwNzAwNTcwNi9lbi9HbG9iYWwtTmV1cm9ibGFzdG9tYS1EcnVncy1NYXJrZXQtMjAxOS0yMDIzLUV2b2x2aW5nLU9wcG9ydHVuaXRpZXMtd2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYi1hbmQtSm9obnNvbi1Kb2huc29uLVRlY2huYXZpb9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "The top 10 largest biopharma M&A deals in 2019 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTEwLWxhcmdlc3QtYmlvcGhhcm1hLW0tYS1kZWFscy0yMDE50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Potential Lymphoma Therapy Liso-cel Submitted for FDA Approval - Lymphoma News Today",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vbHltcGhvbWFuZXdzdG9kYXkuY29tLzIwMjAvMDEvMDcvcG90ZW50aWFsLWx5bXBob21hLXRoZXJhcHktbGlzby1jZWwtc3VibWl0dGVkLWZvci1mZGEtYXBwcm92YWwv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Kitov Pharma Announces Closing of FameWave Acquisition - GlobeNewswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9lbi9uZXdzLXJlbGVhc2UvMjAyMC8wMS8wOC8xOTY3NzY3LzAvZW4vS2l0b3YtUGhhcm1hLUFubm91bmNlcy1DbG9zaW5nLW9mLUZhbWVXYXZlLUFjcXVpc2l0aW9uLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/27/2019": {
        "artical1": {
            "title": "Gilead, Biogen, GSK, Pfizer and Others Increase List Prices of Some ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3BoYXJtYS1jb21wYW5pZXMtcmluZy1pbi10aGUtbmV3LXllYXItd2l0aC1hbm51YWwtbGlzdC1wcmljZS1pbmNyZWFzZXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Revlimid-Rituximab Combo for Pre-treated Follicular Lymphoma ... - Lymphoma News Today",
            "link": "https://news.google.com/rss/articles/CBMigAFodHRwczovL2x5bXBob21hbmV3c3RvZGF5LmNvbS8yMDIwLzAxLzAyL3JldmxpbWlkLXJpdHV4aW1hYi1jb21iby1hcHByb3ZlZC1pbi1ldXJvcGUtZm9yLXByZXZpb3VzbHktdHJlYXRlZC1mb2xsaWN1bGFyLWx5bXBob21hL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Objective Subtle Cognitive Difficulties Predict Amyloid Accumulation ... - UC San Diego Health",
            "link": "https://news.google.com/rss/articles/CBMikgFodHRwczovL2hlYWx0aC51Y3NkLmVkdS9uZXdzL3ByZXNzLXJlbGVhc2VzLzIwMTktMTItMzAtb2JqZWN0aXZlLXN1YnRsZS1jb2duaXRpdmUtZGlmZmljdWx0aWVzLXByZWRpY3QtYW15bG9pZC1hY2N1bXVsYXRpb24tYW5kLW5ldXJvZGVnZW5lcmF0aW9uL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "The new paid family leave: Companies giving workers time to be ... - The Washington Post",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9idXNpbmVzcy8yMDE5LzEyLzMwL25ldy1wYWlkLWZhbWlseS1sZWF2ZS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Michel Andy Townsend, Football Coach, Assisted Texas A & M to the Finals in One of His Greatest Career Highlights - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9taWNoZWwtYW5keS10b3duc2VuZC1mb290YmFsbC1jb2FjaC0xNDUwMDA4NDUuaHRtbNIBWWh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL21pY2hlbC1hbmR5LXRvd25zZW5kLWZvb3RiYWxsLWNvYWNoLTE0NTAwMDg0NS5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "EXCEL Trial Authors Say European Surgery Society Claims of Bad ... - Diagnostic and Interventional Cardiology",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9leGNlbC10cmlhbC1hdXRob3JzLXNheS1ldXJvcGVhbi1zdXJnZXJ5LXNvY2lldHktY2xhaW1zLWJhZC1zY2llbmNlLWFyZS1ncm91bmRsZXNz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "7 M&As That Defined a Decade of Dealmaking\u2014and Reshaped the Economy - Fortune",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vZm9ydHVuZS5jb20vMjAxOS8xMi8yNy9tZXJnZXJzLWFuZC1hY3F1aXNpdGlvbnMtbS1hbmQtYS10aGlzLWRlY2FkZS0yMDEwcy11cy1lY29ub215L9IBYWh0dHBzOi8vZm9ydHVuZS5jb20vMjAxOS8xMi8yNy9tZXJnZXJzLWFuZC1hY3F1aXNpdGlvbnMtbS1hbmQtYS10aGlzLWRlY2FkZS0yMDEwcy11cy1lY29ub215L2FtcC8?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/20/2019": {
        "artical1": {
            "title": "FDA approves first generic of Bristol-Myers, Pfizer's blood thinner ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLW15bGFuLW5sLWZkYS1icmlzdG9sLW15ZXJzL2ZkYS1hcHByb3Zlcy1maXJzdC1nZW5lcmljLW9mLWJyaXN0b2wtbXllcnMtcGZpemVycy1ibG9vZC10aGlubmVyLWVsaXF1aXMtaWRVU0tCTjFZUjIwVy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "FDA clears first generics of Pfizer/BMS' anticoagulant Eliquis - PMLiVE - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvZmRhX2NsZWFyc19maXJzdF9nZW5lcmljc19vZl9wZml6ZXJibXNfYW50aWNvYWd1bGFudF9lbGlxdWlzXzEzMjA5MDDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Sarepta makes history with Roche deal - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvZGVhbHMvc2FyZXB0YS1tYWtlcy1oaXN0b3J5LXJvY2hlLWRlYWzSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTQyOS9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Ustekinumab beneficial through 1 year in SLE - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5oZWFsaW8uY29tL3JoZXVtYXRvbG9neS9sdXB1cy9uZXdzL29ubGluZS8lN0JhY2M2ZGU4NC0xYTUzLTQzMTYtOWM1Ni1iZmQ0NzJhNmQzYzElN0QvdXN0ZWtpbnVtYWItYmVuZWZpY2lhbC10aHJvdWdoLTEteWVhci1pbi1zbGXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Is it feasible to change the immunotherapy dose schedule for a ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvaGVtYXRvbG9neS1vbmNvbG9neS8yMDE5MTIyMC9pcy1pdC1mZWFzaWJsZS10by1jaGFuZ2UtdGhlLWltbXVub3RoZXJhcHktZG9zZS1zY2hlZHVsZS1mb3ItYS1wYXRpZW50LWluLWNvbXBsZXRlLXJlc3BvbnNl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Nigeria orders release of Sowore, Dasuki, heeding court orders ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL25pZ2VyaWEtcG9saXRpY3MvbmlnZXJpYS1vcmRlcnMtcmVsZWFzZS1vZi1zb3dvcmUtZGFzdWtpLWhlZWRpbmctY291cnQtb3JkZXJzLWF0dG9ybmV5LWdlbmVyYWwtaWRVU0w4TjI4WTFTOC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Most Important Drugs Over the Past 10 Years - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL21vc3QtaW1wb3J0YW50LWRydWdzLW92ZXItdGhlLXBhc3QtMTAteWVhcnMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/13/2019": {
        "artical1": {
            "title": "Bristol-Myers wins $752 million in U.S. patent case against Gilead - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtYnJpc3RvbC1teWVycy1naWxlYWQtc2NpZW5jZXMtcGF0ZW50LWlkVVNLQk4xWUgyQlMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "After jumping the BMS-Celgene ship, Paul Biondi boards Flagship ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWZ0ZXItanVtcGluZy1ibXMtY2VsZ2VuZS1zaGlwLXBhdWwtYmlvbmRpLWJvYXJkcy1mbGFnc2hpcC1waW9uZWVyaW5n0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "WindMIL Therapeutics Announces Clinical Research Collaboration ... - GlobeNewswire",
            "link": "https://news.google.com/rss/articles/CBMi_AFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAxOS8xMi8xOS8xOTYyNjg1LzAvZW4vV2luZE1JTC1UaGVyYXBldXRpY3MtQW5ub3VuY2VzLUNsaW5pY2FsLVJlc2VhcmNoLUNvbGxhYm9yYXRpb24td2l0aC1CcmlzdG9sLU15ZXJzLVNxdWliYi10by1FdmFsdWF0ZS1NYXJyb3ctSW5maWx0cmF0aW5nLUx5bXBob2N5dGVzLU1JTHMtaW4tQ29tYmluYXRpb24td2l0aC1uaXZvbHVtYWItT3BkaXZvLWZvci1ULmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Gilead owes BMS millions after losing Yescarta patent infringement ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvZ2lsZWFkX293ZXNfYm1zX21pbGxpb25zX2FmdGVyX2xvc2luZ195ZXNjYXJ0YV9wYXRlbnRfaW5mcmluZ2VtZW50X3RyaWFsXzEzMjAyMzjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Industry Leaders Eye Health Equity Through Community Programs - PatientEngagementHIT.com",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vcGF0aWVudGVuZ2FnZW1lbnRoaXQuY29tL25ld3MvaW5kdXN0cnktbGVhZGVycy1leWUtaGVhbHRoLWVxdWl0eS10aHJvdWdoLWNvbW11bml0eS1wcm9ncmFtc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Cancer risk slightly higher among patients treated with abatacept - Healio",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9yaGV1bWF0b2xvZ3kvMjAxOTEyMTYvY2FuY2VyLXJpc2stc2xpZ2h0bHktaGlnaGVyLWFtb25nLXBhdGllbnRzLXRyZWF0ZWQtd2l0aC1hYmF0YWNlcHTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Roche to complete $4.3 billion Spark deal as regulators give all clear - Reuters",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLXNwYXJrLW0tYS1yb2NoZS91LXMtYW50aXRydXN0LWVuZm9yY2Vycy1naXZlLXJvY2hlLWFwcHJvdmFsLXRvLWJ1eS1zcGFyay10aGVyYXBldXRpY3MtaWRVU0tCTjFZSzI2Mi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/06/2019": {
        "artical1": {
            "title": "Deal of the Year: Bristol-Myers Squibb buys Celgene - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYnJpc3RvbC1teWVycy1idXlzLWNlbGdlbmUtZGVhbC1kaXZlLWF3YXJkcy81NjYyNDQv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "After Its Celgene Acquisition, Bristol-Myers Squibb's Future Looks ... - Nasdaq",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvYWZ0ZXItaXRzLWNlbGdlbmUtYWNxdWlzaXRpb24tYnJpc3RvbC1teWVycy1zcXVpYmJzLWZ1dHVyZS1sb29rcy1icmlnaHQtMjAxOS0xMi0xMtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Ash 2019 \u2013 Johnson & Johnson overshadows Bluebird\u2019s registrational reveal - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2gtMjAxOS1qb2huc29uLWpvaG5zb24tb3ZlcnNoYWRvd3MtYmx1ZWJpcmRzLXJlZ2lzdHJhdGlvbmFs0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTUzNzkvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "How Yardley Went From Quaint, Sleepy Suburb to Happening River ... - Philadelphia magazine",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LnBoaWxseW1hZy5jb20vbmV3cy8yMDE5LzEyLzA3L3lhcmRsZXktdmF1bHQtYnJld3B1Yi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Analysis: Large pharma companies do little new drug innovation ... - STAT",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzEyLzEwL2xhcmdlLXBoYXJtYS1jb21wYW5pZXMtcHJvdmlkZS1saXR0bGUtbmV3LWRydWctZGV2ZWxvcG1lbnQtaW5ub3ZhdGlvbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Port Reading Fire Department and EMS deliver holiday cheer with ... - My Central Jersey",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3Lm15Y2VudHJhbGplcnNleS5jb20vc3RvcnkvbmV3cy8yMDE5LzEyLzA3L3BvcnQtcmVhZGluZy1maXJlLWRlcGFydG1lbnQtYW5kLWVtcy1kZWxpdmVyLWhvbGlkYXktY2hlZXIvNDM3MjMzOTAwMi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Ash 2019 \u2013 Roche doesn\u2019t disappoint with bispecific - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9hc2gtMjAxOS1yb2NoZS1kb2VzbnQtZGlzYXBwb2ludC1iaXNwZWNpZmlj0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTUzODAvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/29/2019": {
        "artical1": {
            "title": "In Early Active pSS, Orencia Fails to Reduce Disease Activity... - Sjogren's Syndrome News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL3Nqb2dyZW5zc3luZHJvbWVuZXdzLmNvbS9uZXdzL29yZW5jaWEtZmFpbHMtdG8tcmVkdWNlLWRpc2Vhc2UtYWN0aXZpdHktaW4tcGF0aWVudHMtd2l0aC1lYXJseS1hY3RpdmUtcHJpbWFyeS1zam9ncmVucy1zeW5kcm9tZS10cmlhbC1zaG93cy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Merck's Keytruda is bound for new bladder cancer territory. But can it ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2tleXRydWRhLW5hYnMtZmRhLXF1aWNrLXJldmlldy1mb3ItbmV3LWJsYWRkZXItY2FuY2VyLXVzZS1hLWdlbmUtdGhlcmFweS1icmVhdGhpbmctZG93btIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Shared Decision Making Its Impact On Clinical Trial Consideration - Clinical Leader",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmNsaW5pY2FsbGVhZGVyLmNvbS9kb2Mvc2hhcmVkLWRlY2lzaW9uLW1ha2luZy1pdHMtaW1wYWN0LW9uLWNsaW5pY2FsLXRyaWFsLWNvbnNpZGVyYXRpb24tMDAwMdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Top 10 Immuno-Oncology Startups of 2019 - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2EtbGlzdHMvdG9wLTEwLWltbXVuby1vbmNvbG9neS1zdGFydHVwcy1vZi0yMDE5L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "1 in 3 older Eliquis users at risk for 'potentially serious' interactions - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9wcmltYXJ5LWNhcmUvMjAxOTEyMDQvMS1pbi0zLW9sZGVyLWVsaXF1aXMtdXNlcnMtYXQtcmlzay1mb3ItcG90ZW50aWFsbHktc2VyaW91cy1pbnRlcmFjdGlvbnPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Hundreds of New Jersey high school swimmers will help children in ... - My Central Jersey",
            "link": "https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5teWNlbnRyYWxqZXJzZXkuY29tL3N0b3J5L3Nwb3J0cy9oaWdoLXNjaG9vbC8yMDE5LzEyLzAxL2h1bmRyZWRzLW5ldy1qZXJzZXktaGlnaC1zY2hvb2wtc3dpbW1lcnMtaGVscC1jaGlsZHJlbi1uZWVkLzQzNDk0ODMwMDIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "German basal cell carcinoma guidelines strengthen global consensus - Dermatology Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LmRlcm1hdG9sb2d5dGltZXMuY29tL3ZpZXcvZ2VybWFuLWJhc2FsLWNlbGwtY2FyY2lub21hLWd1aWRlbGluZXMtc3RyZW5ndGhlbi1nbG9iYWwtY29uc2Vuc3Vz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/22/2019": {
        "artical1": {
            "title": "What Percent Does Bristol-Myers Squibb Spend On R&D, 30%, 40%, Or 50%? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxOS8xMS8yOC93aGF0LXBlcmNlbnQtZG9lcy1icmlzdG9sLW15ZXJzLXNxdWliYi1zcGVuZC1vbi1yZC0zMC00MC1vci01MC_SAX1odHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMTkvMTEvMjgvd2hhdC1wZXJjZW50LWRvZXMtYnJpc3RvbC1teWVycy1zcXVpYmItc3BlbmQtb24tcmQtMzAtNDAtb3ItNTAvYW1wLw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb completes acquisition of Celgene - European Pharmaceutical Review",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmV1cm9wZWFucGhhcm1hY2V1dGljYWxyZXZpZXcuY29tL25ld3MvMTA2Mjg4L2JyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBsZXRlcy1hY3F1aXNpdGlvbi1vZi1jZWxnZW5lL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Global Sickle Cell Disease Treatment Market 2019-2023| Evolving ... - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMitwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MTEyMjAwNTI5Ny9lbi9HbG9iYWwtU2lja2xlLUNlbGwtRGlzZWFzZS1UcmVhdG1lbnQtTWFya2V0LTIwMTktMjAyMy1Fdm9sdmluZy1PcHBvcnR1bml0aWVzLXdpdGgtQURETUVESUNBLWFuZC1CcmlzdG9sLU15ZXJzLVNxdWliYi1UZWNobmF2aW_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Esmo-Asia \u2013 Avastin could be Roche\u2019s secret sauce in liver cancer - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvc25pcHBldHMvZXNtby1hc2lhLWF2YXN0aW4tY291bGQtYmUtcm9jaGVzLXNlY3JldC1zYXVjZS1saXZlci1jYW5jZXLSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTMxMS9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "RA remission with abatacept, methotrexate best maintained by ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvcmhldW1hdG9sb2d5LzIwMTkxMTI3L3JhLXJlbWlzc2lvbi13aXRoLWFiYXRhY2VwdC1tZXRob3RyZXhhdGUtYmVzdC1tYWludGFpbmVkLWJ5LWNvbnRpbnVlZC10cmVhdG1lbnTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Bristol-Myers Squibb completa la adquisici\u00f3n de Celgene 65.000 ... - PlantaDoce",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LnBsYW50YWRvY2UuY29tL2VtcHJlc2EvYnJpc3RvbC1teWVycy1zcXVpYmItY29tcGxldGEtbGEtYWRxdWlzaWNpb24tZGUtY2VsZ2VuZS02NTAwMC1taWxsb25lcy1kZS1ldXJvcy5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Is it feasible to commute between countries for work? - SiliconRepublic.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LnNpbGljb25yZXB1YmxpYy5jb20vcGVvcGxlL2Jtcy1hbmRyZXctZ2lsbW9yZS1ob21lLWZyb20taG9tZdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/15/2019": {
        "artical1": {
            "title": "BMS completes $74bn Celgene acquisition - PharmaTimes - PharmaTimes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LnBoYXJtYXRpbWVzLmNvbS9uZXdzL2Jtc19jb21wZXRlc18kNzRibl9jZWxnZW5lX2FjcXVpc2l0aW9uXzEzMTc4NDTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS Completes $74 Billion Celgene Takeover - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2RvbmUtYm1zLWFuZC1jZWxnZW5lLW1lcmdlci1jb21wbGV0ZS03NC1iaWxsaW9uLW1lcmdlci_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Squibb Completes Acquisition of Celgene, Creating a ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MTEyMDAwNTkyOS9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi1Db21wbGV0ZXMtQWNxdWlzaXRpb24tb2YtQ2VsZ2VuZS1DcmVhdGluZy1hLUxlYWRpbmctQmlvcGhhcm1hLUNvbXBhbnnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb wins antitrust approval to buy Celgene, but ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtY2VsZ2VuZS1tLWEtYnJpc3RvbC1teWVycy1pZFVTS0JOMVhQMkNI0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Keytruda overtakes Opdivo in Q3 sales to reach $3.1bn - European Pharmaceutical Review",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmV1cm9wZWFucGhhcm1hY2V1dGljYWxyZXZpZXcuY29tL25ld3MvMTA1ODA3L2tleXRydWRhLW92ZXJ0YWtlcy1vcGRpdm8taW4tcTMtc2FsZXMtdG8tcmVhY2gtMy0xYm4v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Amgen Completes Otezla Acquisition - Contract Pharma",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmNvbnRyYWN0cGhhcm1hLmNvbS9jb250ZW50cy92aWV3X2JyZWFraW5nLW5ld3MvMjAxOS0xMS0yMS9hbWdlbi1jb21wbGV0ZXMtb3RlemxhLWFjcXVpc2l0aW9uL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Roche to Acquire Fibrosis-Focused Promedior for Up to $1.4 Billion - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3JvY2hlLXNuYXBzLXVwLWlwZi1haW1lZC10aGVyYXBldXRpYy1pbi1hY3F1aXNpdGlvbi1vZi1wcm9tZWRpb3Iv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/08/2019": {
        "artical1": {
            "title": "Celgene's drug for anemia in beta thalassemia priced at $3441/ 25 ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWNlbGdlbmUtZmRhL2NlbGdlbmVzLWRydWctZm9yLWFuZW1pYS1pbi1iZXRhLXRoYWxhc3NlbWlhLXByaWNlZC1hdC0zNDQxLTI1LW1nLXZpYWwtaWRVU0tCTjFYSTI1TS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Celgene, Acceleron Win FDA OK for Drug to Treat Anemia in Adults ... - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvY2VsZ2VuZS1hY2NlbGVyb24td2luLWZkYS1vay1mb3ItZHJ1Zy10by10cmVhdC1hbmVtaWEtaW4tYWR1bHRzLXdpdGgtYmV0YS10aGFsYXNzZW1pYS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "GlobalData Discloses Top 20 Pharma Rankings | McDonnell ... - JD Supra",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3Lmpkc3VwcmEuY29tL2xlZ2FsbmV3cy9nbG9iYWxkYXRhLWRpc2Nsb3Nlcy10b3AtMjAtcGhhcm1hLTk5ODc0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bob Feldman rolls out Dialogue Project - PR Week",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LnByd2Vlay5jb20vYXJ0aWNsZS8xNjY1NDM1L2JvYi1mZWxkbWFuLXJvbGxzLWRpYWxvZ3VlLXByb2plY3TSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Pomalyst (Pomalidomide) - Myeloma Research News",
            "link": "https://news.google.com/rss/articles/CBMiNmh0dHBzOi8vbXllbG9tYXJlc2VhcmNobmV3cy5jb20vcG9tYWx5c3QtcG9tYWxpZG9taWRlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Anticoagulant Benefits for Atrial Fibrillation Decrease With Age - ucsf.edu",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LnVjc2YuZWR1L25ld3MvMjAxOS8xMS80MTU4OTYvYW50aWNvYWd1bGFudC1iZW5lZml0cy1hdHJpYWwtZmlicmlsbGF0aW9uLWRlY3JlYXNlLWFnZdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "'Simple' Way to Stop, Restart DOACs for Surgery in Atrial Fib - Medscape",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85MjEwMTXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/01/2019": {
        "artical1": {
            "title": "After being bumped by BMS, ex-CSO Lynch lands as chair of Kleo ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYWZ0ZXItYmVpbmctYnVtcGVkLWJ5LWJtcy1pdHMtZXgtY3NvLWx5bmNoLWxhbmRzLWFzLWNoYWlyLWtsZW8tcGhhcm1h0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Specialty chemical company relocating HQ to former Bristol-Myers ... - NJBIZ",
            "link": "https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vbmpiaXouY29tL2NvbGxpZXJzLXNlY3VyZXMtbGVhc2UtZm9ybWVyLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBsZXgv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "8minute to build massive solar-plus-storage plant to serve LA utility - Renewables Now",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vcmVuZXdhYmxlc25vdy5jb20vbmV3cy84bWludXRlLXRvLWJ1aWxkLW1hc3NpdmUtc29sYXItcGx1cy1zdG9yYWdlLXBsYW50LXRvLXNlcnZlLWxhLXV0aWxpdHktNjc1NDI4L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "U.S. solar firms see growth in fire-stricken California - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvY2FsaWZvcm5pYS13aWxkZmlyZS1zb2xhci91LXMtc29sYXItZmlybXMtc2VlLWdyb3d0aC1pbi1maXJlLXN0cmlja2VuLWNhbGlmb3JuaWEtaWRVU0wyTjI3RzFGSy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "[Event] Rx Drug Advertising and Promotion Executive Think Tank ... - JD Supra",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3Lmpkc3VwcmEuY29tL2xlZ2FsbmV3cy9ldmVudC1yeC1kcnVnLWFkdmVydGlzaW5nLWFuZC1wcm9tb3Rpb24tNTE3NzEv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Positive Data for the Ranger Drug-coated Balloon and Eluvia ... - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9wb3NpdGl2ZS1kYXRhLXJhbmdlci1kcnVnLWNvYXRlZC1iYWxsb29uLWFuZC1lbHV2aWEtdmFzY3VsYXItc3RlbnTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "BMW surprises with a strong third quarter - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9ibXctYmVhdHMtZXhwZWN0YXRpb25zLXdpdGgtYS1zdHJvbmctdGhpcmQtcXVhcnRlci0wOTAyNDc0OTIuaHRtbNIBaGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2Jtdy1iZWF0cy1leHBlY3RhdGlvbnMtd2l0aC1hLXN0cm9uZy10aGlyZC1xdWFydGVyLTA5MDI0NzQ5Mi5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/25/2019": {
        "artical1": {
            "title": "Amgen exits neuroscience R&D as pharma pulls back from field - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZXhpdHMtbmV1cm9zY2llbmNlLXJkLWFzLXBoYXJtYS1wdWxscy1iYWNrLWZyb20tZmllbGQvNTY2MTU3L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "IDO Inhibitor Development Shows Fresh Signs of Life Across Tumor ... - OncLive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3Lm9uY2xpdmUuY29tL3ZpZXcvaWRvLWluaGliaXRvci1kZXZlbG9wbWVudC1zaG93cy1mcmVzaC1zaWducy1vZi1saWZlLWFjcm9zcy10dW1vci10eXBlc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Google parent company Alphabet eyeing acquisition of Fitbit ... - FierceHealthcare",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmZpZXJjZWhlYWx0aGNhcmUuY29tL3RlY2gvZ29vZ2xlLXBhcmVudC1jb21wYW55LWFscGhhYmV0LWV5ZWluZy1hY3F1aXNpdGlvbi1maXRiaXQtYWNjb3JkaW5nLXRvLW1lZGlhLXJlcG9ydHPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "The best-selling drugs of the next 5 years - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS92aWV3cy1hbmFseXNpcy1zYWxlcy1tYXJrZXRpbmcvdGhlLWJlc3Qtc2VsbGluZy1kcnVncy1vZi10aGUtbmV4dC01LXllYXJz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "20 Large-Cap Dividend Stocks With More Cash Than Debt - Kiplinger's Personal Finance",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmtpcGxpbmdlci5jb20vc2xpZGVzaG93L2ludmVzdGluZy90MDE4LXMwMDEtMjAtbGFyZ2UtY2FwLWRpdmlkZW5kLXN0b2Nrcy13aXRoLW1vcmUtY2FzaC10aGFuLWQvaW5kZXguaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "J&J Says Suspect Baby Powder Is Asbestos-Free - The Wall Street Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvai1qLXNheXMtc3VzcGVjdC1iYWJ5LXBvd2Rlci1pcy1hc2Jlc3Rvcy1mcmVlLTExNTcyMzg2NjY10gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Amgen takes 20.5% stake in BeiGene to sell cancer drugs in China - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiPmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtYW1nZW4tYmVpZ2VuZS1pZFVTS0JOMVhBMktB0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/18/2019": {
        "artical1": {
            "title": "Rapt Therapeutics revives IPO, files to raise $75M - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvcmFwdC10aGVyYXBldXRpY3MtcmV2aXZlcy1pcG8tZmlsZXMtdG8tcmFpc2UtNzVt0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol might play a role in front-line lung cancer after all - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9icmlzdG9sLW1pZ2h0LXBsYXktcm9sZS1mcm9udC1saW5lLWx1bmctY2FuY2VyLWFmdGVyLWFsbNIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1MjAyL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "How working manufacturing night shifts changed this graduate's ... - SiliconRepublic.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQmh0dHBzOi8vd3d3LnNpbGljb25yZXB1YmxpYy5jb20vcGVvcGxlL2Jtcy1ncmFkdWF0ZXMtaGF6ZWwtaGFyZm9yZNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "A change of the guard for the world\u2019s biggest cancer companies - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9jaGFuZ2UtZ3VhcmQtd29ybGRzLWJpZ2dlc3QtY2FuY2VyLWNvbXBhbmllc9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1MTgzL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "A New Actor in Cancer Immunity | Harvard Medical School - Harvard Medical School",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiNmh0dHBzOi8vaG1zLmhhcnZhcmQuZWR1L25ld3MvbmV3LWFjdG9yLWNhbmNlci1pbW11bml0edIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "After Record Fundraising Haul From Big Pharma, McConnell Vows ... - Sludge",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vcmVhZHNsdWRnZS5jb20vMjAxOS8xMC8xOC9hZnRlci1yZWNvcmQtZnVuZHJhaXNpbmctaGF1bC1mcm9tLWJpZy1waGFybWEtbWNjb25uZWxsLXZvd3MtdG8tYmxvY2stZHJ1Zy1wcmljaW5nLWJpbGwv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "China implementing new rules to make business easier: state planner - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWNoaW5hLWVjb25vbXktcG9saWN5L2NoaW5hLWltcGxlbWVudGluZy1uZXctcnVsZXMtdG8tbWFrZS1idXNpbmVzcy1lYXNpZXItZnJvbS1qYW4tMS1zdGF0ZS1wbGFubmVyLWlkVVNLQk4xWDIxNE4v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/11/2019": {
        "artical1": {
            "title": "Bristol-Myers Squibb 2019: More of everything - PharmaLive",
            "link": "https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LnBoYXJtYWxpdmUuY29tL2JyaXN0b2wtbXllcnMtc3F1aWJiLTIwMTktbW9yZS1vZi1ldmVyeXRoaW5nL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Uncovering biopharma\u2019s hidden treasures - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS91bmNvdmVyaW5nLWJpb3BoYXJtYXMtaGlkZGVuLXRyZWFzdXJlc9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE1MTA1L2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "J&J, Bayer's Xarelto scores FDA nod to treat acutely ill patients ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2otai1iYXllci1zLXhhcmVsdG8tc2NvcmVzLWZkYS1ub2QtdG8tdHJlYXQtYWN1dGVseS1pbGwtcGF0aWVudHMtZHVyaW5nLWFuZC1hZnRlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Five Prime Eliminates 70 Jobs in Restructuring - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvZml2ZS1wcmltZS1lbGltaW5hdGVzLTcwLWpvYnMtaW4tcmVzdHJ1Y3R1cmluZy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Leana Wen Addresses Her Tweet That Abortion Should Be 'Rare' - TIME",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vdGltZS5jb20vY29sbGVjdGlvbi90aW1lLTEwMC1oZWFsdGgtc3VtbWl0LTIwMTkvNTcwMzU3NS9sZWFuYS13ZW4tYWJvcnRpb24tc2FmZS1sZWdhbC1yYXJlL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Healthcare M&A deal value drops to $20B in Q3 as buyers target ... - spglobal.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiogFodHRwczovL3d3dy5zcGdsb2JhbC5jb20vbWFya2V0aW50ZWxsaWdlbmNlL2VuL25ld3MtaW5zaWdodHMvbGF0ZXN0LW5ld3MtaGVhZGxpbmVzL2hlYWx0aGNhcmUtbS1hLWRlYWwtdmFsdWUtZHJvcHMtdG8tMjBiLWluLXEzLWFzLWJ1eWVycy10YXJnZXQtYmlvdGVjaHMtNTQ2NDUzNDDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Consumer banking powers Citigroup's profit beat - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdWstY2l0aWdyb3VwLXJlc3VsdHMtaWRJTktCTjFXVTFOUy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "10/04/2019": {
        "artical1": {
            "title": "Global Lymphopenia Therapeutics Market 2019-2023 | Evolving ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MTAwNzAwNTg5My9lbi9HbG9iYWwtTHltcGhvcGVuaWEtVGhlcmFwZXV0aWNzLU1hcmtldC0yMDE5LTIwMjMtRXZvbHZpbmctT3Bwb3J0dW5pdGllcy13aXRoLUJyaXN0b2wtTXllcnMtU3F1aWJiLUNvLi1hbmQtQ1NMLUx0ZC4tVGVjaG5hdmlv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "AbbVie, Bristol-Myers Among Patient Advocacy Groups' Big Backers ... - Bloomberg Government",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vYWJvdXQuYmdvdi5jb20vbmV3cy9hYmJ2aWUtYnJpc3RvbC1teWVycy1hbW9uZy1wYXRpZW50LWFkdm9jYWN5LWdyb3Vwcy1iaWctYmFja2Vycy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Merck and Co's cancer drug Keytruda to smash sales records by ... - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL21lcmNrcy1jYW5jZXItZHJ1Zy1rZXl0cnVkYS10by1zbWFzaC1zYWxlcy1yZWNvcmRzLWJ5LTIwMjMtZm9yZWNhc3TSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Top 20 Pharma Companies by Market Cap in Q1 2019 - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RvcC0yMC1waGFybWEtY29tcGFuaWVzLWJ5LW1hcmtldC1jYXAtaW4tcTEtMjAxOS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Takeda breaks into top 20 largest pharmas with Shire merger - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL3Rha2VkYS1icmVha3MtaW50by10b3AtMjAtbGFyZ2VzdC1waGFybWFzLXdpdGgtc2hpcmUtbWVyZ2Vy0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Geek on the Street: Who inspires you? Summit attendees point to ... - GeekWire",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmdlZWt3aXJlLmNvbS8yMDE5L2dlZWstc3RyZWV0LWluc3BpcmVzLXN1bW1pdC1hdHRlbmRlZXMtcG9pbnQtdGVjaC1sZWFkZXJzLWZhbWlseS1vdGhlcnMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Silent (R)evolution in Medical Affairs Through the Power of ... - Pharmaceutical Executive",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy9zaWxlbnQtcmV2b2x1dGlvbi1tZWRpY2FsLWFmZmFpcnMtdGhyb3VnaC1wb3dlci1wYXJ0bmVyc2hpcHMtYW5kLWNvbGxhYm9yYXRpb25z0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/27/2019": {
        "artical1": {
            "title": "Esmo 2019 \u2013 Opdivo could have done better in liver cancer - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2V2ZW50cy9jb25mZXJlbmNlcy9lc21vLTIwMTktb3BkaXZvLWNvdWxkLWhhdmUtZG9uZS1iZXR0ZXItbGl2ZXItY2FuY2Vy0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTUxMTIvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "One in two pts with metastatic melanoma alive after 5 years with ... - EurekAlert",
            "link": "https://news.google.com/rss/articles/CBMiL2h0dHBzOi8vd3d3LmV1cmVrYWxlcnQub3JnL25ld3MtcmVsZWFzZXMvODUyMjc50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "How Recession Proof Is The Pharmaceutical Industry? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvam9zaHVhY29oZW4vMjAxOS8xMC8wMi9ob3ctcmVjZXNzaW9uLXByb29mLWlzLXRoZS1waGFybWFjZXV0aWNhbC1pbmR1c3RyeS_SAWtodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2pvc2h1YWNvaGVuLzIwMTkvMTAvMDIvaG93LXJlY2Vzc2lvbi1wcm9vZi1pcy10aGUtcGhhcm1hY2V1dGljYWwtaW5kdXN0cnkvYW1wLw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Advice on career advancement and work/life/balance for women - Inside Story - WPVI-TV",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vNmFiYy5jb20vMjAxOS1wZW5uc3lsdmFuaWEtY29uZmVyZW5jZS1mb3Itd29tZW4td29yay1saWZlLWJhbGFuY2UtZmVtYWxlLWV4ZWN1dGl2ZXMtcGF5LWVxdWFsaXR5LzU1NzM0Mjkv0gF1aHR0cHM6Ly82YWJjLmNvbS9hbXAvMjAxOS1wZW5uc3lsdmFuaWEtY29uZmVyZW5jZS1mb3Itd29tZW4td29yay1saWZlLWJhbGFuY2UtZmVtYWxlLWV4ZWN1dGl2ZXMtcGF5LWVxdWFsaXR5LzU1NzM0Mjkv?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "ESMO 2019: Efficacy and Safety of Nivolumab in Combination with ... - UroToday",
            "link": "https://news.google.com/rss/articles/CBMi8wFodHRwOi8vd3d3LnVyb3RvZGF5LmNvbS9jb25mZXJlbmNlLWhpZ2hsaWdodHMvZXNtby0yMDE5L2VzbW8tMjAxOS1wcm9zdGF0ZS1jYW5jZXIvMTE1MjYxLWVzbW8tMjAxOS1lZmZpY2FjeS1hbmQtc2FmZXR5LW9mLW5pdm9sdW1hYi1pbi1jb21iaW5hdGlvbi13aXRoLWRvY2V0YXhlbC1pbi1tZW4td2l0aC1tZXRhc3RhdGljLWNhc3RyYXRpb24tcmVzaXN0YW50LXByb3N0YXRlLWNhbmNlci1pbi1jaGVja21hdGUtOWtkLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "The Value Of A Scientific Background In The Pharma Business ... - Life Science Leader Magazine",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5saWZlc2NpZW5jZWxlYWRlci5jb20vZG9jL3RoZS12YWx1ZS1vZi1hLXNjaWVudGlmaWMtYmFja2dyb3VuZC1pbi10aGUtcGhhcm1hLWJ1c2luZXNzLXdvcmxkLWFuLWludGVydmlldy13aXRoLWZhYnJpY2UtY2hvdXJhcXVpLTAwMDHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Mesothelioma trial suggests immunotherapy as an alternative to ... - EurekAlert",
            "link": "https://news.google.com/rss/articles/CBMiL2h0dHBzOi8vd3d3LmV1cmVrYWxlcnQub3JnL25ld3MtcmVsZWFzZXMvNTY5MTI30gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/20/2019": {
        "artical1": {
            "title": "Man convicted in 1996 murder eligible for Community Transition Program, family member of victim reacts - 14 News WFIE Evansville",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LjE0bmV3cy5jb20vMjAxOS8wOS8yNy9tYW4tY29udmljdGVkLW11cmRlci1lbGlnaWJsZS1jb21tdW5pdHktdHJhbnNpdGlvbi1wcm9ncmFtLWZhbWlseS1tZW1iZXItdmljdGltLXJlYWN0cy_SAYgBaHR0cHM6Ly93d3cuMTRuZXdzLmNvbS8yMDE5LzA5LzI3L21hbi1jb252aWN0ZWQtbXVyZGVyLWVsaWdpYmxlLWNvbW11bml0eS10cmFuc2l0aW9uLXByb2dyYW0tZmFtaWx5LW1lbWJlci12aWN0aW0tcmVhY3RzLz9vdXRwdXRUeXBlPWFtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major ... - TCTMD",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2F1Z3VzdHVzLWFwaXhhYmFuLWJhc2VkLWR1YWwtdGhlcmFweS1iZXN0LWFjcm9zcy1tYWpvci1zdWJncm91cHPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Michelle Regna, Andrew Deek - The New York Times",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMTkvMDkvMjIvZmFzaGlvbi93ZWRkaW5ncy9taWNoZWxsZS1yZWduYS1hbmRyZXctZGVlay5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "California saw reduction in out-of-network care from affected ... - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMijQFodHRwczovL3d3dy5icm9va2luZ3MuZWR1L2FydGljbGVzL2NhbGlmb3JuaWEtc2F3LXJlZHVjdGlvbi1pbi1vdXQtb2YtbmV0d29yay1jYXJlLWZyb20tYWZmZWN0ZWQtc3BlY2lhbHRpZXMtYWZ0ZXItMjAxNy1zdXJwcmlzZS1iaWxsaW5nLWxhdy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Thousands of RIT students to attend Fall Career Fair for co-ops and ... - rit.edu",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LnJpdC5lZHUvbmV3cy90aG91c2FuZHMtcml0LXN0dWRlbnRzLWF0dGVuZC1mYWxsLWNhcmVlci1mYWlyLWNvLW9wcy1hbmQtcGVybWFuZW50LWpvYnPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Tobacco Stocks in Play After Abandoned Merger - Investopedia",
            "link": "https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vdG9iYWNjby1zdG9ja3MtaW4tcGxheS1hZnRlci1hYmFuZG9uZWQtbWVyZ2VyLTQ3NzEzODLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "France\u2019s Innate Pharma eyes $100m Nasdaq IPO - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvZnJhbmNlc19pbm5hdGVfcGhhcm1hX2V5ZXNfJDEwMG1fbmFzZGFxX2lwb18xMzAyMjU3P1NRX0RFU0lHTl9OQU1FPTLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/13/2019": {
        "artical1": {
            "title": "MAP: Where does your state stand in Texas v. U.S.? | Brookings - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvbWFwLXdoZXJlLWRvZXMteW91ci1zdGF0ZS1zdGFuZC1pbi10ZXhhcy12LXUtcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Ono Pharma, BMS unveil two P3 trial analyses for Opdivo - KBR",
            "link": "https://news.google.com/rss/articles/CBMiPGh0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3Lmh0bWw_aWR4bm89NjQ1ONIBP2h0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3QW1wLmh0bWw_aWR4bm89NjQ1OA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Another failed midstage asset for Acceleron, another pipeline test ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYW5vdGhlci1mYWlsZWQtbWlkc3RhZ2UtYXNzZXQtZm9yLWFjY2VsZXJvbi1zZWVzLWFub3RoZXItcGlwZWxpbmUtdGVzdC1kdW1wZWTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Comparing Revenue and Key Metrics For The Two Portable Memory ... - Trefis",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiogFodHRwczovL3d3dy50cmVmaXMuY29tL3N0b2NrL3N0eC9hcnRpY2xlcy80NzI0MDIvY29tcGFyaW5nLXJldmVudWUtYW5kLWtleS1tZXRyaWNzLWZvci10aGUtdHdvLXBvcnRhYmxlLW1lbW9yeS1oZWF2eXdlaWdodHMtc2VhZ2F0ZS1hbmQtd2VzdGVybi1kaWdpdGFsLzIwMTktMDktMTjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Advocates say Gilead broke antitrust laws - Bay Area Reporter, America's highest circulation LGBT newspaper",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vd3d3LmViYXIuY29tL3N0b3J5LnBocD9jaD1uZXdzJnNjPWxlZ2FsJmlkPTI4MTk3M9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "AbbVie/Allergan's merger faces public opposition - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYWJidmllYWxsZXJnYW5zX21lcmdlcl9mYWNlc19wdWJsaWNfb3Bwb3NpdGlvbl8xMzAxNTUx0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Gilead's Truvada keeps up PrEP TV push, lands at No. 2 in August ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2dpbGVhZC10cnV2YWRhLWtlZXBzLXVwLXByZXAtdHYtYWQtc3BlbmRpbmctbGFuZHMtYXQtbm8tMi1iZWhpbmQtYWJidmllLWh1bWlyYS1hZ2FpbtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "09/06/2019": {
        "artical1": {
            "title": "Demolition 20% done at former Bristol-Myers Squibb site in ... - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMijAFodHRwczovL3d3dy5teXJlY29yZGpvdXJuYWwuY29tL05ld3MvV2FsbGluZ2ZvcmQvV2FsbGluZ2ZvcmQtTmV3cy9EZW1vbGl0aW9uLTIwLWRvbmUtYXQtZm9ybWVyLUJyaXN0b2wtTXllcnMtU3F1aWJiLXNpdGUtaW4tV2FsbGluZ2ZvcmQuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Better Buy: Amgen vs. Celgene - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE5LzA5LzA4L2JldHRlci1idXktYW1nZW4tdnMtY2VsZ2VuZS5hc3B40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Third strike for BMS' Opdivo in brain cancer - PMLiVE - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvdGhpcmRfc3RyaWtlX2Zvcl9ibXNfb3BkaXZvX2luX2JyYWluX2NhbmNlcl8xMzAwODcx0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Opdivo-Adcetris Shows Promise in PBML Patients with Advanced ... - Lymphoma News Today",
            "link": "https://news.google.com/rss/articles/CBMijAFodHRwczovL2x5bXBob21hbmV3c3RvZGF5LmNvbS8yMDE5LzA5LzEyL29wZGl2by1hZGNldHJpcy1jb21iby1zaG93cy1wcm9taXNlLWluLWFkdmFuY2VkLXByaW1hcnktbWVkaWFzdGluYWwtbGFyZ2UtYi1jZWxsLWx5bXBob21hLWluLXRyaWFsL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Interview: Edward Lee, star dealmaker - Leaders League",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTmh0dHBzOi8vd3d3LmxlYWRlcnNsZWFndWUuY29tL2VuL25ld3MvaW50ZXJ2aWV3LXdpdGgtc3Rhci1kZWFsbWFrZXItZWR3YXJkLWxlZdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Dagliflozin Reduces Death, Hospitalization in Heart Failure Patients - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9kYWdsaWZsb3ppbi1yZWR1Y2VzLWRlYXRoLWhvc3BpdGFsaXphdGlvbi1oZWFydC1mYWlsdXJlLXBhdGllbnRz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Atomwise Enters Three Joint Ventures to Use AI Platform for Drug ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FydGlmaWNpYWwtaW50ZWxsaWdlbmNlLWNvbXBhbnktYXRvbXdpc2UtaW5rcy0zLWNvbGxhYm9yYXRpb25zL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/30/2019": {
        "artical1": {
            "title": "Fall Signature Lectures to bring notable figures to UGA - University of Georgia",
            "link": "https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vbmV3cy51Z2EuZWR1L2ZhbGwtMjAxOS1zaWduYXR1cmUtbGVjdHVyZXMv0gE2aHR0cHM6Ly9uZXdzLnVnYS5lZHUvZmFsbC0yMDE5LXNpZ25hdHVyZS1sZWN0dXJlcy9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Lara Kanitra, Kevin Kozlowski - The New York Times",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMTkvMDkvMDEvZmFzaGlvbi93ZWRkaW5ncy9sYXJhLWthbml0cmEta2V2aW4ta296bG93c2tpLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "For A-fib/PCI Combo, Edoxaban Matches VKA but Not Superior ... - TCTMD",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2ZpYnBjaS1jb21iby1lZG94YWJhbi1tYXRjaGVzLXZrYS1ub3Qtc3VwZXJpb3ItZW50cnVzdC1hZi1wY2nSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Daiichi Sankyo Reports Non-Inferiority in Lixiana Clinical Trial for ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2RhaWljaGktc2Fua3lvLXMtbGl4aWFuYS1lZmZlY3RpdmUtZm9yLWF0cmlhbC1maWJyaWxsYXRpb24tcGF0aWVudHMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "The top pharma companies by revenue 2018 | pharmaphorum - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS92aWV3cy1hbmQtYW5hbHlzaXMvdGhlLXRvcC1waGFybWEtY29tcGFuaWVzLWJ5LXJldmVudWUtMjAxONIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Global Oral Cancer Therapeutics Market 2019 - 2023 | Increasing ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMivwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MDgzMDAwNTA4Ny9lbi9HbG9iYWwtT3JhbC1DYW5jZXItVGhlcmFwZXV0aWNzLU1hcmtldC0yMDE5LS0tMjAyMy1JbmNyZWFzaW5nLWluY2lkZW5jZS1hbmQtcHJldmFsZW5jZS1vZi1vcmFsLWNhbmNlci10by1ib29zdC1tYXJrZXQtZ3Jvd3RoLVRlY2huYXZpb9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Citi proves there is life left in M&A mega-deals - The Banker",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LnRoZWJhbmtlci5jb20vQ2l0aS1wcm92ZXMtdGhlcmUtaXMtbGlmZS1sZWZ0LWluLU0tQS1tZWdhLWRlYWxzLTE1Njc0MTEyMjXSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/23/2019": {
        "artical1": {
            "title": "Bristol Myers Squibb (BMY) announces Amgen's (AMGN) buy out of ... - AlphaStreet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiogFodHRwczovL25ld3MuYWxwaGFzdHJlZXQuY29tL2FtZ2VuLWFtZ24tdG8tYWNxdWlyZS1jZWxnZW5lcy1jZWxnLW90ZXpsYS1mb3ItMTMtNC1iaWxsaW9uLWJteS1icmlzdG9sLW15ZXJzLXNxdWliYi1jZWxnZW5lLW1lcmdlci1leHBlY3RlZC10by1jbG9zZS1ieS1lbmQtb2YtMjAxOS_SAaYBaHR0cHM6Ly9uZXdzLmFscGhhc3RyZWV0LmNvbS9hbWdlbi1hbWduLXRvLWFjcXVpcmUtY2VsZ2VuZXMtY2VsZy1vdGV6bGEtZm9yLTEzLTQtYmlsbGlvbi1ibXktYnJpc3RvbC1teWVycy1zcXVpYmItY2VsZ2VuZS1tZXJnZXItZXhwZWN0ZWQtdG8tY2xvc2UtYnktZW5kLW9mLTIwMTkvYW1wLw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Amgen, maker of Enbrel, to pick up Celgene's Otezla for $13.4B. Will ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FtZ2VuLW1ha2VyLWVuYnJlbC10by1waWNrLXVwLWNlbGdlbmUtcy1vdGV6bGEtZm9yLTEzLTRiLXdpbGwtZnRjLWhpdC1iYWNr0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Amgen to pay $13.4 billion for one drug - Marketplace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3Lm1hcmtldHBsYWNlLm9yZy8yMDE5LzA4LzI2L2FtZ2VuLXRvLXBheS0xMy1iaWxsaW9uLWZvci1vbmUtZHJ1Zy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Six burning Otezla questions - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3NpeC1idXJuaW5nLW90ZXpsYS1xdWVzdGlvbnPSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTAxNC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Celgene, Immatics Launch Up-to-$1.5B+ Cancer T-Cell Collaboration - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvY2VsZ2VuZS1pbW1hdGljcy1sYXVuY2gtdXAtdG8tMS01Yi1jYW5jZXItdC1jZWxsLWNvbGxhYm9yYXRpb24v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Can Eliquis Continue To Add $1 Billion In Annual Sales For Bristol-Myers Squibb? - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMTkvMDgvMjMvY2FuLWVsaXF1aXMtY29udGludWUtdG8tYWRkLTEtYmlsbGlvbi1pbi1hbm51YWwtc2FsZXMtZm9yLWJyaXN0b2wtbXllcnMtc3F1aWJiL9IBjQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMTkvMDgvMjMvY2FuLWVsaXF1aXMtY29udGludWUtdG8tYWRkLTEtYmlsbGlvbi1pbi1hbm51YWwtc2FsZXMtZm9yLWJyaXN0b2wtbXllcnMtc3F1aWJiL2FtcC8?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Pharmaindustrie: Bristol-Myers verkauft Blockbuster-Medikament f\u00fcr Celgene-\u00dcbernahme - Handelsblatt",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5oYW5kZWxzYmxhdHQuY29tL3VudGVybmVobWVuL2luZHVzdHJpZS9waGFybWFpbmR1c3RyaWUtYnJpc3RvbC1teWVycy12ZXJrYXVmdC1ibG9ja2J1c3Rlci1tZWRpa2FtZW50LWZ1ZXItY2VsZ2VuZS11ZWJlcm5haG1lLzI0OTQyODAwLmh0bWzSAZcBaHR0cHM6Ly9hbXAyLmhhbmRlbHNibGF0dC5jb20vdW50ZXJuZWhtZW4vaW5kdXN0cmllL3BoYXJtYWluZHVzdHJpZS1icmlzdG9sLW15ZXJzLXZlcmthdWZ0LWJsb2NrYnVzdGVyLW1lZGlrYW1lbnQtZnVlci1jZWxnZW5lLXVlYmVybmFobWUvMjQ5NDI4MDAuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "08/16/2019": {
        "artical1": {
            "title": "Neptune leaves Astra at sea - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9uZXB0dW5lLWxlYXZlcy1hc3RyYS1zZWHSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNTAwNC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "In a boon for buyer Bristol-Myers, Celgene's JAK med Inrebic scores ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL29uY2UtbGVmdC1mb3ItZGVhZC1jZWxnZW5lLXMtamFrLWluaGliaXRvci1pbnJlYmljLXNjb3Jlcy1mZGEtbm9kLWV2ZS10YWtlb3ZlctIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "FDA Approves First Myelofibrosis Drug in Nearly a Decade - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2ZkYS1hcHByb3Zlcy1jZWxnZW5lLXMtNy1iaWxsaW9uLWphay1pbmhpYml0b3ItaW5yZWJpYy1mb3ItYm9uZS1tYXJyb3ctY2FuY2VyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "BMS buoyed by FDA approval of Celgene\u2019s myelofibrosis drug - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvYm1zX2J1b3llZF9ieV9mZGFfYXBwcm92YWxfb2ZfY2VsZ2VuZXNfbXllbG9maWJyb3Npc19kcnVnXzEyOTc5NzLSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Indian shares end lower; financials, consumer stocks weigh - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvaW5kaWEtc3RvY2tzLWNsb3NlL2luZGlhbi1zaGFyZXMtZW5kLWxvd2VyLWZpbmFuY2lhbHMtY29uc3VtZXItc3RvY2tzLXdlaWdoLWlkVVNCOE4yNEIwMkYv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "AstraZeneca, Novo Nordisk A/S Stick Up for Animals! - PETA",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnBldGEub3JnL2Jsb2cvYXN0cmF6ZW5lY2Etbm92by1ub3JkaXNrLWFzLXNhdmUtYW5pbWFscy1iYW4tZm9yY2VkLXN3aW0tdGVzdC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Merck's Frazier tops list of highest-paid US pharma CEOs in 2018 - spglobal.com",
            "link": "https://news.google.com/rss/articles/CBMinAFodHRwczovL3d3dy5zcGdsb2JhbC5jb20vbWFya2V0aW50ZWxsaWdlbmNlL2VuL25ld3MtaW5zaWdodHMvbGF0ZXN0LW5ld3MtaGVhZGxpbmVzL21lcmNrLXMtZnJhemllci10b3BzLWxpc3Qtb2YtaGlnaGVzdC1wYWlkLXVzLXBoYXJtYS1jZW9zLWluLTIwMTgtNTMzNzQxMzbSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/09/2019": {
        "artical1": {
            "title": "Faulty manufacturing trips up Nektar's Bristol-partnered cancer drug ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFudWZhY3R1cmluZy9uZWt0YXItcy1icmlzdG9sLXBhcnRuZXJlZC1jYW5jZXItZHJ1Zy10cmlwcGVkLW92ZXItbWFudWZhY3R1cmluZy1taXgtdXDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "CMOs to pick up Big Pharma non-core facilities - Bioprocess Insider - BioProcess Insider",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vYmlvcHJvY2Vzc2ludGwuY29tL2Jpb3Byb2Nlc3MtaW5zaWRlci9mYWNpbGl0aWVzLWNhcGFjaXR5L2Ntb3MtdG8tY29udGludWUtcGlja2luZy11cC1iaWctcGhhcm1hLW5vbi1jb3JlLWZhY2lsaXRpZXMv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "China's SDIC says receives government approval for London IPO - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLXNkaWMtbG9uZG9uLWxpc3RpbmcvY2hpbmFzLXNkaWMtc2F5cy1yZWNlaXZlcy1nb3Zlcm5tZW50LWFwcHJvdmFsLWZvci1sb25kb24taXBvLWlkVVNLQ04xVjEwNkQv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "OliPass to inject W1.2b for establishing unit in US - The Investor",
            "link": "https://news.google.com/rss/articles/CBMiNmh0dHBzOi8vbS50aGVpbnZlc3Rvci5jby5rci92aWV3LnBocD91ZD0yMDE5MDgxMjAwMDYwM9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Nektar Therapeutics Drops Sharply for Second Day After Admitting ... - TheStreet",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihQFodHRwczovL3d3dy50aGVzdHJlZXQuY29tL2ludmVzdGluZy9zdG9ja3MvbmVrdGFyLXRoZXJhcGV1dGljcy1kcm9wcy1zaGFycGx5LWZvci1zZWNvbmQtc2Vzc2lvbi1hZnRlci1hZG1pdHRpbmctYmF0Y2gtaXNzdWVzLTE1MDUzNzk00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Roche's personalized cancer treatment wins FDA approval - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtcm9jaGUtaGxkZy1mZGEtaWRVU0tDTjFWNTJBVy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "New ABB CEO is committed to at least five years at company - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiQWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtYWJiLWNlby1jaGFpcm1hbi1pZFVTS0NOMVYyME1V0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "08/02/2019": {
        "artical1": {
            "title": "25 Investigates: Local woman fired 2 days after surviving domestic ... - Boston 25 News",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmJvc3RvbjI1bmV3cy5jb20vbmV3cy8yNS1pbnZlc3RpZ2F0ZXMtbG9jYWwtd29tYW4tZmlyZWQtMi1kYXlzLWFmdGVyLXN1cnZpdmluZy1kb21lc3RpYy12aW9sZW5jZS85NzIwNjAwMTYv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Lift off! Celgene MS effort launches hot air balloon to highlight brain ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2xpZnQtb2ZmLWNlbGdlbmUtbXMtYXdhcmVuZXNzLWVmZm9ydC1sYXVuY2hlcy1ob3QtYWlyLWJhbGxvb24tdG8taGlnaGxpZ2h0LWJyYWluLWhlYWx0aNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Pexa-Vec/Nexavar Combination Fails Phase III Trial in Liver Cancer - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvcGV4YS12ZWMtbmV4YXZhci1jb21iaW5hdGlvbi1mYWlscy1waGFzZS1paWktdHJpYWwtaW4tbGl2ZXItY2FuY2VyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "IL-2 player Neoleukin gets a leg up in reverse merger with Aquinox - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvaWwtMi1wbGF5ZXItbmVvbGV1a2luLWdldHMtYS1sZWctdXAtcmV2ZXJzZS1tZXJnZXItYXF1aW5veNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Diabetes risk tied to common chemicals, curbed by healthy habits - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWhlYWx0aC1kaWFiZXRlcy1jaGVtaWNhbHMvZGlhYmV0ZXMtcmlzay10aWVkLXRvLWNvbW1vbi1jaGVtaWNhbHMtY3VyYmVkLWJ5LWhlYWx0aHktaGFiaXRzLWlkVVNLQ04xVVkyM0wv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Daiichi Sankyo wades deeper into oncology with FDA go-ahead in ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2RhaWljaGktc2Fua3lvLW1ha2luZy1vbmNvbG9neS1hLWtleS1mb2N1cy1uYWJzLXR1cmFsaW8tZmRhLWdvLWFoZWFkLWZvci1yYXJlLWpvaW50LWNhbmNlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Reputation of big pharma suffering in the UK, research shows - PR Week",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LnByd2Vlay5jb20vYXJ0aWNsZS8xNTkyOTIxL3JlcHV0YXRpb24tYmlnLXBoYXJtYS1zdWZmZXJpbmctdWstcmVzZWFyY2gtc2hvd3PSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/26/2019": {
        "artical1": {
            "title": "Sydell Miller selling Palm Beach estate - The Real Deal",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vdGhlcmVhbGRlYWwuY29tL21pYW1pLzIwMTkvMDcvMjYvcGFsbS1iZWFjaC1ob21lLXNhbGUtY291bGQtc2V0LW5ldy1yZWNvcmQtZm9yLWNsb3NpbmctcHJpY2Uv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Convicted murderer in July 1996 case could be released in early 2020 - 14 News WFIE Evansville",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LjE0bmV3cy5jb20vMjAxOS8wNy8zMS9jb252aWN0ZWQtbXVyZGVyZXItanVseS1jYXNlLWNvdWxkLWJlLXJlbGVhc2VkLWVhcmx5L9IBZmh0dHBzOi8vd3d3LjE0bmV3cy5jb20vMjAxOS8wNy8zMS9jb252aWN0ZWQtbXVyZGVyZXItanVseS1jYXNlLWNvdWxkLWJlLXJlbGVhc2VkLWVhcmx5Lz9vdXRwdXRUeXBlPWFtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Single-Use Technology Has Biopharma Sizing Up the Recycling Bin - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2luc2lnaHRzL3NpbmdsZS11c2UtdGVjaG5vbG9neS1oYXMtYmlvcGhhcm1hLXNpemluZy11cC10aGUtcmVjeWNsaW5nLWJpbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Pharmaceutical Executive Francis Cuss Joins Glympse Bio Board - Business Wire",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMTkwODAxMDA1NTU2L2VuL1BoYXJtYWNldXRpY2FsLUV4ZWN1dGl2ZS1GcmFuY2lzLUN1c3MtSm9pbnMtR2x5bXBzZS1CaW8tQm9hcmTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "What is surprise billing? | Brookings - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiPGh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvd2hhdC1pcy1zdXJwcmlzZS1iaWxsaW5nL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "The Trump administration has taken on mergers and acquisitions - Axios",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LmF4aW9zLmNvbS8yMDE5LzA3LzMwL3RydW1wLWFkbWluaXN0cmF0aW9uLW1lcmdlcnMtYWNxdWlzaXRpb25zLWJsb2NrZWTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Global scheme to cut price of expensive hepatitis drugs boosts treatment rate - Imperial College London",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LmltcGVyaWFsLmFjLnVrL25ld3MvMTkyMTkwL2dsb2JhbC1zY2hlbWUtcHJpY2UtZXhwZW5zaXZlLWhlcGF0aXRpcy1kcnVncy_SAVlodHRwczovL3d3dy5pbXBlcmlhbC5hYy51ay9uZXdzLzE5MjE5MC9nbG9iYWwtc2NoZW1lLXByaWNlLWV4cGVuc2l2ZS1oZXBhdGl0aXMtZHJ1Z3MvYW1wLw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "07/19/2019": {
        "artical1": {
            "title": "Biotech Company To Move To Former Bristol-Myers Squibb Campus ... - Planet Princeton",
            "link": "https://news.google.com/rss/articles/CBMic2h0dHBzOi8vcGxhbmV0cHJpbmNldG9uLmNvbS8yMDE5LzA3LzI0L2Jpb3RlY2gtY29tcGFueS10by1tb3ZlLXRvLWZvcm1lci1icmlzdG9sLW15ZXJzLXNxdWliYi1jYW1wdXMtaW4tcGxhaW5zYm9yby_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Opdivo\u2019s lung cancer latest: one fail, one shrug - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9vcGRpdm9zLWx1bmctY2FuY2VyLWxhdGVzdC1vbmUtZmFpbC1vbmUtc2hydWfSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDkxMi9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in ... - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvY2VsZ2VuZS1zY3JhcHMtMi02Yi1kZWFsLWxpY2Vuc2VzLWpvdW5jZS1hbnRpYm9keS1pbi1yZXN0cnVjdHVyZWQtY2FuY2VyLWNvbGxhYm9yYXRpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Delhi HC grants Natco Pharma interim relief in BMS patents case | Mint - Mint",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmxpdmVtaW50LmNvbS9jb21wYW5pZXMvbmV3cy9kZWxoaS1oYy1ncmFudHMtbmF0Y28tcGhhcm1hLWludGVyaW0tcmVsaWVmLWluLWJtcy1wYXRlbnRzLWNhc2UtMTU2MzgxODU5MTc2Mi5odG1s0gF-aHR0cHM6Ly93d3cubGl2ZW1pbnQuY29tL2NvbXBhbmllcy9uZXdzL2RlbGhpLWhjLWdyYW50cy1uYXRjby1waGFybWEtaW50ZXJpbS1yZWxpZWYtaW4tYm1zLXBhdGVudHMtY2FzZS9hbXAtMTU2MzgxODU5MTc2Mi5odG1s?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Otezla scores new indication as speculation over potential buyers ... - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHA6Ly93d3cucG1saXZlLmNvbS9waGFybWFfbmV3cy9vdGV6bGFfc2NvcmVzX25ld19pbmRpY2F0aW9uX2FzX3NwZWN1bGF0aW9uX292ZXJfcG90ZW50aWFsX2J1eWVyc19ncm93c18xMjk1MDAw0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Top 5 Vendors in the Sexually Transmitted Diseases (STD ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMijgFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9yZWxlYXNlcy90b3AtNS12ZW5kb3JzLWluLXRoZS1zZXh1YWxseS10cmFuc21pdHRlZC1kaXNlYXNlcy1zdGQtdHJlYXRtZW50LW1hcmtldC1mcm9tLTIwMTktdG8tMjAyMy10ZWNobmF2aW8v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Schizophrenia Drugs Markets, 2024 - Leading Players are Alkermes ... - GlobeNewswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiyQFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAxOS8wNy8yNC8xODg3NDM0LzAvZW4vU2NoaXpvcGhyZW5pYS1EcnVncy1NYXJrZXRzLTIwMjQtTGVhZGluZy1QbGF5ZXJzLWFyZS1BbGtlcm1lcy1CcmlzdG9sLU15ZXJzLVNxdWliYi1FbGktTGlsbHktQ29tcGFueS1Kb2huc29uLUpvaG5zb24tYW5kLUFsbGVyZ2FuLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/12/2019": {
        "artical1": {
            "title": "'No Cure, No Pay' Pilot for Expensive Cancer Drugs - Medscape",
            "link": "https://news.google.com/rss/articles/CBMiK2h0dHBzOi8vd3d3Lm1lZHNjYXBlLmNvbS92aWV3YXJ0aWNsZS85MTU2MDLSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Gilead CSO, R&D head McHutchison the latest to bid company adieu - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvZ2lsZWFkLWNzby1yLWQtaGVhZC1tY2h1dGNoaXNvbi1sYXRlc3QtdG8tYmlkLWNvbXBhbnktYWRpZXXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Neon Therapeutics\u2019 Cancer Vaccine Effective in Melanoma and ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL25lb24tdGhlcmFwZXV0aWNzLWNhbmNlci12YWNjaW5lLWVmZmVjdGl2ZS1pbi1tZWxhbm9tYS1hbmQtbHVuZy1hbmQtYmxhZGRlci1jYW5jZXJzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Artificial Intelligence-Focused Companies Advance Programming - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FpLXJvdW5kdXAtYXJ0aWZpY2lhbC1pbnRlbGxpZ2VuY2UtZm9jdXNlZC1jb21wYW5pZXMtYWR2YW5jZS1wcm9ncmFtbWluZy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "True innovation or just later to market? German agency questions ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RydWUtaW5ub3ZhdGlvbi1vci1qdXN0LWxhdGVyLXRvLW1hcmtldC1nZXJtYW4tYWdlbmN5LXF1ZXN0aW9ucy1iZW5lZml0cy1uZXctZHJ1Z3PSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Pharmacists Can Help Reduce Risk from Extended-Release ... - Pharmacy Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMioQFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aWV3L3BoYXJtYWNpc3RzLWNhbi1oZWxwLXJlZHVjZS1yaXNrLWZyb20tZXh0ZW5kZWRyZWxlYXNlLWFjZXRhbWlub3BoZW4tLWEta2V5LXBvdGVudGlhbC1jb25mb3VuZGluZy1mYWN0b3ItaW4tc3VzcGVjdGVkLW92ZXJkb3Nlc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Pharma's top jet-setting executives of 2018 - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3BoYXJtYS1zLXRvcC1qZXQtc2V0dGluZy1leGVjdXRpdmVzLTIwMTjSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "07/05/2019": {
        "artical1": {
            "title": "TARIS Initiates Clinical Trial of TAR-200 in Combination with Opdivo ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMitwFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL3RhcmlzLWluaXRpYXRlcy1jbGluaWNhbC10cmlhbC1vZi10YXItMjAwLWluLWNvbWJpbmF0aW9uLXdpdGgtb3BkaXZvLW5pdm9sdW1hYi1mb3ItcGF0aWVudHMtd2l0aC1tdXNjbGUtaW52YXNpdmUtYmxhZGRlci1jYW5jZXItMzAwODgyMTAwLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Rosenstein, Ganson \u201921 Attend Organic Chemistry Symposium - News - Hamilton",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LmhhbWlsdG9uLmVkdS9uZXdzL3N0b3J5L2lhbi1yb3NlbnN0ZWluLWp1bGlhLWdhbnNvbi1jaGVtaXN0cnnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Chris Long, MLS' Fire win Humanitarian awards - ESPN - ESPN",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LmVzcG4uY29tL2VzcG4vc3RvcnkvXy9pZC8yNzE1ODQ3OC9jaHJpcy1sb25nLW1scy1maXJlLXdpbi1odW1hbml0YXJpYW4tYXdhcmRz0gFmaHR0cHM6Ly93d3cuZXNwbi5jb20vZXNwbi9zdG9yeS9fL2lkLzI3MTU4NDc4L2NocmlzLWxvbmctbWxzLWZpcmUtd2luLWh1bWFuaXRhcmlhbi1hd2FyZHM_cGxhdGZvcm09YW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "WHO keeps key lung cancer drugs off its essential medicines list - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWhlYWx0aC1tZWRpY2luZXMtd2hvL3doby1rZWVwcy1rZXktbHVuZy1jYW5jZXItZHJ1Z3Mtb2ZmLWl0cy1lc3NlbnRpYWwtbWVkaWNpbmVzLWxpc3QtaWRVU0tDTjFVNDBZUy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "H2-Pharma and CHEPLAPHARM Announce Launch of ... - PR Newswire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LnBybmV3c3dpcmUuY29tL25ld3MtcmVsZWFzZXMvaDItcGhhcm1hLWFuZC1jaGVwbGFwaGFybS1hbm5vdW5jZS1sYXVuY2gtb2YtZXRvcG9waG9zLWluamVjdGlvbi0zMDA4ODI3MTUuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Skyhawk Therapeutics nabs Peloton exec and cancer R&D veteran ... - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvc2t5aGF3ay10aGVyYXBldXRpY3MtbmFicy1wZWxvdG9uLWV4ZWMtYW5kLWNhbmNlci1yLWQtdmV0ZXJhbi1hcy12cC1vbmNvbG9neS1iaW9sb2d50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "J&J moving forward with U.S. peds application for Xarelto, as Bayer ... - MM+M Online",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9qai1tb3ZpbmctZm9yd2FyZC13aXRoLXUtcy1wZWRzLWFwcGxpY2F0aW9uLWZvci14YXJlbHRvLWFzLWJheWVyLXByZXBzLWV1cm9wZWFuLWZpbGluZy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/28/2019": {
        "artical1": {
            "title": "Bristol-Myers Squibb Immuno-Oncology - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2Jlc3Qtb2YtdGhlLXdlYi9icmlzdG9sLW15ZXJzLXNxdWliYi1pbW11bm8tb25jb2xvZ3kv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "In a crowded psoriasis field, who could nab Celgene's Otezla\u2014and ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Nyb3dkZWQtcHNvcmlhc2lzLXdoby1jb3VsZC1waWNrLXVwLWJyaXN0b2wtY2VsZ2VuZS1zLW90ZXpsYS1hdC13aGF0LXByaWNl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "July 2019: NTP paradigm evolves - Environmental Factor Newsletter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiOWh0dHBzOi8vZmFjdG9yLm5pZWhzLm5paC5nb3YvMjAxOS83L2ZlYXR1cmUvMy1mZWF0dXJlLW50cNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Federal surprise billing legislation does not violate the Constitution ... - Brookings Institution",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvZmVkZXJhbC1zdXJwcmlzZS1iaWxsaW5nLWxlZ2lzbGF0aW9uLWRvZXMtbm90LXZpb2xhdGUtdGhlLWNvbnN0aXR1dGlvbi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Top 5 Vendors in the Global Bone Cancer Drugs Market 2019-2023 ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3JlbGVhc2VzL3RvcC01LXZlbmRvcnMtaW4tdGhlLWdsb2JhbC1ib25lLWNhbmNlci1kcnVncy1tYXJrZXQtMjAxOS0yMDIzLXRlY2huYXZpby_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Patent panic gives green light to mega pharma deals - Financial Times",
            "link": "https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50L2JjODQ3ZTA0LTk4MDQtMTFlOS04Y2ZiLTMwYzIxMWRjZDIyOdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Boehringer Ingelheim and Yuhan Corp. in US$870m NASH deal - European Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vZXVyb3BlYW4tYmlvdGVjaG5vbG9neS5jb20vdXAtdG8tZGF0ZS9sYXRlc3QtbmV3cy9uZXdzL2JvZWhyaW5nZXItaW5nZWxoZWltLWFuZC15dWhhbi1jb3JwLWluLXVzODcwbS1uYXNoLWRlYWwuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "06/21/2019": {
        "artical1": {
            "title": "How Does Bristol-Myers Squibb's Oncology Drugs Portfolio Compare To Its Peers? - Forbes",
            "link": "https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMTkvMDYvMjYvaG93LWRvZXMtYnJpc3RvbC1teWVycy1zcXVpYmJzLW9uY29sb2d5LWRydWdzLXBvcnRmb2xpby1jb21wYXJlLXRvLWl0cy1wZWVycy_SAYsBaHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9ncmVhdHNwZWN1bGF0aW9ucy8yMDE5LzA2LzI2L2hvdy1kb2VzLWJyaXN0b2wtbXllcnMtc3F1aWJicy1vbmNvbG9neS1kcnVncy1wb3J0Zm9saW8tY29tcGFyZS10by1pdHMtcGVlcnMvYW1wLw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Celgene, say goodbye to Otezla: BMS agrees to sell psoriasis drug ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3NheS1nb29kYnllLXRvLW90ZXpsYS1ibXMtYWdyZXNzLXRvLXNlbGwtcHNvcmlhc2lzLW1lZC1hcy1wYXJ0LWNlbGdlbmUtbWVyZ2VyLWRlYWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "BMS Selling Celgene's Otezla to Address FTC \"Concerns\" on $74B ... - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL25ld3MvYm1zLXNlbGxpbmctY2VsZ2VuZXMtb3RlemxhLXRvLWFkZHJlc3MtZnRjLWNvbmNlcm5zLW9uLTc0Yi1kZWFsL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Bristol-Myers Squibb Children's Hospital Named A Top Hospital by ... - TAPinto.net",
            "link": "https://news.google.com/rss/articles/CBMiqAFodHRwczovL3d3dy50YXBpbnRvLm5ldC90b3ducy9uZXctYnJ1bnN3aWNrL3NlY3Rpb25zL2hlYWx0aC1hbmQtd2VsbG5lc3MvYXJ0aWNsZXMvYnJpc3RvbC1teWVycy1zcXVpYmItY2hpbGRyZW4tcy1ob3NwaXRhbC1uYW1lZC1hLXRvcC1ob3NwaXRhbC1ieS11LXMtbmV3cy13b3JsZC1yZXBvcnTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Abbvie proves the best at getting the most out of its workers - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9hYmJ2aWUtcHJvdmVzLWJlc3QtZ2V0dGluZy1tb3N0LW91dC1pdHMtd29ya2Vyc9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0Nzc3L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Big Pharma Has to Bet Big on M&A. Investors Don't. - Bloomberg",
            "link": "https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vb3Bpbmlvbi9hcnRpY2xlcy8yMDE5LTA2LTI2L2FiYnZpZS1iaWctcGhhcm1hLWhhdmUtdG8tYmV0LWJpZy1vbi1tLWEtc3RvY2staW52ZXN0b3JzLWRvbi100gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Merck and the pitfalls of biopharma success - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3ZhbnRhZ2Utdmlld3MvbWVyY2stYW5kLXBpdGZhbGxzLWJpb3BoYXJtYS1zdWNjZXNz0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTQ4MDcvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/14/2019": {
        "artical1": {
            "title": "Lung Cancer Screening Awareness Campaign Focuses on At-Risk ... - UKNow",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vdWtub3cudWt5LmVkdS91ay1oZWFsdGhjYXJlL2x1bmctY2FuY2VyLXNjcmVlbmluZy1hd2FyZW5lc3MtY2FtcGFpZ24tZm9jdXNlcy1yaXNrLWtlbnR1Y2tpYW5z0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "New Brunswick Children's Hospital Named One Of Best In U.S. - Patch",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vcGF0Y2guY29tL25ldy1qZXJzZXkvbmV3YnJ1bnN3aWNrL25ldy1icnVuc3dpY2stY2hpbGRyZW4tcy1ob3NwaXRhbC1uYW1lZC1vbmUtYmVzdC11LXPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Celgene Hands Cancer Drug Back to BeiGene, Plus $150 Million - Bloomberg",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDE5LTA2LTE3L2NlbGdlbmUtaGFuZHMtY2FuY2VyLWRydWctYmFjay10by1iZWlnZW5lLXBsdXMtMTUwLW1pbGxpb27SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Big hitters eye Sj\u00f6gren\u2019s syndrome white space - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3Nwb3RsaWdodC9iaWctaGl0dGVycy1leWUtc2pvZ3JlbnMtc3luZHJvbWUtd2hpdGUtc3BhY2XSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDc5OS9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Cancer Therapy Stocks Soar After Pfizer Deal - Investopedia",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmludmVzdG9wZWRpYS5jb20vY2FuY2VyLXRoZXJhcHktc3RvY2tzLXNvYXItYWZ0ZXItcGZpemVyLWRlYWwtNDY5MDc4M9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "The top 20 drugs by 2018 U.S. sales - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTIwLWRydWdzLWJ5LTIwMTgtdS1zLXNhbGVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Novato's Ultragenyx Biopharmaceutical promotes Erik Harris to chief ... - North Bay Business Journal",
            "link": "https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5ub3J0aGJheWJ1c2luZXNzam91cm5hbC5jb20vYXJ0aWNsZS9pbmR1c3RyeS1uZXdzL25vdmF0b3MtdWx0cmFnZW55eC1iaW9waGFybWFjZXV0aWNhbC1wcm9tb3Rlcy1lcmlrLWhhcnJpcy10by1jaGllZi1jb21tZXJjL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "06/07/2019": {
        "artical1": {
            "title": "FiercePharmaAsia\u2014China audits for Big Pharma; Takeda's phase 3 ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMidGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvZmllcmNlcGhhcm1hYXNpYS1jaGluYS1hdWRpdHMtZm9yLWJpZy1waGFybWEtdGFrZWRhLXMtcGhhc2UtMy10cmlhbC1mYWlsdXJl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Ford opens new research center in Tel Aviv - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvZm9yZC1tb3Rvci1pc3JhZWwtaWRVU0w0TjIzSTRJUdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Maverick of cancer immunology on film - Nature.com",
            "link": "https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vd3d3Lm5hdHVyZS5jb20vYXJ0aWNsZXMvZDQxNTg2LTAxOS0wMTgxMS010gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "DECLARE-TIMI 58: Dapagliflozin shows 'robust' potential for kidney ... - Healio",
            "link": "https://news.google.com/rss/articles/CBMilwFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvZW5kb2NyaW5vbG9neS8yMDE5MDYxMi9kZWNsYXJldGltaS01OC1kYXBhZ2xpZmxvemluLXNob3dzLXJvYnVzdC1wb3RlbnRpYWwtZm9yLWtpZG5leS1kaXNlYXNlLXByZXZlbnRpb24taW4tdHlwZS0yLWRpYWJldGVz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Misconduct alleged in class action case involving Portland lawyer - Press Herald",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3LnByZXNzaGVyYWxkLmNvbS8yMDE5LzA2LzA3L21pc2NvbmR1Y3QtYWxsZWdlZC1pbi1jbGFzcy1hY3Rpb24tY2FzZS1pbnZvbHZpbmctcG9ydGxhbmQtbGF3eWVyL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Floating LiDAR to collect data for 1.4-GW offshore wind project in S ... - Renewables Now",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vcmVuZXdhYmxlc25vdy5jb20vbmV3cy9mbG9hdGluZy1saWRhci10by1jb2xsZWN0LWRhdGEtZm9yLTE0LWd3LW9mZnNob3JlLXdpbmQtcHJvamVjdC1pbi1zLWtvcmVhLTY1NzQ5NS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Investor Ackman opposes United Technologies' aerospace merger ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtdXRjLW0tYS1yYXl0aGVvbi1pZFVTS0NOMVRDMkxN0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/31/2019": {
        "artical1": {
            "title": "Bristol-Myers unveils team to lead R&D after Celgene deal closes - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYnJpc3RvbC1teWVycy11bnZlaWxzLXRlYW0tdG8tbGVhZC1yLWQtYWZ0ZXItY2VsZ2VuZS1kZWFsLWNsb3Nlc9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Eli Lilly, BMS among 77 drugmakers targeted in Chinese financial ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2VsaS1saWxseS1ibXMtYW1vbmctNzctZHJ1Z21ha2Vycy10YXJnZXRlZC1jaGluZXNlLWZpbmFuY2lhbC1wcm9iZdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Merck's Keytruda sets new five-year survival standard for advanced ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWhlYWx0aC1jYW5jZXItbWVyY2stY28vbWVyY2tzLWtleXRydWRhLXNldHMtbmV3LWZpdmUteWVhci1zdXJ2aXZhbC1zdGFuZGFyZC1mb3ItYWR2YW5jZWQtbHVuZy1jYW5jZXItaWRVU0tDTjFUMjMzSy_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "10 Jaw-Dropping Numbers About Cancer Drug Development -- and ... - The Motley Fool",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmZvb2wuY29tL2ludmVzdGluZy8yMDE5LzA2LzA1LzEwLWphdy1kcm9wcGluZy1udW1iZXJzLWFib3V0LWNhbmNlci1kcnVnLWRldmVsb3BtLmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "As Bristol-Myers merger marches ahead, what's BeiGene's plan for ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hLWFzaWEvYXMtYnJpc3RvbC1teWVycy1tZXJnZXItdGFraW5nLXNoYXBlLXdoYXQtcy1iZWlnZW5lLXMtcGxhbi1mb3ItY2VsZ2VuZS1wYXJ0bmVyZWQtcGQtMdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Comments on the Lower Health Care Costs Act of 2019 | Brookings - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvY29tbWVudHMtb24tdGhlLWxvd2VyLWhlYWx0aC1jYXJlLWNvc3RzLWFjdC1vZi0yMDE5L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "BMW sells cars globally despite tariffs, no reason to change Mexico ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtbWV4aWNvLWF1dG9zLWJtdy1pZFVTS0NOMVQ3MVlUL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/24/2019": {
        "artical1": {
            "title": "Demolition of former Bristol-Myers Squibb building begins in ... - Meriden Record-Journal",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vTmV3cy9XYWxsaW5nZm9yZC9XYWxsaW5nZm9yZC1OZXdzL0JNUy1kZW1vbGl0aW9uLXN0YXJ0cy1pbi1XYWxsaW5nZm9yZC5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Yervoy (Ipilimumab) - Immuno-Oncology News",
            "link": "https://news.google.com/rss/articles/CBMiMmh0dHBzOi8vaW1tdW5vLW9uY29sb2d5bmV3cy5jb20veWVydm95LWlwaWxpbXVtYWIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Comments on the No Surprises Act | Brookings - Brookings Institution",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvY29tbWVudHMtb24tdGhlLW5vLXN1cnByaXNlLWFjdC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Time to restock big pharma\u2019s leaking pipeline - Evaluate Pharma",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS90aW1lLXJlc3RvY2stYmlnLXBoYXJtYXMtbGVha2luZy1waXBlbGluZdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0NzI0L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "The Whimsy Cookie Company: Special cookies for special occasions - Clarion Ledger",
            "link": "https://news.google.com/rss/articles/CBMimAFodHRwczovL3d3dy5jbGFyaW9ubGVkZ2VyLmNvbS9zdG9yeS9tYWdub2xpYS91cHNpZGUvMjAxOS8wNS8yOC93aGltc3ktY29va2llLWNvbXBhbnktc3BlY2lhbC1jb29raWVzLXNwZWNpYWwtb2NjYXNpb25zLXJpZGdlbGFuZC1taXNzaXNzaXBwaS8zNzY1ODYwMDAyL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Follow the money: How biopharma CEOs and workers got paid in ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvdGVjaC1waGFybWEtY2VvLWVtcGxveWVlLXBheS81NTQyODMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "MiMedx Injectables Don't Meet Regulatory Standards Despite Claim ... - The Wall Street Journal",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvbWltZWR4LWluamVjdGFibGVzLWRvbnQtbWVldC1yZWd1bGF0b3J5LXN0YW5kYXJkcy1kZXNwaXRlLWNsYWltLXRvLWZkYS0xMTU1ODY1NDI3M9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/17/2019": {
        "artical1": {
            "title": "36 Apartments Planned for Former Bristol-Myers Squibb Parking Lot ... - Jersey Digs",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vamVyc2V5ZGlncy5jb20vZGV2ZWxvcG1lbnQtcHJvcG9zZWQtYnJpc3RvbC1teWVycy1zcXVpYmItbG90LWhpbGxzaWRlLW5ldy1qZXJzZXkv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Dana-Farber Scores Major Legal Victory On Cancer Drug Patents ... - WBUR News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUmh0dHBzOi8vd3d3LndidXIub3JnL25ld3MvMjAxOS8wNS8xNy9kYW5hLWZhcmJlci1jYW5jZXItaW1tdW5vdGhlcmFweWNvdXJ0LXZpY3RvcnnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Lilly oncology suffers another blow as Verzenio slapped with safety ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2xpbGx5LW9uY29sb2d5LXN1ZmZlcnMtYW5vdGhlci1ibG93LWFzLXZlcnplbmlvLXNsYXBwZWQtc2FmZXR5LXdhcm5pbmctamFwYW7SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Pharma giant Merck makes $2 billion bet on a Dallas-based cancer drug developer - The Dallas Morning News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5kYWxsYXNuZXdzLmNvbS9idXNpbmVzcy9oZWFsdGgtY2FyZS8yMDE5LzA1LzIxL3BoYXJtYS1naWFudC1tZXJjay1tYWtlcy0yLWJpbGxpb24tYmV0LW9uLWEtZGFsbGFzLWJhc2VkLWNhbmNlci1kcnVnLWRldmVsb3Blci_SAZkBaHR0cHM6Ly93d3cuZGFsbGFzbmV3cy5jb20vYnVzaW5lc3MvaGVhbHRoLWNhcmUvMjAxOS8wNS8yMS9waGFybWEtZ2lhbnQtbWVyY2stbWFrZXMtMi1iaWxsaW9uLWJldC1vbi1hLWRhbGxhcy1iYXNlZC1jYW5jZXItZHJ1Zy1kZXZlbG9wZXIvP291dHB1dFR5cGU9YW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Ren\u00e9 Russo named CEO of new I-O company - The Pharma Letter",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiT2h0dHBzOi8vd3d3LnRoZXBoYXJtYWxldHRlci5jb20vYXJ0aWNsZS9yZW5lLXJ1c3NvLW5hbWVkLWNlby1vZi1uZXctaS1vLWNvbXBhbnnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Nike to Change Pregnancy Policy in Athlete Contracts - The Wall Street Journal",
            "link": "https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvbmlrZS10by1jaGFuZ2UtcHJlZ25hbmN5LXBvbGljeS1pbi1hdGhsZXRlLWNvbnRyYWN0cy0xMTU1ODEzNzQwOdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Sneak Peek! 2024 is Absolutely the Year Bitcoin Becomes Mainstream - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zbmVhay1wZWVrLTIwMjQtYWJzb2x1dGVseS1iaXRjb2luLTE3NTA1MTU0My5odG1s0gFYaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3Mvc25lYWstcGVlay0yMDI0LWFic29sdXRlbHktYml0Y29pbi0xNzUwNTE1NDMuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "05/10/2019": {
        "artical1": {
            "title": "Canadian drug makers hit with $1.1-billion suit for pushing opioids despite risks - Financial Post",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicmh0dHBzOi8vZmluYW5jaWFscG9zdC5jb20vbmV3cy9mcC1zdHJlZXQvY2FuYWRpYW4tZHJ1Zy1tYWtlcnMtaGl0LXdpdGgtMS0xYi1zdWl0LWZvci1wdXNoaW5nLW9waW9pZHMtZGVzcGl0ZS1yaXNrc9IBoAFodHRwczovL2ZpbmFuY2lhbHBvc3QuY29tL25ld3MvZnAtc3RyZWV0L2NhbmFkaWFuLWRydWctbWFrZXJzLWhpdC13aXRoLTEtMWItc3VpdC1mb3ItcHVzaGluZy1vcGlvaWRzLWRlc3BpdGUtcmlza3Mvd2NtL2IzNGE0OTk4LWFhY2ItNDEwMS1iMjUyLTk0YTI3MjA4NjZkZC9hbXAv?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Lawsuit accuses Gilead of propping up cost of lifesaving HIV treatments by blocking generic competition - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMTkvMDUvMTQvbGF3c3VpdC1hbGxlZ2VzLWdpbGVhZC1wcm9wcGVkLXVwLWNvc3Qtb2YtaGl2LWRydWcuaHRtbNIBW2h0dHBzOi8vd3d3LmNuYmMuY29tL2FtcC8yMDE5LzA1LzE0L2xhd3N1aXQtYWxsZWdlcy1naWxlYWQtcHJvcHBlZC11cC1jb3N0LW9mLWhpdi1kcnVnLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "The relationship between network adequacy and surprise billing ... - Brookings Institution",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvdGhlLXJlbGF0aW9uc2hpcC1iZXR3ZWVuLW5ldHdvcmstYWRlcXVhY3ktYW5kLXN1cnByaXNlLWJpbGxpbmcv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Thai Siam Cement acquires Indonesian paper firm Fajar for $665 ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMilAFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLXNpYW0tY2VtZW50LWZhamFyLWFjcXVpc2l0aW9uL3RoYWktc2lhbS1jZW1lbnQtYWNxdWlyZXMtaW5kb25lc2lhbi1wYXBlci1maXJtLWZhamFyLWZvci02NjUtbWlsbGlvbi1pZFVTS0NOMVNHMTRP0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Norwegian oil company Okea to raise $100 million in IPO - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtb2tlYS1pcG8taWRVU0tDTjFTRzBGRC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Drug lawsuit ads are scaring seniors to death - STAT",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzA1LzEzL2RydWctbGF3c3VpdC1hZHMtc2NhcmluZy1zZW5pb3JzL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Electromechanical Wave Imaging Can Correctly Localize Cardiac ... - Diagnostic and Interventional Cardiology",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vYXJ0aWNsZS9lbGVjdHJvbWVjaGFuaWNhbC13YXZlLWltYWdpbmctY2FuLWNvcnJlY3RseS1sb2NhbGl6ZS1jYXJkaWFjLWFycmh5dGhtaWFz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "05/03/2019": {
        "artical1": {
            "title": "Bristol-Myers' Opdivo fails brain tumor test again, this time in new ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtb3BkaXZvLWZhaWxzLWJyYWluLXR1bW9yLXRlc3QtYWdhaW4tdGltZS1uZXctcGF0aWVudHPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Meredith Gordon, Sean Fennel - The New York Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMTkvMDUvMDUvZmFzaGlvbi93ZWRkaW5ncy9tZXJlZGl0aC1nb3Jkb24tc2Vhbi1mZW5uZWwuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Edwin DeJesus, M.D. - TheBody",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiLWh0dHBzOi8vd3d3LnRoZWJvZHkuY29tL2F1dGhvci9lZHdpbi1kZS1qZXN1c9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Joseph McGowan, M.D., F.A.C.P. - TheBody",
            "link": "https://news.google.com/rss/articles/CBMiLmh0dHBzOi8vd3d3LnRoZWJvZHkuY29tL2F1dGhvci9qb3NlcGgtbWMtZ293YW7SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "A Common Vision for Finance - Pharmaceutical Executive",
            "link": "https://news.google.com/rss/articles/CBMiNGh0dHBzOi8vd3d3LnBoYXJtZXhlYy5jb20vdmlldy9jb21tb24tdmlzaW9uLWZpbmFuY2XSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Medicare physician payment reform after two years: Examining ... - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvbWVkaWNhcmUtcGh5c2ljaWFuLXBheW1lbnQtcmVmb3JtLWFmdGVyLXR3by15ZWFycy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Florida House: These were the 9 most-lobbied bills of the session - Tampa Bay Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LnRhbXBhYmF5LmNvbS9mbG9yaWRhLXBvbGl0aWNzL2J1enovMjAxOS8wNS8wMy9mbG9yaWRhLWhvdXNlLXRoZXNlLXdlcmUtdGhlLTktbW9zdC1sb2JiaWVkLWJpbGxzLW9mLXRoZS1zZXNzaW9uL9IBigFodHRwczovL3d3dy50YW1wYWJheS5jb20vZmxvcmlkYS1wb2xpdGljcy9idXp6LzIwMTkvMDUvMDMvZmxvcmlkYS1ob3VzZS10aGVzZS13ZXJlLXRoZS05LW1vc3QtbG9iYmllZC1iaWxscy1vZi10aGUtc2Vzc2lvbi8_b3V0cHV0VHlwZT1hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/26/2019": {
        "artical1": {
            "title": "The entrepreneur behind the cancer immunotherapy revolution - STAT",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzA0LzI5L25pbHMtbG9uYmVyZy1lbnRyZXByZW5ldXItYmVoaW5kLWNhbmNlci1pbW11bm90aGVyYXB5LXJldm9sdXRpb24v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Puerto Rico board files flurry of lawsuits ahead of claim deadline - The Guam Daily Post",
            "link": "https://news.google.com/rss/articles/CBMingFodHRwczovL3d3dy5wb3N0Z3VhbS5jb20vdGhlX2dsb2JlL25hdGlvbi9wdWVydG8tcmljby1ib2FyZC1maWxlcy1mbHVycnktb2YtbGF3c3VpdHMtYWhlYWQtb2YtY2xhaW0tZGVhZGxpbmUvYXJ0aWNsZV9hOWJjNzgwMi02YmQyLTExZTktOTNiMy04Yjk3NTQ4M2NkZTQuaHRtbNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "If you want blockbuster sales, buy them in - Evaluate Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2luc2lnaHRzL290aGVyLWRhdGEvaWYteW91LXdhbnQtYmxvY2tidXN0ZXItc2FsZXMtYnV5LXRoZW3SASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDYxOC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Massachusetts Biotechnology Council opens new office at UMass ... - GazetteNET",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmdhemV0dGVuZXQuY29tL0NvbW1vbndlYWx0aC1zLWJpb3RlY2gtdHJhZGUtZ3JvdXAtdG8tb3Blbi1vZmZpY2UtYXQtVU1hc3MtQW1oZXJzdC0yNTI0OTY4ONIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Healthcare and Biopharma Execs Debate the Advantages of ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FydGlmaWNpYWwtaW50ZWxsaWdlbmNlLWluc2FuZWx5LWdyZWF0LW9yLWp1c3QtYW5vdGhlci10b29sLS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "AbbVie wins hep C contract with Washington state in latest 'Netflix ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLXdpbnMtaGVwLWMtY29udHJhY3Qtd2l0aC13YXNoaW5ndG9uLXN0YXRlLzU1MzU3Ni_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Alzheimer's Disease is a 'Double-Prion Disorder,' Study Shows - ucsf.edu",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LnVjc2YuZWR1L25ld3MvMjAxOS8wNS80MTQzMjYvYWx6aGVpbWVycy1kaXNlYXNlLWRvdWJsZS1wcmlvbi1kaXNvcmRlci1zdHVkeS1zaG93c9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/19/2019": {
        "artical1": {
            "title": "Bristol-Myers Sales Beat Estimates, Driven by Heart Drug - Bloomberg",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDE5LTA0LTI1L2JyaXN0b2wtbXllcnMtc2FsZXMtYmVhdC1lc3RpbWF0ZXMtZHJpdmVuLWJ5LWhlYXJ0LWRydWctZWxpcXVpc9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Former Bristol-Myers Squibb executive named CEO of ... - The Business Journals",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmJpempvdXJuYWxzLmNvbS9waGlsYWRlbHBoaWEvbmV3cy8yMDE5LzA0LzI1L3dpbmRtaWwtdGhlcmFwZXV0aWNzLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNlby5odG1s0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Demolition permit filed for Bristol-Myers Squibb building in Wallingford - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vTmV3cy9XYWxsaW5nZm9yZC9XYWxsaW5nZm9yZC1OZXdzL0JNUy1kZW1vbGl0aW9uLXBlcm1pdC1maWxlZC1pbi1XYWxsaW5nZm9yZC5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "La misi\u00f3n de Bristol-Myers Squibb: proveer medicamentos innovadores - elEconomista",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiwFodHRwczovL3d3dy5lbGVjb25vbWlzdGEuZXMvc2FsdWQtaW5ub3ZhY2lvbi9ub3RpY2lhcy85ODQwMDM5LzA0LzE5L0xhLW1pc2lvbi1kZS1CcmlzdG9sTXllcnMtU3F1aWJiLXByb3ZlZXItbWVkaWNhbWVudG9zLWlubm92YWRvcmVzLS5odG1s0gF7aHR0cHM6Ly93d3cuZWxlY29ub21pc3RhLmVzL3NhbHVkLWlubm92YWNpb24vYW1wLzk4NDAwMzkvTGEtbWlzaW9uLWRlLUJyaXN0b2xNeWVycy1TcXVpYmItcHJvdmVlci1tZWRpY2FtZW50b3MtaW5ub3ZhZG9yZXMt?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Zurich to pay $5.1 million penalty to U.S. in tax-evasion case - Yahoo Finance",
            "link": "https://news.google.com/rss/articles/CBMiRGh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy96dXJpY2gtcGF5LTUtMS1taWxsaW9uLTA1MjgxNDE4Ny5odG1s0gFMaHR0cHM6Ly9maW5hbmNlLnlhaG9vLmNvbS9hbXBodG1sL25ld3MvenVyaWNoLXBheS01LTEtbWlsbGlvbi0wNTI4MTQxODcuaHRtbA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "19 Surprising Stocks With a History of Earnings Surprises - Kiplinger's Personal Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmtpcGxpbmdlci5jb20vc2xpZGVzaG93L2ludmVzdGluZy90MDUyLXMwMDEtMTktZ3JlYXQtc3RvY2tzLWhpc3Rvcnktb2YtZWFybmluZ3Mtc3VycHJpc2VzL2luZGV4Lmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Despite a Q1 Drop in Sales, J&J Anticipates New Indications Will ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihAFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9kZXNwaXRlLWEtcTEtZHJvcC1pbi1zYWxlcy1qLWFuZC1qLWFudGljaXBhdGUtbmV3LWluZGljYXRpb25zLXdpbGwtaW5jcmVhc2UteGFyZWx0by1yZXZlbnVlLWdyb3d0aC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/12/2019": {
        "artical1": {
            "title": "Thumbs-up on $74B BMS-Celgene deal ends months of activist ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3RodW1icy11cC03NGItYm1zLWNlbGdlbmUtZGVhbC1mcm9tLXNoYXJlaG9sZGVycy1lbmRzLW1vbnRocy1hY3RpdmlzdC1vdXRyYWdl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Arrakis reels in $75 million to drug RNA with small molecules - Chemical & Engineering News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vY2VuLmFjcy5vcmcvYnVzaW5lc3Mvc3RhcnQtdXBzL0FycmFraXMtcmVlbHMtNzUtbWlsbGlvbi1kcnVnLzk3L3dlYi8yMDE5LzA00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Starboard takes new position in KAR Auction Services - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihwFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLWhlZGdlZnVuZHMtc3RhcmJvYXJkLWthci1hdWN0aW9uL3N0YXJib2FyZC10YWtlcy1uZXctcG9zaXRpb24taW4ta2FyLWF1Y3Rpb24tc2VydmljZXMtaWRVU0tDTjFSUzFCNi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "PathAI Lands $60M to Accelerate AI-Powered Pathology Platform - HIT Consultant",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vaGl0Y29uc3VsdGFudC5uZXQvMjAxOS8wNC8xNy9wYXRoYWktYWktcG93ZXJlZC1wYXRob2xvZ3ktcGxhdGZvcm0v0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "What to Do When Anti\u2013PD-1 Therapy Fails in Patients With Melanoma - Cancer Network",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmNhbmNlcm5ldHdvcmsuY29tL3ZpZXcvd2hhdC1kby13aGVuLWFudGlwZC0xLXRoZXJhcHktZmFpbHMtcGF0aWVudHMtbWVsYW5vbWHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Epclusa achieves best SVR rates in patients with HCV genotype 3 - Healio",
            "link": "https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9oZXBhdG9sb2d5LzIwMTkwNDE2L2VwY2x1c2EtYWNoaWV2ZXMtYmVzdC1zdnItcmF0ZXMtaW4tcGF0aWVudHMtd2l0aC1oY3YtZ2Vub3R5cGUtM9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Tocilizumab linked to lower cardiovascular risk than TNF inhibitors ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmhlYWxpby5jb20vbmV3cy9yaGV1bWF0b2xvZ3kvMjAxOTA0MTYvdG9jaWxpenVtYWItbGlua2VkLXRvLWxvd2VyLWNhcmRpb3Zhc2N1bGFyLXJpc2stdGhhbi10bmYtaW5oaWJpdG9ycy1pbi1yYdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "04/05/2019": {
        "artical1": {
            "title": "Nobel laureate behind Bristol-Myers' I-O superstar Opdivo demands ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL25vYmVsLWxhdXJlYXRlLWJlaGluZC1vcGRpdm8tY2FsbHMtZm9yLWJpZ2dlci1jdXQtZHJ1Zy1zLXdvcmxkd2lkZS1wcm9maXRz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Concerto HealthAI signs on with Pfizer to apply real-world data to ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvY29uY2VydG8taGVhbHRoYWktc2lnbnMtcGZpemVyLXRvLWFwcGx5LXJlYWwtd29ybGQtZGF0YS10by1wcmVjaXNpb24tY2FuY2VyLW1lZGljaW5l0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "The top 15 pharma companies by 2018 revenue - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTE1LXBoYXJtYS1jb21wYW5pZXMtYnktMjAxOC1yZXZlbnVl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Continual Improvements Advance Continuous Biomanufacturing - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2luc2lnaHRzL2NvbnRpbnVhbC1pbXByb3ZlbWVudHMtYWR2YW5jZS1jb250aW51b3VzLWJpb21hbnVmYWN0dXJpbmcv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Ambry Genetics Makes Advances in RNA Genetic Testing - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FtYnJ5LWdlbmV0aWNzLW1ha2VzLWFkdmFuY2VzLWluLXJuYS1nZW5ldGljLXRlc3Rpbmcv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "CVS, Cigna, Humana blame Big Pharma at Senate hearing for skyrocketing US drug prices - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMTkvMDQvMDkvY3ZzLWNpZ25hLWh1bWFuYS1ibGFtZS1iaWctcGhhcm1hLWZvci1oaWdoLWRydWctcHJpY2VzLWluLXNlbmF0ZS1oZWFyaW5nLmh0bWzSAXFodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAxOS8wNC8wOS9jdnMtY2lnbmEtaHVtYW5hLWJsYW1lLWJpZy1waGFybWEtZm9yLWhpZ2gtZHJ1Zy1wcmljZXMtaW4tc2VuYXRlLWhlYXJpbmcuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Obeticholic acid improves liver fibrosis and other histological ... - EurekAlert",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiL2h0dHBzOi8vd3d3LmV1cmVrYWxlcnQub3JnL25ld3MtcmVsZWFzZXMvODkyMzY00gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/29/2019": {
        "artical1": {
            "title": "Starboard abandons campaign to scuttle Bristol-Myers-Celgene deal - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtY2VsZ2VuZS1icmlzdG9sLW15ZXJzLWlzcy1pZFVTS0NOMVJBMUpL0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Ligand selector steers C\u2013N cross-couplings down most sustainable ... - Chemistry World",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmNoZW1pc3RyeXdvcmxkLmNvbS9uZXdzL2xpZ2FuZC1zZWxlY3Rvci1zdGVlcnMtYy1uLWNyb3NzLWNvdXBsaW5ncy1kb3duLW1vc3Qtc3VzdGFpbmFibGUtcGF0aC8zMDEwMzIyLmFydGljbGXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Examining surprise billing: Protecting patients from financial pain ... - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiZmh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvZXhhbWluaW5nLXN1cnByaXNlLWJpbGxpbmctcHJvdGVjdGluZy1wYXRpZW50cy1mcm9tLWZpbmFuY2lhbC1wYWluL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Global pharma giant AstraZeneca strikes $6.9 billion deal to expand cancer portfolio - CNBC",
            "link": "https://news.google.com/rss/articles/CBMiYWh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMTkvMDMvMjkvYXN0cmF6ZW5lY2Etc3RyaWtlcy02cG9pbnQ5LWJpbGxpb24tZGVhbC13aXRoLWRhaWljaGktc2Fua3lvLmh0bWzSAWVodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAxOS8wMy8yOS9hc3RyYXplbmVjYS1zdHJpa2VzLTZwb2ludDktYmlsbGlvbi1kZWFsLXdpdGgtZGFpaWNoaS1zYW5reW8uaHRtbA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "AACR 2019 \u2013 Foundation Medicine sets the scene for liquid biopsy approval - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9hYWNyLTIwMTktZm91bmRhdGlvbi1tZWRpY2luZS1zZXRzLXNjZW5lLWxpcXVpZC1iaW9wc3ktYXBwcm92YWzSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDUzMy9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "US syndicated lending drops to 3-yr low in tenuous quarter - Reuters",
            "link": "https://news.google.com/rss/articles/CBMidmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXNsZW5kaW5nLTFxL3VzLXN5bmRpY2F0ZWQtbGVuZGluZy1kcm9wcy10by0zLXlyLWxvdy1pbi10ZW51b3VzLXF1YXJ0ZXItaWRVU0wxTjIxRzBaSS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Swiss medical device maker Medacta valued at $1.9 billion in IPO - Reuters",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtbWVkYWN0YS1pcG8vc3dpc3MtbWVkaWNhbC1kZXZpY2UtbWFrZXItbWVkYWN0YS12YWx1ZWQtYXQtMS05LWJpbGxpb24taW4taXBvLWlkVVNLQ04xUkcwRVQv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "03/22/2019": {
        "artical1": {
            "title": "Bristol-Myers Squibb taps Concerto HealthAI for real-world cancer ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL21lZHRlY2gvYnJpc3RvbC1teWVycy1zcXVpYmItdGFwcy1jb25jZXJ0by1oZWFsdGhhaS1mb3ItcmVhbC13b3JsZC1jYW5jZXItZGF0YS13b3JrLWFuZC10cmlhbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers, Pfizer defeat Eliquis bleeding risk lawsuits on appeal - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2hlYWx0aC1lbGlxdWlzL2JyaXN0b2wtbXllcnMtcGZpemVyLWRlZmVhdC1lbGlxdWlzLWJsZWVkaW5nLXJpc2stbGF3c3VpdHMtb24tYXBwZWFsLWlkVVNMMU4yMUQxVzcv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Top 10 Immuno-Oncology Collaborations - Genetic Engineering & Biotechnology News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2EtbGlzdHMvdG9wLTEwLWltbXVuby1vbmNvbG9neS1jb2xsYWJvcmF0aW9ucy0zL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "UNDP, World Bank Propose Indicators to Measure LGBTI Inclusion ... - IISD's SDG Knowledge Hub",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vc2RnLmlpc2Qub3JnL25ld3MvdW5kcC13b3JsZC1iYW5rLXByb3Bvc2UtaW5kaWNhdG9ycy10by1tZWFzdXJlLWxnYnRpLWluY2x1c2lvbi1pbi1kZXZlbG9wbWVudC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Astellas, Seattle plan FDA filing after cancer ADC clears test - FierceBiotech",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvYXN0ZWxsYXMtc2VhdHRsZS1wbGFuLWZkYS1maWxpbmctYWZ0ZXItY2FuY2VyLWFkYy1jbGVhcnMtdGVzdNIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Sydell Miller buys 24th floor of The Bristol - Palm Beach Daily News",
            "link": "https://news.google.com/rss/articles/CBMioQFodHRwczovL3d3dy5wYWxtYmVhY2hkYWlseW5ld3MuY29tL3N0b3J5L2xpZmVzdHlsZS9yZWFsLWVzdGF0ZS8yMDE5LzAzLzIyL2RlZWQtbWF0cml4LW1vZ3VsLXBheXMtNDI1Nm0tZm9yLWVudGlyZS0yNHRoLWZsb29yLW9mLXdlc3QtcGFsbS1iZWFjaC1jb25kby81NjMwNzA3MDA3L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Biogen, Eisai End Phase III Aducanumab Trials In AD - Contract Pharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LmNvbnRyYWN0cGhhcm1hLmNvbS9jb250ZW50cy92aWV3X2JyZWFraW5nLW5ld3MvMjAxOS0wMy0yMi9iaW9nZW4tZWlzYWktZW5kLXBoYXNlLWlpaS1hZHVjYW51bWFiLXRyaWFscy1pbi1hZC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/15/2019": {
        "artical1": {
            "title": "AUGUSTUS: Dual therapy with apixaban, P2Y12 inhibitor safe in ... - Healio",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMinAFodHRwczovL3d3dy5oZWFsaW8uY29tL25ld3MvY2FyZGlhYy12YXNjdWxhci1pbnRlcnZlbnRpb24vMjAxOTAzMTcvYXVndXN0dXMtZHVhbC10aGVyYXB5LXdpdGgtYXBpeGFiYW4tcDJ5MTItaW5oaWJpdG9yLXNhZmUtaW4tYWZpYi1wYXRpZW50cy1wb3N0LWFjcy1vci1wY2nSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "China\u2019s blueprint for a checkpoint blocker price war - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3Nwb3RsaWdodC9jaGluYXMtYmx1ZXByaW50LWNoZWNrcG9pbnQtYmxvY2tlci1wcmljZS13YXLSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDUwOC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Apixaban Effective in Specific Cohort of Non-Valvular Atrial ... - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9hcGl4YWJhbi1lZmZlY3RpdmUtc3BlY2lmaWMtY29ob3J0LW5vbi12YWx2dWxhci1hdHJpYWwtZmlicmlsbGF0aW9uLXBhdGllbnRz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Edoxaban Joins Other NOACs as Option During Catheter Ablation ... - TCTMD",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2Vkb3hhYmFuLWpvaW5zLW90aGVyLW5vYWNzLW9wdGlvbi1kdXJpbmctY2F0aGV0ZXItYWJsYXRpb24tZmli0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "Celgene Pays Exscientia $25 Million up Front for 3-Year AI ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL2FpLWNvbXBhbnktZXhzY2llbnRpYS1pbmtzLTMteWVhci1wYXJ0bmVyc2hpcC13aXRoLWNlbGdlbmUv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Shipbroker McQuilling ends tanker contracts with Venezuela's PDVSA - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtdmVuZXp1ZWxhLXBvbGl0aWNzLXRhbmtlcnMtaWRVU0tDTjFRVzJMNtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Victory! Johnson & Johnson Bans Water Tank Test - PETA",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LnBldGEub3JnL2Jsb2cvam9obnNvbi1hbmQtam9obnNvbi1mb3JjZWQtc3dpbS10ZXN0L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/08/2019": {
        "artical1": {
            "title": "Does Bristol-Myers have a plan B if activists scuttle its Celgene buy? - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2RvZXMtYnJpc3RvbC1teWVycy1zcXVpYmItaGF2ZS1hLXBsYW4tYi1pZi1hY3RpdmlzdHMtc2N1dHRsZS1jZWxnZW5lLWJ1edIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Celgene's Abraxane flops in pivotal pancreatic cancer study - MedCity News",
            "link": "https://news.google.com/rss/articles/CBMiW2h0dHBzOi8vbWVkY2l0eW5ld3MuY29tLzIwMTkvMDMvY2VsZ2VuZXMtYWJyYXhhbmUtZmxvcHMtaW4tcGl2b3RhbC1wYW5jcmVhdGljLWNhbmNlci1zdHVkeS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Why old-school asset managers are copying the activists - Financial Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50LzNmNGZlMGFlLTQxN2UtMTFlOS05YmVlLWVmYWI2MTUwNmY0NNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Bristol\u2019s doomsday scenario: could Opdivo start shrinking next year? - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMieGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3ZhbnRhZ2Utdmlld3MvYnJpc3RvbHMtZG9vbXNkYXktc2NlbmFyaW8tY291bGQtb3BkaXZvLXN0YXJ0LXNocmlua2luZ9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0NDU2L2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Roche's Tecentriq notches win in breast cancer with U.S. approval - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtcm9jaGUtaW1tdW5vdGhlcmFweS1pZFVTS0NOMVFQMjBDL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Roche's I-O drug Tecentriq picks up key first-in-class breast cancer ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3JvY2hlLXMtdGVjZW50cmlxLXBpY2tzLXVwLWtleS1maXJzdC1jbGFzcy1icmVhc3QtY2FuY2VyLW5vZC10bmJjLW9r0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Scholar thinks Glaxo made a wise move to back Merck - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvY29ycG9yYXRlLXN0cmF0ZWd5L3NjaG9sYXItdGhpbmtzLWdsYXhvLW1hZGUtd2lzZS1tb3ZlLWJhY2stbWVyY2vSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDQ1NS9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "03/01/2019": {
        "artical1": {
            "title": "2 months after BMS megamerger, Celgene's JAK inhibitor to get ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvMi1tb250aHMtYWZ0ZXItYm1zLW1lZ2FtZXJnZXItY2VsZ2VuZS1zLWphay1pbmhpYml0b3ItZ2V0cy1wcmlvcml0eS1yZXZpZXfSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Top Life Science Companies Hiring Now in March - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiUGh0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RvcC1saWZlLXNjaWVuY2UtY29tcGFuaWVzLWhpcmluZy1ub3ctaW4tbWFyY2gv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "FDA OKs new Johnson & Johnson antidepression drug - Fox Business",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmZveGJ1c2luZXNzLmNvbS9oZWFsdGhjYXJlL2ZkYS1va3MtbmV3LWpvaG5zb24tam9obnNvbi1hbnRpLWRlcHJlc3Npb24tZHJ1Z9IBW2h0dHBzOi8vd3d3LmZveGJ1c2luZXNzLmNvbS9oZWFsdGhjYXJlL2ZkYS1va3MtbmV3LWpvaG5zb24tam9obnNvbi1hbnRpLWRlcHJlc3Npb24tZHJ1Zy5hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Lilly takes a leaf out of Mylan\u2019s book to defuse insulin price complaints - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMid2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvcHJpY2luZy9saWxseS10YWtlcy1sZWFmLW91dC1teWxhbnMtYm9vay1kZWZ1c2UtaW5zdWxpbi1wcmljZS1jb21wbGFpbnRz0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTQ0MDUvYW1w?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Opinion | Treat Medicines Like Netflix Treats Shows - The New York Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3Lm55dGltZXMuY29tLzIwMTkvMDMvMDUvb3Bpbmlvbi9jYW4tbmV0ZmxpeC1zaG93LWFtZXJpY2Fucy1ob3ctdG8tY3V0LXRoZS1jb3N0LW9mLWRydWdzLmh0bWzSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "CHMP backs Lynparza in breast cancer, Dupixent in asthma - PMLiVE",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvY2htcF9iYWNrc19seW5wYXJ6YV9pbl9icmVhc3RfY2FuY2VyLF9kdXBpeGVudF9pbl9hc3RobWFfMTI4MDQ2NdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Starboard builds stake in Zayo, presses for sale - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvemF5by1ncC1zdGFyYm9hcmQvc3RhcmJvYXJkLWJ1aWxkcy1zdGFrZS1pbi16YXlvLXByZXNzZXMtZm9yLXNhbGUtaWRVU0w1TjIwVTBNNi_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/22/2019": {
        "artical1": {
            "title": "Starboard joins opposition to Bristol-Myers' $74 billion Celgene deal - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtY2VsZ2VuZS1tLWEtYnJpc3RvbC1teWVycy13ZWxsaW5ndG9uLWlkVVNLQ04xUUgxSzcv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Celgene CEO Alles to bag $28M if he departs after BMS merger - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiX2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2NlbGdlbmUtY2VvLWFsbGVzLXRvLWJhZy0yOG0taWYtaGUtZGVwYXJ0cy1hZnRlci1ibXMtbWVyZ2Vy0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Obsolescence of Wallingford's former BMS building reflects shift in ... - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMihgFodHRwczovL3d3dy5teXJlY29yZGpvdXJuYWwuY29tL05ld3MvV2FsbGluZ2ZvcmQvV2FsbGluZ2ZvcmQtTmV3cy9CaW8tVGVjaHMtbm8tbG9uZ2VyLWhhdmUtdXNlLWZvci1sYXJnZS1yZXNlYXJjaC1hbmQtZGV2ZWxvcG1lbnQuaHRtbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Drug price hearing on Capitol Hill has similarities to one nearly 60 years ago - ABC News",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vYWJjbmV3cy5nby5jb20vSGVhbHRoL2RydWctcHJpY2UtaGVhcmluZy1jYXBpdG9sLWhpbGwtc2ltaWxhcml0aWVzLTYwLXllYXJzL3N0b3J5P2lkPTYxMjQzMjUy0gFpaHR0cHM6Ly9hYmNuZXdzLmdvLmNvbS9hbXAvSGVhbHRoL2RydWctcHJpY2UtaGVhcmluZy1jYXBpdG9sLWhpbGwtc2ltaWxhcml0aWVzLTYwLXllYXJzL3N0b3J5P2lkPTYxMjQzMjUy?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "These Senators Received The Biggest Checks From Pharma Companies Testifying Tuesday - Forbes",
            "link": "https://news.google.com/rss/articles/CBMiqwFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL21pY2hlbGF0aW5kZXJhLzIwMTkvMDIvMjYvdGhlc2Utc2VuYXRvcnMtcmVjZWl2ZWQtdGhlLWJpZ2dlc3QtY2hlY2tzLWZyb20tcGhhcm1hLWNvbXBhbmllcy10ZXN0aWZ5aW5nLWRydWctcHJpY2luZy1hYmJ2aWUtc2Fub2ZpLW1lcmNrLXBmaXplci_SAa8BaHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9taWNoZWxhdGluZGVyYS8yMDE5LzAyLzI2L3RoZXNlLXNlbmF0b3JzLXJlY2VpdmVkLXRoZS1iaWdnZXN0LWNoZWNrcy1mcm9tLXBoYXJtYS1jb21wYW5pZXMtdGVzdGlmeWluZy1kcnVnLXByaWNpbmctYWJidmllLXNhbm9maS1tZXJjay1wZml6ZXIvYW1wLw?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Pharma execs offer Senate ideas to lower drug costs \u2013 except actually cutting prices - CNBC",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmNuYmMuY29tLzIwMTkvMDIvMjYvcGhhcm1hLWV4ZWNzLW9mZmVyLXNlbmF0ZS1pZGVhcy10by1sb3dlci1kcnVnLWNvc3RzLWV4Y2VwdC1wcmljZS1jdXRzLmh0bWzSAW5odHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAxOS8wMi8yNi9waGFybWEtZXhlY3Mtb2ZmZXItc2VuYXRlLWlkZWFzLXRvLWxvd2VyLWRydWctY29zdHMtZXhjZXB0LXByaWNlLWN1dHMuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Drug company CEOs admit prescription prices are too high. But will they change? - PBS NewsHour",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3LnBicy5vcmcvbmV3c2hvdXIvaGVhbHRoL2RydWctY29tcGFueS1jZW9zLWFkbWl0LXByZXNjcmlwdGlvbi1wcmljZXMtYXJlLXRvby1oaWdoLWJ1dC13aWxsLXRoZXktY2hhbmdl0gF1aHR0cHM6Ly93d3cucGJzLm9yZy9uZXdzaG91ci9hbXAvaGVhbHRoL2RydWctY29tcGFueS1jZW9zLWFkbWl0LXByZXNjcmlwdGlvbi1wcmljZXMtYXJlLXRvby1oaWdoLWJ1dC13aWxsLXRoZXktY2hhbmdl?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/15/2019": {
        "artical1": {
            "title": "Are the big corporate venture arms retreating? - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvdmVudHVyZS1maW5hbmNpbmcvYXJlLWJpZy1jb3Jwb3JhdGUtdmVudHVyZS1hcm1zLXJldHJlYXRpbmfSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDM1MC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "State approaches to mitigating surprise out-of-network billing ... - Brookings Institution",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvc3RhdGUtYXBwcm9hY2hlcy10by1taXRpZ2F0aW5nLXN1cnByaXNlLW91dC1vZi1uZXR3b3JrLWJpbGxpbmcv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "PET scans show biomarkers could spare some breast cancer ... - EurekAlert",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LmV1cmVrYWxlcnQub3JnL3B1Yl9yZWxlYXNlcy8yMDE5LTAyL2pobS1wczAyMjExOS5waHDSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "US corporates tap term loans as they look to avert downgrades - Reuters",
            "link": "https://news.google.com/rss/articles/CBMif2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvY29ycG9yYXRlLXRlcm1sb2Fucy91cy1jb3Jwb3JhdGVzLXRhcC10ZXJtLWxvYW5zLWFzLXRoZXktbG9vay10by1hdmVydC1kb3duZ3JhZGVzLWlkSU5MMU4yMEcyMzDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "In Boston Courtroom, Cancer Research Titans Clash Over Patents ... - WBUR News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LndidXIub3JnL25ld3MvMjAxOS8wMi8xNS9pbW11bm90aGVyYXB5LXBhdGVudC1iaWxsaW9ucy1zdWl0LWRhbmEtZmFyYmVy0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "As medical costs mount, Japan to weigh cost-effectiveness in setting ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiPGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtamFwYW4tZHJ1Z3MtaWRVU0tDTjFRNzFaR9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "FDA Approves IDE Study for Foldax Biopolymer Heart Valve Platform - Diagnostic and Interventional Cardiology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9mZGEtYXBwcm92ZXMtaWRlLXN0dWR5LWZvbGRheC1iaW9wb2x5bWVyLWhlYXJ0LXZhbHZlLXBsYXRmb3Jt0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "02/08/2019": {
        "artical1": {
            "title": "Merck's Keytruda looks to zoom past Opdivo with fast head and neck ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMic2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL21lcmNrLXMta2V5dHJ1ZGEtbG9va3MtdG8tem9vbS1wYXN0LW9wZGl2by1oZWFkLWFuZC1uZWNrLWNhbmNlci1icmVha3Rocm91Z2jSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "For a Chinese cancer drug developer, Bristol-Celgene deal is ... - STAT",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5zdGF0bmV3cy5jb20vMjAxOS8wMi8xMy9mb3ItYS1jaGluZXNlLWNhbmNlci1kcnVnLWRldmVsb3Blci1icmlzdG9sLWNlbGdlbmUtZGVhbC1pcy1wb2lzZWQtdG8taGF2ZS1iaWctcmlwcGxlLWVmZmVjdHMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "The 'Big Pharma' candidate? As he runs for president, Cory Booker ... - STAT",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzAyLzEyL2NvcnktYm9va2VyLXByZXNpZGVudGlhbC1ydW4tcGhhcm1hY2V1dGljYWwtaW5kdXN0cnktdGllcy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Keytruda shows the high price of curing cancer - Financial Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiP2h0dHBzOi8vd3d3LmZ0LmNvbS9jb250ZW50L2MxZGFjY2E2LTJlYzItMTFlOS1iYTAwLTAyNTEwMjI5MzJjONIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Final ANNEXA-4 Results Published, Confirm Rapid Andexanet Alfa ... - TCTMD",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2ZpbmFsLWFubmV4YS00LXJlc3VsdHMtcHVibGlzaGVkLWNvbmZpcm0tcmFwaWQtYW5kZXhhbmV0LWFsZmEtZWZmZWN0c9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "5 Tiny Biotech Stocks With Superb Growth Potential - Nasdaq",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3Lm5hc2RhcS5jb20vYXJ0aWNsZXMvNS10aW55LWJpb3RlY2gtc3RvY2tzLXN1cGVyYi1ncm93dGgtcG90ZW50aWFsLTIwMTktMDItMTPSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Apixaban plus aspirin may be beneficial after MitraClip implantation - Healio",
            "link": "https://news.google.com/rss/articles/CBMiuwFodHRwczovL3d3dy5oZWFsaW8uY29tL2NhcmRpYWMtdmFzY3VsYXItaW50ZXJ2ZW50aW9uL3N0cnVjdHVyYWwvbmV3cy9vbmxpbmUvJTdCODgxYTM2YWYtZDEyMy00NDJjLTg5NDktMGZlMmY3OTU0ZDIyJTdEL2FwaXhhYmFuLXBsdXMtYXNwaXJpbi1tYXktYmUtYmVuZWZpY2lhbC1hZnRlci1taXRyYWNsaXAtaW1wbGFudGF0aW9u0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "02/01/2019": {
        "artical1": {
            "title": "Wall Street banks rake in $300m on Bristol-Myers Squibb takeover - Financial News",
            "link": "https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmZubG9uZG9uLmNvbS9hcnRpY2xlcy93YWxsLXN0cmVldC1iYW5rcy1yYWtlLWluLTMwMG0tb24tYnJpc3RvbC1teWVycy1zcXVpYmItdGFrZW92ZXItMjAxOTAyMDTSAW5odHRwczovL3d3dy5mbmxvbmRvbi5jb20vYW1wL2FydGljbGVzL3dhbGwtc3RyZWV0LWJhbmtzLXJha2UtaW4tMzAwbS1vbi1icmlzdG9sLW15ZXJzLXNxdWliYi10YWtlb3Zlci0yMDE5MDIwNA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Top 12 Life Sciences Companies Hiring Now in February - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiV2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RvcC0xMi1saWZlLXNjaWVuY2VzLWNvbXBhbmllcy1oaXJpbmctbm93LWluLWZlYnJ1YXJ5L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Licensing deal activity follows buyout market downwards - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMiemh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9saWNlbnNpbmctZGVhbC1hY3Rpdml0eS1mb2xsb3dzLWJ1eW91dC1tYXJrZXQtZG93bndhcmRz0gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTQzMTgvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Novartis and Gilead\u2019s multiple myeloma CARs diverge - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3Nwb3RsaWdodC9ub3ZhcnRpcy1hbmQtZ2lsZWFkcy1tdWx0aXBsZS1teWVsb21hLWNhcnMtZGl2ZXJnZdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0MzIyL2FtcA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bispecific, Multispecific Antibodies Grapple with Cancer - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2luc2lnaHRzL2Jpc3BlY2lmaWMtbXVsdGlzcGVjaWZpYy1hbnRpYm9kaWVzLWdyYXBwbGUtd2l0aC1jYW5jZXIv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Study finds no association between trazodone and reduced ... - EurekAlert",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiL2h0dHBzOi8vd3d3LmV1cmVrYWxlcnQub3JnL25ld3MtcmVsZWFzZXMvODY5MTA50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Investor Who Made Olive Garden Salt Its Pasta Wants to Make Papa ... - TIME",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vdGltZS5jb20vNTUyMDQwNi9vbGl2ZS1nYXJkZW4taW52ZXN0b3ItcGFwYS1qb2hucy1waXp6YS_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/25/2019": {
        "artical1": {
            "title": "New owners of former BMS campus are auctioning off collectable art ... - Meriden Record-Journal",
            "link": "https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vTmV3cy9XYWxsaW5nZm9yZC9XYWxsaW5nZm9yZC1OZXdzL1dhbGxpbmdmb3JkLUJNUy1hdWN0aW9uLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Celgene Strikes Deal Worth Nearly $1 Billion for Blood Cancer ... - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiggFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9jZWxnZW5lLXN0cmlrZXMtZGVhbC13b3J0aC1uZWFybHktMS1iaWxsaW9uLXdpdGgtdHJpcGhhc2UtYWNjZWxlcmF0b3ItZm9yLWJsb29kLWNhbmNlci10cmVhdG1lbnQv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "US companies turning to term loans for acquisition debt - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiOmh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvbWEtdGVybWxvYW5zLWlkVVNMMU4xWlAwWDDSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Ovid CEO Jeremy Levin Puts the Patient First as He Seeks to ... - BioSpace",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiiQFodHRwczovL3d3dy5iaW9zcGFjZS5jb20vYXJ0aWNsZS9vdmlkLWNlby1qZXJlbXktbGV2aW4tcHV0cy10aGUtcGF0aWVudC1maXJzdC1hcy1oZS1zZWVrcy10by1yZXZvbHV0aW9uaXplLWRydWctZGV2ZWxvcG1lbnQtaW4tbmV1cm9sb2d5L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Thubrikar Announces First-in-Human Implant of Optimum TAVI System - Diagnostic and Interventional Cardiology",
            "link": "https://news.google.com/rss/articles/CBMiYGh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC90aHVicmlrYXItYW5ub3VuY2VzLWZpcnN0LWh1bWFuLWltcGxhbnQtb3B0aW11bS10YXZpLXN5c3RlbdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Amgen adds bone drug Xgeva to pharma's cancer-related lineup on ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2FtZ2VuLWFkZHMteGdldmEtdG8tb25jb2xvZ3ktcmVsYXRlZC1kcnVncy10di1mb2N1c2luZy1jYW5jZXItcGF0aWVudHMtYm9uZS1tZXRhc3Rhc2Vz0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Fresenius Kabi Introduces Leucovorin Calcium Injection, USP - Contract Pharma",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5jb250cmFjdHBoYXJtYS5jb20vY29udGVudHMvdmlld19icmVha2luZy1uZXdzLzIwMTktMDEtMjkvZnJlc2VuaXVzLWthYmktaW50cm9kdWNlcy1sZXVjb3ZvcmluLWNhbGNpdW0taW5qZWN0aW9uLXVzcC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/18/2019": {
        "artical1": {
            "title": "Bristol-Myers Reports Higher Sales but Another Lung-Cancer Setback - The Wall Street Journal",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvYnJpc3RvbC1teWVycy1yZXBvcnRzLWhpZ2hlci1zYWxlcy1idXQtYW5vdGhlci1sdW5nLWNhbmNlci1zZXRiYWNrLTExNTQ4MzMxMjAw0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Look out for a Q4 surprise from BMS' Opdivo, but Merck's Keytruda ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMie2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Zvci1xNC1leHBlY3QtdG8tc2VlLWJtcy1vcGRpdm8tc3VycHJpc2UtYWdhaW4tYnV0LW1lcmNrLXMta2V5dHJ1ZGEtc3RheS10b3AtYW5hbHlzdNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Celgene, sold for $74 billion, leaves a legacy of chutzpah in science ... - STAT",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LnN0YXRuZXdzLmNvbS8yMDE5LzAxLzIyL2NlbGdlbmUtbGVnYWN5LWNodXR6cGFoLXNjaWVuY2UtZHJ1Zy1wcmljaW5nL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Italy drugmaker Zambon ready to splash out in U.S., China push - Yahoo Finance UK",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vdWsuZmluYW5jZS55YWhvby5jb20vbmV3cy9pdGFseS1kcnVnbWFrZXItemFtYm9uLXJlYWR5LXNwbGFzaC11LWNoaW5hLXB1c2gtMTUzNjQ4OTkwLS1zZWN0b3IuaHRtbNIBcWh0dHBzOi8vdWsuZmluYW5jZS55YWhvby5jb20vYW1waHRtbC9uZXdzL2l0YWx5LWRydWdtYWtlci16YW1ib24tcmVhZHktc3BsYXNoLXUtY2hpbmEtcHVzaC0xNTM2NDg5OTAtLXNlY3Rvci5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Tom Brady and Drew Brees battled Iowa Hawkeyes last century - The Gazette",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vd3d3LnRoZWdhemV0dGUuY29tL2hhd2tleWUtZm9vdGJhbGwvdG9tLWJyYWR5LWFuZC1kcmV3LWJyZWVzLWJhdHRsZWQtaW93YS1oYXdrZXllcy1sYXN0LWNlbnR1cnkv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "BMS, Ono Pharma wins more indication for Opdivo in EU - KBR",
            "link": "https://news.google.com/rss/articles/CBMiPGh0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3Lmh0bWw_aWR4bm89NDk4NtIBP2h0dHBzOi8vd3d3LmtvcmVhYmlvbWVkLmNvbS9uZXdzL2FydGljbGVWaWV3QW1wLmh0bWw_aWR4bm89NDk4Ng?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Roche dominates 2019\u2019s big patent expiries - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMibGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9yb2NoZS1kb21pbmF0ZXMtMjAxOXMtYmlnLXBhdGVudC1leHBpcmllc9IBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0MjY3L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "01/11/2019": {
        "artical1": {
            "title": "BMS/Celgene deal will create haematology powerhouse BMS ... - Pharmaceutical Technology",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vd3d3LnBoYXJtYWNldXRpY2FsLXRlY2hub2xvZ3kuY29tL2NvbW1lbnQvYm1zLWNlbGdlbmUtZGVhbC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "BMS in Wallingford to be demolished, but future of property is unclear - Meriden Record-Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vTmV3cy9XYWxsaW5nZm9yZC9XYWxsaW5nZm9yZC1OZXdzL0FmdGVyLUJNUy1kZWNpc2lvbi1XYWxsaW5nZm9yZC1wcm9wZXJ0eS1mdXR1cmUtdW5jbGVhci5odG1s0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "EU approval for Opdivo combo in renal cell cancer - PMLiVE - PMLiVE",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LnBtbGl2ZS5jb20vcGhhcm1hX25ld3MvZXVfYXBwcm92YWxfZm9yX29wZGl2b19jb21ib19pbl9yZW5hbF9jZWxsX2NhbmNlcl8xMjc1MTI00gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Another AstraZeneca executive hits the exit, joins alumnus at ... - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvaW1tdW5vY29yZS1uYW1lcy1leC1hc3RyYXplbmVjYS1icmlzdG9sLW15ZXJzLWV4ZWMtYXMtci1kLWNoaWVm0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Lilly eyes more cancer deals, but wary of CAR-T, gene therapy - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiPWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtbGlsbHktY2FuY2VyLWlkVVNLQ04xUDUyOTTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "There Is Value To Being At The Center Of The JPM Universe - Life Science Leader Magazine",
            "link": "https://news.google.com/rss/articles/CBMiZGh0dHBzOi8vd3d3LmxpZmVzY2llbmNlbGVhZGVyLmNvbS9kb2MvdGhlcmUtaXMtdmFsdWUtdG8tYmVpbmctYXQtdGhlLWNlbnRlci1vZi10aGUtanBtLXVuaXZlcnNlLTAwMDHSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Big Pharma Faces the Curse of the Billion-Dollar Blockbuster - Bloomberg",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmJsb29tYmVyZy5jb20vbmV3cy9hcnRpY2xlcy8yMDE5LTAxLTExL2JpZy1waGFybWEtZmFjZXMtdGhlLWN1cnNlLW9mLXRoZS1iaWxsaW9uLWRvbGxhci1ibG9ja2J1c3RlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "01/04/2019": {
        "artical1": {
            "title": "Johns Hopkins, Bristol-Myers must face $1 billion syphilis infections ... - Reuters",
            "link": "https://news.google.com/rss/articles/CBMilgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLW1hcnlsYW5kLWxhd3N1aXQtaW5mZWN0aW9ucy9qb2hucy1ob3BraW5zLWJyaXN0b2wtbXllcnMtbXVzdC1mYWNlLTEtYmlsbGlvbi1zeXBoaWxpcy1pbmZlY3Rpb25zLXN1aXQtaWRVU0tDTjFPWTFOMy_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "The BMS-Celgene merger's Achilles heel? An earlier-than-expected ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtYm9vc3RzLW9uY29sb2d5LXBpcGVsaW5lLWNlbGdlbmUtYnV5b3V0LWJ1dC1yZXZsaW1pZC1wYXRlbnQtd29ycmllcy1hYm91bmTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Celgene, Bristol-Myers set $2.2 billion termination fee for their mega ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtY2VsZ2VuZS1tLWEtYnJpc3RvbC1teWVycy1pZFVTS0NOMU9ZMUIwL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Japan's MUFG extends $18bn loan to Bristol-Myers for megadeal - Nikkei Asia",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibGh0dHBzOi8vYXNpYS5uaWtrZWkuY29tL0J1c2luZXNzL0J1c2luZXNzLWRlYWxzL0phcGFuLXMtTVVGRy1leHRlbmRzLTE4Ym4tbG9hbi10by1CcmlzdG9sLU15ZXJzLWZvci1tZWdhZGVhbNIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Bristol-Myers Squibb provides backers with a test of nerve - The Times",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnRoZXRpbWVzLmNvLnVrL2FydGljbGUvYnJpc3RvbC1teWVycy1zcXVpYmItcHJvdmlkZXMtYmFja2Vycy13aXRoLWEtdGVzdC1vZi1uZXJ2ZS04ZGd4NXhkcXTSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Lilly to buy Loxo Oncology for $8B - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5LWxveG8tb25jb2xvZ3ktOC1iaWxsaW9uLWRlYWwvNTQ1NDA1L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "BMS and Celgene see cell therapies as future of oncology - BioPharma-Reporter.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJpb3BoYXJtYS1yZXBvcnRlci5jb20vQXJ0aWNsZS8yMDE5LzAxLzA5L0JNUy1hbmQtQ2VsZ2VuZS1zZWUtY2VsbC10aGVyYXBpZXMtYXMtZnV0dXJlLW9mLW9uY29sb2d50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/28/2018": {
        "artical1": {
            "title": "Bristol-Myers Squibb's $74 billion acquisition of Celgene would combine two troubled companies - CNBC",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmNuYmMuY29tLzIwMTkvMDEvMDMvYnJpc3RvbC1teWVycy1zcXVpYmItc2hhcmVzLWZhbGwtb24tNzQtYmlsbGlvbi1jZWxnZW5lLWFjcXVpc2l0aW9uLmh0bWzSAWtodHRwczovL3d3dy5jbmJjLmNvbS9hbXAvMjAxOS8wMS8wMy9icmlzdG9sLW15ZXJzLXNxdWliYi1zaGFyZXMtZmFsbC1vbi03NC1iaWxsaW9uLWNlbGdlbmUtYWNxdWlzaXRpb24uaHRtbA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb to buy Celgene in $74 billion deal - CNN",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmNubi5jb20vMjAxOS8wMS8wMy9idXNpbmVzcy9icmlzdG9sLW15ZXJzLXNxdWliYi1jZWxnZW5lLW1lcmdlci9pbmRleC5odG1s0gFaaHR0cHM6Ly9hbXAuY25uLmNvbS9jbm4vMjAxOS8wMS8wMy9idXNpbmVzcy9icmlzdG9sLW15ZXJzLXNxdWliYi1jZWxnZW5lLW1lcmdlci9pbmRleC5odG1s?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Squibb to Acquire Celgene to Create a Premier ... - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MDEwMzAwNTMxMS9lbi9CcmlzdG9sLU15ZXJzLVNxdWliYi10by1BY3F1aXJlLUNlbGdlbmUtdG8tQ3JlYXRlLWEtUHJlbWllci1Jbm5vdmF0aXZlLUJpb3BoYXJtYS1Db21wYW550gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "BMS to buy Celgene in deal worth $74 billion - Chemical & Engineering News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiTWh0dHBzOi8vY2VuLmFjcy5vcmcvcGhhcm1hY2V1dGljYWxzL29uY29sb2d5L0JNUy1idXktQ2VsZ2VuZS1kZWFsLXdvcnRoLzk3L2kx0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "In another record year for pharma TV ads, spending soars to $3.7B ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2Fub3RoZXItcmVjb3JkLXllYXItZm9yLXBoYXJtYS10di1hZHMtc3BlbmRpbmctdG9wcy0zLTctYmlsbGlvbi0yMDE40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Dow plunges more than 650 points as Apple flashes warning signs - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9zdG9jay1mdXR1cmVzLXR1bWJsZS1hcHBsZS1mbGFzaGVzLXdhcm5pbmctc2lnbnMtMTI0OTAwOTc3Lmh0bWzSAWZodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9zdG9jay1mdXR1cmVzLXR1bWJsZS1hcHBsZS1mbGFzaGVzLXdhcm5pbmctc2lnbnMtMTI0OTAwOTc3Lmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Bristol-Myers Squibb compra Celgene por 65.000 millones de euros - Expansi\u00f3n",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmV4cGFuc2lvbi5jb20vZW1wcmVzYXMvMjAxOS8wMS8wMy81YzJlMTRkMTQ2MTYzZjY2OTg4YjQ1YmUuaHRtbNIBS2h0dHBzOi8vYW1wLmV4cGFuc2lvbi5jb20vZW1wcmVzYXMvMjAxOS8wMS8wMy81YzJlMTRkMTQ2MTYzZjY2OTg4YjQ1YmUuaHRtbA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/21/2018": {
        "artical1": {
            "title": "YEAR IN REVIEW: Wallingford's top stories of 2018 - Meriden Record-Journal",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3Lm15cmVjb3Jkam91cm5hbC5jb20vQXJ0aWNsZXMvMjAxOC8xMi8yNi9XYWxsaW5nZm9yZC10b3Atc3Rvcmllcy1vZi0yMDE40gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "When and how can a Singapore patent application be corrected? - Lexology",
            "link": "https://news.google.com/rss/articles/CBMiU2h0dHBzOi8vd3d3LmxleG9sb2d5LmNvbS9saWJyYXJ5L2RldGFpbC5hc3B4P2c9N2NlNjY5MDEtOTQ5YS00NWQ1LTlkNmUtNzg1ODI1NzIwNzFh0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "EDPR secures tax equity for 399 MW of US wind - Renewables Now",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVGh0dHBzOi8vcmVuZXdhYmxlc25vdy5jb20vbmV3cy9lZHByLXNlY3VyZXMtdGF4LWVxdWl0eS1mb3ItMzk5LW13LW9mLXVzLXdpbmQtNjM3NjQ5L9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Psychiatric Hospitals With Safety Violations Still Get Accreditation - The Wall Street Journal",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvcHN5Y2hpYXRyaWMtaG9zcGl0YWxzLXdpdGgtc2FmZXR5LXZpb2xhdGlvbnMtc3RpbGwtZ2V0LWFjY3JlZGl0YXRpb24tMTE1NDU4MjAyMDHSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "How Alphabet, Amazon, Apple, and Microsoft are shaking up healthcare - and what it means for the future of the - Business Insider India",
            "link": "https://news.google.com/rss/articles/CBMiqgFodHRwczovL3d3dy5idXNpbmVzc2luc2lkZXIuaW4vaG93LWFscGhhYmV0LWFtYXpvbi1hcHBsZS1hbmQtbWljcm9zb2Z0LWFyZS1zaGFraW5nLXVwLWhlYWx0aGNhcmUtYW5kLXdoYXQtaXQtbWVhbnMtZm9yLXRoZS1mdXR1cmUtb2YtdGhlLWluZHVzdHJ5L2FydGljbGVzaG93LzY3Mjc5NDgyLmNtc9IBrgFodHRwczovL3d3dy5idXNpbmVzc2luc2lkZXIuaW4vaG93LWFscGhhYmV0LWFtYXpvbi1hcHBsZS1hbmQtbWljcm9zb2Z0LWFyZS1zaGFraW5nLXVwLWhlYWx0aGNhcmUtYW5kLXdoYXQtaXQtbWVhbnMtZm9yLXRoZS1mdXR1cmUtb2YtdGhlLWluZHVzdHJ5L2FtcF9hcnRpY2xlc2hvdy82NzI3OTQ4Mi5jbXM?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "South Korea's SK Innovation bets on Europe, China electric vehicle ... - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMimgFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL3VzLXNrLWlubm92YXRpb24tZWxlY3RyaWMtYmF0dGVyaWVzL3NvdXRoLWtvcmVhcy1zay1pbm5vdmF0aW9uLWJldHMtb24tZXVyb3BlLWNoaW5hLWVsZWN0cmljLXZlaGljbGUtZGVtYW5kLWlkVVNLQ04xT1AxQlUv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "French court fines oil group Total in Iran bribery case - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtdG90YWwtaXJhbi1maW5lLWlkVVNLQ04xT0sxSUXSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    },
    "12/14/2018": {
        "artical1": {
            "title": "Bristol-Myers Squibb nears $1.6B sale of OTC unit Upsa to Taisho ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLW5lYXJzLTEtNmItc2FsZS1vdGMtdW5pdC11cHNhLXRvLXRhaXNoby1yZXBvcnTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Taisho Pharma to buy Bristol-Myers Squibb unit for $1.6bn - Nikkei Asia",
            "link": "https://news.google.com/rss/articles/CBMiaGh0dHBzOi8vYXNpYS5uaWtrZWkuY29tL0J1c2luZXNzL0J1c2luZXNzLWRlYWxzL1RhaXNoby1QaGFybWEtdG8tYnV5LUJyaXN0b2wtTXllcnMtU3F1aWJiLXVuaXQtZm9yLTEuNmJu0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Squibb hands Upsa consumer biz to Taisho for $1.6B - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLWhhbmRzLXVwc2EtY29uc3VtZXItYml6LXRvLXRhaXNoby1mb3ItMS02YtIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "As immuno-oncology heads into 2019, one thing is clear: It's good to ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FzLWltbXVuby1vbmNvbG9neS1oZWFkcy1pbnRvLTIwMTktaXQtcy1nb29kLXRvLWJlLW1lcmNr0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "No peak in sight: Cancer marketing spreads across media ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2NhbmNlci1tYXJrZXRpbmctbm90LWNsb3NlLXRvLXBlYWtpbmctYnV0LXBoYXJtYS1zcGVuZGluZy1hY3Jvc3MtbW9yZS1tZWRpYS1mcm9tLXR2LXRv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "In, out, in, out, Glaxo shakes consumer health about - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMiWWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvb3V0LW91dC1nbGF4by1zaGFrZXMtY29uc3VtZXItaGVhbHRoLWFib3V00gEnaHR0cHM6Ly93d3cuZXZhbHVhdGUuY29tL25vZGUvMTQxNjcvYW1w?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Will pharma's exodus from consumer health continue into 2019? It ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL3dpbGwtcGhhcm1hLWV4b2R1cy1mcm9tLWNvbnN1bWVyLWhlYWx0aC1jb250aW51ZS1pbnRvLTIwMTnSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "12/07/2018": {
        "artical1": {
            "title": "Bristol-Myers Squibb's Oncology Revenues Will Likely Be Around $11 Billion By Next Year - Forbes",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMikAFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMTgvMTIvMTAvYnJpc3RvbC1teWVycy1zcXVpYmJzLW9uY29sb2d5LXJldmVudWVzLXdpbGwtbGlrZWx5LWJlLWFyb3VuZC0xMS1iaWxsaW9uLWJ5LW5leHQteWVhci_SAZQBaHR0cHM6Ly93d3cuZm9yYmVzLmNvbS9zaXRlcy9ncmVhdHNwZWN1bGF0aW9ucy8yMDE4LzEyLzEwL2JyaXN0b2wtbXllcnMtc3F1aWJicy1vbmNvbG9neS1yZXZlbnVlcy13aWxsLWxpa2VseS1iZS1hcm91bmQtMTEtYmlsbGlvbi1ieS1uZXh0LXllYXIvYW1wLw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "FSU creator of life-saving breast cancer drug elected to National ... - Florida State News",
            "link": "https://news.google.com/rss/articles/CBMijwFodHRwczovL25ld3MuZnN1LmVkdS9uZXdzL3NjaWVuY2UtdGVjaG5vbG9neS8yMDE4LzEyLzExL2ZzdS1jcmVhdG9yLW9mLWxpZmUtc2F2aW5nLWJyZWFzdC1jYW5jZXItZHJ1Zy1lbGVjdGVkLXRvLW5hdGlvbmFsLWFjYWRlbXktb2YtaW52ZW50b3JzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Top 12 Life Sciences Companies Hiring Now for Candidates Like You - BioSpace",
            "link": "https://news.google.com/rss/articles/CBMiY2h0dHBzOi8vd3d3LmJpb3NwYWNlLmNvbS9hcnRpY2xlL3RvcC0xMi1saWZlLXNjaWVuY2VzLWNvbXBhbmllcy1oaXJpbmctbm93LWZvci1jYW5kaWRhdGVzLWxpa2UteW91L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Roche's Tecentriq wins key lung cancer approval. Its prize? A ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMifGh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL3JvY2hlLXMtdGVjZW50cmlxLXdpbnMta2V5LWx1bmctY2FuY2VyLWFwcHJvdmFsLWl0cy1wcml6ZS1hLXNob3dkb3duLWZvcm1pZGFibGUtbWVyY2vSAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Allison receives Nobel Prize in Sweden for immunotherapy ... - Texas Medical Center News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMia2h0dHBzOi8vd3d3LnRtYy5lZHUvbmV3cy8yMDE4LzEyL2FsbGlzb24tcmVjZWl2ZXMtbm9iZWwtcHJpemUtdG9kYXktaW4tc3dlZGVuLWZvci1pbW11bm90aGVyYXB5LWlubm92YXRpb24v0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "Doctors and Disclosures - The New York Times",
            "link": "https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3Lm55dGltZXMuY29tL2ludGVyYWN0aXZlLzIwMTgvMTIvMDgvaGVhbHRoL2pvdXJuYWwtY29uZmxpY3RzLW9mLWludGVyZXN0Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Target PharmaSolutions closes out the year with a pair of partnerships - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Nyby90YXJnZXQtcGhhcm1hc29sdXRpb25zLWNsb3Nlcy1vdXQteWVhci1hLXBhaXItcGFydG5lcnNoaXBz0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/30/2018": {
        "artical1": {
            "title": "Bristol-Myers Squibb to terminate $3.8 billion U.S. pension plan - Pensions & Investments",
            "link": "https://news.google.com/rss/articles/CBMieWh0dHBzOi8vd3d3LnBpb25saW5lLmNvbS9hcnRpY2xlLzIwMTgxMjA1L09OTElORS8xODEyMDk5NTIvYnJpc3RvbC1teWVycy1zcXVpYmItdG8tdGVybWluYXRlLTMtOC1iaWxsaW9uLXUtcy1wZW5zaW9uLXBsYW7SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Bristol-Myers Squibb Closes US Retirement Plan | Chief Investment ... - Chief Investment Officer",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmFpLWNpby5jb20vbmV3cy9icmlzdG9sLW15ZXJzLXNxdWliYi1jbG9zZXMtdXMtcmV0aXJlbWVudC1wbGFuL9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Bristol-Myers Squibb : Quotes, Address, Contact - News-Medical.Net",
            "link": "https://news.google.com/rss/articles/CBMiQGh0dHBzOi8vd3d3Lm5ld3MtbWVkaWNhbC5uZXQvc3VwcGxpZXJzL0JyaXN0b2wtTXllcnMtU3F1aWJiLmFzcHjSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Mouth Ulcer Treatment Market Size and Share to 2023: Noteworthy ... - Medgadget",
            "link": "https://news.google.com/rss/articles/CBMizAFodHRwczovL3d3dy5tZWRnYWRnZXQuY29tLzIwMTgvMTIvbW91dGgtdWxjZXItdHJlYXRtZW50LW1hcmtldC1zaXplLWFuZC1zaGFyZS10by0yMDIzLW5vdGV3b3J0aHktcGxheWVycy1hcy1wZml6ZXItY2h1cmNoLWR3aWdodC1jby10YXJvLXBoYXJtYWNldXRpY2FsLWluZHVzdHJpZXMtbHRkLWJyaXN0b2wtbXllcnMtc3F1aWJiLWNvbXBhbnktZXRjLmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "ASH: Can Johnson & Johnson sell regulators on Xarelto as clot ... - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2Nhbi1qLWotc2VsbC1yZWd1bGF0b3JzLXhhcmVsdG8tY2xvdC1wcmV2ZW50aW9uLWZvci1jYW5jZXItcGF0aWVudHPSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Tianqi buys stake in lithium miner SQM from Nutrien for $4.1 billion - Reuters",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtY2hpbGUtdGlhbnFpLWxpdGhpdW0taWRVU0tCTjFPMjE3RtIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "Expanding caregiving beyond paid leave - Employee Benefit News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiSmh0dHBzOi8vd3d3LmJlbmVmaXRuZXdzLmNvbS9vcGluaW9uL2V4cGFuZGluZy1jYXJlZ2l2aW5nLWJleW9uZC1wYWlkLWxlYXZl0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/23/2018": {
        "artical1": {
            "title": "Bristol-Myers Squibb signs on as sponsor of TV host Robin Roberts ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMigAFodHRwczovL3d3dy5maWVyY2VwaGFybWEuY29tL21hcmtldGluZy9icmlzdG9sLW15ZXJzLXNxdWliYi1zaWducy1hcy1zcG9uc29yLXR2LXJlcG9ydGVyLWFuZC1ob3N0LXJvYmluLXJvYmVydHMtbmV3LWRpZ2l0YWwtZG9jddIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "One more shot at slowing Keytruda\u2019s first-line lung cancer domination - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMicGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3Mvb25lLW1vcmUtc2hvdC1zbG93aW5nLWtleXRydWRhcy1maXJzdC1saW5lLWx1bmctY2FuY2VyLWRvbWluYXRpb27SASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDA5NC9hbXA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Who are the 22 pharma board members who also lead healthcare ... - BioPharma Dive",
            "link": "https://news.google.com/rss/articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2hvLWFyZS10aGUtMjItcGhhcm1hLWJvYXJkLW1lbWJlcnMtd2hvLWFsc28tbGVhZC1oZWFsdGhjYXJlLW5vbnByb2ZpdHMvNTQzMTQ0L9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Is Ireland Really A Startup Nation? - Forbes",
            "link": "https://news.google.com/rss/articles/CBMiWmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvc2hvdXJqeWFzYW55YWwvMjAxOC8xMS8yNy9pcy1pcmVsYW5kLXJlYWxseS1hLXN0YXJ0dXAtbmF0aW9uL9IBXmh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvc2hvdXJqeWFzYW55YWwvMjAxOC8xMS8yNy9pcy1pcmVsYW5kLXJlYWxseS1hLXN0YXJ0dXAtbmF0aW9uL2FtcC8?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "New Rutgers Anesthesiology Chair Committed to 'Chasing Zero' - Newswise",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3Lm5ld3N3aXNlLmNvbS9hcnRpY2xlcy9uZXctcnV0Z2Vycy1hbmVzdGhlc2lvbG9neS1jaGFpci1jb21taXR0ZWQtdG8tJTI3Y2hhc2luZy16ZXJvJTI30gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical6": {
            "title": "ICU stay can lead to depression - Reuters",
            "link": "https://news.google.com/rss/articles/CBMiZ2h0dHBzOi8vd3d3LnJldXRlcnMuY29tL2FydGljbGUvdXMtaGVhbHRoLWljdS1kZXByZXNzaW9uL2ljdS1zdGF5LWNhbi1sZWFkLXRvLWRlcHJlc3Npb24taWRVU0tDTjFOUzJCTi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Third Rock Ventures Names Reid Huber, Ph.D., as Partner - Business Wire",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibmh0dHBzOi8vd3d3LmJ1c2luZXNzd2lyZS5jb20vbmV3cy9ob21lLzIwMTgxMTI3MDA1MjAxL2VuL1RoaXJkLVJvY2stVmVudHVyZXMtTmFtZXMtUmVpZC1IdWJlci1QaC5ELi1hcy1QYXJ0bmVy0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/16/2018": {
        "artical1": {
            "title": "Bristol-Myers Squibb laying off 69 employees in Florida in push to ... - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2JyaXN0b2wtbXllcnMtc3F1aWJiLWxheWluZy1vZmYtNjktZW1wbG95ZWVzLXRhbXBh0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical2": {
            "title": "Astrazeneca drops out of one lung cancer immunotherapy race - evaluate.com",
            "link": "https://news.google.com/rss/articles/CBMidWh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL25ld3MvdHJpYWwtcmVzdWx0cy9hc3RyYXplbmVjYS1kcm9wcy1vdXQtb25lLWx1bmctY2FuY2VyLWltbXVub3RoZXJhcHktcmFjZdIBJ2h0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzE0MDY5L2FtcA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "AstraZeneca's Imfinzi fails key Mystic trial in lung cancer. What now? - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vcGhhcm1hL2FzdHJhemVuZWNhLXMtaW1maW56aS1mYWlscy1rZXktbXlzdGljLXRyaWFsLWx1bmctY2FuY2VyLXdoYXQtbm930gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Lilly gets fresher but Roche\u2019s rot continues - evaluate.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2RhdGEtaW5zaWdodHMvb3RoZXItZGF0YS9saWxseS1nZXRzLWZyZXNoZXItcm9jaGVzLXJvdC1jb250aW51ZXPSASdodHRwczovL3d3dy5ldmFsdWF0ZS5jb20vbm9kZS8xNDA2NC9hbXA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Top 10 Pharma Companies of 2018 - Genetic Engineering & Biotechnology News",
            "link": "https://news.google.com/rss/articles/CBMiQ2h0dHBzOi8vd3d3LmdlbmVuZ25ld3MuY29tL2EtbGlzdHMvdG9wLTEwLXBoYXJtYS1jb21wYW5pZXMtb2YtMjAxOC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "EU approves Ipsen's Cabometyx in second line liver cancer - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiO2h0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL2V1cm9wZWFuLWNvbW1pc3Npb24tY2Fib21ldHl40gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical7": {
            "title": "FDA's Woodcock: 'The clinical trial system is broken' - BioPharma Dive",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhcy13b29kY29jay10aGUtY2xpbmljYWwtdHJpYWwtc3lzdGVtLWlzLWJyb2tlbi81NDI2OTgv0gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/09/2018": {
        "artical1": {
            "title": "The top 10 cancer drug makers of 2024 - FiercePharma",
            "link": "https://news.google.com/rss/articles/CBMiSWh0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vc3BlY2lhbC1yZXBvcnQvdG9wLTEwLWNhbmNlci1kcnVnbWFrZXJzLTIwMjTSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "For Relapsed or Refractory Multiple Myeloma, FDA Approves... - Myeloma Research News",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMibWh0dHBzOi8vbXllbG9tYXJlc2VhcmNobmV3cy5jb20vbmV3cy9mZGEtYXBwcm92ZXMtZW1wbGljaXRpLWNvbWJpbmF0aW9uLXJlbGFwc2VkLXJlZnJhY3RvcnktbXVsdGlwbGUtbXllbG9tYS_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "7 companies hiring scientists right now - SiliconRepublic.com",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiRWh0dHBzOi8vd3d3LnNpbGljb25yZXB1YmxpYy5jb20vam9icy1uZXdzL3NjaWVudGlzdHMtY29tcGFuaWVzLWhpcmluZ9IBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical4": {
            "title": "Nektar Stock Pops On Immunotherapy Test With Bristol - Investor's Business Daily",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiWGh0dHBzOi8vd3d3LmludmVzdG9ycy5jb20vbmV3cy90ZWNobm9sb2d5L25la3Rhci1zdG9jay1pbW11bm90aGVyYXB5LW1lbGFub21hLXRyZWF0bWVudC_SAQA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Alirocumab Should Be Priced at $6300 Annually: ODYSSEY Cost ... - TCTMD",
            "link": "https://news.google.com/rss/articles/CBMiZWh0dHBzOi8vd3d3LnRjdG1kLmNvbS9uZXdzL2FsaXJvY3VtYWItc2hvdWxkLWJlLXByaWNlZC02MzAwLWFubnVhbGx5LW9keXNzZXktY29zdC1lZmZlY3RpdmVuZXNzLXN0dWR50gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "AG preview? Senate Dems drop Chris Christie's baggage on court ... - NorthJersey.com",
            "link": "https://news.google.com/rss/articles/CBMiigFodHRwczovL3d3dy5ub3J0aGplcnNleS5jb20vc3RvcnkvbmV3cy9uZXctamVyc2V5LzIwMTgvMTEvMTMvYWctcHJldmlldy1zZW5hdGUtZGVtcy1kcm9wLWNocmlzLWNocmlzdGllcy1iYWdnYWdlLWNvdXJ0LW5vbWluZWUvMTk4ODMyNjAwMi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "Merck gets FDA okay for Keytruda as liver cancer therapy - pharmaphorum",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiVmh0dHBzOi8vcGhhcm1hcGhvcnVtLmNvbS9uZXdzL21lcmNrLWdldHMtZmRhLW9rYXktZm9yLWtleXRydWRhLWFzLWxpdmVyLWNhbmNlci10aGVyYXB50gEA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "11/02/2018": {
        "artical1": {
            "title": "Analysis | RIP, Evelyn Y. Davis: An irrepressible shareholder activist ... - The Washington Post",
            "link": "https://news.google.com/rss/articles/CBMicWh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS9idXNpbmVzcy8yMDE4LzExLzA4L3JpcC1ldmVseW4teS1kYXZpcy1hbi1pcnJlcHJlc3NpYmxlLXNoYXJlaG9sZGVyLWFjdGl2aXN0LWFnZXMv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "The Role of RTU Products in Pharmacy - Pharmacy Times",
            "link": "https://news.google.com/rss/articles/CBMiSGh0dHBzOi8vd3d3LnBoYXJtYWN5dGltZXMuY29tL3ZpZXcvdGhlLXJvbGUtb2YtcnR1LXByb2R1Y3RzLWluLXBoYXJtYWN5LdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical3": {
            "title": "Memory of mom steadies Prescott - Austin American-Statesman",
            "link": "https://news.google.com/rss/articles/CBMifWh0dHBzOi8vd3d3LnN0YXRlc21hbi5jb20vc3Rvcnkvc3BvcnRzL3Byby8yMDE4LzExLzAyL21lbW9yeS1vZi1tb20tc3RlYWRpZXMtcHJlc2NvdHQtYW1pZC11cHMtZG93bnMtd2l0aC1jb3dib3lzLzkzNDY3NDIwMDcv0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "Goodbye to Lyrica ads? Big TV spender drops off top 10 list in October - FiercePharma",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMib2h0dHBzOi8vd3d3LmZpZXJjZXBoYXJtYS5jb20vbWFya2V0aW5nL2dvb2RieWUtdG8tbHlyaWNhLWFkcy10eXBpY2FsLWJpZy10di1hZC1zcGVuZGVyLWRyb3BzLW9mZi10b3AtMTAtb2N0b2JlctIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical5": {
            "title": "Noting Military Potential, FDA Approves Powerful Painkiller Dsuvia - The Wall Street Journal",
            "link": "https://news.google.com/rss/articles/CBMiaWh0dHBzOi8vd3d3Lndzai5jb20vYXJ0aWNsZXMvbm90aW5nLW1pbGl0YXJ5LXBvdGVudGlhbC1mZGEtYXBwcm92ZXMtcG93ZXJmdWwtcGFpbmtpbGxlci1kc3V2aWEtMTU0MTIwMDc2NdIBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Top Women in Law 2018: Mary-Alice Barrett | New Jersey Law Journal - Law.com",
            "link": "https://news.google.com/rss/articles/CBMiVWh0dHBzOi8vd3d3Lmxhdy5jb20vbmpsYXdqb3VybmFsLzIwMTgvMTEvMDIvdG9wLXdvbWVuLWluLWxhdy0yMDE4LW1hcnktYWxpY2UtYmFycmV0dC_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "A bitcoin wallet company is giving away $125m-worth of cryptocurrency - Yahoo Finance",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiamh0dHBzOi8vZmluYW5jZS55YWhvby5jb20vbmV3cy9iaXRjb2luLXdhbGxldC1jb21wYW55LWdpdmluZy1hd2F5LTEyNW0td29ydGgtY3J5cHRvY3VycmVuY3ktMTQwMDI3OTgxLmh0bWzSAXJodHRwczovL2ZpbmFuY2UueWFob28uY29tL2FtcGh0bWwvbmV3cy9iaXRjb2luLXdhbGxldC1jb21wYW55LWdpdmluZy1hd2F5LTEyNW0td29ydGgtY3J5cHRvY3VycmVuY3ktMTQwMDI3OTgxLmh0bWw?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        }
    },
    "10/26/2018": {
        "artical1": {
            "title": "Eliquis And Opdivo Will Likely Continue To Drive Bristol-Myers Squibb's Earnings Growth - Forbes",
            "link": "https://news.google.com/rss/articles/CBMikQFodHRwczovL3d3dy5mb3JiZXMuY29tL3NpdGVzL2dyZWF0c3BlY3VsYXRpb25zLzIwMTgvMTEvMDEvZWxpcXVpcy1hbmQtb3BkaXZvLXdpbGwtbGlrZWx5LWNvbnRpbnVlLXRvLWRyaXZlLWJyaXN0b2wtbXllcnMtc3F1aWJicy1lYXJuaW5ncy1ncm93dGgv0gGVAWh0dHBzOi8vd3d3LmZvcmJlcy5jb20vc2l0ZXMvZ3JlYXRzcGVjdWxhdGlvbnMvMjAxOC8xMS8wMS9lbGlxdWlzLWFuZC1vcGRpdm8td2lsbC1saWtlbHktY29udGludWUtdG8tZHJpdmUtYnJpc3RvbC1teWVycy1zcXVpYmJzLWVhcm5pbmdzLWdyb3d0aC9hbXAv?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical2": {
            "title": "Roche taps Halozyme's drug delivery tech for up to $520M - FierceBiotech",
            "link": "https://consent.google.com/m?continue=https://news.google.com/rss/articles/CBMiXWh0dHBzOi8vd3d3LmZpZXJjZWJpb3RlY2guY29tL2Jpb3RlY2gvcm9jaGUtdGFwcy1oYWxvenltZS1zLWRydWctZGVsaXZlcnktdGVjaC1mb3ItdXAtdG8tNTIwbdIBAA?oc%3D5&gl=IT&m=0&pc=n&cm=2&hl=en-US&src=1",
            "score": null
        },
        "artical3": {
            "title": "Halozyme Licenses New ENHANZE\u00ae Targets For $25 Million ... - PR Newswire",
            "link": "https://news.google.com/rss/articles/CBMinAFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL2hhbG96eW1lLWxpY2Vuc2VzLW5ldy1lbmhhbnplLXRhcmdldHMtZm9yLTI1LW1pbGxpb24tdXBmcm9udC1wYXltZW50LWZ1dHVyZS1taWxlc3RvbmVzLWFuZC1yb3lhbHRpZXMtMzAwNzQwMDY4Lmh0bWzSAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical4": {
            "title": "State individual mandates: Hows and whys | Brookings - Brookings Institution",
            "link": "https://news.google.com/rss/articles/CBMiS2h0dHBzOi8vd3d3LmJyb29raW5ncy5lZHUvYXJ0aWNsZXMvc3RhdGUtaW5kaXZpZHVhbC1tYW5kYXRlcy1ob3dzLWFuZC13aHlzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical5": {
            "title": "French-born ex-diplomat is frontrunner as Georgia picks president - Reuters",
            "link": "https://news.google.com/rss/articles/CBMigQFodHRwczovL3d3dy5yZXV0ZXJzLmNvbS9hcnRpY2xlL2dlb3JnaWEtZWxlY3Rpb24vZnJlbmNoLWJvcm4tZXgtZGlwbG9tYXQtaXMtZnJvbnRydW5uZXItYXMtZ2VvcmdpYS1waWNrcy1wcmVzaWRlbnQtaWRVU0w4TjFYNzBMMi_SAQA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical6": {
            "title": "Home Monitoring Confirms Clinic Diagnosis of High Blood Pressure - Diagnostic and Interventional Cardiology",
            "link": "https://news.google.com/rss/articles/CBMiYmh0dHBzOi8vd3d3LmRpY2FyZGlvbG9neS5jb20vY29udGVudC9ob21lLW1vbml0b3JpbmctY29uZmlybXMtY2xpbmljLWRpYWdub3Npcy1oaWdoLWJsb29kLXByZXNzdXJl0gEA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        },
        "artical7": {
            "title": "A Donald Trump appointee \u2014 also a Saudi government lobbyist ... - The Center for Public Integrity",
            "link": "https://news.google.com/rss/articles/CBMieGh0dHBzOi8vcHVibGljaW50ZWdyaXR5Lm9yZy9wb2xpdGljcy9hLWRvbmFsZC10cnVtcC1hcHBvaW50ZWUtYWxzby1hLXNhdWRpLWdvdmVybm1lbnQtbG9iYnlpc3QtaXMtcmVhc3Nlc3NpbmctaGlzLXJvbGVzL9IBAA?oc=5&hl=en-US&gl=US&ceid=US:en",
            "score": null
        }
    }
}